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Noëlia Sanchez 
 
1 Abstract: miRNAs as tools to improve CHO cell bioprocess 
phenotypes 
 
miRNAs are small non-coding RNA molecules that are capable of regulating hundreds 
of genes and are involved in many, if not, all biological pathways. We sought to 
investigate the utility of these molecules as potential engineering targets in CHO cells 
and subsequently to identify the mechanisms by which they mediate any observed 
effect. Previous miRNA profiling studies conducted in our laboratory identified several 
candidate miRNAs associated with cell proliferation. Functional assessment of several 
of these miRNAs using mimic and inhibitor molecules showed that miR-30e-5p, miR-
29a, miR-10a and let-7e impacted on growth and, despite contrasting results between 
assays and cell lines could be good candidates to manipulate three main bioprocess-
relevant CHO properties, i.e. cell proliferation, cell survival and protein 
production/secretion. 
The functional importance of miR-24 in CHO cell proliferation was also demonstrated. 
Transient overexpression or knockdown of the three members of the miR-23a~27a~24-
2 cluster proved to be a better approach than manipulation of the individual miRNAs 
due to their presumably cooperative roles in regulating cell growth. Furthermore, stable 
cell lines expressing antisense transcripts to simultaneously knockdown the miR-
23~27a~24-2 cluster members showed increased proliferation of up to 71% compared to 
control lines.  
The anti-proliferative role of miR-7 was verified using mimics in several different CHO 
cell lines in serum-free medium and we found that the arrest of cell growth upon pm-7 
transfection was associated with accumulation in G1 of the cell cycle without induction 
of apoptosis. Expression profiling and experimental validation revealed that miR-7 
targets key regulators of the G1 to S phase transition, including Skp2, Myc and p27Kip1 
to temporarily arrest cell growth in the G1 phase. The down-regulation via miR-7 of 
critical pro-apoptotic regulators, including p53, as well as DNA repair factors such as 
Rad54L, with the concomitant up-regulation of anti-apoptotic factors like p-Akt, 
promoted cell survival while arrested in G1. Finally, we successfully extended the 
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longevity of culture and consequently improved CHO cell proliferation by 3.27-fold as 
well as viability by 28.9% respectively in batch-fed culture using an antisense ‘miRNA 
sponge’ approach to stably knockdown endogenous miR-7. 
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2 Abbreviations 
 
Ab - antibody 
am - inhibitor for mature miRNA 
Amp - ampicilin 
ATCC - American Tissue Culture Collection 
ATP - adenosine triphosphate 
am-neg - negative control for inhibitors 
BSA - bovine albumin serum 
cDNA - complementary 
CDS - coding sequence 
CHO - Chinese Hamster Ovary 
CMV - cytomegalovirus 
DMEM - Dulbecco's Modified Eagle Medium 
DMSO - dimethyl sulfoxide 
DNA - deoxyribonucleic acid 
Dox - doxycyline 
FSC - forward scatter 
g - gram 
G - gravitational force 
GAPDH - glyceraldehyde-6-phosphate dehydrogenase 
GFP - green fluorescent protein 
hrs - -hours 
Hyg - hygromycin 
LB - Luria-Bertani medium 
miR - mature microRNA 
miRNA - microRNA 
mL - millilitre 
mM - milimolar 
µL - microliter 
µM - micromolar 
mRNA - messenger RNA 
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nM - nanomolar 
ORF - open reading frame 
P - promoter 
PBS - phosphate buffered saline 
PCR - polymerase chain reaction 
pm - mimic of mature miRNA 
pm-neg - negative control for mimics 
qRT-PCR - quantitative real time PCR 
RISC - RNA-induced silencing complex 
RNA - ribonucleic acid 
rpm - revolutions per minute 
RT - reverse transcription 
SDS - Sodium Dodecyl Sulphate 
SEAP - Secreted Embryonic Alkaline Phosphatase 
SFM - serum-free medium 
shRNA - short hairpin RNA 
siRNA - small-interfering RNA 
Tet – tetracycline 
Tet O – tetracycline operator sequences 
Tet R – tetracycline repressor 
TF – transcription factor 
TLDA – TaqMan Low Density Array 
TRE – tetracycline response element 
TS – Temperature Shift 
tTA – tetracycline activator 
UHP - Ultra High Pure water 
3’UTR - untranslated region at the 3’end 
5’UTR - untranslated region at the 5’end 
VCP - Valosin-containing protein 
ZFN - zinc-finger nuclease 
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3 Introduction 
 
3.1 The emergence of recombinant proteins as new medecines 
 
The discovery of recombinant DNA technology in 1973 by Cohen and Boyer made 
possible the emergence of biotechnology and its application in society (Cohen, et al. 
1973). The production of recombinant proteins as new medicines is an important area 
where the use of biotechnology has been essential for both drug development and 
manufacturing. In 1982, insulin was the first therapeutic made via recombinant protein 
technology in Escherichia coli in application to diabetes mellitus treatment (Butler 
2005). In 1986, tissue plasminogen activator, a thrombolytic agent for breakdown of 
blood clots, was the first biological therapeutic produced in mammalian cells (Vehar, et 
al. 1986). Since the 1980s many therapeutics have been made using this approach (some 
examples are listed in Table 3.1. Nowadays, monoclonal antibodies (mAbs) represent 
nearly 70% of all biopharmaceutical products and contribute notably to the success of 
biomedicines in terms of medical research, diagnosis and therapy (Rodrigues, et al. 
2010, Wurm 2004, Jenkins, Parekh and James 1996) (few examples are listed in Table 
3. 2). The first Mabs were produced using hybridomas which derived from the fusion 
between immune cells and cancer cells. Recently, more specific drugs have been 
developed leading to chimeric (murine variable regions fused onto human constant 
regions of an antibody) and human monoclonal antibodies which bind to specific cell-
type receptor and are commercially produced in mammalian cells (Nelson, Dhimolea 
and Reichert 2010). For clinical purpose, high doses of mAbs are needed during therapy 
for chronic diseases due to their low potency therefore the cost of these drugs remains 
quite expensive and not affordable for every country. 
 
7 
 
Table 3.1 (part 1/2): List of some therapeutic proteins, their commercial name and clinical application  
Recombinant 
protein 
Alpha-
galactosidase A 
Human insulin 
(BHI) 
Follicule-
stimulating 
hormone (FSH) 
Factor VIII, 
Factor IX 
Erythropoietin 
(EPO) 
Granulocyte 
colony-
stimulating factor 
(G-CSF) 
Commercial 
name 
Fabrazyme 
Humulin 
Novolin 
Follistim Kogenate Epogen 
Neupogen 
Neulasta 
Clinical 
application 
Fabry disease Diabetes 
Problem of 
Fertility 
Ovulation 
problem 
Hemophilia A, 
Hemophilia B 
Anemia (chronic 
renal failure) 
Neutropenia (low 
number of 
neutrophils) from 
chemotherapy, 
bone marrow 
Supplier 
company 
Genzyme 
Lilly 
Novo Nordisk 
Serono Bayer Amgen Amgen 
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Table 3.1 (part 2/2): List of some therapeutic proteins, their commercial name and clinical application 
Recombinant 
protein 
Alpha-L-
iduronidase 
Dornase alpha 
Tissue 
plasminogen 
activator 
Insulin-like 
growth factor 1 
(IGF-1) 
Interferon beta-
1a 
Envelope protein 
of the hepatitis B 
Commercial 
name 
Aldurazyme Pulmozyme Activase 
Increlex 
(Mecasermin) 
Avonex 
 
Engeric-B 
(vaccine) 
Clinical 
application 
Mucopolysacchar
idosis I 
Cystic fibrosis 
Acute ischemic 
stroke 
Heart attacks and 
acute massive 
pulmonary 
embolism 
Growth failure 
due to 
severe primary 
IGF-1 deficiency 
Multiple 
sclerosis 
Hepatitis B 
Supplier 
company 
BioMarin 
Pharmaceutical 
 
Genentech Genentech 
Tercica 
Pharmaceuticals 
Biogen Idec 
 
GlaxoSmithKline 
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Table 3.2 (part 1/2): List of some commercially available monoclonal antibodies, their biological target and their clinical application 
Commercial 
name 
Abciximab Adalimumab Afutuzumab Bapineuzumab Benralizumab Blosozumab 
Biological 
function 
Glycoprotein 
IIb/III receptor 
antagonist 
TNF inhibitor Immunomodulator 
Beta amyloid 
plaques inhibitor 
CD125 inhibitor 
Negative regulator 
of osteoblast 
activity 
Target 
CD41 (integrin 
alpha-IIb) 
TNF-α CDC20 
Beta amyloid 
plaques 
CD125 SOST 
Clinical  
application 
Platelet 
aggregation 
inhibition 
Rheumatoid 
arthritis, 
Crohn’s disease, 
Plaque Psoriasis 
Lymphoma 
Alzeihmer’s 
disease 
Asthma Osteoporosis 
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Table 3.2 (part 2/2): List of some commercially available monoclonal antibodies, their biological target and their clinical application 
Commercial 
name 
Brodalumab Cedelizumab Edobacomab Exbivirumab Ibalizumab Motavizumab 
Biological 
function 
IL-17 inhibitor CD4 inhibitor 
Gram-negative 
endotoxin inhibitor 
Hepatitis B 
surface 
antigen 
CD4 inhibitor 
Respiratory 
syncytial virus 
surface inhibitor 
Target IL-17 CD4 Endotoxin 
Hepatitis B 
surface 
CD4 
Respiratory 
syncytial virus 
Clinical  
application 
Inflammatory 
diseases 
treatment of 
autoimmune 
diseases 
Sepsis caused by 
Gram-negative 
bacteria 
Hepatitis B HIV infection 
Respiratory 
syncytial virus 
infection 
(prevention) 
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3.2 Bioprocess requirements 
 
To answer the increasing market demand (35% per annum), many improvements have 
been achieved in upstream (cell culture) and downstream (purification) processes for 
mAb production (Butler 2005, Rodrigues, et al. 2010, Wurm 2004, Jenkins, Parekh and 
James 1996, Kaufmann, et al. 1999, Kim, Kim and Lee 2012). Most of the 
improvements have been made in medium formulation and process feeding, including 
adaptation to serum-free environment. In the 1980s, the maximum cell density achieved 
in seven days of batch culture was typically 1–2 million cells/ml, with a yield of 50–
100mg/l  (Wurm 2004) (Figure 3.2). Nowadays, a fed-batch culture lasts up to 21 days, 
with cells reaching 10–15 million cells/ml and producing 1–5g/l of proteins. However, 
specific cellular productivities, now in the range of 50–60 pg/cell/day, have only been 
improved by 2-fold since the 1980s (Hacker, De Jesus and Wurm 2009). Recently, 
CHO cells have been reported to produce up to 10g/L of proteins (Kim, Kim and Lee 
2012). 
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Figure 3.2: Comparison of cell culture processes from 1986 and 2004  
The viable cell mass and viability (a) and the productivity (b) of both cell culture 
processes are shown. The examples are derived from processes comprising suspension 
cultures of CHO cells. The data from 2004 was generated from a process for the 
expression of a human recombinant antibody at the 10-liter scale. The hypothetical 
process from 1986 is based on unpublished results. For clarity the product accumulation 
data for the hypothetical 1986 process is also represented in the insert in b. Data 
courtesy of Lonza Biologics, Slough, UK.  
Figures and legend were taken from the following paper: ‘Production of recombinant 
protein therapeutics in cultivated mammalian cells’ (Wurm 2004). 
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In cell culture technology, the main desirable characteristics of a cell line are rapid cell 
growth, sustained viability and high specific productivity (Qp). The improvement of 
these three cell characteristics leads to the increase of total yield. To achieve high total 
yield in large-scale culture, different parameters are to be considered.  
 
3.2.1 Choice of host system for recombinant protein production 
 
The choice of the host system is critical and depends on the recombinant protein being 
produced and its application. Besides mammalian cells, bacteria, yeast, insect cells and 
plants are also used as expression systems for biopharmaceutical production (Wurm 
2004). Among different mammalian cells including baby hamster kidney, mouse 
myeloma-derived NS0 and human embryonic kidney (HEK)-293, Epithelial-like 
Chinese Hamster Ovary (CHO) cells are the most widely used host producer. These 
cells were initiated by T.T. Puck in 1957 (PUCK 1957, Sato, Fisher and Puck 1957). 
They are fast growing and easily cultivated in large-scale culture. CHO cells are able to 
synthesize and secrete glycoproteins with similar carbohydrate structures to those found 
in humans, allowing human-like post-translational modifications particularly 
glycosylation, proper folding, resulting in correct and efficient biological function. In 
addition, they are non-human in origin consequently the risk of human viral 
contamination is importantly reduced (Wurm 2004).  
Mammalian cells are the most widely used host system for complex protein production 
due to their capacity to confer appropriate posttranslational modifications. During the 
glycosylation process, different carbohydrate structures known as glycans are added to 
synthesized proteins (Butler 2005, Jenkins, Parekh and James 1996). The production of 
these glycan structures is essential to the biological activity of the recombinant protein. 
Variation of glycosylation patterns can lead to immunogenicity (Walsh 2006). 
Consistency of glycosylation pattern must be maintained over the culture (Restelli, et al. 
2006) and for this reason complex protein production is more limited in other systems 
such as E.coli, yeast and insect (baculovirus). Despite the easy manipulation and the 
low cost of E.coli, its cellular machinery does not allow post-translational modifications 
and proper protein folding. The biological activity and immunogenicity of the 
recombinant protein may differ from the native protein. Recent reports showed that 
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post-translational modifications can be achieved by manipulation of E.coli particularly 
by engineering the glycosylation pathway (Wacker, M et al 2002; Zhang Zet al 2004).  
Yeast is more difficult to manipulate than E.coli, protein purification is not easily 
feasible as the cell wall is difficult to break and it has different glycosylation patterns 
than in mammals. Insect cells are not suitable either due to their lack of glycosylation 
mechanisms thus preventing the protein to be active.  
 
3.2.2 Cell culture parameters 
 
3.2.2.1 Media optimization 
 
Media optimization and serum-free culture development have resulted in large 
improvements in productivity. Serum is not desirable in cell culture due to its high cost, 
batch-to-batch variation and the risk of transmitting adventitious agents (viruses, 
bacteria, mycoplasma and prion contaminations) (Even, Sandusky and Barnard 2006). 
However, a serum-free medium can contain serum constituents or substitutes derived 
from animals (e.g: transferrin, albumin, insulin, protein lysates). Other types of serum-
free media have been developed and do not contain components of animal origin thus 
they are referred to as protein-free or chemically-defined.  
Feeding optimization in a fed-batch culture is a simple and reliable method consisting of 
the addition of essential components like glutamine, glucose and amino-acids at 
appropriate concentrations (Bibila, et al. 1994, Bibila and Robinson 1995). Growth 
factors (Epidermal Growth Factor, Fibroblast Growth Factor, Insulin Growth Factor), 
proteins, lipids, carbohydrates, vitamins and small molecules are also added at defined 
concentrations in serum-free media formulation. Nowadays a lot of chemically-defined 
serum-free and protein-free media are commercially available. 
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3.2.2.2 Mode of culture 
 
Different modes of culture of which the most common are batch and fed-batch modes 
(considered as non-continuous culture) can be used for different applications. Other 
existing cultures are continuous culture with (perfusion) or without (chemostat or 
cytostat) cell retention.  
 
3.2.2.2.1 Batch culture 
 
Batch culture mode is a straightforward technique largely used in industry that consists 
of cells grown in suspension culture with limited nutrient supply and no renewal of 
medium. Cell growth and viability decline at later stages of culture due to the lack of 
available nutrients in culture (glucose, glutamine) and the accumulation of waste 
products (ammonia and lactate) which inhibit cell growth and antibody production 
(Butler 1987, Hayter, et al. 1992, Newland, et al. 1994). To avoid waste accumulation, a 
perfusion culture can be considered instead allowing removal of waste and constant 
nutrient supply (Butler, et al. 1983, Butler 1985). 
 
3.2.2.2.2 Fed-batch culture 
 
An alternative of the batch mode is fed-batch culture, which is a simple and reliable 
method. This mode of culture can lead to high volumetric productivity (Li, et al. 2005, 
Dorka, et al. 2009). Nutrients are supplied at appropriate concentrations at different time 
points of the culture (Bibila and Robinson 1995, Xie and Wang 2006). Through this 
method waste accumulation can not be avoided but it can be minimized by slow feeding 
and low concentrations of essential components (Butler 2005, Kim, et al. 2012). Lower 
levels of glucose and glutamine or replacement by other carbon sources (Duval, et al. 
1992, Altamirano, et al. 2004) prevent lactate and ammonia accumulation by improving 
oxidation of glucose to CO2 (Xie and Wang 2006, Zhou, et al. 2011, De Alwis, et al. 
2007)  
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3.2.2.2.3 Perfusion 
 
The perfusion culture of non-adherent cells is a very advantageous approach in 
increasing cell productivity (Tokashiki and Takamatsu 1993). The difference with fed-
batch mode is that a perfusion culture allows a constant input of feed solutions and a 
constant withdrawal of toxic byproducts produced, without disturbing cells in culture. 
Cells are retained in the bioreactor using filtration, sedimentation or centrifugation. 
However, with these approaches it is difficult to maintain sterility. In addition, cells can 
be stressed by shear and potential oxygen depletion resulting in suboptimal product 
quality and quantity.  
 
3.2.3 Cellular environment parameters 
 
3.2.3.1 Low temperature 
 
To achieve the best cell culture conditions, different parameters can be optimised 
including temperature, pH, osmolarity, dissolved oxygen and carbon dioxide. Low 
temperature is a common strategy to improve batch-culture performance in a biphasic 
culture (Kaufmann, et al. 1999). The shift of temperature from 37°C to 28-31°C applied 
when cells are actively growing (corresponding to the middle of the exponential phase) 
causes reduction or arrest of proliferation in the G1 phase of the cell cycle. 
Consequently, a longer and more viable production phase is maintained by delaying 
apoptosis (Kaufmann, et al. 1999, Oguchi, et al. 2006, Al-Fageeh, et al. 2006). Cells 
arrested in this phase are morphologically different and are metabolically more active 
than non arrested cells. After temperature-shift, levels of recombinant mRNA are 
increased either due to enhanced transcription or increased mRNA stability (Yoon, 
Song and Lee 2003). Mammalian cells respond to low temperature by synthesizing 
specific cold-inducible proteins (CSPs) induced by the change of the initial 
environmental conditions whereas transcription and subsequent translation of proteins 
expressed in physiological temperature culture are suppressed. Initially, two proteins 
were identified from the glycine-rich RNA binding protein family (GRP), the mouse 
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cold inducible RNA binding protein (CIRP) and the RNA binding motif protein 3 
(RBM3) (Nishiyama, et al. 1997b, Nishiyama, et al. 1997a). RBM3 is expressed in a 
wide variety of human foetal tissues. At low temperature, this latter undergoes 
regulation at both, transcriptional and translational levels. RBM3 expression may also 
alter global protein synthesis by having an effect on the levels of small non-coding 
RNAs known as miRNA, suggesting a role of RBM3 and miRNAs in the mechanisms 
of homeostatic regulation (Nishiyama, et al. 1997b, Dresios, et al. 2005). However, 
cold-inducible proteins are not conserved among all species and this effect is extremely 
variable and appears to be both cell line and expression system dependent . Currently, 
the detailed cellular and molecular mechanisms of this cold stress response in 
eukaryotes are not well understood. 
 
3.2.3.2 pH 
 
pH stability is critical to achieve optimal cell culture conditions. Change in pH can 
affect cell growth, productivity and glycosylation patterns (Oguchi, et al. 2006, Borys, 
Linzer and Papoutsakis 1993). pH is closely related to other parameters such as 
temperature, carbon dioxide and glucose content . In addition, the optimal pH slightly 
differs among cell lines, and some cell lines are less sensitive to variations of pH than 
others (Kurano, et al. 1990). 
 
3.2.3.3 Dissolved oxygen  
 
Dissolved oxygen (DO) is critical for cell growth and product formation, being closely 
related to pH in the media (Hanson, et al. 2007). Oxygen is a key requirement for 
animal cell culture and oxygen limitation can be a major problem when high density is 
reached leading to lactate production and lower pH (Hanson, et al. 2007). Variations of 
DO concentration can affect cell metabolism cell growth rate and glycosylation 
(Thommes, et al. 1993, Kunkel, et al. 1998).  
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3.3 Bioprocess engineering methods 
 
3.3.1 Generation of a producer cell line 
 
To express an exogenous protein, the protein coding-gene of interest is inserted by 
cloning in a suitable vector, which contains specific transcriptional elements, and 
transferred into the cells by transfection. DNA enters the nucleus and integrates at a 
random location or precise site in the genome, depending of the elements present in the 
vector. Another gene is inserted in the same vector or a second vector to allow selection 
of cells that have taken-up the recombinant gene. An antibiotic (neomycin, hygromycin 
or zeocin) is commonly used for selection of mammalian single cell clones. Besides 
antibiotic selection, other systems have been developed with dihydrofolate reductase 
(DHFR) or glutamine synthetase (GS). Following addition of the selection agent, only 
cells that express the resistance gene survive. There are several methods of transfection 
that differ in the techniques used or in the transfection reagent formulation. Physical 
methods include biolistic technology, microinjection or electroporation. Chemical 
methods include carriers such as lipofection, calcium-phosphate or DEAE-dextran 
(polycationic derivative of dextran, a carbohydrate polymer). For each cell line and each 
experiment, the choice of transfection method needs to be determined and should be 
optimised. These cells that survive selection are referred as mixed population. Then 
cells are transferred to a fresh culture as single cell clones. Selection of single-cell 
clones can be performed manually or using fluorescence-activated cell sorting (FACS) 
if cells express a reporter gene. After expansion in clonal population, different 
parameters are monitored to select the best clones. To further improve the phenotypes of 
these clones, an amplification step can be conducted to increase the copy number of the 
transfected gene (Butler 2005). There are two gene amplification systems in CHO cells, 
the DHFR system with resistance to methotrexate (MTX) and the GS system with 
methionine sulfoxamine (MSX) resistance. The DHFR approach is commonly applied 
to CHO cells deficient in DHFR activity. Methotrexate (MTX) blocks the activity of 
DHFR leading to considerable cell death. After 2-3 weeks of MTX exposure, only a 
small number of cells are able to survive by overproducing DHFR due to amplification 
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of copy number, with this amplification leading to an increase in recombinant protein 
expression (Pallavicini, et al. 1990, Gandor, et al. 1995). DHFR converts the folate to 
tetrahydrofolate, this latter being required for synthesis of purine, pyrimidine and 
glycine (Goeddel 1990). MTX is an analog of folate which competes by binding to 
DHFR and inhibits the synthesis of tetrahydrofolate thus leading to cell death. During 
gene amplification, the culture is supplemented with increasing levels of MTX allowing 
selection of cells that only express high copies of DHFR. The approach taken for the 
GS/MSX system is based on the same principle.  
 
3.3.2 Targeted integration 
 
The control of DNA insertion in a specific site of the genome is desirable to avoid 
insertional mutagenesis and to minimize phenotypic heterogeneity due to random 
integration (Orlando, et al. 2010). Different strategies including Cre/loxP, zinc-finger 
nucleases and cis-acting elements among others have been shown to promote efficiently 
site-specific integration, insertion and expression a transgene. 
 
3.3.2.1 Cre/loxP system: recombinase-mediated cassette exchange strategy 
 
The use of gene targeting based on the Cre/loxP system was first described for human 
monoclonal antibody production in CHO cells by Kito et al., in 2002 (Kito, et al. 2002). 
The P1 bacteriophage Cre recombinase catalyses a site-specific recombination between 
two loxP sites (Sadowski 1993). The loxP sites are sequences consisting of an 8-bp core 
sequence, where recombination takes place, and two flanking 13-bp inverted repeats. 
Besides the Cre/loxP system, two other systems based on the same principle are used 
for transgene integration in the mammalian genome, the Saccharomyces cerevisiae-
derived Flp and the bacteriophage ΦC31-derived integrase which recognise the 
recombination target sites FRT and attB/attP respectively (Wirth, et al. 2007). This 
strategy has been applied in CHO cells leading to successful production of recombinant 
proteins (Kito, et al. 2002, Huang, et al. 2007). Wiberg and co-workers reported the 
production of a human polyclonal anti-RhD antibody following the integration of 25 
individual antibody expression cassettes into a defined FRT target site in CHO cells 
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(Wiberg, et al. 2006). The repeated insertion of multiple genes into one target site was 
achieved subsequently to the integration of an accumulative site-specific gene 
integration using the Cre/loxP system (Kameyama, et al. 2010).  
3.3.2.2 Zinc-finger nuclease-based technology 
 
Engineering site-specific nucleases, based on zinc-finger DNA binding motifs, has been 
reported to stimulate homologous recombination (Pavletich and Pabo 1991). Zinc-finger 
nucleases (ZFNs) consist of the fusion between zinc-finger DNA binding domains and 
the nuclease domain of the type IIs restriction enzyme FokI (Kim, Cha and 
Chandrasegaran 1996). This fusion and the dimerization of zinc-finger DNA binding 
domain chains induce DNA double strand break (DSB). The new DNA is inserted and 
ligation occurs via non-homologous end-joining (NHEJ) or by homology-directed repair 
(HDR) (Weterings and van Gent 2004)(Orlando, et al. 2010). ZFNs have been used to 
create mutant for GDP-fucose transporter SLC35C1 which regulates the fucosylation of 
glycans (Zhang, et al. 2012b). The knockout of Bak and Bax, two pro-apoptotic 
proteins, by this technology increases apoptosis resistance in CHO cells (Cost, et al. 
2010). ZFNs have also been used to create glutamines synthetase (GS) gene knockout 
cells to study the impact of GS on selection efficiency in CHO cell line generation (Fan, 
et al. 2012).  
Recently, other endonuclease-based approaches have also been developed such as 
meganucleases, transcription activators like effector (TALE-nucleases) and the DNA 
recombinase-based mammalian artificial chromosome engineering (ACE ) system, this 
latter allowing large cloning capacity (Kennard, et al. 2009a, Kennard, et al. 2009b, 
Silva, et al. 2011). 
 
3.3.2.3 Cis-acting elements 
  
Scaffold/matrix attachment region (S/MAR) is one the most commonly used cis-acting 
elements strategy to improve protein production (Harraghy, et al. 2012). This region is 
involved in chromatin remodelling to maintain an active configuration of the transgene. 
In CHO cells, S/MARs from different origins have been tested including human β-
globin MAR, β-interferon SAR and chicken lysozyme MAR (Girod, Zahn-Zabal and 
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Mermod 2005, Kim, et al. 2004a, Zahn-Zabal, et al. 2001). Successful increased 
antibody production has been achieved using another type of cis-acting elements known 
as ubiquitous chromatin opening elements (UCOEs) combined with a strong viral 
promoter (Benton, et al. 2002). 
 
3.4 Bioprocess-relevant CHO cell engineering  
 
Recently, CHO cell engineering using single gene manipulation studies has proven to be 
an efficient method to enhance cell proliferation, secretion capacities and specific 
productivity as well as to inhibit apoptosis. The advantage of this approach is to turn on 
the expression of a specific gene using constitutive or inducible system at different 
phases of culture. 
 
3.4.1 Cell cycle pathway engineering  
 
Overexpression of the oncogene c-Myc, a key node gene involved in cell cycle 
regulation, has been reported to significantly impact on cell proliferation in attached and 
suspension CHO-K1 cell culture (Ifandi and Al-Rubeai 2005). Cell productivity can be 
enhanced using cell-cycle dependent factors such as cyclin-dependent kinase inhibitors 
p21CIP1 and p27KIP1 that induce cell cycle arrest and consequently cell productivity 
increase in CHO-K1 SEAP cells. Overexpression of transcription factors involved in 
cell cycle progression, cyclin-dependent kinase like 3, cyclin E and E2F-1, successfully 
improved cell proliferation (Jaluria, et al. 2007, Majors, et al. 2008, Renner, et al. 1995). 
Up-regulation of mammalian target of rapamycine (mTOR),  a serine-threonine kinase 
involved in many pathways including translation, metabolism, vesicle traffic, cell 
survival, and cell proliferation, significantly increased viability, robustness, cell size, 
proliferation and antibody production in CHO cells (Dreesen and Fussenegger 2011). 
Multigene metabolic engineering using a combination of growth-enhancing factor like 
Bcl-xL and its stabilizer C/EBPα (CCAAT/enhancer binding protein α) resulted in a 
further enhancement of cell growth (Fussenegger, et al. 1998).
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3.4.2 Apoptosis pathway engineering 
 
3.4.2.1 Single-gene engineering 
 
The accumulation of waste in culture, nutrient deprivation, shear stress and elevated 
osmolarity promote DNA damage and apoptosis induction leading to poor process 
performance (Kim, Kim and Lee 2012, Muller, Katinger and Grillari 2008, Arden and 
Betenbaugh 2004). Apoptosis is a programmed cell death characterized by plasma 
membrane blebbing, cell shrinkage, nuclear fragmentation, chromosome condensation 
and chromosome DNA fragmentation (Danial and Korsmeyer 2004). Apoptosis is 
regulated by the intrinsic pathway (mitochondria, endoplasmic reticulum (ER) and the 
extrinsic pathway (cellular surface death receptors). Caspases are cysteine proteases that 
play a key role in the signalling cascades of apoptosis (Majors, Betenbaugh and Chiang 
2007).  
Over-expression of Bcl-2 and Bcl-xL, two anti-apoptotic factors that regulate apoptosis 
in the mitochondria, provoked proliferation increase and apoptosis resistance in CHO 
cells (Kim, et al. 2003, Meents, et al. 2002, Chang, et al. 2005). Knockdown of pro-
apoptotic proteins like Bax and Bak has been employed to increase viable cell density 
(Cost GJ 2010). Another strategy is the suppression of caspases, which regulate 
apoptosis induction through proteolytic cascades. Apoptosis resistance can also be 
achieved by overexpression of intracellular caspase inhibitors, such as X-linked 
mammalian inhibitor of apoptosis (XIAP), an inhibitor of caspase-3/caspase-7/caspase-
9 (Sauerwald, Oyler and Betenbaugh 2003, Sauerwald, Betenbaugh and Oyler 2002). 
Overexpression of other factors, including the human telomerase reverse transcriptase 
(hTERT), the inhibitor for p53 tumor suppressor protein and Aven, the inhibitor of 
apoptosome activation via interacting Apaf-1, has been reported to successfully increase 
apoptosis resistance (Crea, et al. 2006, Arden, et al. 2007, Choi, et al. 2006, Figueroa, et 
al. 2007). 
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3.4.2.2 RNAi to improve apoptosis resistance in CHO cells 
 
As described in the previous section, apoptosis is a programmed-cell death that can be 
promoted by waste accumulation and other stress in the cells. To improve resistance 
against apoptosis, pro-apoptotic factors can be targeted including proteins from the Bcl-
2 family. Using shRNA technology to knockdown Bax and Bak, Lim et al reported the 
enhancement of cell viability and CHO cell productivity (Lim, et al. 2006) . Following 
addition of Sodium Butyrate (NaBu) in culture which leads cytotoxicity, simultaneous 
silencing of caspase-3 and caspase-7 was successful in improving recombinant 
thrombopoietin production in CHO cells but negatively impacted on cell growth and 
viability (Sung, et al. 2007, Sung, Hwang and Lee 2005). The knockdown of other pro-
apoptotic factors like the apoptosis linked gene 2 (Alg-2) and the zinc finger protein 
transcriptional factor Requiem have been reported to improve cell viability and 
recombinant interferon-γ production in CHO cells (Lim, et al. 2010). 
 
3.4.3 Glycosylation pathway engineering 
 
3.4.3.1 Single-gene engineering 
 
The glycan pattern of a recombinant protein is critical to its biological activity. 
Variations in this pattern can be a problem for protein folding, aggregation or secretion 
leading to protein degradation and immunogenicity. It can also be an issue with the 
Food and Drug Act (FDA) regulation which considered the glycosylation very seriously 
particularly in the case of biosimilars. It can be a challenge to keep the glycan structure 
patterns consistent between different batches as glycosylation can be dependent on the 
cell culture process including the recombinant protein itself and extracellular 
environment (Jenkins, Parekh and James 1996, Reuter and Gabius 1999), the host cell 
line (Goochee 1992, Goto 2007, Sheeley, Merrill and Taylor 1997) and the method of 
culture (Jenkins and Curling 1994, Gawlitzek, Conradt and Wagner 1995, Schweikart, 
et al. 1999). The glycoforms, which represent the different glycoproteins generated 
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during a culture process, are evaluated for product safety and biological activity. In this 
regard, the culture parameters are precisely controlled to ensure the reproducibility of 
the bioprocess culture between the different batches to avoid heterogeneity of glycan 
patterns (Butler 2006). This pattern is dependent on the expression of various 
glycosyltransferase enzymes that are present in the Golgi of cells. Over-expression of  
β1,4 N-acetyl glucosaminoyltransferase, that catalyzes the transfer of N-
acetylglucosamine (GlcNAc) to core 2 branched O-glycans, enhances antibody 
dependent cellular toxicity (ADCC) in CHO cells (Davies, et al. 2001, Umana, et al. 
1999). Thus engineered modifications of glycosylation can lead to lower 
immunogenicity, higher stability of the protein and enhanced its biological activity 
(Butler 2006). 
 
3.4.3.2 RNAi for glycosylation engineering 
 
The glycan patterns of a recombinant protein are critical to its biological activity. The 
variation of these patterns can be a problem for protein folding, aggregation, secretion 
leading to protein degradation and immunogenicity. ADCC is an immune response 
mediated by recognition of an antigen by the fragment crystallisable (Fc) region of an 
Immunoglobulin G (IgG). This recognition between antibody and antigen recruits a 
particular Fc receptor present on natural killers (NK) cells, leading to infected cell 
destruction. The use of siRNA has been successful in α-1,6 fucosyltransferase (FUT8) 
mRNA inhibition leading also to enhanced ADCC (Mori, et al. 2004). FUT8 protein 
catalyzes the addition of fucose to the first GlcNAc residue. The knockdown of both 
FUT8 and GDP-mannose 4,6-dehydratase (GMD), an enzyme that converts D-glucose 
to GDP-fucose to produce GDP-mannose, had a synergistic effect on ADCC activity 
(Imai-Nishiya, et al. 2007). 
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3.4.4 Metabolic pathway engineering 
 
3.4.4.1 Single-gene engineering 
 
Cell engineering can also be applied to improve metabolic phenotypes and overcome 
environmental stress in the cells (Irani, Beccaria and Wagner 2002, Abston and Miller 
2005, Tigges and Fussenegger 2006). Glycolysis pathway can be targeted to increase 
energy and reduce undesirable byproducts such as lactate. Silencing of lactate 
dehydrogenase (LDH), an enzyme involved in pyruvate-lactate reaction and NAD+ 
formation, has been reported to reduce glycolysis rate (Zhou, et al. 2011, Kim and Lee 
2007).  
Overexpression of Glutamine synthetase, an enzyme which combines glutamate with 
ammonia to yield glutamine, has been shown to reduce the amount of ammonia 
production (Zhang, et al. 2006). Similarly, the overexpression of carbamoyl phosphate 
synthetase I and ornithine transcarbamoylase involved in urea cycle has been shown to 
decrease ammonia accumulation (Park, et al. 2000). 
 
3.4.4.2 RNAi for metabolism engineering 
 
To improve cell proliferation and cell viability capacities, the accumulation of 
byproducts such as lactate produced by glucose and glutamine catabolism should be 
reduced. The knockdown of lactate dehydrogenase (LDH) the enzyme responsible for 
the conversion of pyruvate to lactate inhibited lactate production, consequently reduced 
acidose-mediated apoptosis and improved production of tissue plasminogen activator 
protein in CHO cells by about 150% (Jeong, et al. 2006). Another study on LDH 
knockdown using shRNA reported the reduction of glucose consumption rates by 13–
46% per cell and lactate production by 21–55%, without any changes in the glutamine 
consumption rate (Kim and Lee 2007). 
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3.4.5 Unfolded protein response and secretion pathway engineering 
 
The accumulation of proteins in the endoplasmic reticulum (ER) lumen in addition to 
environmental perturbations trigger a stress response known as the unfolded protein 
response (UPR) (Cudna and Dickson 2003, Rutkowski and Kaufman 2004). Following 
UPR activation, global translation is attenuated while degradation of unfolded proteins 
is promoted (Chakrabarti, Chen and Varner 2011). These three pathways are regulated 
by the chaperone protein Bop/Grp78 which promotes proper folding of proteins in the 
ER. Under ER stress, the interaction of Bop with three transmembrane ER transducers, 
inositol requiring kinase 1 (IRE1), double-stranded RNA-activated protein kinase 
(PKR)-like endoplasmic reticulum kinase (PERK) and activating transcription factor 6 
(ATF6) is abolished leading to activation of these proteins and subsequent UPR 
signalling activation (Chakrabarti, Chen and Varner 2011). A prolonged UPR leads to 
apoptosis-dependent cell death by the activation of the three ER stress-sensing pathways 
IRE1, PERK, and ATF6 (Forman, Lee and Trojanowski 2003). 
To increase the ER capacity and counteract this stress response, the expression of 
different transcription factors involved in the UPR has been manipulated. Increasing the 
spliced form of Xbp-1 (Xbp1-(s)) has been shown to enhance SEAP production in CHO 
cells (Tigges and Fussenegger 2006). Other approaches have focused on reversing the 
attenuation of translation in response to ER stress. Up-regulation of ATF4, a 
transcription factor involved in the UPR, triggers phosphorylation of eukaryotic 
initiation factor-2α (eIF2α) via induction of growth arrest and DNA damage inducible 
protein 34 (GADD34). This was shown to restore translation and consequently to 
enhance antithrombin III (AT-III) specific productivity (Ohya, et al. 2008, Omasa, et al. 
2008). Targets in the secretion pathway include N-ethylmaleimide-sensitive factor 
attachment protein receptors (SNAREs) and Sec1/Munc18 (SM) proteins. SNAREs 
mediate the fusion between transport vesicles and the cell membrane via interaction 
with SM proteins (Toonen and Verhage 2003). Overexpression of SNAREs or SM 
proteins improves CHO cell productivity (Peng and Fussenegger 2009).  
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3.5 The use of RNA interference in CHO cell engineering  
 
Single-gene engineering has been used to successfully improve CHO cell growth, 
viability, apoptosis resistance as well as to manipulate their metabolic and secretory 
pathways to adapt the cellular machinery to produce more. However, manipulating one 
or multiple gene(s) in a specific pathway can negatively impact on other pathways. For 
instance, if CHO cells are engineered to improve cell proliferation, cell productivity can 
be compromised. It appears also that single-gene engineering is designed to target key 
regulators of a cellular function rather than entire pathways. Therefore other approaches 
have been focused on global changes in DNA, RNA and proteins.  
 
3.5.1 RNA interference mechanism 
 
RNA interference (RNAi) based cell engineering techniques have been developed to 
knockdown the expression of a target gene in a sequence-dependent manner. The use of 
ribonucleic acid (RNA) antisense technology as a tool for gene function studies was 
first applied to the inhibition of thymidine kinase by Izant and co-workers (Izant and 
Weintraub 1984). Although, sense and antisense RNA were each sufficient to cause 
interference in Caenorhabditis elegans (C.elegans), the presence of a double-strand 
RNA was more effective in silencing the endogenous mRNA transcript, a process that 
was later called RNAi (Fire, et al. 1998, Fire, et al. 1991). RNAi has also been reported 
in plants as post-transcriptional gene silencing (PTGS) mechanism (Hamilton and 
Baulcombe 1999). PTGS is thought to be a mechanism for host protection against 
viruses and mobile genetic elements like transposons that use double-stranded RNAs 
(dsRNAs) in their life cycles (Jensen, Gassama and Heidmann 1999, Ratcliff, 
MacFarlane and Baulcombe 1999). If transposable elements share homology with their 
host genomes, repression can be induced by the same phenomenon. RNAi since has 
been discovered in other species such as fungi (mechanism called quelling) (Romano 
and Macino 1992), drosophila (Hammond, et al. 2000), insects (Kennerdell and 
Carthew 1998), frogs (Thompson, Goodwin and Wickens 2000), mammals and human 
(Svoboda, et al. 2000, Wianny and Zernicka-Goetz 2000, Shendure and Church 2002). 
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RNAi was studied later in more details and described as the degradation of a mRNA, 
induced by a dsRNA in a sequence-specific manner (Figure 3.5.1). This processing is 
triggered by an endoribonuclease related to the RNase III-like enzyme family, called 
Dicer. The cleavage induces the production of small interfering RNA (siRNA) duplexes 
with a length of 21 to 23-nucleotides (nt) and with 3’dinucleotide overhangs (Elbashir, 
et al. 2001). One strand of the siRNA duplex assembles into the RNA-induced silencing 
complex (RISC), leading to degradation of the target transcript due to total 
complementarity between the selected strand and the mRNA sequence. Synthetic 
chemically-modified siRNAs are often used in reverse genetic experiments to 
investigate the function of a gene by its knockdown through perfect complementarity 
(Mac Manus 2002). However, these molecules are expensive and their effect is only 
temporary therefore short hairpin RNAs (shRNAs) have been engineered in appropriate 
vectors to allow long-term studies. Expression of shRNA is driven by RNA polymerase 
II or III promoters and induces stable knockdown for a longer period of time (Kim and 
Rossi 2007). RNA polymerase III promoters (such as U6) are used for general small 
RNAs expression whereas RNA polymerase II promoters are used for tissue-specific 
expression or for the expression of several shRNAs in a single unit and for miRNA 
(miRNA) precusor expression. miRNAs are another class of small non-coding RNAs 
involved in post-transcriptional regulation, in a similar manner to siRNAs (Kim and 
Rossi 2007). Recent publications in bioprocessing have reported the use of RNAi in 
mammalian cells to improve cell productivity or cell proliferation rate (Wu 2009). 
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Figure 3.5.1: Mechanism of siRNA silencing RNAi is activated by the presence of a 
dsRNA or by a shRNA construct in a sequence-specific manner. An RNase III-like 
enzyme called Dicer recognises the double-stranded molecule and triggers cleavage. 
This cleavage leads to the production of a small interfering RNA (siRNA) duplexes 
with a length of 21 to 23-nt characterized by a dinucleotide 3’overhangs. One strand of 
the siRNA duplex assembles into the RNA-induced silencing complex (RISC) that 
comprises Argonaute protein. This complex guides the siRNA to its fully 
complementary target mRNA and this pairing provokes degradation of the transcript 
due to total complementarity.  
(http://www.unikonstanz.de/FuF/chemie/jhartig/)
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3.5.2 miRNAs 
 
Similar to siRNAs, miRNAs are another class of small non-coding RNAs involved in 
post-transcriptional regulation (Kim and Rossi 2007). miRNAs are small non-coding 
RNAs, involved in many biological pathways and have been shown to be highly 
conserved between species. Since their discovery, they have expanded the world of 
small RNAs and given a new perception of post-transcriptional regulation. A single 
miRNA can potentially regulate hundreds of targets and, in contrast to functional 
proteins miRNAs do not need to be translated to exert their function (Muller, Katinger 
and Grillari 2008). This peculiarity of miRNAs make them potentially attractive tools 
for CHO cell engineering as well as better understanding of the molecular mechanisms 
regulating CHO behaviour in culture. 
 
3.5.2.1 miRNA discovery 
 
miRNAs were first identified in C.elegans with the discovery of linage-4 (lin-4), a 
critical stage-specific gene, involved in the timing of worm larvae development (Lee, 
Feinbaum and Ambros 1993)(Lee and Ambros 2001). Lin-4 negatively regulates LIN-
14 protein, using an antisense mechanism involving complementarity between lin-14 
3’UTR sequence and lin-4 miRNA (Lee, Feinbaum and Ambros 1993). Following this 
initial discovery, many papers have been published on miRNAs in several species such 
as worm (Lau, et al. 2001), drosophila, human (Mourelatos, et al. 2002, Lagos-
Quintana, et al. 2001), plants, green algae and viruses (Griffiths-Jones 2006). Recently 
other small non-coding RNAs have been discovered known as Piwi-interacting RNA 
(piRNAs). PiRNAs bind to Piwi proteins that are one of the two subfamilies of animal 
Argonaute proteins. They are small RNAs known to be key regulators of germline 
development in most animals (Aravin, Hannon and Brennecke 2007). Although their 
biogenesis and their mode of target regulation are different, there is a link between 
siRNA, miRNA and piRNA pathways. miRNAs are derived from transcripts that form 
hairpin structures whereas siRNAs are derived from longer hairpins or bimolecular 
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RNA duplexes and piRNAs originate from precursors that do not seem to have a 
double-stranded primary structure (Bartel 2004). 
 
3.5.2.2 miRNA biogenesis  
 
Mature miRNAs are single-stranded RNA molecules, of 21-23 nt, that are derived from 
the transcription of a long primary miRNA (pri-miRNA). Pri-miRNAs can be as long as 
several kilobases and contain one or more secondary structures consisting of extended 
stem-loop structures (Lee, et al. 2002). They are usually transcribed by RNA 
polymerase II (RNA pol II) and like other RNA pol II transcripts, pri-miRNAs undergo 
similar transcriptional regulation to protein-coding mRNAs such as 5’ cap and poly(A) 
tail (Ding, Weiler and Grosshans 2009). However, for miRNAs located in Alu and other 
repetitive elements, transcription occurs through RNA polymerase III (Borchert, Lanier 
and Davidson 2006) These small non-coding RNAs are converted into single-stranded 
mature miRNAs after a two step cleavage process by RNase III-like enzyme (Figure 
3.5.2.2). This cleavage, called “cropping” (Ding, Weiler and Grosshans 2009), occurs in 
the nucleus, by a complex containing Drosha and its cofactor DiGeorge syndrome 
critical region gene 8 (DGCR8 or Pasha), also known as Microprocessor (Kim, Han and 
Siomi 2009). The cofactor DGCR8 may recognize a junction, called the SD junction, 
localized between the single and double-stranded region and the 33-base pair (bp) stem 
of the pri-miRNA substrate. After recognition, interaction occurs between the dsRNA 
binding domain (dsRBD) and the stem, leading to RNA duplex cleavage about 11bp 
from the SD junction (Han, et al. 2009). This cleavage takes place at the stem of the 
hairpin structure, allowing the formation of a 70-nucleotide hairpin molecule, known as 
the precursor miRNA (pre-miRNA). The pre-miRNA is exported into the cytoplasm by 
RanGTP-dependent exportin-5 and processed into a 21-23 nt miRNA duplex, by 
DICER/transactivation response element RNA-binding protein RNA binding protein 
(TRBP) complex (Chendrimada, et al. 2005). Like Drosha, Dicer leaves a characteristic 
two-nucleotide 3’overhang (Hutvagner, et al. 2004). Following cleavage by Dicer, the 
RNA duplex interacts with an Argonaute (AGO) protein to form the pre-RISC (RNA 
induced silencing complex).The guide strand is thought to be bound to AGO while the 
other strand, known as the passenger strand or also called the star strand (miRNA*), is 
thought to be unwounded from the duplex and degraded leading to the mature RISC 
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complex (Matranga, et al. 2005, Rand, et al. 2005, Gregory, et al. 2005, Kawamata and 
Tomari 2010). In mammals there are four Argonaute proteins (AGO1-4 also known as 
EIF2C proteins). All four can mediate repression of partially complementary target 
mRNAs through slicer-independent mechanisms but only AGO2 is able to mediate 
endonucleolytic cleavage (known as ‘Slicer’ activity) (Peters and Meister 2007). Slicer 
proteins, by analogy with Dicer, are endonucleases that cleave substrate RNA 
complementary to the bound small RNA. However, this phenomenon rarely occurs in 
animals in contrast to plants. Recently, a conserved miRNA biogenesis pathway that 
requires AGO2 catalysis but not DICER has been identified during mouse (Cheloufi, et 
al. 2010) and zebrafish development (Cifuentes, et al. 2010). In this study, Dicer-
independent cleavage is likely due to the short sequence (17-nucleotide) of pre-miR-451 
stem region that can not be recognised and processed by Dicer.  In addition, the mature 
strand sequence starts in the loop region and extends to the complementary strand of the 
hairpin precursor. This structural feature prevents the miRNA sequence from being 
recognised by Drosha and Dicer and consequently impairs miRNA maturation 
(Cheloufi, et al. 2010). 
Selection of the strand is dependent on the thermodynamic stability of the 5’end and is 
followed by target miRNA binding resulting in translation repression and/or mRNA 
cleavage (Pillai 2005, Valencia-Sanchez, et al. 2006). Recently, studies on miRNA* 
function revealed that these miRNAs could be play significant functional role and exist 
in abundance in cells (Okamura, et al. 2008, Ro, et al. 2007, Jagadeeswaran, et al. 
2010). It has been demonstrated that miRNA and miRNA* bind to different Argonaute 
proteins (Okamura, et al. 2008). In drosophila the sequence from the dominant arm (the 
guide strand or mature miRNA) binds to Ago 1 leading to translational repression and 
the sequence from the opposite arm, (passenger strand, star strand or miRNA*) binds to 
Ago 2 and also triggers transcriptional repression (Czech, et al. 2009, Ghildiyal and 
Zamore 2009). In the same family of miRNAs, the relative ratio of left-arm and right-
arm products can differ among members. Some other families show highly asymmetric 
or more equivalent miRNA hairpin outputs. Thus the mechanism of arm switching is 
responsible for miRNA* fate and reveals a diversification of miRNA function during 
miRNA gene evolution (Okamura, et al. 2008, Yang and Lai 2010). The selection of 
which miRNA strand to incorporate into the RISC complex, may also be tissue and 
developmental stage dependent (Ro, et al. 2007, Ruby, et al. 2007, Chiang, et al. 2010). 
In D.melanogaster and T.castaneum, miR-10 is processed from different arms. 
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However, the duplex miRNA-miRNA* sequences were the same in both, 
D.melanogaster and T.castaneum (Griffiths-Jones, et al. 2011). Using computational 
prediction, authors have shown that the dominant arm had fewer predicted targets than 
the other arm (miRNA*), suggesting another level of regulation of miRNA target sites 
and on miRNA functions by arm switching (Griffiths-Jones, et al. 2011).  
In contrast to plants and flies, the mRNA target regulation by miRNAs is more complex 
in animals and not fully understood.Imperfect complementarity between a miRNA and 
its target mRNA provokes protein synthesis inhibition or mRNA instability causing 
deadenylation and degradation, depending of the miRNA/mRNA pair (Behm-Ansmant, 
et al. 2006). Decay of mRNA is promoted by the recruitment of GW182, CCR:NOT and 
DCP1:DCP2 deadenylase complexes. GW182 (Glycine-tryptophan protein of 182kDa) 
belongs to the core of miRISC complexes. GW182 promotes deadenylation and 
decapping by interacting with AGO1 at its amino-terminal end and its carboxy-terminus 
interacts with the poly(A) binding protein (PABP), acting downstream of AGO1. 
Messenger RNA decay occurs in cytoplasmic foci called P-bodies (PBs) where not only 
Argonaute proteins (AGO1-AGO4), miRNAs, and mRNAs are found  but also other 
molecules such as decapping DCP1:DCP2 complex and cofactors, CCR:NOT  
deadenylases, the cap-binding protein eIF4E and the RNA helicase Dhh1/Me31B 
involved in translational repression (Pillai 2005, Valencia-Sanchez, et al. 2006, 
Jakymiw, et al. 2007, Liu, et al. 2005, Meister, et al. 2005). GW182, required for PBs 
integrity, also co-localises in these structures. Deadenylation of mRNA at the 3’end is 
the first step in mRNA decay, followed by the removal of the cap at the 5’ end, leading 
to exonucleolytic cleavage from 5’ to 3’. Intracellular localization of a protein or a 
ribonucleoprotein (RNP) is really important to determine their function and regulation. 
Moreover, compartmentalization ensures the control of different interactions between 
partners that act together (Krol, Loedige and Filipowicz 2010). From this observation, 
several authors suggested a model in which miRNA targets are sequestered and 
degraded in these P-bodies (Jakymiw, et al. 2007, Sen and Blau 2005). Argonaute 
proteins are distributed diffusely in the cytoplasm. When cells are subjected to stress, 
they accumulate into PBs and cytoplasmic aggregations called stress granules (SGs) 
(Leung, Calabrese and Sharp 2006). In addition to AGO proteins, artificial miRNAs 
mimic and repressed mRNA are also retained in these SGs (Kedersha, et al. 2005). SG 
and P-bodies are functionally linked and interact together continuously. The role of PBs 
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and SGs in translation regulation and the link between miRNA and Argonaute protein 
localization in SGs and PBs is not yet fully understood. 
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Figure 3.5.2.2: The biogenesis of miRNAs.   
miRNA (miRNA) genes are generally transcribed by RNA Polymerase II (Pol II) in the 
nucleus to form large pri-miRNA transcripts, which are capped (7MGpppG) and 
polyadenylated (AAAAA). These pri-miRNA transcripts are processed by the RNase III 
enzyme Drosha and its co-factor, Pasha or DGCR8, to release the ~70-nucleotide pre-
miRNA precursor product. RAN–GTP and exportin 5 transport the pre-miRNA into the 
cytoplasm. Subsequently, another RNase III enzyme, Dicer, processes the pre-miRNA 
to generate a transient ~ 22-nucleotide miRNA:miRNA* duplex. This duplex is then 
loaded into the miRNA-associated multiprotein RNA-induced silencing complex 
(miRISC) (light blue), which includes the Argonaute proteins, and the mature single-
stranded miRNA (red) is preferentially retained in this complex. The mature miRNA 
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then binds to the 3’UTR of its mRNA target via a complementary site known as with its 
‘seed region’ located in positions 2 to 8 nt at the 5’end of mature miRNA (Pillai 2005, 
Guo and Lu 2010, Doench, Petersen and Sharp 2003, Stark, et al. 2005, Lewis, Burge 
and Bartel 2005b, Grimson, et al. 2007). This specific binding negatively regulates gene 
expression in one of two ways depending on the degree of complementarity between the 
miRNA and its target. Imperfect binding induces a block at the level of protein 
translation without interfering with the mRNA, whereas perfect (or nearly perfect) 
complementarity induces target-mRNA degradation.  
Figure and legend were taken from the following paper: Oncomirs miRNAs with a role 
in cancer (Esquela-Kerscher and Slack 2006) 
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3.5.2.3 Nomenclature of miRNAs 
 
To facilitate access to miRNA information, a database called miRBase was developed 
to gather together miRNA identity data including sequences, annotation, species 
affiliation, genomic site origin, target prediction resources and literature references 
(Griffiths-Jones 2006, Griffiths-Jones, et al. 2008, Griffiths-Jones, et al. 2006).  
The first criterion in the miRBase classification is the species affiliation designated by 
three or four letter prefixes of the species. For example hsa-miR-24 indicates that this 
miR-24 is found in human (Homo sapiens). In addition, “miR” designates the mature 
form of miRNA in contrast to “mir” for pri-miRNA and pre-miRNA sequences. A star 
is added to the passenger strand name, hsa-miR-23b*, also known as star strand, in 
order to distinguish between the guide strand and the passenger strand. Besides the 
nomenclature that exists for orthologous sequences such as hsa-miR-24 in human and 
mmu-miR-24 in mouse, there is a specific nomenclature for paralogous sequences. For 
instance, hsa-miR-24-1 and hsa-miR-24-2 represent the same mature miRNA sequence 
but their transcripts originate from different genomic loci. In addition, mature miRNAs 
with only one or two different nucleotides will be given lettered suffixes e.g., hsa-miR-
23a and hsa-miR-23b. The excision of mature miRNA sequences from the 5’or 3’end of 
the hairpin precursor also gives rise to additional terminology such as hsa-miR-30e-3p 
(3’arm of hairpin) or hsa-miR-30e-5p (5’ arm of hairpin). When several miRNAs are 
organized in a cluster, the terminology is different. For example miR-23a, miR-27a and 
miR-24-2 are gathered together in miR-23a~27a~24-2 cluster. miRNAs can be grouped 
by family if they shared a common seed region (Lewis 2003). One example of miRNA 
family is the let-7 family which reassembles 13 members originated from nine different 
genomic loci (Roush and Slack 2008, Boyerinas, et al. 2010). Due to their common seed 
sequence, these members are likely to have shared targets and also common functional 
roles. Although these principles represent general rules for most species, there are some 
differences of miRNA nomenclature in plants and viruses. 
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3.5.2.4 Genomic organization of miRNAs 
 
Transcription of these small non-coding RNAs can be driven by their own promoters or 
by the promoter of their host gene. miRNA promoters have also been discovered up to 
several kilobases (kb) away from miRNA sequence, suggesting that primary miRNAs 
(pri-miRNAs) can be very long trancripts (Corcoran, et al. 2009). miRNAs can be 
classified as intergenic or intragenic, according to their genomic localization in introns 
or as independent loci (Figure 3.5.2.4). Intergenic miRNAs form their own 
transcription units (TUs) as initially described (Lau, et al. 2001, Saini, Enright and 
Griffiths-Jones 2008). Most intergenic human miRNAs have a transcription start site 
and poly(A) signal (Saini, Enright and Griffiths-Jones 2008, Saini, Griffiths-Jones and 
Enright 2007). Many of these miRNAs are transcribed as polycistronic transcripts due 
to their organization in clusters and most clusters are thought to be driven by a common 
promoter because of their similar expression profiles (Saini, Enright and Griffiths-Jones 
2008, Baskerville and Bartel 2005). 36% to 47% of miRNAs are organised in clusters in 
zebrafish, mouse and human (Griffiths-Jones, et al. 2008, Thatcher, et al. 2008) and 
approximately 50 distinct miRNAs clusters exist in the human and mouse genomes 
(Yuan, et al. 2009). Generally, a cluster consists of two or three miRNAs, however 
larger clusters of six miRNAs such as the human mir-17~92 cluster or eigth miRNAs 
like miR-302 cluster have been reported (Yuan, et al. 2009). miRNAs in a cluster either 
share sequence homology or may not be related (Lee and Ambros 2001, Lau, et al. 
2001). Sequence homology presents the possibility of targeting the same genes and 
possibly regulating genes that belong to a unique cellular pathway and interact with 
each other (Bartel 2004, Yuan, et al. 2009, Olena and Patton 2010, Kim and Nam 2006, 
Yu, et al. 2006).  
Numerous miRNA genes are found in introns of either coding or nonconding 
transcription units (TUs) (Rodriguez, et al. 2004) and are often processed from 
unspliced intronic regions (Kim and Kim 2007). Intronic miRNAs are likely to be 
expressed by their host gene promoter (Baskerville and Bartel 2005) but they can also 
be transcribed from their own promoter (Aboobaker, et al. 2005). Mirtrons, another 
class of intronic miRNAs, are spliced and debranched introns that are co-expressed with 
their host genes. They mimic the structural features of pre-miRNAs to enter the 
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miRNA-processing pathway without Drosha-mediated cleavage (Ruby, Jan and Bartel 
2007). As seen previously, the flanking regions of the miRNA hairpin are crucial for 
Drosha processing as well as the distance of 11bp that separates the stem and the 
junction with the flanking sequences (Berezikov, et al. 2007). However, mitrons have 
canonical splice sites instead of extensive pairing at the base of the hairpin in pri-
miRNAs (Ruby, Jan and Bartel 2007) and are processed through splicing instead of 
Drosha-mediated cleavage.  
miRNAs can be located within the exons of genes or overlap between exons and introns 
which are usually non-coding transcripts. This class is represented only by a small 
number of miRNAs whereas the other classes are more common (Rodriguez, et al. 
2004, Maselli, Di Bernardo and Banfi 2008). 
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Figure 3.5.2.4: Genomic organization of miRNAs 
There are four classes of organization. (1) Intergenic miRNAs, as the name suggests, are 
located in isolation from other genes and occur as either a monocistronic (a) or 
polycistronic unit (b). Their transcription is driven by their own promoter upstream and 
may be either RNA PolII- or PolIII-dependent. (2) Intronic miRNAs are located within 
an intron of a protein-coding gene, again as monocistronic or polycistronic units. They 
may be under the control of their own independent promoter or may be co-transcribed 
with the host gene. In the latter case they are processed into pre-miRNAs by the 
Microprocessor complex subsequent to intron splicing. (3) Mirtrons exist in short 
introns and differ from other intronic miRNAs in that they by-pass processing by 
Drosha and are exported directly to the cytoplasm to engage Dicer. They are co-
expressed with the host gene. (4) Exonic miRNAs are located in an exon and are 
independently transcribed from their own promoter. Black arrow: host gene promoter 
start site, Black arrow with lines: miRNA promoter start site, Diamond-shape with 
lines: intron, Purple arrow: exon, Blue Rectangle: gene. 
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3.5.2.5 Mode of action of miRNA 
 
3.5.2.5.1 Translation regulation through 3’UTR binding  
 
In animals, imperfect complementarity, between a mature miRNA and its target mRNA 
leads to protein synthesis inhibition and/or mRNA instability causing degradation. 
Originally, this base-pairing was described by computational prediction studies to occur 
only between the seed region, located in positions 2 to 8 nt from the 5’end of the mature 
miRNA and binding to the 3’-UTR of the mRNA (Pillai 2005, Doench, Petersen and 
Sharp 2003, Stark, et al. 2005, Grimson, et al. 2007, Doench and Sharp 2004, Doench 
and Sharp 2004, Lewis, Burge and Bartel 2005a) . This feature was also shown later by 
a proteomic study that confirmed superior protein inhibition capacity for the 3’UTR 
sites (Baek, et al. 2008). Grimson et al., identified both computationally and 
experimentally, general features of miRNA-mRNA interaction that are important for the 
efficacy of repression such as AU-rich nt composition near the seed site and binding site 
positioning (Grimson, et al. 2007). However, these are general rules and cannot be 
applied to all miRNA-mRNA pairs. The degree of repression is variable and not all 
predicted seed sites give rise to repression. Stark et al., showed that genes with a 
development-related function have long 3’UTRs enriched in miRNA binding sites 
whereas genes involved in basic cellular processes tend to have shorter 3’UTRs with a 
lower number of miRNA binding sites (Stark, et al. 2005). miRNAs may impact on 
3’UTR length and content and so they likely play a role in 3’UTR evolution of protein-
coding genes (Zhang and Su 2009). It has also been suggested that the 3’-end of 
miRNAs could be involved in mRNA-miRNA interaction by complementing a seed 
match to enhance target recognition or compensating for a mismatch to the seed 
(Grimson, et al. 2007, Doench and Sharp 2004, Kiriakidou, et al. 2004, Kloosterman, et 
al. 2004).  
Vasudevan and co-workers have demonstrated that miRNAs can induce translational 
up-regulation of target mRNAs by AGO2-3’UTR interaction in non-proliferating cells 
that are in cell cycle arrest but on the other hand, miRNAs induce repression of 
translation in proliferating cells (Vasudevan, Tong and Steitz 2007b). These authors 
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proposed that translation regulation can switch between these two antagonistic 
mechanisms of repression and activation, depending on the cell cycle phase. 
 
3.5.2.5.2 Tranlsation up-regulation through 5’UTR 
 
Other experimental studies have demonstrated interaction between the 3’end of a 
miRNA and the 5’UTR of a target mRNA resulting in up-regulation of the target 
protein-coding gene (Lytle, Yario and Steitz 2007, Lee, et al. 2009, Orom, Nielsen and 
Lund 2008). 
 
3.5.2.5.3 Non-canonical binding 
 
Recently, Shin and co-workers identified another class of miRNA targets called 
“centered sites” that lack both perfect seed pairing and 3’-compensatory pairing, and 
instead have 11-12 contiguous Watson-Crick pairs towards the center of the miRNA 
(Shin, et al. 2010). Potential miRNA targets have also been computational predicted and 
experimental genome-wide analyses within open reading frame (ORF) in mammals 
(Grimson, et al. 2007, Lewis, Burge and Bartel 2005a, Baek, et al. 2008, Farh, et al. 
2005) (Figure 3.5.2.5.3). The binding of miRNA to the target ORF appears to be less 
frequent and less effective than 3′ -UTR targeting but still much more frequent than 5′-
UTR targeting (Bartel 2009). 
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Figure 3.5.2.5.3: Types of miRNA Target Sites  
(A–C) Canonical, 7–8 nt seed-matched sites. Vertical dashes indicate contiguous 
Watson–Crick pairing (D–E). Marginal, 6 nt sites matching the seed region. These 6mer 
sites typically have reduced efficacy and are conserved by chance more frequently than 
the larger sites. (F–G) Sites with productive 3′ pairing. For 3′ -supplementary sites (F), 
Watson–Crick pairing usually centering miRNA nucleotides 13–16 (orange) 
supplements a 6–8 nt site (A–E). At least 3–4 well-positioned contiguous pairs are 
typically required for increased efficacy, which explains why 3′ -supplementary sites are 
atypical. For 3′ -compensatory sites (G), Watson–Crick pairing usually centering on 
miRNA nucleotides 13–16 (orange) can compensate for a seed mismatch and thereby 
create a functional site. Figures and legend were taken from the following review: 
MicroRNAs: Target recognition and regulatory functions (Bartel 2009). 
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3.5.2.6 miRNA regulation  
 
miRNAs were previously thought to have a long half-life but several examples are now 
in contrast with this. In plants, the 3’→ 5’ small RNA degrading nuclease (SDN1), 
homolog of the yeast RNA exonuclease 1 (Rexp1), triggers mature miRNA decay in 
vitro. The knockdown of SDN1 induces an increase in miRNA level and developmental 
defects. Therefore, SDN1 is thought to be an important regulator of miRNA turnover in 
plant development (Ramachandran and Chen 2008). In C.elegans, the 5’→ 3’ 
exoribonuclease, XRN-2 prompts miRNA degradation and affects functional miRNA 
homeostasis in vivo (Chatterjee and Grosshans 2009). Turnover is an important cellular 
mechanism to control cell homeostasis and to ensure maintenance of miRNA steady-
state levels in the cells. This type of regulation may modulate miRNA expression in 
different tissues and at a specific stage, for example, during development (Chatterjee 
and Grosshans 2009). miRNAs enriched in different types of neurons, undergo rapid 
turnover and degradation but all miRNAs do not undergo turnover in all types of 
neurons (Krol, Loedige and Filipowicz 2010, Sethi and Lukiw 2009). Another level of 
regulation, known as RNA editing, has been shown to play an important role in pri-
miRNA and pre-miRNA maturation. Pri-miRNAs and pre-miRNAs are thought to be 
under regulation of A-to-I RNA editing, this mechanism being responsible for miRNA 
processing alterations (Scadden and Smith 2001). RNA editing is a site-specific 
modification of an RNA sequence which consequently triggers base-pairing and 
structural property alteration of transcripts (Blow, et al. 2006). RNA editing is directed 
by Adenosine deaminases acting on RNAs (ADARs) that can convert adenosine to 
inosine by deamination, in various dsRNA substrates. For instance, editing can prevent 
Drosha from pri-miRNA processing (Yang, et al. 2006, O'Connell and Keegan 2006). It 
can also trigger miRNA functional modulation and extension of miRNA diversity and 
their targets (Blow, et al. 2006, Heale, et al. 2009). For instance, editing within the seed 
sequence leads to a big impact on target specificity of edited miRNAs. Editing seems to 
have different and selective effects on RNAi processes and appears to depend 
significantly on the RNA-binding activities of ADARs. ADARs can bind to many 
transcripts without editing them (Klaue, et al. 2003). Besides turnover and editing, 
miRNA expression may be regulated by feedback loops, recent studies have focused on 
the regulation network between miRNAs and transcription factors (TFs) (Shalgi, et al. 
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2007, Hobert 2004, Wang, et al. 2010, Sun, et al. 2012). Maps of transcriptional 
regulatory networks have been studied in mammals (Boyer, et al. 2005) and other 
organisms (Fazi, et al. 2005, Johnston, et al. 2005, Varghese and Cohen 2007, Martinez, 
et al. 2008). These maps have uncovered the existence of feed-forward and feedback 
loops, promoting robustness and maintenance of homeostasis (Milo, et al. 2002, Shen-
Orr, et al. 2002, Alon 2007). An example of a negative feedback loop in miRNA 
processing is the regulation of Drosha (Han, et al. 2009) and Dicer levels (Tokumaru, et 
al. 2008, Forman, Legesse-Miller and Coller 2008). Drosha negatively regulates its 
cofactor DGCR8 by mRNA cleavage and DGCR8 stabilizes levels of Drosha protein 
leading to Drosha up-regulation (Han, et al. 2009). Another example is the 
miRNA/mRNA pair let-7/LIN28, involved in double-negative feedback loop regulation 
where repression of LIN28 protein synthesis is controlled by let-7 and alternatively, 
LIN28 prevents let-7 maturation (Newman and Hammond 2010, Viswanathan and 
Daley 2010). miRNA regulation occurs at different levels of miRNA maturation, 
including regulation of the different forms of miRNA and of the different key regulators 
of this mechanism such as Dicer and Drosha. Perturbation of miRNA regulation induces 
defects in development and diseases (Thomson, et al. 2006, Chang, et al. 2004).  
 
3.5.2.7 Computational identification of miRNAs 
 
Mature miRNAs are only 22-23 nt in length, are often expressed at low concentration 
and they have tissue/cell specific and time-specific expression. Computational programs 
have been developed based on machine learning techniques in order to be able to 
identify new miRNA sequences, but the miRNA properties described above make the 
development of algorithms challenging (Chaudhuri and Chatterjee 2007, Bentwich 
2005). These distinct properties are divided in two classes, structural features and 
sequence features. The structural features include hairpin and hairpin-loop length, 
thermodynamic stability, base-pairing, bulge size and location, and distance of the 
miRNA from the loop of its hairpin precursor. Sequence features include nucleotide 
content and location, sequence complexity, repeat elements and inverted sequence 
repeats (Bentwich 2005). The different miRNA prediction algorithms often search for 
sequence and structure conservation in other organisms and give a score to the 
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prediction depending on the feature similarities they found and on the probability of 
having found novel miRNAs.  
 
3.5.2.8 Biological role of miRNAs  
 
miRNAs have been demonstrated to be involved in many cellular functions including 
development (Lee, Feinbaum and Ambros 1993), differentiation (Chang, et al. 2004), 
cell growth and apoptosis (Cheng, et al. 2005), cell cycle (Chivukula and Mendell 2008, 
Lal, et al. 2009a, Lal, et al. 2008), DNA-damage response (Pothof, et al. 2009), 
chromatin-remodelling (Yoo, et al. 2009),  DNA methylation (Wu, et al. 2010a), control 
of signal transduction (Wu, et al. 2010a, Inui, Martello and Piccolo 2010) and cell 
metabolism (Gao, et al. 2009, Lin, et al. 2009). Some studies have shown that miRNAs 
can act as a rheostat to maintain homeostasis and limit the response to environmental 
fluctuations (Stark, et al. 2005, Li, et al. 2009, Hornstein and Shomron 2006). miRNAs 
have also been found to be deregulated in multiple diseases (Borel and Antonarakis 
2008),  including cancers (He, et al. 2005, He, et al. 2007b), heart diseases 
(Papageorgiou, et al. 2012), diabetes (Correa-Medina, et al. 2009) and viral infection 
(Buck, et al. 2010). miRNAs could be used as biomarkers or therapeutic treatments in 
several illnesses. However, miRNA regulation networks need to be better understood 
before achieving these goals. Loss and gain of function approaches are often the method 
chosen to investigate endogenous miRNA roles.  
 
3.5.2.9 Functional validation  
 
3.5.2.9.1 Loss of function approaches 
 
2’-OMe (methylated oligonucleotides) 
In short term studies, antisense silencing technology is frequently exploited using 
chemical modifications for stability and cholesterol conjugation for delivery 
(Soutschek, et al. 2004). Different silencing technologies have been used such as 
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inhibitors named 2’-O-methyl-modified oligoribonuleotides (2’-OMe) that are 
complementary to the targeted miRNA (Hutvagner, et al. 2004, Meister, et al. 2004). 
 
AntagomiRs 
Other modified molecules developed are cholesterol-conjugated single-stranded RNAs 
complementary to miRNAs called ‘antagomirs’ stabilized with a partial 
phosphorothioate backbone in addition to complete 2’-O-methyl modifications, with 
dose-dependent and long-lasting effect of at least three weeks (Krutzfeldt, Poy and 
Stoffel 2006, Krutzfeldt, et al. 2005).  
 
Antisense oligonucleotides 
A similar strategy is the use of antisense oligonucleotides (ASOs) (Horwich and 
Zamore 2008), which are unconjugated single-stranded RNAs and carry 
phosphorothioate backbones and 2’-Omethoxyethyl modifications. Antagomirs and 
ASOs have been shown to have similar efficacy of silencing. 
49 
 
 
LNA-antimiR 
More recently, locked –nucleic-acid-modified oligonucleotides (LNA-antimiR) have 
been developed to efficiently antagonize miRNA in vivo after intravenous injection of 
hypercholesterolemic mice and African green monkeys (Elmen, et al. 2008). This 
method is dose-dependent, has long-lasting effects and does not seem to cause any 
associated toxicity. Another advantage of LNAs is their ability to differentiate miRNAs 
that are derived from the same primary transcript and so specifically silence only one of 
them.  
 
Mtg-AMOs 
Lu et al. have developed a multiple-target technology named MTg- AMOs which are 
engineered in a single unit to target multiple miRNAs (Lu, et al. 2009). The application 
of this method in miRNA cluster studies, can overcome problems of miRNA inhibition 
compensation from other members of the cluster. In this case, this system is more 
efficient and relevant than targeting a single miRNA as multiple miRNAs have been 
shown to work together to regulate cellular processes and gene expression.  
 
miRNA sponge 
There is also the possibility of more stable long term knockdown using a miRNA 
“sponge”(miR-SP), by cloning miRNA antisense sequences into an appropriate vector. 
This construct is usually driven by a strong RNA polymerase II promoter and comprises 
multiple tandem binding sites for a specific miRNA downstream of a fluorescent 
reporter gene (Ebert, Neilson and Sharp 2007, Ebert and Sharp 2010). The key 
advantage of the miR-SP is its ability to inhibit a whole miRNA family (miRNAs that 
share a common seed region), by using complementary heptameric seed. Inhibition of a 
unique miRNA may not be phenotypically effective due to compensation by other 
members of the miRNA family (Loya, et al. 2009, Brown and Naldini 2009).  
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3.5.2.9.2 Gain of function approaches 
 
Mimic molecules 
To mimic endogenous mature miRNAs, double-stranded molecules have been designed. 
miRNA mimic molecules are often used in parallel to miRNA inhibitors in transient 
transfection assays. These mimics are chemically modified, short and double-stranded 
molecules. Their introduction in the cells leads to higher levels of the studied miRNA. 
Impact of the mimic molecules is not long-lasting therefore these molecules are only 
used in short-term studies. 
 
shRNA  
 
Instead shRNA-expression vectors can be used for long-term study. It has been 
demonstrated that the flanking and loop sequences of miR-30 have important features 
and are sufficient to enhance siRNA/miRNA precursor processing into the mature form 
(Zeng, Wagner and Cullen 2002, Boden, et al. 2004). Zeng and co-workers reported the 
artificial expression of precursor miRNA using this approach. The stem sequence of the 
human miR-30 was replaced with a drosophila-specific gene sequence which was not 
conserved in human and the chimeric sequence was successful expressed. Thus miR-30-
based shRNA vector can be used in transient and stable expression studies. The use of 
strong promoters and viral vectors can increase the expression of the siRNA/miRNA 
and it can be applied for knockdown and overexpression. The expression of the 
transgene can also be controlled in an inducible or spatiotemporal manner using 
different promoters. Since the report by Zeng and co-workers, many papers have 
reported efficient expression of miRNA or siRNA using miR-30 backbone in gene 
function studies but also for gene therapy applications where miR-30-based shRNA 
contruct is an advantageous approach because it does not trigger cellular immune 
response (Boden, et al. 2004, Bauer, et al. 2009).  
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3.5.2.10 Experimental validation for miRNA identification 
 
Novel miRNAs identified by computational prediction can be validated by different 
experimental techniques. However, for the same reasons described above, validation of 
miRNAs can be challenging because of their short length, their sequence similarity with 
other miRNAs, their time- and stage-specific expression and their frequently low level 
of expression (Chaudhuri and Chatterjee 2007, Bentwich 2005). 
 
3.5.2.10.1 Hybridization techniques 
  
Hybridization techniques including northern blot, RNase protection assay, primer 
extension and signal-amplifiying ribozyme method are commonly used to validate 
miRNA expression (Berezikov, et al. 2005)(Lee, et al. 2002, Berezikov, et al. 2005, 
Hartig, et al. 2004).  
Northern blot is used to detect the mature and the precursor form of miRNAs (Lee and 
Ambros 2001, Lau, et al. 2001, Lagos-Quintana, et al. 2001) and to confirm high-
throughput data (Sempere, et al. 2004). However, it is not sensitive and specific enough 
to capture low expressed miRNAs and for this reason large amount of RNA needs to be 
extracted from the original sample (Chaudhuri and Chatterjee 2007).  
RNase protection assay consists of in vitro transcription of a labelled RNA probe. This 
RNA probe is complementary to the sequence of interest and hybridized to total RNA 
(Chaudhuri and Chatterjee 2007). Unhybridized single-strand RNA molecules are 
digested by a nuclease enzyme whereas the miRNA of interest coupled to the probe is 
protected. Resulting labelled fragments are run on a gel. This method requires the use of 
radioisotopes and it is a low-throughput technique (Sandelin, et al. 2007). In the primer 
extension technique, a labelled DNA primer recognises the 3’end of the miRNA 
followed by reverse transcription. Products are partially digested and run on a gel to 
evaluate the product size. This method also is a low-throughput technique and requires 
the use of radioisotopes (Chaudhuri and Chatterjee 2007).   
Ribozymes are nucleases with hairpin structure that cleave RNA molecules in a 
sequence specific manner (Suryawanshi, Scaria and Maiti 2010). The hammerhead 
52 
 
ribozyme can be easily engineering because of its simple form and size. For these 
reasons, it can be applied for gene expression inactivation (Michienzi, et al. 2000). 
Reporter-ribozymes comprised the complementary sequence of the miRNA of interest 
in their hairpin structure to direct specific binding. A reporter is placed at the 3’-end of 
the enzyme and a quencher at the 5’end. This binding triggers miRNA cleavage and a 
fluorescent signal is detected. Different cloning approaches such as random or specific 
cloning of size-fractioned RNA and amplified-partial sequencing have been developed 
to validate miRNA identification (Bentwich 2005, Lim, et al. 2005, Takada, et al. 
2006).  
A recent novel bead-based flow cytometry strategy has been used for miRNA profiling 
where beads can be coupled to different dyes facilitating simultaneously study of 
several miRNAs (Lu, et al. 2005). 
 
3.5.2.10.2 Real-time PCR  
 
Real-time PCR is another method for detection of mature and precursor miRNAs 
(Schmittgen, et al. 2004, Fu, et al. 2006, Tang, et al. 2006) as well as the use of 
microarrays which are sensitive and specific even for rare miRNAs (Lim, et al. 2005, 
Schmittgen, et al. 2004, Fu, et al. 2006, Schmittgen, et al. 2008, Barad, et al. 2004, Liu, 
et al. 2008). The detection of the mature strand is very specific with Real-PCR. In fact, 
the reverse-transcription (RT) primer can be designed with a stem-loop to distinguish 
between the mature and the precursor strand and to be specific to the mature miRNA 
only (Schmittgen, et al. 2008, Chen, et al. 2005). The TaqMan qRT-PCR method uses 
this system combined with the fluorescence resonance energy transfer (FRET)  
Another method is to reverse transcribed the RNA extract with oligodT or random 
primers and use an intercalator fluorescent dye that binds to double strand DNA during 
the PCR step such as SYBR green. The detection is monitored by measuring the 
increase in fluorescence during PCR cycling. This approach is less specific than the 
TaqMan and can lead to detection of non-specific double-stranded DNA.
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3.5.2.10.3 Microarray based-technology  
 
Microarray based-methods are more suitable for miRNA profiling and for high 
throughput studies. The microarray approach has been applied to the identification of 
differentially regulated miRNAs upon different conditions (Kantardjieff, et al. 2009, 
Koh, et al. 2009). A study was conducted in our laboratory to monitor the changes of 
miRNA expression under temperature-shift in CHO cell culture using human/mouse-
miRNA hybridization array (Gammell, et al. 2007). The application of a non-CHO 
specific microarray was possible to profile miRNAs in CHO cells due to the high 
conservation of mature miRNAs across species (Bartel 2009). 
 
3.5.2.10.4 Next generation sequencing  
 
Besides qRT-PCR and microarray, next-generation sequencing has proven to be a 
reliable alternative in miRNA profiling studies. This method does not need as much 
information as these two approaches therefore it was recently used in CHO cells and led 
to the identification and annotation of 387 mature miRNAs from six CHO cell lines in 
different conditions (Hackl, et al. 2011). Another study using the recent release of the 
whole CHO genome sequencing combined with miRBASE reported the detection of 
190 conserved miRNA hairpin precursors (Hammond, et al. 2012). 
 
3.5.2.11 miRNA target identification 
 
3.5.2.11.1 Computational prediction  
 
Initial miRNA target prediction algorithms have been based on seed pairing between 
miRNA-mRNAs and free energy of binding between each miRNA and its target, 
leading to high false positive rate. Improvements have been made by incorporation of 
binding site evolutionary conservation (Lewis, Burge and Bartel 2005a). Other 
algorithms are now based on folding patterns of RNA sequences conserved between 
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species such as miRseeker (Lai, et al. 2003) and the RNA folding and the hairpin 
sequence conservation in MirScan (Lim, et al. 2003). Other programs have taken into 
account stem-loop structure formation and nucleotide conservation in miRNA 
precursors (Berezikov, et al. 2005).     
In plants, targets of miRNAs are much easier to find than in mammals because of their 
near-perfect complementarity between miRNA-mRNAs whereas in animals, this perfect 
match that triggers mRNA cleavage only occurs occasionally. In this regard, miRNA 
target prediction algorithms in plants minimize high false positive rates (Rhoades, et al. 
2002). miRNA target prediction algorithms take into account different features of which 
the most common is based on Watson-Crick pairing at the seed region (Lewis, Burge 
and Bartel 2005a, Krek, et al. 2005) and evolutionary miRNA target site conservation 
(Bartel 2009). Seed sequence evolutionary conservation gives more robustness to target 
prediction as well as other features such as secondary structure of mRNA for structural 
accessibility (Kertesz, et al. 2007, Hammell, et al. 2008), nucleotide composition of 
target sequences  and location of the binding sites within the 3’UTR (Grimson, et al. 
2007, Baek, et al. 2008, Gaidatzis, et al. 2007). A score is associated with each 
predicted target to evaluate the authenticity of the prediction. The higher the target score 
is, the more confident is the prediction. Additional validation using experimental 
studies, such as transcriptomic or proteomic profiling, increases the discrimination of 
target rank (Baek, et al. 2008, Selbach, et al. 2008). Alexiou and coworkers, evaluated 
the prediction performance of five common databases, DIANA-microT 3.0; TargetScan 
5.0, TargetScan S, Pictar and EIMMo against genes targeted after miRNA 
overexpression or knockdown in a study conducted by Selbach et al., in 2008 . The 
precision of the program (correctly target predicted/ total target predicted) was 
estimated at 50% and their sensitivity (correctly target predicted/ total correct) between 
6 and 12%. These five programs are based mostly on the evolutionary conservation of 
the seed region and other features including accessibility of the binding site region and 
thermodynamic stability (Alexiou, et al. 2009). Considering the different properties of 
each algorithm, it was thought that the combination of several programs could give 
more accurate target prediction. However, multiple prediction approach appears to be 
less robust than single prediction program and the enrichment in true targets was very 
weak (Alexiou, et al. 2009, Alexiou, et al. 2009). To increase accuracy in prediction, 
Ritchie et al. suggested using a unique algorithm but with different 3’UTR sequences 
from different databases, to take into account the co-expression of miRNA and its 
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targets, to consider the presence of different binding sites for these multiple targets and 
to accept only high p-values for the identification of different genes that share a 
common biological function and are regulated by a single miRNA (gene ontology (GO) 
study) (Ritchie, Flamant and Rasko 2009). The use of experimental validation for 
predicted miRNA targets found in silico, has shown that computational predictions 
cannot be considered as final and conclusive results. To increase miRNA target 
prediction accuracy, algorithms should not only incorporate conserved 3’UTR-seed base 
pairing (Table 3.3) but also 5’UTR, ORF, 5’ or 3’ compensatory and multiple binding 
sites (Peter 2010, Wu, et al. 2010b). To improve these tools for researchers, additional 
features have been added to these different prediction programs, resulting in new 
databases such as TarBase or mirZ, where information from different gene, miRNA or 
protein databases and experimental studies are gathered together and help functional 
annotation (Min and Yoon 2010).  
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Table 3.3: Computational prediction of miRNAs 
Program 
Species 
specificity 
Algorithm description Webserver 
miRNA 
target at 
EMBL 
Drosophila Complementarity with 3’UTR 
http://www.russell.embl
-heidelberg.de/miRNAs/ 
miRanda Flies, vertebrates 
Complementarity with 3’UTR,  
thermodynamic stability, 
duplex species conservation 
 
http://www.miRNA.
org/miRNA/home.d
o 
RNAhybrid Any 
Complementarity with 3’UTR,  
thermodynamic stability, 
binding conservation 
 
http://bibiserv.techfak.u
ni-
bielefeld.de/rnahybrid/ 
TargetBoost 
Worm and fruit 
fly 
miRNA-mRNA binding site 
characteristics 
https://demo1.interagon.
com/targetboost/ 
psRNAtarget Plants 
Multiple complementary 
sequence approach 
http://bioinfo3.noble.org
/psRNATarget/ 
miRU Plants 
Perfect complementarity 
sequence, thermodynamic 
stability, sequence 
conservation (genome/ESTs) 
http://bioinfo3.noble
.org/miRNA/miRU.
htm 
miTarget Any 
Thermodynamic stability and 
sequence complementarity 
http://cbit.snu.ac.kr/~mi
Target/ 
Pictar 
Flies 
Vertebrates 
Worm 
Perfect and partial 
complementary sequence with 
3’UTR, 
Thermodynamic stability 
http://pictar.mdc-
berlin.de/ 
RNA22 Any 
miRNA-mRNA binding sites 
characteristics,Complementarit
y with 3’UTR, no cross-
species conservation 
http://cbcsrv.watson.ibm
.com/rna22.html 
MicroTar Any 
Complementarity with 3’UTR 
and thermodynamic stability 
http://tiger.dbs.nus.edu.s
g/microtar/ 
EIMMo 
Humans, mice, 
fish, 
Flies, worms 
miRNA binding sites 
conservation 
http://www.mirz.unibas.
ch/ElMMo2/ 
GenmiR++ Any Sequence complementarity, http://www.psi.toronto.e
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based on expression data sets du/genmir 
PITA Any 
Target site accessibility 
thermodynamic 
http://genie.weizmann.a
c.il/pubs/mir07/mir07_d
ata.html 
NBmiRTar Any 
Sequence and duplex 
characterisitics, no sequence 
conservation, 
 
http://wotan.wistar.upen
n.edu/NBmiRTar/login.
php 
mirWIP Worm 
Structure of target site 
accessibility,  thermodynamic 
stability, based on 
experimental data sets 
http://146.189.76.171/qu
ery.php 
Sylamer Any 
Based on microarray data to 
identify 3’UTR sites 
http://www.ebi.ac.uk/en
right/sylamer/ 
miRTarget2 Vertebrates 
Based on microarray data to 
identify 3’UTR sites 
http://mirdb.org/miRDB
/ 
TargetScan 
TargetScan S 
Vertebrates 
Complementarity with 3’UTR,  
thermodynamic stability, 
duplex species conservation 
 
http://www.targetscan.or
g/ 
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3.5.2.11.2 Experimental validation of miRNA targets 
 
Reporter assays 
The most common miRNA target experimental validation is cloning of the 3’UTR of a 
potential mRNA target downstream of a luciferase or a green fluorescent protein (GFP) 
ORF sequence (Kiriakidou, et al. 2004). Co- transfection of this construct and the 
mimic miRNA of interest is performed into cells that endogenously lack this miRNA. 
Expression of the reporter luciferase or GFP is measured after 24-48 hours (Krutzfeldt, 
Poy and Stoffel 2006, Kuhn, et al. 2008). However, miRNA overexpression by adding 
exogenous molecules can trigger “off-target” effects on other genes that miRNA gene 
targets.  
 
Loss and gain of function studies 
To validate a miRNA target, a loss of function study using antisense oligonucleotides or 
reporter vector technologies can be performed which leads to miRNA inhibition and 
consequently overexpression of the target gene (Kuhn, et al. 2008). Another strategy is 
the combination of transient transfections with mimics or inhibitors of mature miRNAs 
and other methods including microarray assays, western blotting, or proteomics in order 
to identify targets that are directly or indirectly down-regulated or up-regulated by this 
miRNA (Lim, et al. 2005).  
 
SILAC 
Stable-Isotope labelling by Amino-Acids (SILAC), a common method used in 
functional and quantitative proteomics in cell culture (Mann 2006), has been used for 
miRNA target identification in the Hela cell proteome (Vinther, et al. 2006). 12 out of 
504 miRNA targets were repressed by miR-1 via their 3’UTR. These genes overlapped 
with miR-1 regulated genes identified by DNA array and validated by computational 
prediction databases including miRanda, PicTar and TargetScan S that are based on 
seed pairing. The other targets were likely to be regulated via non-canonical binding 
sites or were secondary targets. This technique has been used in addition to mass-
spectrometry after miR-223 knockout in mouse neutrophils leading to the identification 
of 2,773 differentially expressed proteins, including primary and secondary targets 
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(Baek, et al. 2008). In this paper, in addition to SILAC, microarray profiling was 
performed to also identify changes at the transcriptional level. The authors showed that 
mRNA destabilization was the principal mode of endogenous miR-223 inhibition 
leading to strong repression (> 50%) in contrast to translational repression that led to 
modest repression (< 33%). A similar study identified targets of let-7b using pulsed 
SILAC (pSILAC) and microarray techniques after knockdown or overexpression of this 
miRNA (Selbach, et al. 2008). The conclusions from this study showed that miRNA let-
7b represses many proteins and that mRNA and protein levels were down-regulated. 
Repression of protein was mild as demonstrated previously in other studies (Baek, et al. 
2008). 
 
HIT-CLIP 
Recently, high-throughput sequencing of RNAs isolated by crosslinking 
immunoprecipitation (HIT-CLIP) allowed the identification of Argonaute protein-RNA 
interaction complexes in mouse brain leading to miRNA-mRNA interaction site 
identification (Chi, et al. 2009). This technique allows identification of direct protein-
RNA interaction in a genome-wide manner thus only primary targets are revealed 
(Licatalosi, et al. 2008). The principle of the method is based on ultraviolet irradiation 
to induce covalent crosslinks between RNA-protein complexes followed by purification 
of these RNA-binding proteins and small RNAs, which are amplified and sequenced 
(Licatalosi, et al. 2008). In the same manner, Chi and co-workers purified Ago bound to 
mouse brain RNAs, radiolabelled the RNAs, purified the Ago-RNA complexes and 
visualised them by autoradiography (Chi, et al. 2009). They identified ternary 
complexes of Ago protein, miRNA and mRNA. A combination of experimental and in 
silico data led to the identification of interaction sites between miRNAs and their target 
mRNAs. From these interaction sites, genome-wide interaction maps have been 
generated for miR-124 and for the twenty most abundant miRNAs in mouse brain 
tissue. 
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3.5.3 miRNAs as potential tools for CHO cell engineering 
 
The use of single-gene engineering is limited due to the nature of the technology which 
allows the overexpression of a small number of genes at a time. Multiple 
overexpression of genes requires co-transfection which increases the production of 
ectopic proteins and can compete with the endogenous translational machinery. In 
addition, positive cells which express the different transgenes are selected with different 
markers that are produced by the translational machinery and possibly overload it. As 
an alternative to coding-gene engineering approach, miRNAs do not compete with the 
endogenous translational machinery (Muller, Katinger and Grillari 2008). The capacity 
of miRNAs to target hundreds of genes makes them very promising tools to target entire 
cellular pathways such as cell growth and cell cycle, cell metabolism, stress, secretion 
and apoptosis. For example, overexpression and/or knockdown of different miRNAs 
using constitutive and inducible promoters might allow mimicking the effect of 
temperature-shift in a biphasic culture. Stable cell lines could be engineered with 
miRNAs to increase proliferation and at the middle of the logarithmic growth phase, an 
inducible system promoting the induction of other miRNAs with suppressive impact on 
proliferation and positive impact on secretion or metabolism to trigger cell growth arrest 
and direct the cellular machinery towards production. The participation of miRNAs in 
different cellular pathways presents exciting opportunities to engineer cells in different 
ways and to apply all these tools at different time points of the cell culture.  
 
3.5.3.1 Let-7 family 
 
Many miRNAs have been reported to be involved in proliferation including let-7, one of 
the first studied miRNA. Let-7 has an essential role in the development of C.elegans, 
with its deregulation leading to growth abnormalities (Pasquinelli, et al. 2000). Let-7 
sequence and function are well conserved across species (Thomson, et al. 2006, 
Sempere, et al. 2004, Sempere, et al. 2002, Liu, et al. 2010). Most of let-7 family 
members act as tumor suppressors in many cancers (Esquela-Kerscher and Slack 2006, 
Roush and Slack 2008, Slack and Weidhaas 2006). It has been reported that one cluster 
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of this family that consists of let-7a, let-7d and let-7f is directly down-regulated by Myc 
overexpression thus promoting tumorigenesis (Chang, et al. 2009). Myc is a 
transcription factor often deregulated in cancers (Cascon and Robledo 2012, Dang 
2012). However, hypomethylation of let-7a-3 triggers its up-regulation in human lung 
cancer cells causing induction of tumorigenesis (Brueckner, et al. 2007). This is a 
common characteristic of miRNAs which have been reported to display antagonising 
role for a same cellular function depending of the cell/tissue-type and the environment 
conditions (Cheng, et al. 2005). 
 
3.5.3.2 miR-17~92 cluster and its paralogs 
 
The miR-17~92 cluster and its paralogs miR-106b-25 and miR-106a-363 clusters are 
oncogenes involved in many cancers (He, et al. 2005, Volinia, et al. 2010). They 
promote proliferation and high survival rate (Hayashita, et al. 2005, Lu, et al. 2007). In 
B cell lymphoma, induction of the miR-17~92 cluster promotes tumor progression and 
inhibits apoptosis (O'Donnell, et al. 2005). Interestingly, MYC is responsible for miR-
17~92 cluster transactivation. The miR-17~92 cluster directly targets Bim, a pro-
apoptotic protein which regulates cell death by antagonizing anti-apoptotic proteins like 
Bcl-2 (Koralov, et al. 2008). The miR-17~92 cluster and its paralogs are also involved 
in cell cycle. E2F family members involved in G1/S progression are direct targets of the 
miR-17~92 cluster and its paralogs and they also regulate the transcription of these 
miRNAs in a negative feedback loop (O'Donnell, et al. 2005, Sylvestre, et al. 2007, 
Woods, Thomson and Hammond 2007, Petrocca, et al. 2008). miR-17 has been reported 
to influence cell cycle progression by targeting p21, a cyclin-dependent kinase inhibitor 
involved in the G1/S phase (Petrocca, et al. 2008, Ivanovska, et al. 2008).  
 
3.5.3.3 miR-34 family 
 
The tumor suppressor p53 targets miR-34a, miR-34b and miR-34c which in turn repress 
downstream targets to trigger cell cycle arrest in G1 phase and apoptosis (Hermeking 
2010, Hermeking 2007, Tarasov, et al. 2007). p53 is negatively regulated by miR-504 
and by miR-125b preventing apoptosis and cell cycle arrest (Hu, et al. 2010). In 
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addition, miR-34c has been reported to target c-Myc to prevent genomic instability in 
DNA damage response (Cannell and Bushell 2010).  
 
3.5.3.4 miR-21 
 
miR-21 is very well studied and acts as an oncomiR in many human cancers (Pan, 
Wang and Wang 2011, Chan, Krichevsky and Kosik 2005) Targets of miR-21 include 
regulators of tumorigenesis, cell cycle control and apoptosis including p53 pathway 
components and TGF-β (Papagiannakopoulos, Shapiro and Kosik 2008), the 
PTEN/AKT signaling pathway (Zhang, et al. 2010), antagonists of the RAS pathway 
(Frankel, et al. 2008, Zhu, et al. 2008), FasL (Wang and Li 2010) and Cdc25A (Wang, 
et al. 2009b). 
 
3.5.3.5 miR-24 
 
miR-24 has been previously shown to be involved in cell proliferation, cell cycle , 
apoptosis and DNA repair genes (Lal, et al. 2009a, Qin, et al. 2010, Mishra, et al. 2009). 
The up-regulation of miR-24 induces down-regulation of H2AX leading to inhibition of 
DNA repair in differentiated blood cells (Lal, et al. 2009b). miR-24 up-regulation was 
reported to trigger cell cycle arrest in G1 phase via targeting key nodes of the cell cycle, 
MYC and E2F2, and their downstream targets including CCNB1, CDC2, CDK4, 
p27Kip1 and VHL were also found to be targeted by miR-24 (Lal, et al. 2009a). Other 
targets involved in other phases of the cell cycle were also differentially regulated 
including FEN1, MCM4, MCM10, PCNA (S-phase) and AURKB (M-phase).  
miR-24-2 is co-transcribed with miR-23a and miR-27a as part of miR-23a~27a~24-2 
cluster. In humans, miR-23a~27a~24-2 cluster is intergenic and localized on 
chromosome 9q22 and its paralog miR-23b~27b~24-1 cluster is localized on 
chromosome 19p13 and is intronic (Chhabra, Dubey and Saini 2010). It has been 
reported that it is not uncommon for miRNA clusters to have homologs and paralogs 
(Yu, et al. 2006) . The role of the whole cluster in cell proliferation and apoptosis has 
been studied in cancer diseases. Up-regulation of miR-23a~27a~24-2 cluster induced 
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apoptosis in human embryonic kidney cells (Chhabra, et al. 2009, Chhabra, et al. 2009, 
Chhabra, Dubey and Saini 2011). 
3.5.3.6 miR-23a/b 
 
Recent reports showed the role of c-Myc in glutamine catabolism through repression of 
miR-23a and miR-23b (Gao, et al. 2009, Dang 2010). c-Myc has been shown to regulate 
glucose metabolism by promoting glycolysis in transformed cells (Osthus, et al. 2000, 
Kim, et al. 2004b). Altered glucose metabolism in cancer is known as the Warburg 
effect. Cancer cells take up excessive amounts of glucose and convert it to lactate even 
in the presence of adequate levels of oxygen (Dang 2010). c-Myc also regulates 
Hypoxia-inducible factor 1 (HIF-1) expression, a key regulator of hypoxia (oxygen 
deprivation), in normal and cancer cells (Doe, et al. 2012). Through the Warbug effect, 
glucose and glutamine are used as great sources of energy to provide ATP and NAPDH 
to new cancer cells formed (Dang 2010). As c-Myc is involved in the Warburg effect 
and it increases the expression of mitochondria glutaminase by repression of miR23a/b 
in transformed cells, miR-23b could also be involved in the metabolism of CHO cells. 
 
3.5.3.7 miR-27a/b 
 
miR-27 is involved in cell metabolism, through adipogenesis regulation. PPARγ, a key 
regulator of adipogenesis has been validated as miR-27 target (Lin, et al. 2009). miR-27 
has been shown to affect cholesterol homeostasis, fatty acid metabolism and lipogenesis 
(Sacco and Adeli 2012, Fernandez-Hernando, et al. 2011). miR-27 is also involved in 
the G2/M checkpoint of the cell cycle in breast cancer cells (Mertens-Talcott, et al. 
2007).  
 
3.5.3.8 miR-7 
 
miR-7 is highly conserved across species, from annelids to humans suggesting that its 
functional role may also be conserved (Prochnik, Rokhsar and Aboobaker 2007). In 
human, mature miR-7 sequence is derived from three miRNA precursors, miR-7-1, 
64 
 
miR-7-2 and miR-7-3. The miR-7 homolog in mice originates from two precursors, 
mmu-miR-7a and mmu-miR-7b, whose sequences differ from one or two nucleotides. 
miR-7 is an intronic miRNA which resides in the first intron of heterogenous 
ribonuclear protein K gene on chromosome 9 in humans and on chromosome 13 in 
mice. Generally, the expression of intronic miRNAs is highly correlated to the 
expression of the host gene (Baskerville and Bartel 2005). However, it is not the case 
for miR-7 which exhibits differential expression profile to that of its host gene hnRNP-
K (Aboobaker, et al. 2005).  
 
3.5.3.8.1 The role of miR-7 in cell proliferation and apoptosis 
 
miR-7 is involved in cell proliferation, apoptosis regulation and its deregulation has 
been reported in many cancers including breast cancer, pancreatic cancer, 
glioblastomas, lung cancer and tongue squamous cell carcinoma (Chou, et al. 2010, 
Kefas, et al. 2008, Ikeda, et al. 2012, McInnes, et al. 2012, Jiang, et al. 2010). In most of 
these studies, miR-7 acts as a tumor suppressor, its induction causing inhibition of 
tumor progression. miR-7 has been shown to regulate the phenotypes-associated with 
cancers by targeting EGFR and IGFR, two signalling pathways involved in the 
development of tumorigenesis. 
Jiang L et al reported the depletion of IGF1R (insulin-like growth factor 1 receptor) at 
both the mRNA and protein levels upon overexpression of miR-7 in tongue squamous 
cell carcinoma (TSCC) and confirmed the direct interaction between  miR-7 and IGF1R 
using luciferase-reporter assay (Jiang, et al. 2010, Jiang, et al. 2010). The IGF1 (insulin-
like growth factor 1)-dependent activation of Akt (protein kinase B) was repressed as a 
result of IGF1R inhibition by miR-7 leading to cell proliferation reduction and cell-
cycle arrest and on the other hand enhanced apoptotic rate. Recently, the levels of miR-
7 have also been shown to anti-correlate with those of IGF1R leading to reduced gastric 
cancer cell migration and invasion (Zhao, et al. 2012). 
In contrast to IGF1R, many studies have focused on the repression of Epidermal 
Growth Factor Receptor (EGFR) by miR-7 induction. miR-7 has been reported to 
repress the EGFR pathway, the Akt pathway and extracellular signal-regulated kinase 
1/2 (ERK1/2), its downstream effectors which are both activated in glioblastomas, 
prostate, lung and breast (Kefas, et al. 2008, Giles, et al. 2011, Webster, et al. 2009). 
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The protein kinase B/Akt, is involved in the control regulation of proliferation, invasion, 
angiogenesis, and apoptosis resistance in glioblastomas as well as prostate cancers 
(Giles, et al. 2011). Webster and co-workers showed that miR-7 reduced the expression 
levels of EGFR mRNA and protein expression in cancer cell lines (lung, breast, and 
glioblastoma), inducing cell cycle arrest and cell death (Webster, et al. 2009). miR-7 is 
also involved in the regulation of the phosphoinositide 3-kinase (PI3K)/AKT/mTOR 
(mammalian target of rapamycin) pathway, another critical pathway downstream of 
EGFR which is also associated with cell proliferation, survival, and metastasis (Fang, et 
al. 2012). The negative regulation of the effectors of the PI3K/AKT/mTOR pathway by 
miR-7 induced G0 /G1-specific cell-cycle arrest and impaired cell migration in 
hepatocellular carcinoma. It has been suggested that EGFR induces miR-7 expression 
through the Ras/ERK/Myc pathway (Chou, et al. 2010) Besides EGFR, miR-7 has been 
shown to also inhibit p21-activated kinase 1 (Pak1), and activated Cdc42-associated 
kinase (Ack1) signaling pathways in Schwannomas tumors (Saydam, et al. 2011). 
Recently, Foxp3, a member of the Fork-head family of transcription factors, has been 
reported to promote miR-7 inducing suppression of oncogene STAB1 by a feed-forward 
loop in breast cancer (McInnes, et al. 2012). BCL-2, a critical regulator of apoptosis was 
found to be down-regulated by miR-7 at both mRNA and protein levels leading to 
growth suppression and apoptosis of in lung carcinoma cell line A549 (Xiong, et al. 
2011).  
 
3.5.3.8.2 The role of miR-7 in secretion regulation 
 
miR-7 has been shown to be one of the most abundant miRNA in Langerhans islets, in 
the endocrine pancreas of rat, human, mice and in neurosecretory cells of zebrafish 
(Bravo-Egana, et al. 2008, Wienholds, et al. 2005, Lynn, et al. 2007, Tessmar-Raible, et 
al. 2007). The role of miR-7 in secretion regulation is supported by its increased levels 
of expression correlated to the increase of insulin transcript during the 
development/differentiation of human pancreas and in the adult pancreas (Correa-
Medina, et al. 2009, Joglekar, Joglekar and Hardikar 2009). In agreement with this, 
Nieto M et al., reported that miR-7 knockdown attenuated insulin production, decreased 
β-cell numbers, and glucose intolerance during early embryonic life of mice (Nieto, et 
al. 2011). Another study showed that insulin receptor substrate 1 (IRS1) expression was 
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down-regulated as well as insulin-stimulated Akt phosphorylation and glucose uptake 
upon miR-7 overexpression (Li, et al. 2011). 
 
3.5.3.8.3 The role of miR-7 in robustness  
  
In addition to its involvement in cell proliferation, apoptosis and secretion regulation, 
miR-7 has been reported to impart robustness during drosophila development. Induction 
of miR-7 in drosophila cells led to reduction of Notch expression, a gene involved in 
developmental processes including tissues growth (Stark, et al. 2003). Later, miR-7 was 
shown to fine-tune the expression of development-specific genes to avoid major cell 
perturbation and to maintain robustness during environmental flux (Li, et al. 2009, Li 
and Carthew 2005). Lin X et al., demonstrated that under temperature fluctuation 
(between 31°C and 18°C), miR-7 is able to buffer specific gene expression and cell 
fates in the development of Drosophila larvae. Upon temperature fluctuation and in 
presence of miR-7, there were no changes in miR-7 targets expression, Ato (atonal) and 
Yan, two critical factors for the development of insect sensory organs. Under the same 
conditions, miR-7 mutant showed strong repression of Ato and high expression of Yan 
leading to development defects.  
 
3.5.3.8.4 The role of miR-7 in CHO cells 
 
The gathered information from the miR-7 studies described above reported that miR-7 
is involved in cell growth, apoptosis, secretion and homeostasis regulation. All these 
pathways are relevant to bioprocess application and may be subjected to manipulation 
to improve CHO cell density, viability and recombinant protein production.  
We previously reported that transient overexpression of miR-7 induced cell growth 
reduction and improved normalised productivity in low serum-supplemented CHO-K1 
SEAP culture (Barron, et al. 2011). The overexpression of miR-7 was recently reported 
to impact negatively on ribosomal proteins in CHO cells (Meleady, et al. 2012). Several 
of these down-regulated proteins, including RPS10, have been shown to be associated 
with cell proliferation, cell cycle, apoptosis and development regulation (Ren, et al. 
2010, Lindstrom 2009, Warner and McIntosh 2009, Wang, et al. 2006). The induction 
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of miR-7 in CHO cells also promoted the expression inhibition of histone proteins 
including histones H3 and H4. These recent findings indicate that miR-7 may be a 
promising target in the improvement of bioprocess-relevant CHO characteristics. 
 
3.5.3.9 Limitations of miRNAs in CHO cells and future perspectives  
 
Until recently with the release of CHO-K1 cell line genome (Xu, et al. 2011), sequence 
information on CHO cells was not publicly available therefore research on cDNA and 
miRNAs as tools to engineer CHO cells was based on sequence homology and 
conservation in similar species such as human, rat and mouse. Although mature miRNA 
sequences are well conserved across species, notably on the hairpin and the loop of 
miRNAs, the flanking sequences on either side are not (Berezikov, et al. 2005, Hertel, et 
al. 2006). Thus the unknown degree of homology with CHO and other species was 
limiting the panel of tools applicable to CHO cell engineering. In 2007, our laboratory 
used miRNA bioarrays designed with specific probes to human, rat and mouse RNA to 
identify differentially regulated miRNAs upon temperature–shift in CHO cells 
(Gammell, et al. 2007). In this study, the design of primers, based on the identification 
of a consensus sequence following alignment of pre-mir-21 flanking sequences across 
different species, allowed the identification and sequencing of miR-21 in CHO cells, 
listed as cgr-miR-21 in the miRBAse miRNA registry (http://miRNA.sanger.ac.uk/). 
Based also on miRNA sequence conservation across species, a microarray platform 
(miRCURY LNA™ miRNA Array) and a qRT-PCR method validated in human and 
mouse was applied for miRNA profiling in CHO cells (Lin, et al. 2010). The difference 
with the previous study was the probes which were designed using Locked Nucleic 
Acid (LNA™) technology increasing binding specificity. More recently, the use of 
high-throughput sequencing and annotation by homology with human, mouse and rat, 
resulted in the identification of 350 distinct miRNAs and miRNAs* sequences from 
four CHO cell lines (Johnson, et al. 2011). Unlike microarray technology, next-
generation sequencing allows the identification of novel miRNAs. In addition, read 
lengths produced are compatible with the length of mature miRNAs and siRNAs 
(Nobuta, et al. 2010, Morozova and Marra 2008). In a short time, new tools were 
available to identify and annotate mature miRNAs in CHO cells with no need for 
sequence information (Hackl, et al. 2011). In one study, the sequencing of 26 validated 
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targets of miR-17~92 cluster, showed that 19 had their binding sites conserved whereas 
the 7 others could not be detecte (Hackl, et al. 2012). This is likely due to either 
incomplete sequencing coverage or due to possible shorter 3’UTRs of CHO-specific 
mRNA isoforms (Bartel 2009). This knowledge of mature and precursor miRNA 
sequences will help to develop CHO cell-specific technologies, including microarray 
and qPCR primers. 
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4 Aims of thesis 
 
The aims of this thesis were as follows: 
 
• To adapt CHO-K1 SEAP cells in serum-free suspension culture 
 
• To validate candidate miRNAs as potential tools to improve CHO cell 
phenotypes 
Previously in our laboratory, a first miRNA profiling study using TLDA array was 
performed to investigate the changes of miRNA expression associated with temperature 
reduction and cell growth decrease and a second one was carried out to identify 
miRNAs which changes of expression were associated with fast and slow cell 
proliferation. 
We propose to screen these candidate miRNAs in a range of functional assays using 
transient transfection of mimic or inhibitor molecules where appropriate in order to 
assess their impact on important bioprocess-relevant phenotypes including cellular 
growth rate, maintenance of viability and recombinant protein production. The outcome 
from these assays would allow selection of suitable miRNAs for further investigation 
and prioritization on their role in CHO cells and their potential to improve CHO 
phenotypes. 
 
• To investigate the potential of the individual miR-23a~miR-27a~24-2 cluster 
members in improving CHO cell characteristics 
A recent study in our laboratory indicated that miR-24-2 could be a useful tool for 
modifying CHO cell growth. miR-24 is expressed as part of a cluster so we aim to 
investigate this potential in greater details as well as assessing the utility of the other 
cluster members miR-23a and miR-27a. We propose to screen these three miRNAs 
individually and simultaneously in a range of functional assays using transient 
transfection of mimic or inhibitor molecules and evaluate their potential in ameliorating 
CHO characteristics. This functional study would unravel the individual and 
cooperative effects of miRNAs inside the cluster and their impact on CHO phenotypes. 
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• To generate CHO cell clones with improved characteristics by stable 
manipulation of miR-23a~miR-27a~24-2 cluster 
We aim to achieve depletion of miR-23a~miR-27~24-2 cluster and to investigate its 
impact on cell proliferation. We considered a multiple antisense approach (‘multi-
antisense cluster) and propose to generate stable multi-antisense cluster –expressing cell 
lines to knockdown simultaneously the miR-23a~miR-27~24-2 cluster members. 
 
• To investigate the potential of miR-7 in improving CHO cell characteristics 
Previous results from our laboratory indicated that miR-7 could be a useful tool for 
modifying CHO cell growth and productivity. We aim to investigate whether miR-7 
could be a target for engineering CHO cell lines. We propose to screen miR-7 in a range 
of functional assays using transient transfection of mimic or inhibitor molecules and 
monitor its impact on important bioprocess-relevant phenotypes including cellular 
growth rate, maintenance of viability and recombinant protein production.  
 
• To generate CHO cell clones with improved characteristics by stable 
manipulation of miR-7 
We propose to use an inducible system which would allow overexpression of miR-7 at 
the middle of the logarithmic phase to stop cell proliferation and consequently turn the 
cellular machinery towards production. On the other hand, we planned to use an 
antisense approach known as miRNA sponge to sequester miR-7 and to improve cell 
proliferation. The generation of stable cell lines would enable the monitoring of cell 
growth, viability and productivity over a longer period of time, in batch and fed-batch 
culture.  
 
• To investigate the functional role of miR-7 in CHO cells 
To understand the molecular mechanisms underlying cell growth arrest upon miR-7 
induction, we aim to identify miR-7 targets using microarray approach and validate 
these targets through real-time PCR, 3’UTR reporter analysis and western blotting. To 
further understand the network of factors involved in miR-7-dependent regulation of 
cell proliferation, we propose to identify any changes in expression of other CHO minas 
subsequent to exogenous miR-7 expression. 
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5 Materials and Methods 
 
5.1 GENERAL TECHNIQUES OF CELL CULTURE 
 
5.1.1 Ultrapure water 
 
All solutions were made with ultrapure water. This water was purified by a reverse 
osmosis system (Millipore Milli-RO 10 Plus, Elgastat UHP) to a standard of 12-
18MΩ/cm resistance. 
 
5.1.2 Sterilisation 
 
All glassware, water and thermostable solutions were autoclaved 121˚C for 20 minutes 
under a pressure of 1bar. Thermolabile solutions (i.e. 10% DMSO, serum) were filtered 
through a 0.22µm sterile filter (Millipore, millex-gv, SLGV-025BS). 
 
5.1.3 Cell culture cabinet 
 
Cell culture work was performed in a class II laminar air-flow (LF) cabinet (Holten). 
Cleaning of the LF cabinet was carried out with 70% industrial methylated spirits (IMS) 
before and after use. Prior to use any items in the LF cabinet, they were also sterilised 
by IMS. No more than one cell line was brought in the LF cabinet to avoid cross-
contamination between cell lines. Before working with another cell line, a 15 min 
period was given to allow clearance of any possible contaminations. Weekly cleaning of 
LF cabinet included Virkon, a detergent solution (Virkon, Antec International; TEGO, 
TH. Goldschmidt Ltd.), followed by water and IMS. 
74 
 
 
5.1.4 Incubators 
 
Adherent cells were maintained at 37C, in an atmosphere with 5% CO2 and 80% 
humidity. Cells in suspension were also maintained in these conditions in an ISF1-X 
(Climo-Shaker) Kuhner incubator with a speed at 130-170 rpm. Weekly cleaning of the 
incubators followed the same protocol described for the cell culture cabinet.  
 
5.2 Subculture of cell lines 
 
5.2.1 Anchorage-dependent culture 
 
CHO-K1 SEAP cells were split every three days and seeded at 3x105cells/ml in T-75 
flask with vented cap. Culture medium consisted of ATCC medium, (DMEM/F-12 Ham 
containing glutamine and sodium pyruvate; Sigma) supplemented with 5% fetal bovine 
serum (FBS) (Sigma). Every passage, cells were washed with 3ml PBS and detached 
using 3ml of pre-warmed trypsin/EDTA (TV). Cells were incubated with TV for five 
minutes until detachment from the treated flask was observed. 10ml of ATCC medium 
supplemented with serum were added to the flask to inactivate TV. Cells were spun 
down at 1000 rpm for 5 min, supernatant was removed and pellet was resuspended with 
10ml fresh medium to seed a new flask. 
 
5.2.2 Suspension culture 
 
Suspension-adapted CHO-K1 SEAP cells were passaged every three days and seeded at 
2x105cells/ml in 30ml spin tubes (CultiFlask, Sartorius) or 250 mL spinner flasks 
vented cap. Cells were maintained at 170rpm on spinner platform at 37°C, 
supplemented with 5% CO2. Cells were spun down at 1000 rpm for 5 min, supernatant 
was removed and pellet was resuspended with 10ml fresh medium to seed a new flask. 
Cells were adapted to serum-free medium in CHO-S-SMF II (Life technologies) and 
HyClone (Thermo SCIENTIFIC) media. CHO-S-SMF II is a complete, serum-free 
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and low protein (<100µg/ml) cell culture medium applied for recombinant protein 
production in CHO cells. HyClone is a defined serum-free and protein-free medium, 
designed for high cell yield and recombinant protein production. For fed-batch culture, 
CHO CD EfficientFeed™ A was added at 15% of the final volume at day 0 and at 10% 
of the final volume every 3 days for 13 days. Cells were maintained in the same 
conditions described for the batch culture but the speed was reduced to 130rpm. 
 
5.2.3 Cell counting and viability determination 
 
5.2.3.1.1 Trypan blue method 
 
Trypan blue is a dye exclusion technique that penetrates and stained dead cells through 
their damage membrane. This dye is excluded from alive cells which still have an intact 
membrane. Equal amount of cells and trypan blue were mixed to a final volume of 100 
µl and 10µl of this mixture was transferred to a hemocytometer (Neubauer) covered 
whith a coverslip. The number of cells was evaluated by the cell count average of four 
grids in the hemocytometer. This number was multiplied by 104, which is the volume of 
the grid and by the dilution factor to get the number of cells/ml in the original sample.  
 
5.2.3.1.2 Cedex Automated Cell Counter 
 
The Cedex Automated Cell Counter (Roche innovatis AG) is an automated cell 
counting system based on the Trypan Blue exclusion method for determining cell 
density, cell viability and cell size. This counter is more accurate and precise than the 
manual count and allows the visualisation of viable, dead cells and aggregates.  
 
5.2.3.1.3 Flow cytometry  
 
Guava Viacount reagent (Merck-Millipore) distinguishes viable and non-viable cells 
based on differential permeability of two DNA-binding dyes. The membrane permeant-
dye (LDS-751) stains all nucleated cells, leaving nuclear debris unstained. The 
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membrane impermeant-dye (propidium iodide) stains only damaged cells thus only 
apoptotic and dying cells are detected. This combination of dyes enables the Guava 
ViaCount Assay to distinguish viable, apoptotic, and dead cells. Cells were diluted in 
Guava Viacount reagent at appropriate concentration and cell counting was performed 
through Guava EasyCyte flow cytometry system. 
 
5.2.4 Cell freezing 
 
Cells were harvested at the middle of the exponential phase of growth and resuspended 
in fresh medium few hours prior cryopreservation. Cells were counted, spun down at 
1000 rpm for 5 min and resuspended with pre-chilled mixture of 1ml of ATCC/50% 
FBS and 1ml of 10% filtered cryo-protective agent dimethyl sulfoxide (DMSO). DMSO 
was added slowly and dropwise to avoid cell membrane damage. This mixture was 
transferred to a cryovial and was stored at -20°C for one hour, -80°C overnight and 
placed into liquid nitrogen at -196°C. 
 
5.2.5 Cell thawing 
 
5ml of pre-warmed ATCC + 5%FBS was added quickly to the frozen cells in cryovial 
to avoid cell toxicity by DMSO. Cells were spun down at 1000 rpm for 5 min. Pellet 
was resuspended with fresh medium (ATCC + 5%FBS or serum-free medium) and cell 
counting was carried out to evaluate cell viability. Cells were transferred in an 
appropriate cell culture vessel and incubated at 37°C for 12 hours. Cells were spun 
down again and resuspended with fresh medium to eliminate any residual traces of 
DMSO. 
 
5.2.6 Cell cycle analysis 
 
Cells were washed in 1X PBS, fixed with 200µl ice-cold 70% ethanol and refrigerated 
for 12hours prior to staining. After overnight incubation at 4°C, the cell pellet was 
washed in 1X PBS, resuspended in 200µl Guava Cell Cycle reagent containing 
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propidium iodide (Merck-Millipore) and incubated in the dark at 37˚C for 15min before 
analysis with a Guava Easycyte96 (Merck-Millipore). For each step, centrifugation was 
performed at 1000 rpm for 5min at room temperature. The data from the FCS files were 
analysed using MutliCycle™ DNA analysis in the FCS Express 4 flow cytometry 
software (De Novo software). 
 
5.2.7 Apoptosis analysis 
 
Cells were harvested and resuspended in 200 µl Guava Nexin reagent (Merck-
Millipore) at 72hrs and 120hrs after transfection. Cells were incubated for 20min at 
room temperature before analysis with a Guava Easycyte96 (Millipore).  
 
5.2.8 Senescence assay 
 
Cells were fixed 72hrs after miR-7 transfection or 96hrs after BrdU addition (Sigma-
Aldrich). β -galactosidase activity at pH 6 was assayed as recommended in the 
senescence β-galactosidase staining kit (#9860 Cell Signalling). 
 
5.3 OTHER TECHNIQUES OF CELL CULTURE 
 
5.3.1 Single cell clone Limited dilution 
 
To obtain one single cell clone, serial dilution was performed in 96-well plates. Cells 
were cultivated in adherent format for few days until reaching 90% confluence. They 
were fed with fresh medium few hours before the dilution process. Cells were rinsed 
and detached with pre-warmed TV after 5 min incubation at 37°C. 9ml of fresh medium 
were added to the cells and mixing by pipetting up and down was repeated several times 
to increase the chance of precise dilution. An aliquot was harvested for cell counting 
and cells were centrifuged at 1000 rpm for 5 min. Cells were resuspended with fresh 
medium and cell counting was performed three times for accuracy. Serial dilution was 
carried out with pre-warmed, filtered sterilised conditioned medium taken from 48 
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hours after culture. Final cell concentration was 5 cells/ml and aliquots of 100µl were 
transferred to a 96-well plates to get approximately one clone per two wells. Cells were 
incubated for one week and during this period of time, plates were observed under 
microscope to ensure the presence of one single colony per well. The number of single 
cell clones per plate was estimated at around ten. 
 
5.3.2 Single cell clone sorting 
 
Fluorescence-activated cell sorter (FACS) can separate cells on the basis of their size 
and fluorescence. To increase the amount of single cell clones per plate, cell sorting was 
done using FACS. Cells are directed into a stream that forms droplets after a laser is 
directed at the stream. These droplets may contain a cell that results in fluorescence 
detection. Cells were sorted by rate of fluorescence, medium or high GFP percentage 
detected by FITC channel, in 96 well plates containing equal amount of conditioned 
medium and fresh ATCC + 5% FBS medium, supplemented with 50µg sterile-filtered 
Penicillin/Streptomycin solution (to avoid Gram-negative and Gran-positive bacterial 
contaminations) and 500µg/ml of G418.  
FITC (fluorescein isothiocyanate) is a fluorochrome dye that absorbs ultraviolet or blue 
light causing molecules to become excited and emit a visible yellow-green light 
(excitation and emission wavelength are 494 nm and 518 nm respectively). A strict cut 
off was performed using unstained cells to allow the software to distinguish between 
GFP negative and positive cells.  
 
5.3.3 Transfection 
 
5.3.3.1.1 Transfection of cDNA molecules using lipid-based reagent 
 
Cells were seeded at 1x106 cells/ml in ATCC + 5% FBS medium, in 6-well plates. 
Before transfection, medium was replaced by fresh medium without drugs. 11µl of 
lipid-based transfection reagent (lipofectamine 2000) were diluted into 260µl of serum-
free medium and incubated 5min at room temperature. 5µg of plasmid were diluted in 
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260 µl of serum-free medium and mixed gently to lipofectamine solution for 20min at 
room temperature. The mixture was transferred drop by drop on the adherent cells and 
the plate was incubated at 37°C.  
 
5.3.3.1.2 Transfection of cDNA by electroporation 
 
All materials used (plasmid DNA, cells, buffer, cuvettes) were incubated on ice for 
30min before starting. Cells were seeded at 8x106 cells/ml in 800µl chilled 
filtered/sterilised electroporation buffer (2mM HEPES, 15mM K+PO4, 1mM MgCl2 and 
250mM Mannitol in 50ml final volume) in eppendorf tube and 5µg of plasmid DNA 
was added to the tube. Appropriate volume of medium needed to resuspend cells after 
electroporation (5ml in spin tube or 12ml in T75 flask with 1% serum to if the original 
culture was in serum-free medium) was pre-warmed at 37°C during the assay. The 
machine was set up at a capacitance of 500µF and 200 volts.  High capacitance was 
chosen for eukaryotic cells (> 50µF). Sample was mixed by pipetting up and down and 
transferred to the cuvette. After electroporation, actual voltage and time constance were 
recorded. Electroporated cells were suspended in warm medium by pipetting up and 
down few times and put in culture at 37°C. 
 
5.3.3.1.3 Selection of transgenic clones 
 
Medium of transfection was replaced by fresh medium 6 hours following the assay. 
This medium was then replaced by fresh medium supplemented with drugs for positive 
cell selection 48 hours after transfection. The minimum concentration to kill 90% of 
cells was found to be 250-350µg of hygromycin, 1000µg/mL of G418. Doxycyclin 
when required was added 6 hours after transfection at 10µg/mL. The surviving cells 
were expanded and used for single cell cloning as mentioned. 
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5.3.3.1.4 Tet OFF gene expression system 
  
The first critical component of the Tet Systems is the regulatory protein, based on TetR. 
In the Tet-Off System, this 37-kDa protein is a fusion of amino acids 1–207 of TetR and 
the C-terminal 127 amino acids. of the Herpes simplex virus VP16 activation domain 
(AD; Triezenberg et al., 1988). Addition of the VP16 domain converts the TetR from a 
transcriptional repressor to a transcriptional activator, and the resulting hybrid protein is 
known as the tetracycline-controlled transactivator (tTA). tTA is encoded by the pTet-
Off regulator plasmid, which also includes a neomycin-resistance gene to permit 
selection of stably transfected cells. 
The second critical component is the response plasmid which expresses a gene of 
interest (Gene X) under control of the tetracycline-response element, or TRE. TRE 
consists of seven direct repeats of a 42-bp sequence containing the tetO, located just 
upstream of the minimal CMV promoter (PminCMV). PminCMV lacks the strong 
enhancer elements normally associated with the CMV immediate early promoter. 
Because these enhancer elements are missing, there is extremely low background 
expression of Gene X from the TRE in the absence of binding by the TetR domain of 
tTA or the rTetR domain of rtTA. In the Tet-Off System, tTA binds the TRE and 
activates transcription in the absence of Tc or Dox. 
 
5.3.3.1.5 Cell transfection with miRNAs/siRNAs  
 
CHO-K1 SEAP cells seeded at 1x105 cells/ml with a viability at minimum 90%, were 
transiently transfected with a total concentration of 30-100nM mimic molecules (Pre-
miR, Applied Biosystems or #M-01-D, double stranded microRNA mimics, 
GenePharma), inhibitor molecules (Anti-miR, Applied Biosystems or #M-02-D, single 
stranded microRNA inhibitors) non specific controls (#M-03-D, double stranded 
microRNA mimic negative control, GenePharma or #M-06-D, single-stranded 
microRNA negative control) or siRNAs (Custom design, Integrated DNA 
Technologies) using  SiPORT NeoFx™ transfection reagent (Ambion), a lipid based 
transfection reagent. Mimic and inhibitor molecules were diluted into 100µl of serum-
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free medium. NeoFX was diluted into 100µl of serum-free medium, mix to the diluted 
miRNA mixture and incubated 10 min at room temperature. Once the complex formed, 
it was gently added to the cells in suspension cultured in a 2ml final volume reaction. 
 
5.3.4 3’UTR cloning  
 
RNA was extracted using TRI reagent (Sigma Aldrich) and reverse transcribed using 
the High-Capacity cDNA Reverse Transcription kit (#4368814, Life technologies), with 
oligodT or specific reverse primers. PCR amplicons from PSME3, RAD54L and SKP2 
were generated using the Platinium® PCR SuperMix High Fidelity (#12532-016, Life 
technologies). The PCR program consisted of a denaturation step at 95°C for 2min 
followed by 5 cycles at 95°C for 1min, 58°C for 30sec, 72°C for 2 min and 25 cycles at 
95°C for 1min, 55°C for 30sec, 72°C for 2min and 72°C for 10min.  
 
Primers used were the following (Custom design, MWG eurofins):  
Psme3 F: AAAACTCGAGAATCAGTATGTCACCCTACA 
Psme3 R: AAAAGAATTCGCAGCTTTAGAAAGAGGTC 
Rad54L F: AAAACTCGAGCTTCACCTACAGCCATC 
Rad54L R: AAAAGAATTCTCCTGGGCTTACCAATC 
Skp2 F: AAAACTCGAGCCAGCTGTGTATGAAGTG 
Skp2 R: AAAAGAATTCTTGTTCTTCAAAATCAAGT 
 
The PCR products were restriction enzyme digested and inserted between XhoI and 
EcoRI sites in the CMV-d2GFP-XE vector (modified vector derived from pcDNA5-
CMV-d2eGFP vector, a kind gift from the Sharp lab, MIT). Ligation was performed 
using Rapid DNA Ligation kit (#11635379001, Roche) at 16°C for 30min.  
 
5.3.5 Evaluation of GFP expression 
 
GFP expression was assessed by Guava EasyCyte flow cytometry system using Guava 
Express Plus software. Forward scatter gating as well as % fluorescence (log) gating 
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was fixed at 550-600volts depending on the assay. The data acquired was based on 
these settings and always maintained for the entire experiment.  
 
5.4 MOLECULAR BIOLOGY TECHNIQUES 
 
5.4.1 RNA extraction using miRVana kit 
 
RNA was isolated from CHO cells using mirVanamiRNA Isolation Kit (Ambion) for 
total RNA extraction. Cells were spun down at 1000 rpm for 5 min and resuspended in 
300-600µl of lysis buffer, depending on the cell density. Cells were disrupted after 
pipetting up and down. Organic extraction was done by adding 1/10 volume of miRNA 
Homogenate Additive to the cells followed by 10 min of incubation on ice. Addition of 
300-600 µl of Acid-Phenol:Chloroforme to the lysate, vortex step and centrifugation  
for 5 min at maximum speed, led to RNA extraction. The upper phase (aqueous phase) 
was removed and 1.25 volumes 100% ethanol kept at room temperature was added to 
this phase. Lysate/ethanol mixture was applied to a filter cartridge provided in the kit 
and centrifuged at maximum speed for 15 seconds. Flow-through was discarded and 
filter was washed once with 700µl of Wash Solution 1 and twice with 500µl of Wash 
Solution 2/3. A quick spin at maximum speed was applied between each wash steps and 
flow-through was discarded. Column was spun down 1 min to remove residual fluids 
from washing steps. Filter cartridge was transferred to a new collection tube and RNA 
was eluted by applying 100µl of pre-heated (95°C) Elution Solution to the centre of 
filter and column was spun down 30 sec at maximum speed to recover RNA. 
 
5.4.2 RNA extraction using Tri Reagent 
 
Tri Reagent® is a mixture of guanidine thiocyanate and phenol in a monophase solution 
which dissolves DNA, RNA, and protein on homogenization or lysis of tissue sample. 
1ml is sufficient to lyse 5-10x106cells/ml. 200µl of chloroform were added to the lysis 
to separate DNA, RNA and proteins into 3 phases: an aqueous phase (RNA), the 
interphase (DNA), and an organic phase (proteins). RNA was then precipitated by 
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addition of 500µl ispropanol, wash with 500µl of 75% ethanol and after centrifugation 
the pellet was briefly air-dried under a vacuum and resuspended in appropriate volume 
(generally 20µl) in nuclease-free water. 
 
5.4.3 RNA and DNA concentration evaluation 
 
Concentration of extracted RNA was measured by NanoDrop 2000 (Thermo scientific), 
a spectrophotometer for nucleic acid and protein quantitation. A sample volume of 1.5µl 
was applied to the pedestal of the NanoDrop. A column is formed between the pedestal 
and the arm of the instrument allowing measurement of nucleic acid at absorbance 
260nm and sample purity at 260/280nm. 
 
5.4.4 Reverse transcription 
 
RNA was reverse transcribed into cDNA using High Capacity cDNA reverse 
transcription kit. 10µl of master mix, containing 10x RT Buffer, 25xdNTP Mix 
(100mM), 10x Random primers, 1µl of Multiscribe Reverse Transcriptase (50U/µl) 
and 1µl of RNase Inhibitor, was added to 2µg of RNA in 10µl volume. An appropriate 
volume of nuclease free water was added to have a final volume of 20µl. Tubes were 
spun down briefly and loaded into the thermal cycler. Conditions of thermal cycler 
consisted in four steps. Step one was run at 25°C for 10 min, step 2 at 37°C for 120 min, 
step 3 at 85°C for 5min and temperature was hold at 4°C after the end of the reverse 
transcription cycle. 
 
5.4.5 Polymerase Chain Reaction 
 
DNA samples were amplified using Platinium PCR SuperMix High Fidelity kit, a 
mixture of Taq DNA polymerase and proofreading polymerase Pyroccocus species GB-
D (3’ to 5’ exonuclease activity), dNTPs, salts and magnesium. The volume reaction 
was set up at 50µl, containing 45µl of SuperMix High Fidelity solution, 5µl of primer at 
concentration of 100nM and DNA at a concentration of 1 to 200ng. For amplification, 
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30 cycles of PCR were performed with three different steps for each cycle. Denaturation 
step was run at 95°C for 30 sec, annealing step at 55-60°C for 30sec and extension step 
at 68-72°C for 1min.  
 
5.4.6 PCR purification 
 
QIAquick PCR kit (QIAgen) was used to purify amplicon products up to 10µg from 
PCR reaction. In a microcentrifuge tube, five volumes of Buffer PB was added to 1 
volume of PCR product and solution was mixed. Then solution was transferred to a 
column in a microcentrifuge tube and vaccum was applied to allow fluid to go through 
the column. 750µl of Buffer PE was transferred to the column, vaccum was applied and 
flow-through was discarded. QIAquick column was spun down 1min to remove any 
residual fluid and placed into a new microcentrifuge tube. DNA elution was performed 
by appling 50µl of EB buffer to the centre of the column. The column was let 1 min at 
room temperature and spun down at maximum speed for 1 min. 
 
5.4.7 Agarose gel 
 
To check the size of DNA samples, agarose gel was performed at different 
concentrations, between 0.8% for large DNA fragment (5-10kb) and 2% for small DNA 
fragment (0.2-1kb). Agarose powder was diluted into TAE 1X buffer (made from TAE 
50X buffer consisting of 242g if Tris base, 57.1ml of glacial acid and 100ml of 0.5M 
EDTA in final volume of 1L, pH 8.5) in a 50ml volume. The solution was warmed up 
for 1min 20sec in a microwave to dissolve the agarose and ethidium bromide at 
0.5µg/ml (EtBR) was added to it. This mixture was incubated at room temperature for 
30min to set up the gel, transferred to a small gel tank (8-10cm) and run at 90 volts for 
30min. DNA samples were diluted at a concentration minimum of 20ng and mixed with 
10x loading buffer (made from 25mg of blue bromophenol, 30% of glycerol, 25mg of 
xilene cyanol and water in a final volume of 6.25ml). 
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5.4.8 Quantitative Polymerase Chain Reaction (qPCR) using SYBR green 
method 
 
Fast SYBR Green I dye was used to detect PCR product expression by binding to all 
double-stranded DNAs formed during the cycling of the PCR reaction. Fluorescent 
intensity of the intercalant dye is proportional to the amount of PCR product amplified. 
10µl of 2x Fast SYBR Green Master mix were added to a combination of reverse and 
forward primers (concentration minimal 200nM for each primer), to cDNA 
(concentration of 20ng) and nuclease-free water in 20µl final volume reaction. Reaction 
was run for 40 cycles in the thermal cycler using 7500 fast program. For each cycle, the 
first step of AmpliTaq Fast DNA Polymerase (the activation) was run at 95°C for 20 
sec, denaturation was run at 95°C for 1 sec and the last step corresponding to the 
annealing/extension step was set up at 60°C for 20sec.  
 
5.4.9 MicroRNAs Reverse transcription and real time PCR using TaqMan 
 
5.4.9.1.1 Reverse transcription  
 
Following total RNA extraction using mirVanamiRNA Isolation Kit (Ambion) or Tri 
regent (Sigma), RNA was quantified by NanoDrop spectrophotometer. RNA was 
diluted in nuclease-free water at 2ng for the RT reaction. A 10µl reaction solution 
including 0.15µl of 100mM of dNTPs, 10x reverse transcription buffer, 1µl of 
Multiscribe Reverse Transcriptase (50U/µl), 0.19µl of RNase inhibitor (20U/µl) was 
added to 5µl of RNA. Solution was mixed gently and spun down briefly. Tubes were 
transferred to the thermal cycler and program was set up for one cycle, with the first 
step at 16°C for 30min, the second step at 42°C for 30min and 85°C for 5min. 
86 
 
 
 
Step 1: Stem-loop RT. Stemloop RT primers are annealed to miRNA targets and 
extended in the presence of reverse transcriptase. 
 
5.4.9.1.2 Real-time PCR 
 
Real-time PCR reaction master mix was done in a 18.67µl reaction with TaqMan 
Small RNA Assay 20x, TaqMan Universal PCR Master Mix 2x and 7.67µl of 
nuclease-free water and added to 1.33µl of RT reaction sample to get a final volume 
reaction of 20µl. Solution was mixed by pipetting up and down in a 96-well plate. Plate 
was placed into thermal cycler and run mode was the standard one. Thermal cycling 
conditions were set up at 95°C for 10min in the first step followed by 95°C for 15 sec in 
the second step and 40 cycles at 95°C for 15 sec for the denaturation step and 60°C for 
60 sec for the annealing/extension step.  
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Step 2: Real-time PCR. miRNA-specific forward primer, TaqMan® probe, and reverse 
primer are used for PCR reactions. Quantitation of miRNAs is estimated based on 
measured CT values. MGB: minor groove binder; NFQ: non-fluorescent quencher; R: 
reporter dye (FAM™ dye). 
 
5.4.9.1.3 5’nuclease process 
 
During the amplification of cDNA, the TaqMan® MGB probe anneals specifically to a 
complementary sequence between the forward and reverse primer sites. The MGB 
probe at the 3’end of the probe increases specificity through the increase of melting 
temperature without changes in the probe length (Afonina, et al. 1997, Kutyavin, et al. 
1997). 
When the probe is intact, the proximity of the reporter dye to the quencher dye results in 
suppression of the reporter fluorescence, primarily by Förster-type energy transfer 
(Lakowicz and Maliwal 1983). The lack of fluorescence of the quencher allows a more 
accurate measurement of the reporter dye. Following recognition of the probe by the 
DNA polymerase, cleavage occurs and prevents the interaction between the reporter dye 
and the quencher dye. Consequently signal fluorescence of the reporter is released.  
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Figure 5.4.9.1.3: Schematic of 5’ nuclease assay process. 
A: Polymeriszation; B: Strand displacement; C: Cleavage; D: Completion of pol 
ymerization. 
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5.4.10 Bioanalyzer 
 
Extracted RNA samples quality was checked using Agilent RNA 6000 Nano kit 
bioanalyzer (Agilent) before microarray assay. Denaturation of samples was performed 
at 70°C for 2 min and samples were transferred on ice. 9µl of loading gel dye was 
transferred to the chip in three different wells. 5µl of Agilent marker was loaded into all 
12 wells and in the ladder well followed by tranfer of 1µl of ladder and 1µl of samples 
in the same wells to have a final volume of 6µl in each well of the chip. Chip was 
placed on a IKA vortex for 1 min at 2400 rpm and transferred to the bionalyser within 5 
min to be analysed. 
 
5.4.11 CHO-specific oligonucleotide arrays 
 
Cells were seeded at 1x105 cells/ml and transfected with either 50nM of non-specific 
control (PM-Neg, Ambion) or miR-7 mimic (PM-7) in a 2ml serum-free suspension 
culture. Total RNA extraction was performed 24 hours after transfection using the 
mirVana miRNA Isolation Kit (#AM1560; Life technologies). RNA quality from 
biological triplicates was checked using an Agilent 2100 Bioanalyzer (Agilent 
Technlogies). 100 ng of total RNA from each sample underwent cDNA synthesis, 
followed by cleanup, overnight IVT amplification and labeling using the GeneChip 3' 
IVT Express Kit (#901229, Affymetrix) according to manufacturer's instructions. cRNA 
cleanup was carried out using the GeneChip Sample Cleanup Module (#900371, 
Affymetrix) according to manufacturer's instructions. The custom CHO oligonucleotide 
WyeHamster3a microarray (Affymetrix) used in these analyses contains a total of 
19,809 CHO-specific transcripts, combining library-derived CHO and publicly-
available hamster sequences. 
 
5.4.12 Data processing and analysis 
 
Microarray data were pre-processed as described in (Clarke, et al. 2011). Differential 
expression analysis was carried out using the R package, linear models for microarray 
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data LIMMA (Wettenhall and Smyth 2004). Genes were considered to be differentially 
expressed upon observation of a 1.2 fold change in either direction along with a 
Bonferroni adjusted p-value <0.05. The functional relevance of those differentially 
expressed genes was determined using the PANTHER (Protein Analysis through 
Evolutionary Relationships) Classification System.  
 
5.4.13 Real-time PCR of miRNAs using TaqMan Low Density Array  
 
TaqMan Low Density Array is based on the TaqMan PCRmethod in an array format 
which contains probes for human miRNA signatures. The protocol for the reverse 
transcription used the High Capacity cDNA reverse transcription (described in the 
materials and methods). The primers used are the Megaplex™ RT Primers-predefined 
pools comprising 381 RT primers which bind specifically to the miRNA probes in the 
381 wells of the card. 
Following reverse transcription, 30-1000ng of cDNA diluted in a final volume of 50 µl 
is mixed to 50µl of TaqMan® Universal PCR master mix. The 100µl of the mixture is 
then loaded into the fill reservoir of a 384-well TaqMan array card and two steps of 
centrifugation at 1200rpm for 1min were performed to ensure complete filling of the 
card. The TaqMan cards were sealed and miRNA expression was analysed using the 
∆∆Ct PCR quantification in the Applied biosystems 7900HT Fast Real-Time PCR 
System. The PCR program consisted in the activation of the AmpliTaq Gold® enzyme 
for 10min at 95°C for, followed by 40 cycles at 95°C for 15 sec for the denaturation 
step and 60°C for 60 sec for the annealing/extension step. 
 
5.4.14 Cloning methods 
 
5.4.14.1.1 Oligonucleotide annealing 
 
For annealing of oligonucleotides, 1.5µl of each oligonucleotide was mixed to 5µl of 
10x annealing buffer (1M Tris pH 8, 0.5M EDTA pH 8, 2.5M NaCl) and 42µl of 
nuclease free water. This solution was incubated at 97°C for 5min in heater block. 
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Heater block was switched off and samples were left in the block to allow the 
temperature to gently drop for 3 hours to approximately 46°C. Then annealed 
oligonucleotides were kept on ice for 5 min and kinase treatment was performed. 0.5µl 
of annealed oligonucleotides were added to 2µl of T4 kinase buffer (ROCHE), 0.4µl of 
50Mm ATP at pH 7.5, 17µl of nuclease free water and 0.4µl of T4 polynucleotide 
Kinase at 10U/µl (ROCHE). The solution was incubated at 37°C for 30min. To stop the 
reaction, samples were transferred on ice. 
 
5.4.14.1.2 Bacterial Transformation for cloning 
 
One Shot Max Efficiency DH5α-T1 competent cells were transformed using 
appropriate plasmid-derived vectors. One vial of 50µl DH5α competent cells was 
thawed for each transformation reaction and 1µl of ligation reaction was added to the 
cells. Mixture was incubated on ice for 30min followed by a heat shock step at exactly 
42°C in water bath for 30 sec. Vial was removed and placed on ice for few minutes. 
250µl of pre-warmed S.O.C medium (rich medium) was added to the vial and incubated 
1hour at 37°C in a shaking incubator at 225 rpm. Vial was spun down at 1500 rpm for 
5min to remove almost all supernatant and 20-30µl was left to be spread into a plate 
containing LB agar with appropriate antibiotic for clone selection. Plate were incubated 
at 37°C overnight, transformation efficiency was evaluated by the number of colonies 
present in the control provided by the kit , pUC19 DNA. 
 
5.4.14.1.3 Purification of plasmid DNA: Miniprep 
 
QIAprep Spin Miniprep Kit was used to purify up to 20µg of plasmid after 
transformation. A single colony was harvested from the plate and inoculated into a 5ml 
LB medium culture supplemented with appropriate antibiotic concentration at 37°C in a 
shaking incubator. Bacterial Culture was spun down for 5 min at 3000 rpm, pellet was 
resuspended with 250µl of P1 buffer and transferred to a microcentrifuge tube. 250µl of 
lysis buffer P2 was added and tube was inverted several times to allow cell lysis. Then 
350µl of buffer P3 was added to enhance DNA precipitation and tube was inverted 
several times and spun down at maximum speed (13,000 rpm) for 10 min. Supernatant 
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was applied to a QIAprep spin column and vacuum was applied to draw the solution 
through the column. Column was washed with 500µl of Buffer PB to remove any traces 
of nuclease activity if using certain strains of bacteria followed by addition of 700µl 
Buffer PE. After this step, column was centrifuged at maximum speed for 1 min to 
avoid any residual ethanol from Buffer PE. DNA was eluted by applying 50µl of EB 
buffer at pH 8, in the centre of the filter. Column was left 1 min at room temperature 
followed by centrifuge step for 1 min at maximum speed.  
 
5.4.14.1.4 Purification of plasmid DNA: Maxiprep 
 
QIAGEN Plasmid Maxi kit was used to purify up to 500µg of plasmid after 
transformation. 
A single colony was harvested from the plate and inoculated into a 5ml LB medium 
culture supplemented with appropriate antibiotic concentration at 37°C in a shaking 
incubator for 8 hours. Bacterial Culture was then transferred to a 250ml culture 
supplemented with appropriate antibiotic concentration and incubated overnight at 
37°C. Culture was harvested and spun down at 6000xg for15 min at 4°C. Pellet was 
resuspended with 10mL of Buffer P1, 10mL of buffer P2 for lysis and tube was mixed 
by inversion and incubated at room temperature for 5 min. 10mL of pre-chilled Buffer 
P3 (neutralization buffer) was added to the mixture and tube was mixed vigourously. 
Buffer P3 enhanced DNA precipitation. Lysate was transferred to a QIAfilter cartridge 
and incubated for 10 min at room temperature. Plunger was inserted to the cartridge to 
allow lysate to be filtered. A QIAGEN-tip 500 was equilibrated using 10mL of Buffer 
QBT that contains detergent leading to reduction in surface tension and fluid to enter 
through the filter. Cartridge was washed twice with 30 mL of Buffer QC to remove any 
possible contaminants. DNA was eluted with 15mL of buffer QN, precipitated with 
10.5mL of room temperature isopropanol. Tube was mixed and spun down at 15,000 x 
g for 30min at 4°C. Pellet was washed with 5ml 70% ethanol to remove precipitated 
salts and centrifuges at 15,000 x g for 10min. Pellet was air-dried 5-10 min and 
redissolved in TE buffer (10mM Tris-Cl, pH 8). 
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5.4.14.1.5 Restriction Enzymatic digestion 
 
For cloning protocol, plasmid DNA at 2µg was doubled digested with appropriate 
enzymes in 10x buffer and 100x BSA if required in a 60µl final volume reaction. 
Incubation was performed for 1h at 37°C for simple digestion or several hours if 
sequential digestion was required. 
 
5.4.14.1.6 Alkaline phosphatase treatment 
 
Alakline phosphatase (New England BioLabs) catalyses the removal of 5’-phosphate 
groups from DNA or RNA and prevents the CIP-treated DNA fragments to self-ligate 
because of the lack of 5’-phosphoryl termini groups. This treatment increases the 
efficiency during cloning assay. 2µg of digested plasmid were transferred to a tube 
containing 5µl of 10x CIP buffer, CIP enzyme (20U/µl) in a final volume reaction of 
50µl. Tube was incubated at 37°C for 1h.  
 
5.4.14.1.7 DNA polymerase I, large (Klenow) Fragment treatment 
 
DNA polymerase I, large (Klenow) Fragment is a proteolytic product of E.coli DNA 
Polymerase I which retains polymerisation and 3’→5’ exonuclease activity, but has lost 
5’→3’ exonuclease activity. A 30µl reaction was set up using 25µl of digested DNA, 
10x NEB2 buffer, 33µM of dNTP and 3x Klenow enzyme (5U/µl). Incubation was 
performed at 25°C for 15 min. Reaction was stopped by adding EDAT at 10Mm 
followed by incubation at 75°C for 20 min. 
 
5.4.14.1.8 DNA Ligation 
 
Double digested DNA with appropriate enzymes were incubated with T4 DNA ligase 
and 1x ligation buffer (Roche), at 16°C for 4 hours or overnight in ice/water. T4 DNA 
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ligase catalyses the formation of phosphodiester bonds between 3’OH and 5’Phosphate 
ends in double-stranded DNA with sticky or blunt ends. 
 
5.5 Protein assays 
 
5.5.1 SEAP Assay 
 
The enzymatic assay for quantification of SEAP protein was adapted from the method 
reported previously by Berger and co-workers (Lipscomb, et al. 2005, Berger, et al. 
1988). Conditioned medium was collected from cells and was spun down at 13000rpm 
for 5min. 50µl of cell-free conditioned medium were transferred to individual wells of a 
96-well flat bottom plate. 50µl of 2x SEAP reaction buffer (solution stock contains 
10.50 g diethanolamine (100%), 50 µl of 1 M MgCl, and 226 mg of L-homoarginine in 
a total volume of 50 mL) was added to each sample. Plates were incubated for 10 min at 
37°C and then 10 µl of substrate solution (158 mg of p-nitrophenolphosphate from 
Sigma, St. Louis,in 5 mL of 1x SEAP reaction buffer, made fresh for each use) was then 
added to each well. The change in absorbance per minute (OD 405/min) of each well 
was monitored by a microplate reader. The change in absorbance per minute was 
considered as indicator of amount of SEAP present in the sample. 
 
5.5.2 Enzyme-linked immunosorbent (ELISA) assay  
 
To quantify the recombinant Human IgG1 (rHIgG1) antibodies secreted in the culture, 
cell were spun down at 1000rpm for 5min and supernatant was harvested in a 
microcentrifuge tube. Supernatant was also spun down again at 13000 rpm for 5 min 
before the assay to avoid any residual cells. Immunoassay plate (Sigma) was coated 
using100µl/well of diluted coating antibody (goat anti-Human IgG-affinity purified), 
overnight at 4°C. To avoid non-specific binding, plate was blocked with 200µl/well of 
1% BSA blocking solution for at least 1hour at room temperature. 100µl of supernatant 
was applied to the plate to allow interaction with the coating antibody. rHIgG1 
antibodies were detected by addition of 100µl/well of secondary antibody, a goat anti-
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Human IgG linked to horse radish peroxidase (HRP). Between each step of the assay, 3 
to 5 washes were done using a wash solution. The enzyme substrate reaction was 
prepared with 100µl of 3,3’,5,5’-Tetramethylbenzidine (TMB) solution. It develops a 
deep blue product after 15min when reacted with HRP conjugates in ELISA and it is 
stopped by a H3P04 solution at 2M (100µl/well) which gives a yellow colour. A 
standard curve with purified rHIgG1 was used to quantify the amount of rHIgG1 
present in samples. Absorbance was measured with a reader plate at 450nm. 
 
5.5.3 Western blotting 
 
5.5.3.1.1 Sample preparation 
 
Proteins for analysis by Western blotting were resolved using SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE). Lysis buffer containing urea was added to cell pellet. 
Lysis was carried out over twenty min on ice and following vortexing, the lysate was 
spun at 4˚C for 15 min at maximum speed to remove any insoluble debris. The protein 
was quantified using the Bradford approach (Bio-Rad; 500-0006). The protein samples 
were diluted in 2xLaemlli buffer (which contains loading dye, Sigma-Aldrich S#3401) 
and appropriate volumes of lysis buffer. Before loading into the gel, samples were 
boiled for 5min and cooled on ice. 
 
5.5.3.1.2 SDS-polyacrylamide gel electrophoresis 
 
5-20μg of protein samples and the molecular weight marker (New England Biolabs) 
were loaded onto 4–12% NuPAGE Bis Tris precast gradient gels (Life technologies). 
Electrophoretic transfer, blocking and development of western blots was carried out as 
described previously. Membranes were probed with the appropriate primary antibodies 
(anti-PSME3 #ab97576 Abcam, anti-SKP2 #ab68455 Abcam, anti-CMYC #ab31426 
Abcam, anti-p53, #M 7001Dako, anti-pAKT #92715 cell signalling, anti-p27 #2552S, 
anti-IGF1R #3027, Cell signalling) diluted in Tris-buffered saline containing 0.1%-
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Tween 20 (TBS-T). An anti-mouse GAPDH monoclonal antibody (#ab8245, Abcam) 
was used as an internal loading control in all experiments. 
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6 Results 
 
6.1 Adaptation of CHO-K1 SEAP cells to serum-free medium 
 
CHO-K1 cells were previously engineered in our laboratory to produce human secreted 
alkaline phosphatase (SEAP). This protein was used as a recombinant protein model in 
cell productivity assays. The SEAP gene was extracted from pSEAP2-control vector 
(Professor Martin Fussenegger, Institute for Chemical and Bioengineering, ETH Zurich) 
and was cloned into pcDNA3.1 (Invitrogen). The final construct was transfected into 
CHO-K1 cells that were previously adapted to grow in ATCC medium (DMEM / F-12 
Ham containing glutamine and sodium pyruvate; Sigma) supplemented with 0.5% 
serum in suspension culture, in 100ml spinner flasks maintained at 37°C, on a shaker 
platform at 60rpm (Thesis of Dr Niraj Kumar). However, in commercial processes the 
cost of serum, the variation of components from batch-to-batch and the risk of viral, 
fungal or prion contamination have led to the adaptation of cells to serum-free culture. 
To start the adaptation, cells were grown in adherent culture of ATCC (DMEM/F12-
HAM) medium, supplemented with 0.5% fetal bovine serum (FBS), at 37°C and 5% 
CO2. During the first two weeks, cells were not attached but were still alive so they 
were transferred to suspension culture in disposable 50ml shaker flasks, at 60 rpm. 
Three serum-free media (SFM) were tested, CHO-S-SFM II (Invitrogen), HyClone 
SFM4CHO (Thermo Scientific) and CD-OptiCHO (Invitrogen). Although some cells 
survived in CHO-S-SFM II and HyClone SFM4CHO, cell viability was low. It was 
likely due to the stress caused by the complete serum-free environment. In addition, the 
agitation speed used was probably too low causing cells to aggregate. To optimise the 
speed of agitation, cells were transferred to disposable 5ml spin flasks with vented caps 
and supplemented with 0.5% FBS. When the rotation speed was set at 100 rpm, the 
cells grew but they still aggregated. The speed was increased to 130 rpm for one week. 
At this stage, 2ml of cells were transferred to a tube supplemented with 3ml of fresh 
medium still containing 0.5% FBS. The speed was increased to 170 rpm for another 
week. Although half of cells were dead at this stage, the remaining ones were still 
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dividing. After four passages, cells became healthier and were placed in a disposable 
50ml shaker flask with vented lid instead of glass spinner flaks. The glass spinner flasks 
are time-consuming to prepare. In addition, they are not convenient for routine cell 
culture work as they do not have a vented cap to allow mixed gas exchange. Following 
adaptation to high speed agitation in suspension, the process of serum elimination was 
initiated. A sequential adaptation method was applied to allow cells to recover gently 
from stress due to serum withdrawal. The principle of this method is to use different 
ratios of media. Cells are supplemented with a combination of serum and serum-free 
media until completely adapted to a serum-free environment. Cell culture was 
performed in 5ml culture, in spin tubes, at 170 rpm, in 25% ATCC media supplemented 
with 0.5% FBS and 75% serum-free medium. Serum concentration was reduced until 
the ratio was at 10%/90% between ATCC medium (0.5% FBS) and serum-free medium. 
Cells were transferred to serum-free culture in CHO-S-SFMII and HyClone SFM4CHO 
medium for six days. Cells growing in CHO-S-SFMII reached a high cell density at day 
2 (4.93x105 cells/ml) and grew rapidly until day 5 (48.4x105 cells/ml) (Figure 6.1.A). 
At this time point, cell viability dropped dramatically, likely due to the lack of nutrients 
that were consumed quickly at the earlier time points as well as the waste accumulation. 
Cells in HyClone SFM4CHO showed a slower growth from day 2 (2.77x105 cells/ml) to 
day 5 (33.73x105 cells/ml) and consequently sustained a higher cell viability (Figure 
6.1.B). We choose to prioritise high cell density in a short time therefore CHO-S-SFMII 
was selected for our cell culture work.  
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Figure 6.1.A: CHO-K1 SEAP cell growth and viability in CHO-S-SFMII serum-
free medium.  
Cell growth and viability were assessed in CHO-K1 SEAP cells cultured in CHO-S-
SFMII serum-free media in 50ml culture, in shaker flasks. Cells were seeded at 2x105 
cells/ml and samples were harvested every day, for six days. Cell number and viability 
were evaluated manually by exclusion method with trypan blue. Bars represent standard 
deviations of three biological samples. 
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Figure 6.1.B: CHO-K1 SEAP cell growth and viability in HyClone SFM4CHO 
medium.  
Cell growth and viability were assessed in CHO-K1 SEAP cells cultured in HyClone 
media in 50ml culture, in shaker flasks. Cells were seeded at 2x105 cells/ml and samples 
were harvested every day, for six days. Cell count and viability were performed 
manually by exclusion method with trypan blue. Bars represent standard deviations of 
biological triplicates. 
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6.2 Functional validation of miRNAs as potential candidates to 
improve bioprocess-relevant CHO characteristics 
 
6.2.1 Screening of miRNAs in fast growing cells 
 
miRNAs are involved in many cellular functions including cell proliferation, cell cycle, 
apoptosis, cell metabolism and signal transduction. Therefore they are attractive and 
potentially useful tools to manipulate important bioprocess-relevant phenotypes 
including cellular growth rate, maintenance of viability and recombinant protein 
production. Previously in our laboratory, miRNA profiling using TLDA arrays, a PCR-
based technique, was performed to identify differentially expressed miRNAs following 
temperature-shifted culture (Gammell, et al. 2007). The aim of this study was to 
investigate the change of miRNA expression associated with temperature reduction and 
cell growth decrease. A total of 237 miRNA species were detected on TLDA cards of 
which 17 miRNAs were differentially expressed (Barron, et al. 2011). Although 
numerous studies have reported on the genes and proteins involved in the cellular 
response to temperature-shift, we wanted to see whether these miRNAs were 
responsible for the observed reduction in cellular growth after decreasing the culture 
temperature. Functional screening of miR-490, miR-34a, miR-34c, let-7e, miR-30e-5p, 
miR-10a and miR-29a was conducted to investigate the impact of these miRNAs on the 
CHO phenotypes mentioned above. Depending on the data from the profiling 
experiment and the established role of these miRNAs in other species, we screened for a 
functional impact using either a mimic or an inhibitor where appropriate (Table 6.2.1). 
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Table 6.2.1: Differentially regulated miRNAs following TS and choice of molecules 
(mimics or pm/inhibitors or am) for functional validation 
 
miRNAs TLDA array data 
Mimic (pm) or inhibitor 
(am) molecules 
miR-490 
Higher expression in the 
middle of the logarithmic 
phase at 37˚C 
pm-490 
miR-34a Down in TS culture am-34a 
miR-34c Down in TS culture am-34c 
let-7e High in TS culture pm-let-7e 
miR-30e-5p Down in TS culture pm-30e-5p 
miR-10a Down in TS culture am-10a 
miR-29a Down in TS culture am-29a 
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Functional analysis using mimic (pm) and inhibitor (am) molecules was conducted in a 
CHO-K1 cell line engineered to produce the Secreted Embryonic Alkaline Phosphatase 
(CHO-K1 SEAP), cultured in serum-free medium in spin flasks. If the results were 
promising, the experiment was repeated in recombinant human Immunoglobulin 
Gamma 1 (rHmIgG1) producing cell lines, CHO1.14 and CHO2B6. Pre-miRs are 
double-stranded molecules that mimic endogenous mature miRNAs and anti-miRs are 
single-stranded molecules that inhibit the mature form of endogenous miRNAs by 
competitively binding to them. Different controls were included in the transient 
transfection. Pre-miR negative (pm-neg) and anti-miR negative (am-neg) molecules are 
non-specific sequences that in theory should not match with any sequences in the 
genome. Non-transfected cells were also included as a control to ensure that cells were 
growing as expected. The lipid-based transfection reagent (siPORTTM NeoFx TM; 
Ambion) was also used on its own to ensure that there was no non-specific impact on 
cell growth and cell viability due to the nature of the assay. A siRNA against Valosin-
containing protein, a housekeeping gene in CHO cells, was used as a positive control of 
transfection efficiency and cell death (Doolan, et al. 2010).  
 
6.2.1.1  Screening of miR-490, miR-34a and miR-34c 
 
6.2.1.1.1 Impact on CHO-K1 SEAP cell growth and cell viability 
 
Non-transfected CHO-K1 SEAP cells grew normally and showed high viability (>90%) 
for the first two days (Figures 6.2.1.1.A&B). At day 4, cells reached very high density 
but maintained a high viability. At day 7, cell density dropped as well as the cell 
viability (23.34%) likely due to the nature of the batch culture. As expected cells treated 
with siRNA against VCP had their cell proliferation dramatically decreased and showed 
a high rate of cell death. Two days after transfection, only 40.76% of cells remained 
viable (Figure 6.2.1.1.A). During the culture period, non-specific impact on cell growth 
was observed in pre-miR negative (pm-neg) and anti-miR negative molecules (am-neg) 
transfected cells. The rate of viable cells in these samples was reduced between 6.40% 
and 6.88% at 48 hours and 96 hours following transfection. The effect of pm-neg and 
am-neg molecules on cell growth was not observed at day 7 and the viability of cells 
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treated with these molecules was higher compared to the viability of the non-transfected 
cells. Thus the effect of pm-neg and am-neg abated at later stages of culture.  
Four days following transient up-regulation of miR-490, cell density was decreased by 
1.28-fold compared to pm-neg treated cells (Figure 6.2.1.1.B). Transient knockdown of 
miR-34a and miR-34c induced a slight reduction of cell density at the same time point 
(1.16-fold and 1.08-fold respectively) in comparison to cells transfected with am-neg 
molecules.  
Cell viability was improved in pm-490 and in am-34a treated cells by 9.39% and 6.45% 
in comparison to their controls at later stages of culture (Figure 6.2.1.1.B) likely due to 
a lower number of cells present in culture at earlier time point. 
The impact of pm-490, am-34a and am-34c on cell proliferation and cell growth was not 
reproducible across repeated experiments. Thus these miRNAs were not selected as 
candidates for further investigation. 
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Figure 6.2.1.1.A: Impact of miR-490, miR-34a and miR-34c on CHO-K1 SEAP cell 
growth.  
Cells were seeded at 1x105cells/ml in serum-free medium prior to transfection with 
50nM miRNAs. Following transfection, cells were harvested at day 2, day 4, day 7 and 
stained with GuavaViacount solution to monitor cell growth by Guava flow Cytometer. 
cells: non-transfected cells cultured at 37˚ C; vcp: siRNA against Valosin-Containing 
Protein (positive control of transfection efficiency); pm-neg: negative control for 
mimics; pm-490; mimic of miR-490; am-neg: negative control for inhibitors; am-34a: 
inhibitor of miR-34a; am-34c
At day 2 and day 4, bars represent standard deviations of three biological replicates. At 
day 7, one sample was used for other assays so only two samples were kept in culture. 
Bars represent the high and low reading of the two remaining biological replicates. For 
statistical analysis a student t-test was performed to compare pm-490 with pm-neg and 
am-34a, am-34c with am-neg. There was no statistically significant difference in growth 
found in this assay. 
: inhibitor of miR-34c.  
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Figure 6.2.1.1.A: Impact of miR-490, miR-34a and miR-34c on CHO-K1 SEAP cell 
viability.  
Cells were seeded at 1x105cells/ml in serum-free medium prior to transfection with 
50nM miRNAs. Cells were harvested at day 2, day 4, day 7 and stained with 
GuavaViacount solution to monitor cell viability by Guava flow Cytometer. cells: non-
transfected cells cultured at 37˚C; vcp: siRNA against Valosin-Containing Protein 
(positive control of transfection efficiency); pm-neg: negative control for mimics; pm-
490; mimic of miR-490; am-neg: negative control for inhibitors; am-34a: inhibitor of 
miR-34a; am-34c: inhibitor of miR-34c. At day 2 and day 4, bars represent standard 
deviations of three biological replicates. At day 7, one sample was used for others 
assays so only two samples were kept in culture. Bars represent the high and low 
reading of the two remaining biological replicates. For statistical analysis a Student t-
test was performed to compare pm-490 with pm-neg and am-34a, am-34c with am-neg. 
There was no statistically significant difference in viability levels found in this assay. 
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6.2.1.1.2 Impact on SEAP total yield and normalised productivity 
 
To investigate the impact of miR-490, miR-34a and miR-34c on SEAP productivity, 
total yield (change in absorbance/min of p-nitrophenolphosphate into p-nitrophenol) and 
normalised productivity (change in absorbance/min/cell) were monitored at day 2, day 4 
and day 7 after transfection. At 96 hours following transient up-regulation of miR-490, 
total yield was improved by 1.17-fold (p-value: 0.03267) in comparison to the non-
specific control (Figure 6.2.1.1.C). However, total yield in these cells was lower than in 
the non-transfected cells. Transient inhibition of miR-34a and miR-34c slightly 
increased total yield (1.05-fold to1.15-fold). Normalised productivity was enhanced by 
1.5-fold (p-value: 0.04272) after transfection of miR-490 and by 1.44-fold (p-value: 
0.02047) following knockdown of miR-34a (Figure 6.2.1.1.D). Upon depletion of miR-
34c, normalised productivity was slightly improved but it was not statistically 
significant. However the reproducibility of these assays showed no consistency 
therefore the investigation of these miRNAs was discontinued. 
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Figure 6.2.1.1.C: Impact of miR-490, miR-34a and miR-34c on CHO-K1 SEAP 
total yield. Supernatant of cells were harvested at day 2, day 4 and day 7 after 
transfection. SEAP total yield was analysed by a colorimetric assay. The change in 
absorbance of SEAP substrate, p-nitrophenolphosphate, was assessed by a 
spectrophotometer at 405nm in a kinetic assay (see materials and methods for details of 
SEAP assay in section 6.5.1). cells: non-transfected cells cultured at 37˚ C; pm-neg: 
negative control for mimics; pm-490; mimic of miR-490; am-neg: negative control for 
inhibitors; am-34a: inhibitor of miR-34a; am-34c
 
: inhibitor of miR-34c. For statistical 
analysis a Student t-test was performed to compare pm-490 with pm-neg and am-34a, 
am-34c with am-neg. At day 2 and day 4 bars represent standard deviations from three 
biological replicates, and at day 7 the average total yield was calculated of two 
biological replicates (one sample was used for others assays). *: p-value< 0.05 (pm-490 
compared to pm-neg treatment at four days after transfection). 
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Figure 6.2.1.1.D: Impact of miR-490, miR-34a and miR-34c on CHO-K1 SEAP 
normalised productivity. Supernatant of cells were harvested at day 2, day 4 and day 7 
after transfection. SEAP productivity was analysed by a colorimetric assay. The change 
in absorbance of SEAP substrate, p-nitrophenolphosphate, was assessed by a 
spectrophotometer at 405nm in a kinetic assay (see materials and methods for details of 
SEAP assay in section 6.5.1). cells: non-transfected cells cultured at 37˚ C; pm-neg: 
negative control for mimics; pm-490; mimic of miR-490; am-neg: negative control for 
inhibitors; am-34a: inhibitor of miR-34a; am-34c: inhibitor of miR-34c. For statistical 
analysis a Student t-test was performed to compare pm-490 with pm-neg and am-34a, 
am-34c with am-neg. At day 2 and day 4, bars represent standard deviations from three 
biological replicates. For technical reasons, the average normalised productivity was 
calculated of two biological replicates at day 7.*: p-value< 0.05 (pm-490 compared to 
pm-neg treatment four days after transfection; am-34a compared to am-neg treatment at 
day 4 after transfection). 
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6.2.1.2 Screening of miR-let-7e, miR-30e-5p, miR-10a and miR-29a in CHO cells 
 
6.2.1.2.1 Impact on CHO-K1 SEAP cell growth and cell viability  
 
As well as being identified in the array profiling experiment, miR-let-7e, miR-30e-5p, 
miR-10a and miR-29a have been shown to be involved in apoptosis, cell proliferation 
and cell cycle. In addition, their deregulation has been previously reported in cancers. 
Therefore these miRNAs were selected for functional validation. 
Non-transfected CHO-K1 SEAP cells grew as expected (Figure 6.2.1.2.A). VCP 
knockdown by RNAi induced dramatic cell growth decrease and led to poor viability 
from day 2 to day 7. The negative control for mimics (pm-neg) had a non-specific 
impact on cell number at day 2 after transfection (more than 50% reduction) and cell 
viability was slightly reduced byless than 5%. On the other hand, the negative control 
for inhibitors led to cell growth decreased during the period of the experiment (Figure 
6.2.1.2.A). The cell viability dropped by 15.59% compared to the non-transfected cells 
48 hours after transfection (Figure 6.2.1.2.B). This is routinely observed in transient 
transfection assays and is a result of the treatment process-i.e., exposure of cells to the 
lipid-miR complexes. 
Four days following transient up-regulation of let-7e, cell density was reduced by 2.97-
fold (p-value=0.0048) (Figure 6.2.1.2.A) as well as cell viability by 8.70% (p-value= 
0.0001) (Figure 6.2.1.2.B). At day 7, there was no more suppressive effect of pm-let-7e 
on cell proliferation and cell viability.  
Four days after transfection, overexpression of miR-30e-5p reduced cell density by 
1.37-fold but it was not statistically significant and slightly cell viability.  
On the other hand, knockdown of miR-10a induced cell density increase of 1.8-fold at 
day 4 (p-value-= 0.0001) and slightly at later stages of culture without statistical 
significance (Figure 6.2.1.2.A). Cell viability was also increased of 7.71% compared to 
pm-neg treated cells.  
Transient inhibition of miR-29a slightly decreased cell density in the early stages of 
culture and enhanced cell viability by 9.91% at day 7 (p-value= 0.0358) independently 
of cell growth (Figures 6.2.1.2.A &B).  
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Figure 6.2.1.2.A: Impact of miR-let-7e, miR-30e-5p, miR-10a and miR-29a on 
CHO-K1 SEAP cell growth. Cells were seeded at 1x105cells/ml in serum-free medium 
prior to transfection with 50nM miRNAs. Cells were harvested at day 2, day 4, day 7 
following transfection and stained with GuavaViacount solution to monitor cell growth 
by Guava flow Cytometer. cells: non-transfected cells cultured at 37˚ C; vcp: siRNA 
against Valosin-Containing Protein (positive control of transfection efficiency); pm-
neg: negative control for mimics; pm-let-7e; mimic of let-7e; pm-30e-5p: mimic of 
miR-30e-5p; am-neg: negative control for inhibitors; am-10a: inhibitor of miR-10a; am-
29a: inhibitor of miR-29a. For statistical analysis a Student t-test was performed to 
compare pm-let-7e and pm-30e-5p with their respective control pm-neg and am-10a, 
am-29a with their specific control am-neg. Bars represent standard deviations of three 
biological replicates. **: p-value< 0.01 (pm-let-7e compared to pm-neg 96 hrs after 
transfection); ***: p-value< 0.001 (am-10a compared to am-neg treatment 96 hrs after 
transfection). 
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Figure 6.2.1.2.B: Impact of miR-let-7e, miR-30e-5p, miR-10a and miR-29a on 
CHO-K1 SEAP cell viability. Cells were seeded at 1x105cells/ml in serum-free 
medium prior to transfection of 50nM miRNAs. Cells were harvested at day 2, day 4, 
day 7 after transfection and stained with GuavaViacount solution to monitor cell 
viability by Guava flow Cytometer. cells: non-transfected cells cultured at 37˚ C; vcp: 
siRNA against Valosin-containing protein (positive control of transfection efficiency); 
pm-neg: negative control for mimics; pm-let-7e; mimics of let-7e; pm-30e-5p: mimics 
of miR-30e-5p; am-neg: negative control for inhibitors; am-10a: inhibitors of miR-10a; 
am-29a: inhibitors of miR-29a. For statistical analysis a Student t-test was performed to 
compare pm-let-7e and pm-30e-5p with the specific control for mimics pm-neg and am-
10a, am-29a with the specific control for inhibitors am-neg. Bars represent standard 
deviations of three biological replicates. *: p-value< 0.05 (am-10a compared to am-neg 
treatment seven days after transfection); ***: p-value< 0.001 (pm-let-7e compared to 
pm-neg 96 hrs after transfection). 
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6.2.1.2.2 Impact on SEAP total yield and normalised productivity 
 
To investigate the impact of let-7e, miR-30e-5p, miR-10a and miR-29a on SEAP total 
yield and normalised productivity, supernatant of samples were harvested at day2, day 4 
and day 7. 
Transient overexpression of let-7e impacted negatively on total yield and normalised 
productivity (Figure 6.2.1.2.C) likely due to the low number of cells in culture.  
Transfection of pm-miR-30e-5p increased total yield by 1.37-fold at later stages of 
culture (p-value= 0.0346) (Figure 6.2.1.2.C) but it did not impact significantly on 
normalised productivity (Figure 6.2.1.2.D).  
Transient knockdown of both miR-10a and miR-29a induced a 1.2 to 1.4 fold increase 
of total yield at day 4 and day 7 (Figure 6.2.1.2.C).Two days following inhibition of 
miR-29a, normalised productivity was significantly increased by 4.93-fold (p-value= 
0.0126) (Figure 6.2.1.2.D).  
 
The suppressive impact of let-7e on cell growth was reproducible in repeats as well as 
the advantage in cell growth following inhibition of miR-10a. The increase of total yield 
and normalised productivity observed after pm-30e-5p and am-10a, am-29a treatment 
was also reproducible in other assays. Therefore the investigation of miR-let-7e, miR-
10a, miR-29a and miR-30e-5p was continued in CHO1.14 cells. 
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Figure 6.2.1.2.C: Impact of miR-let-7e, miR-30e-5p, miR-10a and miR-29a on 
CHO-K1 SEAP total yield. Supernatant of cells were harvested at day 2, day 4 and day 
7 after transfection. The change in absorbance per min of SEAP substrate, p-
nitrophenolphosphate, was assessed by a spectrophotometer (see materials and methods 
for more details on SEAP assay in section 6.5.1). cells: non-transfected cells cultured at 
37˚C; pm-neg: negative control for mimics; pm-let-7e; mimic of let-7e; pm-30e-5p: 
mimic of miR-30e-5p; am-neg: negative control for inhibitors; am-10a: inhibitor of 
miR-10a; am-29a
 
: inhibitor of miR-29a. For statistical analysis a Student t-test was 
performed to compare pm-let-7e and pm-30e-5p with pm-neg and am-10a, am-29a with 
am-neg. Bars represent standard deviations of three biological triplicates.*: p-value< 
0.05 (am-29a was compared to am-neg treatment at day 4 and day 7 after transfection); 
**: p-value< 0.01 (am-10a was compared to am-neg four days after transfection); ***: 
p-value< 0.001 (am-10a was compared to am-neg at day 7 after transfection). 
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Figure 6.2.1.2.D: Impact of miR-let-7e, miR-30e-5p, miR-10a and miR-29a on 
CHO-K1 SEAP normalised productivity. Supernatant of cells were harvested at day 
2, day 4 and day 7 after transfection. The change in absorbance per min and per cell of 
SEAP substrate, p-nitrophenolphosphate, was assessed by a spectrophotometer (see 
materials and methods for more details on SEAP assay in section 6.5.1). cells: non-
transfected cells cultured at 37˚C; pm-neg: negative control for mimics; pm-let-7e; 
mimic of let-7e; pm-30e-5p: mimic of miR-30e-5p; am-neg: negative control for 
inhibitors; am-10a: inhibitor of miR-10a; am-29a: inhibitor of miR-29a. For statistical 
analysis a Student t-test was performed to compare pm-let-7e and pm-30e-5p with pm-
neg and am-10a, am-29a with am-neg. Bars represent standard deviations of three 
biological replicates. *: p-value< 0.05 (am-29a compared to am-neg treatment 48 hrs 
after transfection). The high variation observed in am-10a sample at day 2 was likelydue 
to technical errors. 
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6.2.1.2.3 Impact on CHO1.14 cell growth and cell viability 
 
To investigate whether the impact of miR-let-7e, miR-30e-5p, miR-10a and miR-29a 
was reproducible in other cell lines, the transfection assay was repeated in CHO1.14 
cells. 
Non-transfected cells and vcp siRNA treated cells showed the expected growth and cell 
viability profiles (Figure 6.2.1.2.E). Transfection of pm-neg molecules did not initiate 
non-specific effects on cell proliferation and cell viability. Treatment of cells with am-
neg molecules led to small impact on cell growth two and four days after transfection 
(Figure 6.2.1.2.E). 
Transient overexpression of let-7e provoked cell growth increase at day 2 and day 4 by 
1.42- and 4.02-fold respectively (p-values=0.0002 and 0.0001). This impact was not 
present at later stages of culture. The viability of cells transfected with pm-let-7e 
decreased by 4.59% to 7.87% in the period of the assay (p-values= 0.0210 to 0.0002) 
(Figure 6.2.1.2.F). Cell growth was up-regulated by 1.26-fold 96 hours (p-value= 
0.0121) following transient overexpression of miR-30e-5p and cell viability was 20.4% 
lower (p-value= 0.0026) compared to pm-neg transfected cells at day 7 (Figure 
s6.2.1.2.E &F). These results are in contradiction with what we observed in CHO-K1 
SEAP cells. 
Knockdown of miR-10a slightly increased cell density at day 4 but it was not 
statistically significant. Transfection of am-29a did not impact either on CHO1.14 cell 
growth or on cell viability (Figures 6.2.1.2.E &F). 
Thus overexpression of let-7e resulted in significant cell growth reduction in CHO-K1 
SEAP and CHO1.14 cells and triggered cell death in both cell lines at early stages of 
culture. Therefore the potential of pm-let-7e was investigated in another cell lines. 
Transfection of pm-30e-5p showed inconsistent outcomes across the different repeats 
and between the cell lines. miR-10a had little impact on cell proliferation. miR-29a did 
not impact significantly either on cell proliferation or on cell viability. 
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Figure 6.2.1.2.E: Impact of miR-let-7e, miR-30e-5p, miR-10a and miR-29a on 
CHO-1.14 cell growth. Cells were seeded at 1x105cells/ml in serum-free medium prior 
to transfection with 50nM miRNAs. Cells were harvested at day 2, day 4, day 7 and 
stained with GuavaViacount solution to monitor cell growth by Guava flow Cytometry. 
cells: non-transfected cells cultured at 37˚ C; vcp: siRNA against Valosin-Containing 
Protein (positive control of transfection efficiency); pm-neg: negative control for 
mimics; pm-let-7e; mimic of let-7e; pm-30e-5p: mimic of miR-30e-5p; am-neg: 
negative control for inhibitors; am-10a: inhibitor of miR-10a; am-29a
 
: inhibitor of miR-
29a. For statistical analysis a Student t-test was performed to compare pm-let-7e and 
pm-30e-5p with pm-neg and am-10a, am-29a with am-neg. Bars represent standard 
deviations of three biological replicates. *: p-value< 0.05 (pm-30e-5p compared to pm-
neg 96 hrs following treatment); ***: p-value< 0.001 (pm-let-7e compared to pm-neg 
treatment 48 hrs and 96hrs after transfection). 
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Figure 6.2.1.2.F: Impact of miR-let-7e, miR-30e-5p, miR-10a and miR-29a on 
CHO-1.14 cell viability. Cells were seeded at 1x105cells/ml in serum-free medium 
prior to transfection with 50nM miRNAs. Cells were harvested at day 2, day 4, day 7 
and stained with GuavaViacount solution to monitor cell viability by Guava flow 
Cytometry. cells: non-transfected cells cultured at 37˚ C; vcp: siRNA against Valosin-
Containing Protein (positive control of transfection efficiency); pm-neg: negative 
control for mimics; pm-let-7e; mimic of let-7e; pm-30e-5p: mimic of miR-30e-5p; am-
neg: negative control for inhibitors; am-10a: inhibitor of miR-10a; am-29a: inhibitor of 
miR-29a. For statistical analysis a Student t-test was performed to compare pm-let-7e 
and pm-30e-5p with pm-neg and am-10a, am-29a with am-neg. Bars represent standard 
deviations of three biological triplicates. *: p-value< 0.05; **: p-value< 0.01; ***: p-
value< 0.001 (pm-let-7e was compared to pm-neg treatment 24 hrs, 48 hrs and 96hrs 
after transfection and pm-30e5-p was compared to pm-neg at day 7 after transfection). 
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6.2.1.2.4 Impact on IgG1 total yield and normalised productivity in CHO1.14 cells 
 
To verify whether miR-10a, miR-29a and miR-30e-5p enhanced cell productivity in 
CHO1.14 cells, total yield and normalised productivity were monitored at day 2, day 4 
and day 7 following transfection. Transient up-regulation of miR-let-7e induced a 4.14-
fold increase (p-value= 2.66608E-05) of normalised productivity at day 4 after 
transfection (Figure 6.2.1.2.G).  
Transient knockdown of miR-10a resulted in 1.65-fold (p-value= 0.0026) improvement 
of total yield at day 2 in comparison to the non-specific control (Figure 6.2.1.2.G). 
However, it was lower than the total yield in non-transfected cells and there was no 
major improvement at later stages of culture. Normalised productivity was also 
improved 48 hours after am-10a transfection by 1.99-fold (p-value= 0.0027) but it did 
not exceed the production of non-transfected cells (Figure 6.2.1.2.H). 
Transfection with am-29a and pm-30e-5p did not impact on total yield and normalised 
productivity of IgG1 (Figures 6.2.1.2.G &H). 
In contrast to what we observed in CHO-K1 SEAP cells, transient overexpression of let-
7e impacted on normalised productivity of IgG1. This is likely due to a lower number of 
cells in culture and not due a higer expression of IgG1. The other minas, miR-10a, miR-
29a and miR30e-5p had little or no impact on productivity. Thus the investigation of let-
7e has a candidate miRNA to manipulate CHO cell proliferation and productivity was 
pursued in CHO2B6 cells. 
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Figure 6.2.1.2.G: Impact of miR-let-7e, miR-30e-5p, miR-10a and miR-29a on 
CHO-1.14 total yield. Supernatant of cells were harvested at day 2, day 4 and day 7 
after transfection. The total yield of IgG1 was analysed by ELISA assay. cells: non-
transfected cells cultured at 37˚C; pm-neg: negative control for mimics; pm-let-7e; 
mimic of let-7e; pm-30e-5p: mimic of miR-30e-5p; am-neg: negative control for 
inhibitors; am-10a: inhibitor of miR-10a; am-29a: inhibitor of miR-29a. For statistical 
analysis a Student t-test was carried out to compare pm-let-7e and pm-30e-5p with pm-
neg and am-10a, am-29a with am-neg. Bars represent standard deviations of three 
biological replicates. **: p-value< 0.01 (am-10a was compared to am-neg 48hrs after 
transfection).  
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Figure 6.2.1.2.H: Impact of miR-let-7e, miR-30e-5p, miR-10a and miR-29a on 
CHO-1.14 normalised productivity. Supernatant of cells were harvested at day 2, day 
4 and day 7 after transfection. IgG productivity was analysed using ELISA assay. cells: 
non-transfected cells cultured at 37˚C; pm-neg: negative control for mimics; pm-let-7e; 
mimic of let-7e; pm-30e-5p: mimic of miR-30e-5p; am-neg: negative control for 
inhibitors; am-10a: inhibitor of miR-10a; am-29a: inhibitor of miR-29a. For statistical 
analysis a Student t-test was carried out to compare pm-let-7e and pm-30e-5p with pm-
neg and am-10a, am-29a with am-neg. Bars represent standard deviations for three 
biological replicates. Statistics were evaluated with a Student t-test. **: p-value< 0.01 
(am-10a was compared to am-neg 48hrs after transfection); ***: p-value< 0.001 (pm-
let-7e was compared to pm-neg 96hrs after transfection). 
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6.2.1.2.5 Impact of pm-let-7e on CHO2B6 cell growth and viability 
 
Having established that pm-let-7e impacted significantly on CHO-K1 SEAP and 
CHO1.14 cell growth and viability, we analysed its potential in CHO2B6 cells.  
Following transient up-regulation of let-7e, cell growth was arrested from day 2 to day 7 
(1.39- to 23.4-fold; p-values= 0.0046 to 1.13279E-06) (Figure 6.2.1.2.I). There was a 
significant reduction in cell viability from day 3 to day 7 (from 11.16% to 46.49%; p-
values= 0.0217 to 7.67571E-05) (Figure 6.2.1.2.J). It is worth noting that the impact of 
let-7e on cell proliferation and cell viability was similar to the impact caused by 
knockdown of VCP, an essential housekeeping gene in CHO cells. 
 
In agreement with the original profiling result, high levels of let-7e are associated with 
cell density decrease in all three CHO cell lines, suggesting that under temperature-shift 
let-7e was a mediator of the cell growth arrest. Collectively, these results implied that 
let-7e is critical in the regulation of CHO cell proliferation and cell death therefore 
knockdown of let-7e may be a promising route to improve these cell characteristics. 
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Figure 6.2.1.2.I: Impact of miR-let-7e on CHO2B6 cell growth.  
Cells were seeded at 1x105cells/ml in serum-free medium prior to transfection.with 
50nM miRNAs. Cells were harvested at day 2, day 3, day 5, day 6 and day 7. Cells were 
stained with GuavaViacount reagent to monitor cell growth by Guava flow Cytometry. 
cells: non-transfected cells cultured at 37˚ C; vcp: siRNA against Valosin-Containing 
Protein (positive control of transfection efficiency); pm-neg: negative control for 
mimics; pm-let-7e
 
: mimic of let-7e. For statistical analysis a Student t-test was carried 
out to compare pm-let-7e with pm-neg from day 2 to day 7. Bars represent standard 
deviations of three biological replicates. **: p-value< 0.01; ***: p-value< 0.001. 
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Figure 6.2.1.2.J: Impact of miR-let-7e on CHO2B6 cell viability.  
Cells were seeded at 1x105cells/ml in serum-free medium prior to transfection.with 
50nM miRNAs. Cells were harvested at day 2, day 3, day 5, day 6 and day 7. Cells were 
stained with GuavaViacount reagent to monitor cell viability by Guava flow Cytometry. 
cells: non-transfected cells cultured at 37˚ C; vcp: siRNA against Valosin-Containing 
Protein (positive control of transfection efficiency); pm-neg: negative control for 
mimics; pm-let-7e
 
: mimic of let-7e. For statistical analysis a Student t-test was carried 
out to compare pm-let-7e with pm-neg from day 3 to day 7. Bars represent standard 
deviations of three biological replicates. *: p-value< 0.05; **: p-value< 0.01; ***: p-
value< 0.001. 
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6.2.1.2.6 Impact of pm-let-7e on IgG1 total yield and normalised productivity in 
CHO2B6 cells 
 
To verify whether miR-let-7e impacted on CHO2B6 productivity, IgG1 total yield and 
normalised productivity were monitored at day 3, day 5 and day 7. 
Transient up-regulation of let-7e led to total yield decrease likely due to the low number 
of cells remaining in culture (Figure 6.2.1.2.K). However, it did significantly enhance 
normalised productivity at day 3, day 5 and day 7 by 3.67-fold, 11.74-fold and 14.47-
fold respectively suggesting that the few cells remaining in culture were secreting more 
IgG1 (Figure 6.2.1.2.L). 
This confirms that the anti-proliferative role of let-7e and its negative impact on cell 
viability is conserved between CHO cell lines. Based on these data let-7e is a really 
promising target to manipulate cell growth and improve normalised productivity in 
different CHO cell lines. 
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Figure 6.2.1.2.K: Impact of pm-let-7e on CHO 2B6 total yield. 
Supernatant of cells were harvested at day 3, day 5 and day 7 after transfection. The 
total yield of IgG1 was analysed by ELISA (see materials and methods for more details 
on ELISA protocol in section 6.5.2). Cells: non-transfected cells cultured at 37˚C; pm-
neg: negative control for mimics; pm-let-7e
 
; mimic of let-7e. For statistical analysis a 
Student t-test was carried out to compare pm-let-7e with pm-neg at day 5 and day 7 
after transfection. Bars represent standard deviations of three biological replicates. ***: 
p-value< 0.001. 
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Figure 6.2.1.2.L: Impact of pm-let-7e on CHO 2B6 normalised productivity. 
Supernatant of cells were harvested at day 3, day 5 and day 7 after transfection. IgG 
productivity was analysed by ELISA (see materials and methods for more details on 
ELISA protocol in section 6.5.2). Cells: non-transfected cells cultured at 37˚C; pm-neg: 
negative control for mimics; pm-let-7e: mimic of let-7e. A Student t-test was performed 
allowing the comparison of pm-let-7e to pm-neg at day 3, day 5 and day 7 after 
transfection. Bars represent standard deviations of three biological replicates. **: p-
value< 0.01; ***: p-value< 0.001. 
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6.2.2 Screening of candidates miRNAs in fast versus slow growing cells 
 
6.2.2.1 Impact on CHO-K1 SEAP cell growth and viability 
 
A miRNA profiling experiment was performed by colleagues in our laboratory in the 
aim to identify miRNAs associated with rapid cell growth (Clarke, et al. 2012). Five fast 
growing and five slow growing cell lines were profiled in biological triplicates. These 
clones were all derived from the same cell line development project by collaborators in 
Pfizer. They displayed similar recombinant protein production rates and only differed in 
their cell growth rate. Samples were harvested at day 3, this time point corresponding to 
the middle of the logarithmic phase of growth and miRNA expression was quantified by 
TLDA. Following the analysis of data, a list of miRNAs was generated in which miR-
23b* was found to be up-regulated in fast growing cells. The expression of miR-216b, 
miR-409-5p and miR-874 was reduced in these cell lines. Transient overexpression of 
miR-23b* resulted in cell growth reduction of 1.32-fold at day 3 (p-value= 0.020) and 
to a lesser extent at day 5 after transfection (Figure 6.2.2.1.A). Consequently cell 
viability was improved at day 7 by 44.25% (p-value= 5.01239E-05) due probably to the 
smaller number of cells present in this culture (Figure 6.2.2.1.B). On the other hand, 
transient knockdown of miR-216b slightly increased cell density three and five days 
after transfection and by 1.45-fold at day 7 (Figure 6.2.2.1.A). Cell viability was 
enhanced by 16.57% at later stages of culture independently of cell number (p-value= 
0.0001). Transient inhibition of am-874 led to 1.15-fold to 1.31-fold reduction in cell 
growth and significantly improved cell viability at day 3 and day 5 after transfection (p-
value= 0.0002 and 0.0171) (Figures 6.2.2.1.A &B). Surprisingly, miR-490-5p did not 
impact on cell proliferation or cell viability. 
Thus miR-23b* significantly reduced cell density and both miR-216b and miR-874 
enhanced cell viability at later stages of culture. 
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Figure 6.2.2.1.A: Impact of pm-23b*, am-216b, am-409-5p and am-874 on CHO-
K1 SEAP cell growth. Cells were seeded at 1x105cells/ml in serum-free medium prior 
to transfection with 50nM miRNAs. Cells were harvested at day 3, day 5 and day 7 and 
stained with GuavaViacount reagent to monitor cell growth by Guava flow Cytometry. 
cells: non-transfected cells cultured at 37˚ C;  vcp: siRNA against Valosin Containing 
Protein (positive control of transfection efficiency); pm-neg: negative control for 
mimics; pm-23b*: mimic of miR-23b*; am-neg: negative control for inhibitors; am-
216b: inhibitor of miR-216b; am-409-5p: inhibitor of miR-409-5p; am-874
.
: inhibitor of 
miR-874. Statistical significance was analysed using a Student t-test to compare pm-
23b* with pm-neg and am-216b, am-409-5p, am-874 with am-neg. Bars represent 
standard deviations of three biological replicates.*: p-value< 0.05 
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Figure 6.2.2.1.B: Impact of pm-23b*, am-216b, am-409-5p and am-874 on CHO-
K1 SEAP cell viability. Cells were seeded at 1x105cells/ml in serum-free medium prior 
to transfection with 50nM miRNAs. Cells were harvested at day 3, day 5 and day 7 and 
stained with GuavaViacount reagent to monitor cell viability by Guava flow Cytometry. 
cells: non-transfected cells cultured at 37˚ C;  vcp: siRNA against Valosin Containing 
Protein (positive control of transfection efficiency); pm-neg: negative control for 
mimics; pm-23b*: mimic of miR-23b*; am-neg: negative control for inhibitors; am-
216b: inhibitor of miR-216b; am-409-5p: inhibitor of miR-409-5p; am-874
. 
: inhibitor of 
miR-874. Statistical significance was analysed using a Student t-test in which we 
compared pm-23b* to pm-neg and am-216b, am-409-5p, am-874 to am-neg. Bars 
represent standard deviations for three biological replicates. *: p-value< 0.05; **: p-
value< 0.01; ***: p-value< 0.001. 
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6.2.2.2 Impact on SEAP total yield and normalised productivity 
 
To investigate the impact of miR-23b*, miR-216b, miR-409-5p and miR-874 on SEAP 
total yield and normalised productivity, supernatant of samples were harvested at day 3, 
day 5 and day 7. 
None of these miRNAs enhanced either total yield of CHO-K1 SEAP cell (Figure 
6.2.2.2.A).  
Due to the high standard deviations displayed in am-neg transfected sample, it was 
difficult to conclude on any changes in normalised productivity 48 hours after 
transfection (Figure 6.2.2.2.B). However at day 5 and day 7, am-216b, am-409-5p and 
am-874 did not improved normalised productivity. This assay was conducted only once 
in CHO-K1 SEAP cells. For statistical significance other repeats need to be done before 
validation of these miRNAs. 
 
The results for all miRNA screening are summarised in Table 6.2.2.2. 
 
 
 
 
. 
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Figure 6.2.2.2.A: Impact of pm-23b*, am-216b, am-409-5p and am-874 on SEAP 
total yield. 
 Supernatant of cells were harvested at day 3, day 5 and day 7 after transfection. SEAP 
total yield was analysed by a colorimetric assay. cells: non-transfected cells cultured at 
37˚C; pm-neg: negative control for mimics; pm-23b*; mimic of miR-23b*; am-neg: 
negative control for inhibitors; am-216b: inhibitor of miR-216b; am-409-5p: inhibitor of 
miR-409-5p; am-874
 
: inhibitor of miR-874. For statistical analysis a Student t-test was 
performed to compare pm-23b* with pm-neg and am-216b, am-409-5p, am-874 with 
am-neg. Bars represent standard deviations for three biological replicates. There was no 
statistical significance found in this assay. 
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Figure 6.2.2.2.A: Impact of pm-23b*, am-216b, am-409-5p and am-874 on SEAP 
normalised productivity. Supernatant of cells were harvested at day 3, day 5 and day 7 
after transfection. SEAP productivity was analysed by a colorimetric assay. cells: non-
transfected cells cultured at 37˚C;  pm-neg: negative control for mimics; pm-23b*; 
mimic of miR-23b*; am-neg: negative control for inhibitors; am-216b: inhibitor of miR-
216b; am-409-5p: inhibitor of miR-409-5p; am-874: inhibitor of miR-874. Statistical 
significance was assessed by a Student t-test in which pm-23b* was compared to pm-
neg and am-216b, am-409-5p, am-874 were compared to am-neg. Bars represent 
standard deviations for three biological replicates. There was no statistical significance 
found in this assay. 
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Table 6.2.2.2: Summary of data of miRNA screening  
 
miRNA Screening data Conclusion 
miR-490 Inconsistent Further validation 
miR-34a Inconsistent Further validation 
miR-34c Inconsistent Further validation 
let-7e 
Cell growth arrest, low 
viability 
Knockdown to increase 
cell density and viability 
levels 
miR-30e-5p Inconsistent Further validation 
miR-10a Inconsistent Further validation 
miR-29a Inconsistent Further validation 
miR-23b* 
Low cell density, high 
viability 
Further validation 
miR-216b High viability Further validation 
miR-409-5p No impact Further validation 
miR-874 
Low cell density, high 
viability 
Further validation 
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6.3 Investigation of the individual miR-23a~miR-27a~24-2 cluster 
members potential in improving CHO cell characteristics 
 
6.3.1 Screening of miR-24 
 
Previous profiling data from our laboratory indicated that miR-24 could be a useful tool 
for modifying CHO cell growth. With the intention of manipulating CHO cell 
phenotypes to improve growth and productivity, the potential of miR-24 as a tool to 
engineer CHO cells was further studied using mimic and inhibitor molecules. For 
further details on the description of these molecules and controls used in this study refer 
to section 6.2.1. Transient transfection using pm-24, pm-neg, am-24 and am-neg 
molecules was performed in recombinant human monoclonal immunoglobulin gamma 1 
(rHmIgG1) producing cells, CHO1.14 and CHO2B6, for seven days of culture in 
serum-free medium. The concentration of miRNAs used in this experiment was 100nM. 
Although this concentration may be considered high, this experiment was only to 
observe if a big change in expression of miR-24 could mimic the cell growth decrease 
observed subsequent to temperature shift in the profiling study.  
 
6.3.1.1 Screening of miR-24 in CHO1.14 cells 
 
Non-transfected cells had the expected profiles in cell proliferation and cell viability 
(Figure 6.3.1.1.A). Knockdown of vcp using a siRNA led to dramatic cell growth 
reduction as well as cell viability 96 hours after transfection. The transfection reagent in 
its own displayed a non-specific impact on cell proliferation at day 2 and day 4 
following transfection (Figure 6.3.1.1.A). However, it did not impact negatively on cell 
viability.  
 
Transfection of pm-neg and am-neg molecules induced non-specific decrease of cell 
growth but it did not impact negatively on cell viability at early stages of culture 
(Figures 6.3.1.1.A&B). This was previously observed in the other transient transfection 
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assays using lower concentration of miRNAs. At day 4, up-regulation of miR-24 
induced cell growth decrease by 1.68-fold and improved cell viability by 14.46% at 
later stages of culture compared to the non-specific control pm-neg (Figures 
6.3.1.1.A&B). On the other hand, miR-24 knockdown increased cell growth by more 
than two-fold and had little impact on cell viability (Figures 6.3.1.1.A&B). Although 
the results were not statistically significant due to the number of replicates, the high and 
low reading represented by the bars at day 4 and day 7 indicated that the impact of pm-
24 on cell proliferation and cell viability was interesting to follow in other cell lines. 
138 
 
 
Figure 6.3.1.1.A: Impact of miR-24 on CHO1.14 cell growth. 
miR-24 was up-regulated using miRNA mimic (pm) or inhibited using miRNA inhibitor 
(am) at a concentration of 100nM. Cells were seeded at 1x105cells/ml in serum-free 
medium and harvested at day 2, day 4 and day 7. Cells were stained with 
GuavaViacount reagent to monitor cell growth by Guava flow cytometry. cells: non-
transfected cells; neofx: transfection reagent; vcp: siRNA against Valosin-Containing 
Protein (positive control of transfection efficiency); pm-neg: negative control for 
mimics; am-neg
 
: negative control for inhibitors. At day 2, bars represent standard 
deviations of three biological replicates. At day 4 and day 7, bars represent the high and 
low reading of two biological replicates. There was no statistical significance found in 
this experiment. 
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Figure 6.3.1.1.B: Impact of miR-24 on CHO1.14 cell viability. 
miR-24 was up-regulated using miRNA mimic (pm) or inhibited using miRNA inhibitor 
(am) at a concentration of 100nM. Cells were seeded at 1x105 cells/ml in serum-free 
medium and stained with GuavaViacount reagent to monitor cell viability by Guava 
flow cytometry at day 2, day 4 and day 7. cells: non-transfected cells; neofx: 
transfection reagent; vcp: siRNA against Valosin-Containing Protein (positive control 
of transfection efficiency); pm-neg: negative control for mimics; am-neg: negative 
control for inhibitors. At day 2, bars represent standard deviations of three biological 
replicates. At day 4 and day 7, bars represent the high and low reading of two biological 
replicates. There was no statistical significance found in this experiment. 
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6.3.1.2 Screening of miR-24 in CHO2B6 cells 
 
To investigate whether the impact of miR-24 observed in CHO1.14 cells was 
reproducible in other CHO cell lines, functional validation was repeated in CHO2B6 
cells. 
Non-transfected CHO2B6 cells showed the expected cell growth and viability profiles. 
Cells treated with the transfection reagent (neofx) on its own, pm-neg and am-neg 
molecules showed a cell growth reduction to the same extent. However, no detrimental 
side effects were observed due to the transfection process over the culture (Figure 
6.3.1.2.A).  
Following transfection of pm-24, cell growth decreased by 3-fold at day 4 and by 14-
fold at day 7. Cell viability was also reduced by 1.89-fold to 18.77-fold from day 2 to 
day 7. Transient knockdown of miR-24 did not impact on cell proliferation or on cell 
viability (Figures 6.3.1.2.A &B).  
Although the transient inhibition of miR-24 did not increase CHO2B6 cell proliferation, 
we had some indications that it may enhance the growth of CHO1.14 cells. In addition, 
the overexpression of miR-24 led to more consistent results in both cell lines suggesting 
that miR-24 plays some part in influencing cell growth. Therefore we conducted the 
same transient assay in CHO-K1 SEAP cells. 
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Figure 6.3.1.2.A: Impact of miR-24 on CHO2B6 cell growth. 
miR-24 was up-regulated using mimic (pm) or inhibited using inhibitor (am) molecules 
at a concentration of 100nM. Cells were seeded at 1x105cells/ml in serum-free medium 
and stained with GuavaViacount reagent to monitor cell growth by Guava flow 
cytometry at day 2, day 4 and day 7. cells: non-transfected cells; neofx: transfection 
reagent; vcp: siRNA against Valosin-Containing Protein (positive control of 
transfection efficiency); pm-neg: negative control for mimics; am-neg: negative control 
for inhibitors. At day 2, bars represent standard deviations of three biological replicates. 
At day 4 and day 7, bars represent the high and low reading of two biological replicates. 
There was no statistical significance found in this experiment. 
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Figure 6.3.1.2.B: Impact of miR-24 on CHO2B6 cell viability. 
miR-24 was up-regulated using miRNA mimic (pm) or inhibited using miRNA inhibitor 
(am) at a concentration of 100nM. Cells were seeded at 1x105cells/ml in serum-free 
medium and stained with GuavaViacount reagent to monitor cell growth by Guava flow 
cytometry at day 2, day 4 and day 7. cells: non-transfected cells; neofx: transfection 
reagent; vcp: siRNA against Valosin-Containing Protein (positive control of 
transfection efficiency); pm-neg: negative control for mimics; am-neg: negative control 
for inhibitors. At day 2, bars represent standard deviations of three biological replicates. 
At day 4 and day 7, bars represent the high and low reading of two biological replicates. 
There was no statistical significance found in this experiment. 
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6.3.1.3 Validation of transient overexpression and knockdown of miR-24  
 
Before continuing the investigation on the potential of miR-24 in affecting cell 
proliferation and viability, we aimed to verify that the phenotypes observed upon pm-24 
and am-24 treatment were specific to the changes in expression of miR-24. The 
expression levels of miR-24 were analysed using quantitative PCR at day 4 after 
transfection. 
Levels of miR-24 were increased by 1.68x103-fold in CHO 1.14 cells and by 469-fold 
in CHO2B6 cells in comparison to the non-specific control (Figure 6.3.1.3). 
Surprisingly, knockdown of miR-24 led to a small increase of miR-24 levels in 
CHO1.14 cells. However it induced a 4.01-fold decrease in CHO2B6 cells. Knockdown 
of a particular miRNA could stimulate the cells to produce more of this miRNA. 
Another possibility is that anti-miR molecules do not induce degradation of the miRNA 
but rather sequestration so this duplex could be dissociated during RNA extraction 
process thus the level of this latter would still be detectable. 
These results did not prove that miR-24 levels were down-regulated in CHO1.14 cells. 
Although, it seemed that miR-24 was depleted in CHO2B6 cells, there was no impact 
on cell proliferation.  
Thus we could not conclude on the influence of miR-24 on cell growth. 
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Figure 6.3.1.3: Levels of miR-24 expression in CHO1.14 and CHO2B6 cells.  
Changes in miR-24 expression between pm-24/pm-neg and am-24/am-neg were 
analysed using TaqMan method (see materials and methods for more details on TaqMan 
assayin section 6.4.9) at day 4 after transfection with pm-neg, pm-24, am-neg and am-
24 at a concentration of 100nM. The expression of miRNA was normalised to U6 
snRNA as an endogenous control to correct for variation of RNA input. Analysis was 
performed using the 2-ΔΔCt method with the AB7500 Real Time PCR instrument. Bars 
represent the maximum and minimum of relative quantification from two biological 
samples run in three technical replicates. 
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6.3.1.4 Screening of miR-24 in CHO-K1 SEAP cells 
 
6.3.1.4.1 Impact of pm-24 and am-24 on cell growth and viability 
 
To verify whether the potential of miR-24 impacting cell proliferation was reproducible 
using lower concentration of pre-miR and anti-miR molecules as well as broadening the 
screen to a third cell line, functional analysis was repeated in CHO-K1 SEAP cells. A 
concentration of 50nM was used to reduce the risk of off-target effects. CHO-K1 SEAP 
growth and viability were analysed at day 3 and day 6 after transfection in serum-free 
medium. Non-transfected cells showed high viability and grew as usual at early stages 
of culture. As previously seen, cells treated with siRNA against VCP had their cell 
growth reduced to very low levels and had poor viability. 
Up-regulation of miR-24 reduced cell growth by 1.27-fold and provoked the 
maintenance of cell viability at later stages of culture (87.35% versus 56.99%; p-value= 
0.0004) (Figures 6.3.1.4.A &B). Knockdown of miR-24 increased cell density by 1.37-
fold (p-value= 0.0372) and improved cell viability significantly at day 3 after 
transfection (Figures 6.3.1.4.A &B).  
Thus transfection of pm-24 molecules consistently affect cell proliferation 
(decrease/increase) and cell viability (improvement) between the different cell lines and 
assays, even though the extent at low concentration was not as striking as in the 
previous experiment using high levels of mimics.  
Transfection of am-24 led to variability between the assays and cell lines. However, 
overall there were positive indications that miR-24 plays a role in CHO cell 
proliferation. Thus other strategies were considered to further investigate this 
conjecture. 
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Figure 6.3.1.4.A: Impact of miR-24 on CHO-K1 SEAP proliferation. 
miR-24 was up-regulated using pm-24 molecules or inhibited using am-24 molecules at 
a concentration of 50nM. Cells were harvested at day 3 and day 6 after transfection in 
serum-free medium and stained with GuavaViacount reagent to monitor cell growth by 
Guava flow cytometry. cells: non-transfected cells; vcp: siRNA against Valosin-
Containing Protein (positive control of transfection efficiency); pm-neg: negative 
control for mimics; pm-24; mimic of miR-24; am-neg: negative control for inhibitors; 
am-24: inhibitor of mir-24. A Student t-test was performed to verify the statistical 
significance of the changes of miR-24 expression in pm-24/pm-neg and am-24/am-neg 
comparison. Bars represent standard deviations of three biological replicates. There 
were no replicates for cells and vcp samples. *: p-value< 0.05 
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Figure 6.3.1.4.B: Impact of miR-24 on CHO-K1 SEAP viability.  
miR-24 was up-regulated using pm-24 molecules or inhibited using am-24 molecules at 
a concentration of 50nM. Cells were harvested at day 3 and day 6 after transfection and 
stained with GuavaViacount reagent to monitor cell viability by Guava flow cytometry. 
cells: non-transfected cells; vcp: siRNA against Valosin-Containing Protein (positive 
control of transfection efficiency); pm-neg: negative control for mimics; pm-24; mimic 
of miR-24; am-neg: negative control for inhibitors; am-24: inhibitor of mir-24. For 
statistical analysis, pm-24 was compared to pm-neg and am-24 was compared to am-
neg. A Student t-test was performed to verify the statistical significance of the changes 
of miR-24 expression in pm-24/pm-neg and am-24/am-neg comparison. Bars represent 
standard deviations of three biological replicates. There were no replicates for cells and 
vcp samples. **: p-value< 0.01; ***: p-value< 0.001. 
148 
 
6.3.1.4.2 Impact of pm-24 and am-24 on SEAP total yield and normalised 
productivity 
 
To study the efficacy of miR-24 overexpression or inhibition in improving SEAP 
production, supernatant of samples was harvested three days after transfection. 
Following miR-24 knockdown, total yield was increased by 1.6-fold (p-value=0.0321) 
in comparison to the negative control and normalised productivity was slightly 
increased but it was not statistically significant (Figure 6.3.1.4.C). Transient 
overexpression of miR-24 impacted negatively on SEAP production. 
These transient transfection assays were repeated several times in CHO-K1 SEAP cells. 
As discussed previously, variability was noticed in the results. However it may be 
possible to strengthen the impact of miR-24 on cell proliferation and protein production 
using other strategies.  
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Figure 6.3.1.4.C: Impact of miR-24 on SEAP total yield and normalised 
productivity at day 3 following transfection. 
Supernatant of pm-24 and am-24 treated cells was harvested three days after 
transfection. Total yield and normalised productivity of the SEAP protein were analysed 
by a kinetic assay (see materials and methods for details on SEAP assay). pm-neg: 
negative control for mimics; pm-24; mimic of miR-24; am-neg: negative control for 
inhibitors; am-24: inhibitor of miR-24. Statistical significance of changes in SEAP 
production was analysed by a Student t-test in pm-24/pm-neg and am-24/am-neg 
comparison. Bars represent standard deviations of three biological replicates. Each 
biological replicate was run in technical duplicates. *: p-value< 0.05. 
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6.3.2 Inducible overexpression of miR-24 
 
Functional analysis of miR-24 using mimic and inhibitor molecules revealed that the 
impact on CHO cell growth and productivity was variable but held some promise. It 
may be that transient transfection of mimics and inhibitors leads to transient impact 
which typically lasts less than a week. The reproducibility between assays and cell lines 
was challenging and difficult to achieve even if the conditions of the repeated 
experiments were kept the same. Therefore we used other tools as an alternative to 
manipulate miR-24 expression. 
 
6.3.2.1 Inducible overexpression of miR-24 using a tetracycline-inducible cassette 
 
6.3.2.1.1 Description of the inducible system consisting of pMF111 and pSAM200 
vectors 
 
In the previous section, we showed that transient overeexpression of miR-24 reduced 
cell proliferation. To allow cells to grow to a suitable density, an inducible system was 
considered as an approach to induce miR-24 expression at a desirable time. We were 
interested in using this system in a transient manner first and if the outcome was 
promising to generate stable cell lines. 
The assay consisted of the co-transfection of two vectors pMF111 and pSAM200 
(Figure 6.3.2.1.A). pSAM200 vector contains a tetracycline activator (tTA) and the 
pMF111 vector (Fussenegger, Mazur and Bailey 1997, Mazur, et al. 1998) has a 
tetracycline-inducible promoter PhCMV*-1. This system allows tight regulation of gene 
expression by responding to the presence or absence of doxycyline in culture. In E. coli, 
the Tet repressor protein (TetR) negatively regulates the genes of the tetracycline-
resistance operon on the Tn10 transposon. TetR blocks transcription of these genes by 
binding to the tet operator sequences (tetO) in the absence of tetracycline. TetR and tetO 
provide the basis of regulation and induction for use in mammalian experimental 
systems.
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Figure 6.3.2.1.A: Maps of pMF111-SEAP and pSAM200 vectors. 
- pMF111-SEAP vector (left): PhCMV*: tetracycline-inducible 
cytomegalovirus promoter; SEAP: secreated alkaline phosphatase gene; IRES: 
internal ribosomal entry site allows cap-independent translation initiation; SV40 
pA: Simian Virus 40 large T antigen polyadenylation signal which serves for 
termination of transcription; bla
- pSAM 200 vector (right): 
: bla gene encodes β-lactamase and confers 
resistance to the antibiotic ampicillin. Ampicilin is used in positive colonies 
selection in transformation assays. The two restriction enzymes, EcoRI (5’end) 
and NotI (3’end) used for cloning are highlighted in blue  
SV40 P/E: SV 40 large T antigen 
promoter/enhancer; SV40 sd/sa: SV40 splice donor/splice acceptor; tTA: 
tetracycline activator; ori: origin of replication (site of replication initiation). bla: 
bla gene encodes β-lactamase and confers resistance to the antibiotic ampicillin. 
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In this assay, we used the Tet-OFF system where tTA binds the Tet response element 
(TRE) and activates transcription in the absence of doxycyline, a member of the 
tetracycline antibiotics group (Figure 6.3.2.1.B). In the presence of doxycyline, gene 
expression is turned off and after withdrawal of the drug, gene expression is switch on 
(described by Gossen & Bujard 1992(Gossen and Bujard 1992). 
 
 
 
Figure 6.3.2.1.B: Description of Tet OFF gene expression system. 
PCMV: cytomegalovirus promoter; tetR: Tet repressor protein; VP16: Herpes simplex 
virus VP16 activation domain to convert TetR from a transcriptional repressor to a 
transcriptional activator also known as the tetracycline-controlled transactivator (tTA
 
). 
tTA binds the Tet response element (TRE) and activates transcription in the absence of 
doxycyline. In the presence of doxycyline, gene expression is turned off and after 
withdrawal of the drug, gene expression is switch on. 
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Previously in our laboratory, pMF111-SEAP vector (a gift from Pr Fussenegger‘s 
laboratory) was used to stably express the SEAP gene in CHO-K1 cells (For more 
details refer to the thesis of Dr Niraj Kumar in 2009). The SEAP gene was removed by 
two restriction enzymes EcoRI and NotI and replaced by miR-24 precursor. This 
cloning was done by colleagues using precursor miR-24 which was isolated from CHO 
cells and amplified by PCR giving an amplicon of 367 bp (Figure 6.3.2.1.C). Precursor 
miR-24 consisted in the mature miR-24 strand with CHO flanking sequences. The size 
and sequence of the cassette were checked by digestion and sequencing prior to 
transfection. 
 
 
 
 
Figure 6.3.2.1.C: Schematic of precursor miR-24 insertion into pMF111 at 
restriction sites EcoRI (5’end) and NotI (3’end). 
Forward primer: AATAGAATTCGTGTTCACAGTGGCTAAGTTCCGC (designed 
from human sequence);  
Reverse primer
The sequence shown represents the miR-24 precursor amplicon (78bp). The mature 
sequence of miR-24 is in blue. 
: TATTGCGGCCGCGGGAACCACAGAAATCTCAAGGT (designed 
from mouse sequence).  
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6.3.2.1.2 Inducible overexpression of miR-24 using pMF111-SEAP as a negative 
control  
 
Several transfection controls were included in the assay, the non-transfected cells, 
pMF111-SEAP, peGFP-C1 a vector that constitutively expresses enhanced green 
fluorescent protein (GFP; BD Biosciences) and pmF-GEO, a doxycyline inducible GFP-
neomycin fusion vector. The vector pMF111-SEAP consisted of SEAP gene inserted in 
the vector backbone pMF111. This vector backbone was used as an empty vector 
control. To overexpress miR-24, the SEAP gene was removed and replaced by the CHO 
miR-24 precursor. peGFP-C1 and pmF-GEO vectors were used as controls for 
transfection efficiency and to verify the doxycyline-dependent inducibility. 
To evaluate the transfection efficiency, GFP-expression was assessed in peGFP-C1 
transfected cells using fluorescent microscopy the day after transfection. There were 
approximately 60% GFP-positive cells (Figure 6.3.2.1.D). The inducibility by 
doxycyline was also checked by fluorescent microscopy, before and after removal of the 
drug in pmF-GEO+ pSam200 co-transfected cells. In the presence of doxycyline, faint 
GFP expression was detectable thus the system was not completely turned off (Figure 
6.3.2.1.D). After withdrawal of the drug, more GFP protein was expressed in the cells 
(Figure 6.3.2.1.D) suggesting that the co-transfection worked well. The leaky GFP 
expression observed in the presence of doxycyline showed that the Tet OFF system was 
not optimal but satisfactory for the purpose of first screening. 
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Figure 6.3.2.1.D: Detection of GFP fluorescence. a: non-transfected CHO1.14 cells; 
b: CHO 1.14 cells transfected with peGFP-C1; c: CHO 1.14 cells co-transfected with 
pmF-GEO+ pSam200 and cultured with doxycyline; d: CHO 1.14 cells co-transfected 
with pmF-GEO+ pSam200 and cultured without doxycyline. Magnification x10. 
 
6.3.2.1.3 Investigation of pMF111-miR-24 impact on CHO2B6 growth and viability 
 
To study the impact of miR-24 up-regulation on CHO phenotypes, cell growth and cell 
viability were monitored at day 1, day 4 and day 6 after transfection in CHO1.14 cells. 
Unexpectedly, the co-transfection had a detrimental impact on cell growth in all 
samples cultured with doxycyline, especially four days after transfection (Figure 
6.3.2.1.E).This impact was not detectable at earlier time point and it was abated at day 6 
likely due to the loss of plasmids. In absence of doxycyline, cell growth was further 
reduced in all samples.  
Due to the detrimental impact of transfection on cell growth, these data were difficult to 
analyse. Surprisingly, CHO1.14 viability was not dramatically affected by the 
transfection despite the impact on cell number (Figure 6.3.2.1.F). Non-transfected cells 
had a viability of 80% at day 1 whereas in other assays they usually maintained their 
viability around 90% at early time points. Therefore this assay was repeated in another 
cell line. 
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Figure 6.3.2.1.E: Impact of pMF111-miR-24 transfection on CHO1.14 growth. 
Transfection was performed in suspension with 2µl of lipofectamine 2000 reagent 
(Invitrogen), using 1µg of plasmids, in cells seeded at a concentration of 1x106cells/ml 
in 1ml final volume. Doxycyline was added six hours after transfection, at a final 
concentration of 1µg/ml. Cells were harvested and stained with GuavaViacount reagent 
at day 1, day 4 and day 6 to monitor cell density by Guava flow cytometry. Bars 
represent standard deviations of three biological replicates. Dox+: culture with 
doxycyline; Dox-: culture with no doxycyline. 
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Figure 6.3.2.1.F: Impact of pMF111-miR-24 transfection on CHO1.14 viability.  
Transfection was performed in suspension with 2µl of lipofectamine 2000 reagent 
(Invitrogen), using 1µg of plasmids, in cells seeded at a concentration of 1x106cells/ml 
in 1ml final volume. Doxycyline was added six hours after transfection, at a final 
concentration of 1µg/ml. Cells were harvested and stained with GuavaViacount reagent 
at day 1, day 4 and day 6 to monitor cell density by Guava flow cytometry.Bars 
represent standard deviations of three biological replicates. Dox+: culture with 
doxycyline; Dox-: culture with no doxycyline. 
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6.3.2.1.4 Investigation of pMF111-miR-24 impact on CHO2B6 growth and viability 
 
Transfection of pMF111-SEAP, pMF-GEO and pMF111-miR-24 was repeated in 
CHO2B6 cells. 
Again the transfection of these vectors impacted in a non-specific manner on cell 
proliferation in presence of doxycyline, particularly at day 4 (Figure 6.3.2.1.G). 
However, this impact was much less pronounced than in CHO1.14 cells. Similarly, the 
presence of doxycyline appeared to confer some kind of protective effect compared to 
the culture without doxycyline.This was also more obvious on day 4, though it could be 
seen at day 1 also (Figure 6.3.2.1.G). The decrease of cell viability levels following 
withdrawal of doxycyline, suggested also that doxycyline protected cells against 
transfection toxicity (Figure 6.3.2.1.H). 
Following removal of doxycline from the cell culture, cell growth was decreased in all 
samples (Figure 6.3.2.1.G). Surprisingly, the reduction of cell growth observed four 
days after pMF111-miR-24 transfection was not as obvious as for the controls. However 
the viability of these cells was reduced to the same extent (Figure 6.3.2.1.H). 
Together these results revealed the non-specific impact of the transfection and 
doxycyline on cell proliferation and cell viability. For this reasons, it was difficult to 
decipher any impact of miR-24. 
To eliminate the possibility of the induction of the transgene (SEAP or GEO) 
expression causing the observed reduction in cell numbers after doxycyline removal, the 
experiment was repeated in the same cell lines using pMF111 empty vector. 
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Figure 6.3.2.1.G: Impact of pMF111-miR-24 transfection on CHO2B6 growth.  
Transfection was performed in suspension with 2µl of lipofectamine 2000 reagent 
(Invitrogen), using 1µg of plasmids, in cells seeded at a concentration of 1x106cells/ml 
in 1ml final volume. Doxycyline was added six hours after transfection, at a final 
concentration of 1µg/ml. Cells were harvested and stained with GuavaViacount reagent 
at day 1, day 4 and day 6 to monitor cell density by Guava flow cytometry. Bars 
represented standard deviations of three biological replicates. Dox+: culture with 
doxycyline; Dox-: culture with no doxycyline. 
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Figure 6.3.2.1.H: Impact of pMF111-miR-24 transfection on CHO2B6 viability.  
Transfection was performed in suspension with 2µl of lipofectamine 2000 reagent 
(Invitrogen), using 1µg of plasmids, in cells seeded at a concentration of 1x106cells/ml 
in 1ml final volume. Doxycyline was added six hours after transfection, at a final 
concentration of 1µg/ml. Cells were harvested and stained with GuavaViacount reagent 
at day 1, day 4 and day 6 to monitor cell density by Guava flow cytometry. Bars 
represented standard deviations of three biological replicates. Dox+: culture with 
doxycyline; Dox-: culture with no doxycyline. 
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6.3.2.1.5 Inducible overexpression of miR-24 using pMF111 backbone as a negative 
control  
 
In the previous attempt to overexpress miR-24 using pMF111-SEAP/pSAM200 Tet 
OFF system, the non-specific effect of both the transfection and doxycyline made the 
interpretation of the data difficult. In an effort to enhance the quality of the assay, 
transfection was repeated in CHO 1.14 and CHO 2B6 cells, using pMF111 empty 
vector as negative control. The culture conditions were kept as described in the previous 
section.  
Prior to transfection, the plasmid pMF111-SEAP (5415bp) was digested with EcoRI and 
NotI to remove the SEAP gene and the digested samples were run in an agarose gel for 
visualisation (Figure 6.3.2.1.I). The size of the vector backbone and the SEAP gene 
were expected at 2833bp and 2582bp respectively. Due to the size of the DNA, the two 
bands ran very close to each other on the gel. 
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Figure 6.3.2.1.I: Digestion of pMF111-SEAP with EcoRI and NotI. 
The vector pMF111-SEAP (5415bp) was digested with EcoRI and NotI to remove the 
SEAP gene. Following digestion, samples was run in a 1% agarose gel. Two bands were 
expected at 2833bp for pMF111 vector and at 2582bp for SEAP gene. M: 1kb Plus 
DNA ladder. Lane 1: digested pMF111-SEAP. 
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The plasmid was recircularised after treatment with DNA polymerase I, Large (Klenow) 
Fragment which creates blunt ends. The resulting colonies were miniprepped and 
plasmid linearised using EcoRI and NotI to verify correct size (Figure 6.3.2.1.J). 
 
 
 
Figure 6.3.2.1.J: Linearization of pMF111 by EcoRI and NotI. 
The vector pMF111 (2833bp) was linearised with EcoRI and NotI. Following digestion, 
samples was run in a 1% agarose gel. M: 1kb Plus DNA ladder. Lane 1: linearised 
pMF111. 
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6.3.2.1.6 Impact of pMF111-miR-24 transfection on CHO1.14 growth and viability 
 
Although pMF111 empty vector and pMF111-miR-24 resulted in non-specific impact 
on cell growth in presence of doxycyline particularly at day 4, it was to a lesser extent 
than in the previous assay (Figures 6.3.2.1.K &L). Following doxycyline withdrawal, 
the non-specific impact on cell proliferation was further enhanced four days after 
transfection. In this assay, cell viability was negatively affected by the transfection in 
presence and in absence of doxycyline. 
 
6.3.2.1.7 Impact of pMF111-miR-24 transfection on CHO2B6 growth and viability 
 
In CHO2B6 cells, transfection reduced extensively cell growth in all samples in 
presence and after removal of doxycyline (Figures 6.3.2.1.M &N). Unlike the previous 
assays, cell viability was higher in the non-transfected cells as well as in the other 
samples and doxycyline withdrawal did not affect cell viability. 
 
The results from this assay corroborated the conclusions made in the previous assay. 
The transfection impacted negatively on cell proliferation and often on cell viability. 
Doxycyline removal prevented further cell growth and usually promoted cell death 
increase. In most cases, the non-specific impact diminished at day 6 likely due to the 
loss of the plasmid. To verify whether precursor miR-24 was processed into the mature 
form by the cellular machinery, we investigated the levels of expression of miR-24. 
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Figure 6.3.2.1.K: Impact of pMF111-miR-24 transfection on CHO1.14 growth.  
Transfection was performed in suspension with 2µl of lipofectamine 2000 reagent 
(Invitrogen), using 1µg of plasmids, in cells seeded at a concentration of 1x106cells/ml 
in 1ml final volume. Doxycyline was added six hours after transfection, at a final 
concentration of 1µg/ml. Cells were harvested and stained with GuavaViacount reagent 
at day 1, day 4 and day 6 to monitor cell density by Guava flow cytometry. Bars 
represented standard deviations of three biological replicates. The high standard 
deviations observed in some of the samples at day 6 are likely due to cell clumping. 
Dox+: culture with doxycyline; Dox-: culture with no doxycyline. 
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Figure 6.3.2.1.L: Impact of pMF111-miR-24 transfection on CHO1.14 viability.  
Transfection was performed in suspension with 2µl of lipofectamine 2000 reagent 
(Invitrogen), using 1µg of plasmids, in cells seeded at a concentration of 1x106cells/ml 
in 1ml final volume. Doxycyline was added six hours after transfection, at a final 
concentration of 1µg/ml. Cells were harvested and stained with GuavaViacount reagent 
at day 1, day 4 and day 6 to monitor cell density by Guava flow cytometry. Bars 
represented standard deviations of three biological replicates. The high standard 
deviations observed in some of the samples at day 6 are likely due to cell clumping. 
Dox+: culture with doxycyline; Dox-: culture with no doxycyline. 
 
. 
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Figure 6.3.2.1.M: Impact of pMF111-miR-24 transfection on CHO2B6 growth.  
Transfection was performed in suspension with 2µl of lipofectamine 2000 reagent 
(Invitrogen), using 1µg of plasmids, in cells seeded at a concentration of 1x106cells/ml 
in 1ml final volume. Doxycyline was added six hours after transfection, at a final 
concentration of 1µg/ml. Cells were harvested and stained with GuavaViacount reagent 
at day 1, day 4 and day 6 to monitor cell density by Guava flow cytometry. Bars 
represented standard deviations of three biological replicates. Dox+: culture with 
doxycyline; Dox-: culture with no doxycyline. 
 
 
 
168 
 
 
 
Figure 6.3.2.1.N: Impact of pMF111-miR-24 transfection on CHO2B6 viability.  
Transfection was performed in suspension with 2µl of lipofectamine 2000 reagent 
(Invitrogen), using 1µg of plasmids, in cells seeded at a concentration of 1x106cells/ml 
in 1ml final volume. Doxycyline was added six hours after transfection, at a final 
concentration of 1µg/ml. Cells were harvested and stained with GuavaViacount reagent 
at day 1, day 4 and day 6 to monitor cell density by Guava flow cytometry. Bars 
represented standard deviations of three biological replicates. Dox+: culture with 
doxycyline; Dox-: culture with no doxycyline. 
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6.3.2.1.8 Investigation of miR-24 levels in pMF111-miR-24 transfected cells 
 
To confirm that miR-24 precursor was processed correctly into the mature form and 
overexpressed following transfection of pMF111-miR-24 in absence of doxycyline, the 
levels of miR-24 expression were assessed using real-time PCR in CHO1.14 and 
CHO2B6 cells, in presence or absence of doxycyline. 
Surprisingly, the levels of miR-24 were increased in CHO1.14 cells (Figure 6.3.2.1.O). 
In CHO2B6 cells, there was a slight decrease of the levels of miR-24 (Figure 
6.3.2.1.O).  
Although these results were not statistically significant, this suggests that miR-24 
precursor was processed into miR-24 mature form in CHO1.14 cells but not in 
CHO2B6 cells. From previours studies, we knew that the endogenous levels of 
expression of miR-24 were high in both cell lines (Ct~23-24), however it is unlikely 
that the attempt to further overexpress miR-24 might not be successful. The issues with 
the Tet OFF system pMF111/pSAM200 could not be resolved at the time of the study 
so we considered other approaches to investigate the impact of miR-24 on cell 
proliferation and cell viability. 
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Figure 6.3.2.1.O: Levels of miR-24 expression in pMF111-miR-24 expressing 
CHO1.14 and CHO2B6 cells at day 4 after transfection.  
Changes in miR-24 expression in pMF111-miR-24 transfected cells were analysed after 
removal of doxycyline at day 4 after transfection in CHO1.14 and CHO2B6 cell lines. 
The expression of miRNA was normalised to RNU6B as an endogenous control to 
correct for variation of RNA input. Analysis was performed using the AB7500 Real 
Time PCR instrument. Bars represent the high and low reading from two biological 
samples. 
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6.3.3 Screening of miR-23a and miR-27a 
 
In the functional validation of miR-24 using mimic and inhibitor molecules, the changes 
of miR-24 expression led to variable impacts on cell proliferation and cell viability as 
well as between the cell lines. Overall there was a positive indication that miR-24 may 
influcence these phenotypes particularly when using mimics. The attempt to transiently 
overexpress miR-24 using an inducible system was not effective due to transfection and 
miR-24 processing issues. Therefore we sought other approaches to continue the 
functional validation of miR-24. 
miR-24 is co-transcribed with two other miRNAs, miR-23a and miR-27a, to form the 
miR-23a~miR-27~24-2 cluster. It is thought that these three miRNAs cooperate 
together to regulate the same cellulae pathways. It is possible that manipulating miR-24 
independently of the other members of the cluster, miR-23a and miR-27a, could lead to 
compensation by these miRNAs. Thus this counteraction may result in restoring the 
original phenotype and so little or no effect might be seen.  In addition, as these 
miRNAs are expressed at different levels in the cells, one may be more impactful on the 
phenotype than the others. Therefore the utility of the other cluster members, miR-23a 
and miR-27a, was assessed by individual or simultaneous transfection.  
 
6.3.3.1 Screening of miR-23a in CHO-K1 SEAP cells 
 
Mimics and inhibitors of miR-23a were transfected at 50 nM in CHO-K1 SEAP cells. 
Samples were harvested at day 2, day 4 and day 7 to monitor cell growth, viability and 
productivity. 
CHO-K1 SEAP cells grew as expected for seven days. Cells treated with siRNA against 
VCP had their cell growth and cell viability dramatically reduced. Transfection of pm-
neg and am-neg molecules provoked a decreased of cell growth at day 2 and to a lesser 
extent 96 hours after transfection. At day 7, cells grew rapidly in am-neg treated cells. 
This is possibly due to a technical problem with the preparation of the sample dilution 
or with the cell count. 
At day 4, transfection of pm-23a led to lower cell density (6.5x105cells/ml) than in the 
non-specific control treated cells (1.05x106cells/ml) (Figure 6.3.3.1.A). At this time 
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point, cell viability was also reduced by nearly 10% (Figure 6.3.3.1.B Transient 
knockdown of miR-23a did not impact on cell density but slightly enhanced cell 
viability at day 4 after transfection (Figures 6.3.3.1.A &B).  
As mentioned in the previous screening assays, mimics had more pronounced impact 
than the inhibitor molecules on the phenotypes mentionned above. This assay was 
repeated in the same cell lines and the same cell proliferation and viability profiles were 
observed. Like miR-24, miR-23a may affect cell proliferation. 
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Figure 6.3.3.1.A: Impact of miR-23a on CHO-K1 SEAP growth. 
miR-23a was up-regulated using pm-23a molecules or inhibited using am-23a 
molecules at a concentration of 50nM. Cells were harvested at day 2, day 4 and day 7 
after transfection in serum-free medium and stained with GuavaViacount reagent to 
monitor cell growth by Guava flow cytometry. cells: non-transfected cells; vcp: siRNA 
against Valosin-Containing Protein (positive control of transfection efficiency); pm-
neg: negative control for mimics; pm-23a; mimic of miR-23a; am-neg: negative control 
for inhibitors; am-23a
 
: inhibitor of mir-23a. At day 2, bars represent stardard deviations 
of biological triplicates. At day 4, bars represent the high and low reading of two 
biological replicates. At day 7, one biological sample was monitored. 
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Figure 6.3.3.1.B: Impact of miR-23a on CHO-K1 SEAP viability.  
miR-23a was up-regulated using pm-23a molecules or inhibited using am-23a 
molecules at a concentration of 50nM. Cells were harvested at day 2, day 4 and day 7 
after transfection and stained with GuavaViacount reagent to monitor cell viability by 
Guava flow cytometry. cells: non-transfected cells; vcp: siRNA against Valosin-
Containing Protein (positive control of transfection efficiency); pm-neg: negative 
control for mimics; pm-23a; mimic of miR-23a; am-neg: negative control for inhibitors; 
am-23a
 
: inhibitor of mir-23a. At day 2, bars represent stardard deviations of biological 
triplicates. At day 4, bars represent the high and low reading of two biological 
replicates. At day 7, one biological sample was monitored. 
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6.3.3.2 Screening of miR-27a 
 
6.3.3.2.1 Screening of miR-27 a in CHO1.14 cells 
 
Screening of miR-24 and miR-23a showed a potential impact of both miRNAs on cell 
proliferation. To investigate whether miR-27a expressed at high concentration (100nM) 
would also affect cell proliferation and possibly viability, a transient transfection of pm-
27a and am-27a was carried out in CHO1.14 cells and samples were harvested at day 2, 
day 4 and day 7 to monitor the phenotypes of interest. Non-transfected cells showed the 
usual profile of growth with rapid cell proliferation and appeared to maintain high 
viability at early stages of culture (Figure 6.3.3.2). As expected, knockdown of VCP 
impacted dramatically on cell growth and viability. Transfection of pm-neg, am-neg and 
the transfection reagent (neofx) on its own appeared to have a non-specific effect on 
these phenotypes particularly at day 4. This impact was abated after seven days of 
culture.   
Transient overexpression of miR-27a induced a 1.35-fold cell density increase 48 hrs 
after transfection (p-value= 0.000257) (Figure 6.3.3.2.A). This advantage in cell growth 
was maintained at day 4 after transfection, though it was to a lesser extent. Cell viability 
was enhanced by 8.23% at later stages of culture (Figure 6.3.3.2.B). 
Transient inhibition of miR-27a slightly decreased cell growth two days after 
transfection (Figure 6.3.3.2.A). Surprisingly, it increased cell density by 1.43-fold four 
days following transfection and enhanced CHO1.14 viability by 7.34% at the same time 
point (Figures 6.3.3.2.A &B). Despite inconsistency, these results indicated that 
manipulation of miR-27a expression could influence cell proliferation. 
To further investigate the potential of miR-27a, we repeated the same experiment in 
CHO2B6 cells.  
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Figure 6.3.3.2.A: Impact of miR-27a on CHO1.14 growth. 
miR-27a was up-regulated using pm-27a molecules or inhibited using am-27a 
molecules at a concentration of 100nM. Cells were harvested at day 2, day 4 and day 7 
after transfection in serum-free medium and stained with GuavaViacount reagent to 
monitor cell growth by Guava flow cytometry. cells: non-transfected cells; neofx: lipid-
based transfection reagent; vcp: siRNA against Valosin-Containing Protein (positive 
control of transfection efficiency); pm-neg: negative control for mimics; pm-27a; mimic 
of miR-27a; am-neg: negative control for inhibitors; am-27a
 
: inhibitor of mir-27a. A 
Student t-test was performed to analyse the statistical significance of the impact of miR-
27a overexpression or knockdown on cell proliferation compared to pm-neg and am-
neg. At day 2, bars represent stardard deviations of biological triplicates. At day 4 an 
day 7, bars represent the high and low reading of two biological replicates. ***: p-
value< 0.001 (pm-27 was compared to pm-neg at 48 hrs following transfection). 
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Figure 6.3.3.2.B: Impact of miR-27a on CHO1.14 viability.  
miR-27a was up-regulated using pm-27a molecules or inhibited using am-27a 
molecules at a concentration of 100nM. Cells were harvested at day 2, day 4 and day 7 
after transfection in serum-free medium and stained with GuavaViacount reagent to 
monitor cell viability by Guava flow cytometry. cells: non-transfected cells; neofx: 
lipid-based transfection reagent; vcp: siRNA against Valosin-Containing Protein 
(positive control of transfection efficiency); pm-neg: negative control for mimics; pm-
27a; mimic of miR-27a; am-neg: negative control for inhibitors; am-27a: inhibitor of 
mir-27a. A Student t-test was performed to analyse the statistical significance of the 
impact of miR-27a overexpression or knockdown on cell viability compared to pm-neg 
and am-neg. At day 2, bars represent stardard deviations of biological triplicates. At day 
4 an day 7, bars represent the high and low reading of two biological replicates.  
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6.3.3.2.2 Screening of miR-27 a in CHO2B6 cells 
 
To investigate whether the potential of miR-27a was reproducible, a transient assay was 
performed in CHO2B6 cells, using mimic and inhibitor molecules at a concentration of 
100nM. Samples were harvested at day 2, day 4 and day 7 to assess cell growth and 
viability. 
The observations made in the previous assays for the controls were valid in this 
experiment. There was a non-specific impact of the transfection reagent in its own 
(neofx), pm-neg and am-neg molecules on cell proliferation but the viability was 
maintained at high levels. 
Following transient up-regulation of miR-27a, cell density was improved at day 2 by 
1.6-fold (p-value= 0.000328) and at day 4 by 1.35-fold (Figure 6.3.3.2.C). Cell viability 
was reduced by 4.67% (p-value= 0.03097) and by 7.52% two and four days after 
transfection (Figure 6.3.3.2.D). On the other hand, miR-27a knockdown had little 
impact on cell proliferation and viability (Figures 6.3.3.2.C &D). 
Thus mimics of miR-27a improved cell growth significantly at early stages of culture, 
this increase being maintained at day 4 after transfection for two replicates in both 
CHO1.14 and CHO2B6 cell lines. Variability in the impact on both cell proliferation 
and viability was noticed following knockdown of miR-27a. This transient assay was 
repeated at lower concentration in CHO1.14 cells but the manipulation of miR-27a 
showed little and variable outcomes. 
As mentionned previously, miR-27a, miR-24-2, miR-23a are co-transcribed to form 
miR-23~27a~24-2 cluster. Therefore we considered monitoring the impact of the entire 
cluster on CHO phenotypes rather than monitoring individual miRNA. 
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Figure 6.3.3.2.C: Impact of miR-27a on CHO2B6 growth.  
miR-27a was up-regulated using pm-27a molecules or inhibited using am-27a 
molecules at a concentration of 100nM. Cells were harvested at day 2, day 4 and day 7 
after transfection in serum-free medium and stained with GuavaViacount reagent to 
monitor cell growth by Guava flow cytometry. cells: non-transfected cells; neofx: lipid-
based transfection reagent; vcp: siRNA against Valosin-Containing Protein (positive 
control of transfection efficiency); pm-neg: negative control for mimics; pm-27a; mimic 
of miR-27a; am-neg: negative control for inhibitors; am-27a: inhibitor of mir-27a. A 
Student t-test was performed to analyse the statistical significance of the impact of miR-
27a overexpression or knockdown on cell proliferation compared to pm-neg and am-
neg. At day 2, bars represent stardard deviations of biological triplicates. At day 4 an 
day 7, bars represent the high and low reading of two biological replicates. ***: p-
value< 0.001 (pm-27 was compared to pm-neg treatment 48 hrs after transfection). 
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Figure 6.3.3.2.D: Impact of miR-27a on CHO2B6 viability 
miR-27a was up-regulated using pm-27a molecules or inhibited using am-27a 
molecules at a concentration of 100nM. Cells were harvested at day 2, day 4 and day 7 
after transfection and stained with GuavaViacount reagent to monitor cell viability by 
Guava flow cytometry. cells: non-transfected cells; neofx: lipid-based transfection 
reagent; vcp: siRNA against Valosin-Containing Protein (positive control of 
transfection efficiency); pm-neg: negative control for mimics; pm-27a; mimic of miR-
27a; am-neg: negative control for inhibitors; am-27a: inhibitor of mir-27a. A Student t-
test was performed to analyse the statistical significance of the impact of miR-27a 
overexpression or knockdown on cell viability compared to pm-neg and am-neg. At day 
2, bars represent stardard deviations of biological triplicates. At day 4 an day 7, bars 
represent the high and low reading of two biological replicates. *: p-value< 0.05 (pm-27 
was compared to pm-neg treatment 48 hrs after transfection). 
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6.4 Screening of miR-23a~27a~24-2 cluster on CHO phenotypes  
 
6.4.1 Impact of miR-23~27a~24-2 cluster on CHO-K1 SEAP growth and 
viability 
 
Individual transfection of miR-23a, miR-27a or miR-24-2 showed positive indications 
that manipulation of their expression may affect cell proliferation and possibly viability. 
However, variability was present between the cell lines and the assays. Therefore we 
considered transfecting miR-23a, miR-27a and miR-24-2 simultaneously in CHO-K1 
SEAP cells. To avoid saturation of the RNA interference machinery, the final combined 
concentration of transfected miRNAs was 50 nM. Samples were harvested at day 2, day 
4 and day 7 for cell growth and viability. 
Cells grew as expected while maintaining high viability (Figure 4.4.1.A). Cells treated 
with pm-neg and am-neg had their cell growth reduced, particularly at day 2. This non-
specific impact was not noticed at day 7 after transfection and had no major impact on 
cell viability (Figures 6.4.1.A &B). 
At day 4 following up-regulation of miR-23~27a~24-2 cluster members, cell growth 
was decreased by 2.11-fold and had recovered by day 7 (Figure 6.4.1.A). Simultaneous 
knockdown of miR-23a, miR-27a and miR-24-2 did not impact on cell proliferation. 
CHO-K1 SEAP viability was enhanced slightly at day 2 following up-regulation of the 
miR-23~27a~24-2 cluster members and also at day 4 by 4.47% after simultaneous 
knockdown of miR-23a, miR-27a and miR-24 (Figure 6.4.1.B). 
Thus simultaneous overexpression of miR-23~27a~24-2 cluster members resulted in 
further reduction of cell proliferation compared to the individual effect. The anti-
proliferative effect of these miRNAs was noticed four days after transfection and was 
abated at day 7. Although the statistical significance of this impact was not 
demonstrated, the two biological samples had very similar cell density. This suggested 
that these three miRNAs may act cooperatively to influence cell growth. 
Surprisingly, knockdown of the miR-23~27a~24-2 cluster members did not impact on 
cell proliferation and had little impact on cell viability thus suggesting that knockdown 
was not optimal using transient inhibitor molecules.  
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Figure 6.4.1.A: Impact of miR-23a~27a~24-2 cluster on CHO-K1 SEAP growth. 
Simultaneous transient transfection of miR-23a, miR-27a and miR-24-2 was performed 
at a final concentration of 100nM in CHO-K1 SEAP cells in serum-free medium. 
Samples were harvested at day 2, day 4 and day 7 and cells were stained with 
GuavaViacount reagent to monitor cell growth by Guava flow cytometry. cells: non-
transfected cells; vcp: siRNA against Valosin-Containing Protein (positive control of 
transfection efficiency); pm-neg: negative control for mimics; pm cluster: mimics of 
miR-23a/miR-27a/24-2; am-neg: negative control for inhibitors; am cluster; inhibitors 
of miR-23a/27a/24-2 cluster. At day 2, bars represented standard deviations for 
biological triplicates. At day 4, the bars indicated the high and low reading of two 
biological replicates.At day 7, one biological sample was analysed.  
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Figure 6.4.1.B: Impact of miR-23a~27a~24-2 cluster on CHO-K1 SEAP cell 
viability. Simultaneous transient transfection of miR-23a, miR-27a and miR-24-2 was 
performed at a final concentration of 100nM in CHO-K1 SEAP cells in serum-free 
medium. Samples were harvested at day 2, day 4 and day 7 and cells were stained with 
GuavaViacount reagent to monitor cell viability by Guava flow cytometry. cells: non-
transfected cells; vcp: siRNA against Valosin-Containing Protein (positive control of 
transfection efficiency); pm-neg: negative control for mimics; pm cluster: mimics of 
miR-23a/miR-27a/24-2; am-neg: negative control for inhibitors; am cluster; inhibitors 
of miR-23a/27a/24-2 cluster. At day 2, bars represented standard deviations for 
biological triplicates. At day 4, the bars indicated the high and low reading of two 
biological replicates.At day 7, one biological sample was analysed. *: p-value< 0.05 
(pm cluster was compared to pm-neg treatment at 48 hrs after transfection). 
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6.4.2 Impact of miR-23~27a~24-2 cluster on SEAP total yield and 
normalised productivity 
 
To investigate the impact of the miR-23a~27a~24-2 cluster on total yield and 
normalised productivity supernatants were harvested at day 2, day 4 and day 7. 
Total yield was negatively impacted two and four days following simultaneous 
overexpression of the miR-23a~27a~24-2 cluster members (Figure 6.4.2.A). This can 
be explained by the low cell number present in culture at day 4. However at day 2, cells 
grew as well as the control and showed increased viability. Thus it is possible that the 
transfection of the three inhibitor miRNAs provoked a reduction of total yield 
independently of cell density at early stages of culture. On the other hand total yield was 
enhanced by 1.44-fold at day 7 likely due to the loss of mimics at this stage and the 
consequent higher cell number in culture (Figure 6.4.2.A). Transient knockdown of the 
miR-23a~27a~24-2 cluster members also reduced total yield at day 2 and day 4 and 
recovered by day 7 (Figure 6.4.2.A). Total yield decrease was independent of cell 
density at both time points suggesting that transfection of the three mimic miRNAs 
impacted negatively on total yield. However, both overexpression and knockdown 
showed the same impact. Thus the effect may not be specific to the changes of miRNA 
expression but rather may be a non-specific impact induced by the transfection process. 
Normalised productivity was improved by 1.84-fold at day 4 following simultaneous 
up-regulation of miR-23a, miR-27a and miR-24-2 and by 1.71-fold following 
knockdown of the cluster at later stages of culture (Figure 6.4.2.B). This latter was 
likely due to the recovery of cells following the loss of the inhibitor molecules. 
Considering the lack of biological replicates in this experiment, the impact of miR-
23a~27a~24-2 cluster on total yield and normalised productivity was unclear. The 
results from the cluster member knockdown in this assay and in the previous one 
indicated that knockdown was not optimal using transient inhibitor molecules. 
Therefore we envisaged to knockdown miR-23a~27a~24-2 cluster using another 
antisense approach. 
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Figure 6.4.2.A: Impact of miR-23a~27a~24-2 cluster on total yield in CHO-K1 
SEAP cells. 
Supernatants were harvested at day 2, day 4 and day 7 after transfection in serum-free 
medium. SEAP total yield was analysed by a kinetic assay (see materials and methods 
for more details on SEAP assay in section 6.5.1). The change in absorbance of SEAP 
substrate, p-nitrophenolphosphate, was assessed by a spectrophotometer at 405nm. 
cells: non-transfected cells; pm-neg: negative control for mimics; pm cluster: mimics of 
miR-23a, 27a and 24-2; am-neg: negative control for inhibitors; am cluster
 
: inhibitors of 
miR-23a, 27a and 24-2. One biological sample was tested in this experiment. 
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Figure 6.4.2.B: Impact of miR-23a~27a~24-2 cluster on SEAP normalised 
productivity. Supernatants were harvested at day 2, day 4 and day 7 after transfection. 
SEAP total yield was analysed by a kinetic assay (see materials and methods for more 
details on SEAP assay in section 6.5.1). The change in absorbance of SEAP substrate, 
p-nitrophenolphosphate, was assessed by a spectrophotometer at 405nm. cells: non-
transfected cells; pm-neg: negative control for mimics; pm cluster: mimics of miR-23a, 
27a and 24-2; am-neg: negative control for inhibitors; am cluster: inhibitors of miR-23a, 
27a and 24-2. One biological sample was tested in this experiment. 
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6.4.3 Investigation of miR-24 targets 
 
miR-24 has been previously shown to be involved in cell proliferation, cell cycle, 
apoptosis and DNA repair (Lal, et al. 2009a, Qin, et al. 2010, Mishra, et al. 2009). Our 
results further demonstrated the association of miR-23a~miR-27a~miR-24-2 cluster 
members with cell proliferation. Therefore we considered the validation of previously 
identified targets of miR-24 to verify whether they were conserved in CHO cells. 
Screening of miR-24 targets was done using several genes cited in a recent publication 
by Lal and co-workers (Lal, et al. 2009a) including Cyclin A, MCM4 (minichromosome 
maintenance complex component 4), MYC, FEN1 (Flap structure specific endonuclease 
I) and PCNA (proliferating cell nuclear antigen). It had been reported that these genes 
did not involve canonical seed pairing with miR-24 and were not predicted by seed 
recognition computational prediction method. However, miR-24 is a well conserved 
miRNA in several species so we chose the genes described in this paper to identify any 
changes in expression after treatment with pm-24 or am-24 at a concentration of 50nM. 
PABPNI (polyA binding protein, nuclear 1) was used as endogenous control. This gene 
was previously identified as a suitable endogenous control for qPCR studies in CHO 
cells (Bahr, et al. 2009). However, the expression of PABPNI was variable between 
samples and therefore was not a suitable endogenous control for our study. We repeated 
the qPCR assay using β-ACTIN as the endogenous control and PABPNI as a target. 
Transient knockdown of miR-24 led to up-regulation of MCM4, MYC, PCNA and 
PABPNI by 2- to 3.3-fold (Figure 6.4.3.A). Levels of FEN1 were slightly down-
regulated and Cyclin A expression was not detected. On the other hand, transient up-
regulation of miR-24 induced knockdown of MCM4, MYC, FENI and PABPNI by 
1.25- to 4-fold (Figure 6.4.3.B). PCNA was slightly up-regulated. Thus MCM4, MYC, 
FEN1, PABPNI and CyclinA may be directly or indirectly targeted by miR-24 in CHO 
cells. This suggests that the role of miR-24 in the regulation of cell proliferation, cell 
cycle and DNA repair may be conserved in CHO cells. 
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Figure 6.4.3.A: Changes in expression levels of miR-24 targets following miR-24 
knockdown. Transient knockdown of miR-24 was achieved using inhibitors of miR-24 
at a concentration of 50nM.  Levels of expression of CyclinA, MCM4, MYC, FEN1, 
PCNA and PABPN1 were analysed at day 4 after transfection using the AB7500 Real 
Time PCR instrument. Bars represent the minimum and maximum of two biological 
samples run in technical triplicates. 
189 
 
 
 
Figure 6.4.3.B: Changes in expression levels of miR-24 targets following miR-24 
overexpression. Transient up-regulation of miR-24 was achieved using mimics of miR-
24 at a concentration of 50nM.  Levels of expression of CyclinA, MCM4, MYC, FEN1, 
PCNA and PABPN1 were analysed at day 4 after transfection using the AB7500 Real 
Time PCR instrument. Bars represent the minimum and maximum of two biological 
samples run in technical triplicates. 
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6.5 Stable knockdown of miR-23a~27a~24-2 cluster  
 
In an attempt to circumvent the issues associated with transient transfections, we used a 
multiple antisense approach to simultaneoulsy inhibit the three miR-23a~27a~24-2 
cluster members. This technology is similar to miRNA sponge technology but instead of 
targeting the seed sequence of a miRNA, the antisense transcripts are the exact antisense 
sequences of the mature miR-23a, miR-27 and miR-24-2.  
This approach is derived from the Mtg-AMOs (multiple target anti-miRNA antisense 
oligonucleotideoxyribonucleotides) technology which gives the possibility to 
simultaneously knockdown several miRNAs as well as to impact on their mRNA targets 
(Lu, et al. 2009). We called this approach‘multi-antisense cluster’. 
 
6.5.1 Vector design 
 
Two constructs were designed one containing the exact antisense sequences of miR-23a, 
miR-27a and miR-24-2 cluster members (wild-type (wt) cluster) and the other 
containing random sequences in place of the miRNA sequences (mutant (mut) cluster) 
(Figure 6.5.1.A). miR-23a, miR-27a and miR-24-2 were linked together by a 8 
nucleotide linker. At the time of the study, there was no CHO genome sequence 
available so the random sequence was aligned with other miRNA sequences from 
human, rat and mouse to minimise the potential for any off-target effects. Two 
restriction enzyme sites, XhoI and EcoRI were added to the 5’ and 3’end of the 
oligonucleotides for insertion into pd2EFP-Hyg2 vector. 
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miR-23a~27a~24-2 wild type (wt cluster): Wt Cluster sense strand  
5’TCGAGGGAAATCCCTGGCAATGTGATCTAAATGAGCGGAACTTAGCCACT
GTGAACTAAATGA
 
CTGTTCCTGCTGAACTGAGCCAG 3’  
miR-23a~27a~24-2 wild type (wt cluster): Wt Cluster antisense strand 
5’AATTCTGGCTCAGTTCAGCAGGAACAGTCATTTAGTTCACAGTGGCTAAG
TTCCGCTCATTTAGATCACATTGCCAGGGATTTCCC 
 
3’  
miR-23a~27a~24-2 mutant (mutt cluster): Mutt cluster sense strand 
5’TCGAGGGAAATCCCTGGCCGCTTCAGCTAAATGAGCGGAACTTAGCCTTC
CGACGCTAAATGA
 
CTGTTCCTGCTGAATCGTGATCG 3’  
miR-23a~27a~24-2 mutant (mutt cluster): Mutt cluster antisense strand 
5’AATTCGATCACGATTCAGCAGGAACAGTCATTTAGCGTCGGAAGGCTAAG
TTCCGCTCATTTAGCTGAAGCGGCCAGGGATTTCCC 
 
3’ 
Figure 6.5.1.A: Design of the antisense transcripts and the negative control 
Underlined purple letters represent the restriction enzyme overhangs, XhoI and EcoRI. 
Underlined blue letters represent the 8 nt linker. Black letters represent the antisense 
mature miRNA sequences. The length of the four oligonucleotides was 86bp. 
192 
 
To obtain pd2EGFP-Hyg2 vector (Figure 6.5.1.B), a colleague from our laboratory, Dr 
Nga Lao engineered different vectors derived from pcDNA5-FRT vector (Invitrogen) 
and pCMV-d2EGFP (a gift from Pr Sharp laboratory, MIT). The pd2EGFP-Hyg2 vector 
contains a constitutive CMV promoter, a hygromycin gene for selection and a 
destabilized enhanced GFP (dEGFP). This modified EGFP consists of the fusion of the 
ornithine decarboxylase degradation domain from mouse (MODC) and the C-terminal 
of an enhanced variant of GFP (EGFP). The resulting reporter is very unstable with a 
short half-life of 2hrs. The change of dEGFP fluorescence induced by the binding of the 
miRNA to the antisense transcripts cloned downstream of the d2EGFP can be correlated 
to the changes in miRNA expression. By binding to the antisense transcripts, the 
miRNA prevents dEGFP from being translated so the dEGFP acts as a reporter of 
miRNA depletion. Once the miRNA binds to its antisense, its active levels are 
decreased in the cell and less miRNA molecules are available to bind to their cognate 
mRNA targets. 
 
 
 
 
Figure 6.5.1.B: Design of pd2EGFP-Hyg2 vector for miR-23a~27~24-2 cluster 
stable knockdown. CMV: cytomegalovirus promoter; d2EGFP: destabilized enhanced 
Green Fluorescent Protein; polyA: signal of polyadenylation for transcriptional 
termination; PGK: phosphoglycerate kinase promoter; Hyg: hygromycin (antibiotic for 
selection of positive clones). 
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Following oligonuclotide annealing and cloning of the wt and mut cluster cassettes into 
pd2EFP-Hyg vector, band sizes of the two constructs were checked by digestion with 
BamHI and XbaI. Vector size was expected to be at 6884bp and insert at 1428bp for the 
wt and mutt cluster constructs (Lane 1-3, Figure 6.5.1.C) and bands were expected at 
6884bp and 1345bp for the control (empty vector), (Lane 4, Figure 6.5.1.C).  
Nucleotide sequences were confirmed by sequencing and aligned against BLAST 
nucleotide database (Figure 6.5.1.D)  
 
 
 
         
 
Figure 6.5.1.C: Mutant (mut) and wild-type (wt) cluster digestion with 
BamHI/XbaI in a 1% agarose gel.  
Lanes1-3: three positive clones containing mut cluster (left panel) or wt cluster (right 
panel) inserted between XhoI and EcoRI. Lane 4
 
: negative clone. M: 1kb Plus DNA 
ladder (Invitrogen) used to determine vector and insert sizes. 
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Mut cluster 
GTGCTTCTGCTAGGATCAATGTGTAGGCGGCCGCTCGAGGGAAATCCCTG
GCCGCTTCAGCTAAATGAGCGGAACTTAGCCTTCCGACGCTAAATGACT
GTTCCTGCTGAATCGTGATCGAATTCTCGATGCATGCCTCGACTGTGCCTT
CTAGTTGCCAGCCATCTGTTGTTTGCCCCT 
 
Wt cluster 
CTTCTGCTAGGATCAATGTGTAGGCGGCCGCTCGAGGGAAATCCCTGGCA
ATGTGATCTAAATGAGCGGAACTTAGCCACTGTGAACTAAATGACTGTT
CCTGCTGAACTGAGCCAGAATTCTCGATGCATGCCTCGACTGTGCCTTCTA
GTTGCCAGCCATCTGTTGTTTGCCCCTCCC 
 
Figure 6.5.1.D: Mutant (mut) and wild-type (wt) cluster sequencing 
Sequencing was done by MWG eurofins using a primer that recognises a specific part 
of the dEGFP sequence, situated 630bp upstream of the mut and wt cluster cassette. In 
red are the restriction enzyme sites used for cloning, XhoI for the 5’end and EcoRI for 
the 3’end. The blue letters are the antisense sequences of miR-23a, miR-27a and miR-
24-2 that are linked together by a 8nt linker (purple letters). The black letters represent 
the flanking sequencing from the pd2EGFP-Hyg2 vector. 
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6.5.2 Analysis in mixed population 
 
The two constructs, mut cluster as a negative control and wt cluster, were then 
transfected at a concentration of 5µg/well into CHO-K1 SEAP cells, in a 6-well plate 
using 10µl of lipofectamine reagent. The pEGFP-C1 vector was also transfected as a 
control of transfection efficiency (estimated at approximately 60% by guava flow 
cytometry). The next day two wells were used to evaluate the levels of expression of 
miR-24 using real-time PCR and one well was kept to generate stable cell lines (Figure 
6.5.2). miR-24 was down-regulated by 1.81-fold in the wt cluster transfected cells in 
comparison to the mutt cluster expressing cells. Thus this was a good indication that 
miR-24 was targeted by the wt cluster. 
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Figure 6.5.2: Evaluation of miR-24 expression in mut and wt cluster transfected 
cells. Changes in miR-24 expression in mut and wt cluster expressing cells were 
analysed 24 hours after transfection with the AB7500 Real Time PCR instrument. The 
expression of miR-24 was normalised to U6 snRNA as an endogenous control to correct 
for variation of RNA input. Mut: miR-24 expression in mutant cluster transfected cells; 
wt: miR-24 expression in wild type cluster transfected cells. Bars represent the high and 
low reading of two biological samples run in technical triplicates. 
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To generate stable mut and wt cluster expressing cell lines drugs were added two days 
after transfection. G418 was added at 1000µg/ml to maintain SEAP-producing cells and 
hygromycin was added at 350µg/ml for selection of mut cluster or wt cluster expressing 
cells. 
Cells were transferred to a T-25 flask then scaled-up to a T-75 flask once confluent. 
Having generated a stable population, samples were taken to monitor cell growth, cell 
viability and GFP positivity.  
 
6.5.2.1 Investigation of GFP fluorescence 
 
The number of GFP-positive cells was measured using Guava Express Plus software on 
a Guava benchtop flow cytometry. In wt cluster expressing cells, the average GFP 
positivity in three biological triplicates was significantly lower (10-30%) than in mut 
cluster expressing cells (30-50%) at every time point of the cell culture (Figure 6.5.2.1). 
Thus the reduction of GFP positivity suggested that the miR-23a~27a~24-2 cluster 
members were binding to the wt cluster. 
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Figure 6.5.2.1: Investigation of GFP positivity in wt and mut cluster in mixed 
populations. Cells were seeded at 2x105cells/ml in T-75 flasks in biological triplicates. 
Samples were harvested everyday for six days to monitor GFP positivity by Guava 
Flow cytometry. Bars represented standard deviations of three biological samples. A 
Student t-test was performed to analyse the statistical significance of any changes in 
GFP fluorescence. **: p-value< 0.01; ***: p-value< 0.001. 
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6.5.2.2 Investigation of wt cluster on cell growth and viability of mixed 
populations 
 
Cell growth and viability were monitored in the same populations for six days. Overall, 
the wt cluster transfected cells showed increased cell proliferation compared to the 
control cells (Figure 6.5.2.2.A). At day 5, cell density was improved by 2.87-fold. 
However, due to high standard deviations between the three biological samples 
especially towards the end of the culture, this difference was only significant at day 1. 
The high variations may have been due to aggregation. Cell viability was reduced by 
5.26% (p-value= 0.0084) at day 2 and this reduction was maintained until the fifth day 
(Figure 6.5.2.2.B). It seemed that the negative impact on cell viability was abated by 
day 6. However, the high standard deviations masked the real levels of cell viability 
particularly at later stages of culture. 
Although high standard deviations were displayed towards the end of the assay, the four 
first days provided good indications on the positive impact of the wt cluster in mixed 
populations.  
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Figure 6.5.2.2.A: Profile of cell growth in wt and mut cluster transfected cells in 
mixed populations. Cells were seeded at 2x105cells/ml in T-75 flasks in biological 
triplicates. Samples were harvested everyday for six days and resuspended into 
GuavaViacount reagent to monitor cell growth using Guava Flow cytometry. Bars 
represented standard deviations of three biological samples. A Student t-test was 
performed to analyse the statistical significance of the difference in cell density 
observed upon wt cluster transfection and mut cluster. *: p-value<0.05. 
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Figure 6.5.2.2.B: Profile of cell viability in wt and mut cluster transfected cells in 
mixed populations. Cells were seeded at 2x105cells/ml in T-75 flasks in biological 
triplicates. Samples were harvested everyday for six days and resuspended into 
GuavaViacount reagent to monitor cell viability using Guava Flow cytometry 
technology. Bars represented standard deviations of three biological replicates. A 
Student t-test was performed to analyse the statistical significance of the difference in 
cell viability observed upon wt cluster transfection and mut cluster.  
**: p-value< 0.01. 
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6.5.3 Analysis in single cell clones in 24-well-plate 
 
These promising results encouraged us to pursue our investigation of stable knockdown 
of the miR-23a~27~24-2 cluster. 
Single cell cloning was performed in 96 well plates with ATCC+5% FBS. Colonies 
were transferred to a 24-well plate subjected to drug selection medium. When cells 
reached confluence they were transferred to a 24-well plate in 1ml suspension culture. 
GFP fluorescence, cell growth and cell viability were monitored in 8 randomly chosen 
clones from the wt and the mut group by flow cytometry. 
The data distribution for each group demonstrated that the median of GFP expression, 
representing the 50th percentile (middle of the box), was lower in the wt cluster 
expressing cells from day 1 to day 3 (Figure 6.5.2.3.A). It is worth noting that there was 
a considerable variability in GFP fluorescence between the clones (whiskers). The 
median cell density was higher in wt cluster expressing cells from day 1 to day 5 with 
an improvement of 1.4-fold on day 5 (p-value=0.013) (Figure 6.5.2.3.B). In addition, 
the 25th and 75th percentiles of the data confirmed the cell growth advantage of wt 
cluster expressing clones particularly after day 4. The median cell viability was slightly 
lower in wt cluster expressing cells than in the control cells from day 1 to day 4 (Figure 
6.5.2.3.C) but was enhanced by 12.5% by day 5 in these cells in comparison to the mutt 
cluster expressing cells.  
The trend towards lower GFP expression and increased growth across several clones in 
these experiments suggested that the multi-antisense cluster was successfully depleting 
one or more members of the miR-23a~27~24-2 cluster in these cells. 
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Figure 6.5.2.3.A: Distribution of GFP fluorescence in mut and wt cluster 
expressing CHO-K1 SEAP cells. GFP mean fluorescence was analysed using Guava 
Flow cytometry for 3 days. Distribution of all data was analysed for each group using 
the minimum, the 25%, the 75% and the maximum of all the data. The bottom and top 
of the box represented the 25th and 75th percentile (the lower and upper quartiles, 
respectively), the band near the middle of the box is the 50th percentile (the median) 
and the ends of the whiskers represent the minimum and the maximum of all the 8 
clones for each group.  
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Figure 6.5.2.3.B: Distribution of cell density in mut and wt cluster expressing 
CHO-K1 SEAP cells. Cells were harvested every day for 5 days and stained with 
GuavaViacount solution to monitor cell growth by Guava Flow cytometry. Distribution 
of all data was analysed for each group using the minimum, the 25%, the 75% and the 
maximum of all the data. The bottom and top of the box represents the 25th and 75th 
percentile (the lower and upper quartiles, respectively), the band near the middle of the 
box is the 50th percentile (the median) and the ends of the whiskers represent the 
minimum and the maximum of all the 8 clones for each group. Statistical analysis of the 
mean was performed using a Student t-test. *: p-value< 0.05. 
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Figure 6.5.2.3.C: Distribution of cell viability in mut and wt cluster expressing 
CHO-K1 SEAP cells. Cells were harvested every day for 5 days and stained with 
GuavaViacount solution to monitor cell viability by Guava Flow cytometry. 
Distribution of all data was analysed for each group using the minimum, the 25%, the 
75% and the maximum of all the data. The bottom and top of the box represents the 
25th and 75th percentile (the lower and upper quartiles, respectively), the band near the 
middle of the box is the 50th percentile (the median) and the ends of the whiskers 
represent the minimum and the maximum of all the 8 clones for each group. 
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6.5.4 . Analysis in single cell clones in 5ml spin flasks 
 
To scale up the culture, the three best performing clones from the mut and the wt cluster 
single populations were transferred to a 5ml suspension culture in vented flasks at 
170rpm. We previously demonstrated that the cell density was improved at later stages 
of culture so cell density and viability were monitored from day 3 to day 6 of culture. At 
day 3, cells were resuspended in fresh medium to extend the period of the culture. The 
cell growth profile across the three clones of a same group was very similar (Figure 
6.5.4.A). The average cell density was enhanced at day 5 by 1.71-fold in the wt cluster 
expressing clones in comparison to the mut cluster clones (p-value: 0.0040) (Figure 
6.5.4.B). This advantage was still maintained at day 6 (p-value= 0.0156). Regarding cell 
viability, there was no major difference between the two groups (Figure 6.5.4.C). 
Thus these results suggested that stable knockdown of miR-23a~miR-27a~miR-24-2 
cluster promoted significant advantage in cell proliferation from day 3 to day 6 of 
culture. 
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Figure 6.5.4.A: Cell growth profile of each mut and wt cluster clone in 5ml 
suspension culture. 
Cells were harvested from day 3 to day 6 of culture and stained with trypan blue 
solution to evaluate cell density by the Cedex Automated Cell Counter (Roche). mut: 
mut cluster expressing clones; wt
 
: wt cluster expressing clones.Three clones from each 
group were tested. 
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Figure 6.5.4.B: Profile of the mean cell density of mut and wt cluster expressing 
clones in 5ml suspension culture. Cells were harvested from day 3 to day 6 of culture 
and stained with trypan blue solution to evaluate cell density by the Cedex Automated 
Cell Counter (Roche). mut: mut cluster expressing clones; wt
 
: wt cluster expressing 
clones. Bars represent standard deviations of three clones. Statistical significance of the 
changes in cell density was analysed using a Student t-test. *: p-value <0.05; **: p-
value <0.01 
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Figure 6.5.4.C: Profile of mean viability of mut and wt cluster expressing clones in 
5ml suspension culture. Cells were harvested from day 3 to day 6 of culture and 
stained with trypan blue solution to evaluate cell viability by the Cedex Automated Cell 
Counter (Roche). Bars represent standard deviations of three clones. mut: mut cluster 
expressing clones; wt: wt cluster expressing clones.Bars represent standard deviations 
of three clones.  
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6.5.5 Validation of the multi-antisense cluster approach 
 
To verify that the wt cluster was actually targeting endogenous miR-23a~27~24-2 
cluster in a specific manner, a transient transfection was performed with pm-neg, pm-
23a, pm-27a and pm-24-2 molecules at a concentration of 50nM in mut and wt cluster 
expressing CHO-K1 SEAP cells. The six clones selected in the previous assay were 
subjected to this treatment. In theory, these mimics should bind a functioning antisense 
transcript and further repress GFP expression. 
Transient up-regulation of miR-23a, miR-27a and miR-24-2 did not impact on GFP 
fluorescence in mut cluster expressing clones (Figure 6.5.5). However, a reduction of 
GFP fluorescence was observed in two wt cluster clones (wt clones 1&2). In addition, 
the impact was stronger after pm-24-2 or pm-27a transfection.  
Thus the efficiency of the multi-antisense cluster approach was verified in two clones 
tested out of three. The wt cluster was able to sequester exogenous miRNAs in an 
efficient manner. It is not obvious why the third clone did not show GFP fluorescence 
reduction as an improvement in cell density was demonstrated earlier (Figure 6.5.5). It 
is possible that in clone 3 the Mtg-AMO was expressed at lower level than in the other 
clones. After binding efficiently to endogenous miRNAs it was saturated and could not 
target the exogenous miRNAs delivered in the cells. These results also suggested that 
miR-23a, miR-27a and miR-24-2 depletion contributed to the observed phenotype to a 
different extent which may be due to the differences in their endogenous expression 
levels or the specific mRNAs that each one targets. This validation confirmed that the 
increase of cell growth observed in wt cluster expressing clones was specific to miR-
23a~27~24-2 cluster knockdown. Thus we speculated that miR-23a~27~24-2 cluster 
members may play a role in the regulation of cell proliferation  
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Figure 6.5.5: Analysis of GFP fluorescence in mut and wt cluster expressing clones 
after transfection with pm-neg, pm-23a, pm-27a and pm-24-2. Cells were seeded at 
1*105cells/ml prior to transfection with pm-neg, pm-23a, pm-27a or pm-24-2 molecules 
at a concentration of 50nM. GFP mean fluorescence was analysed using GFP Express 
Plus software by Guava flow cytometry 24 hrs after transfection. pm-neg: negative 
control for mimics; pm-23a: mimic of miR-23a; pm-24-2: mimic of miR-24-2; pm-27a: 
mimic of miR-27a. 
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6.6 Screening of miR-7 and its impact on CHO phenotypes  
 
Recently, we reported that transient overexpression of miR-7 induced cell growth arrest 
for 96hrs while maintaining high cell viability in low-serum culture (Barron, et al. 
2011). Consequently normalised productivity was enhanced in CHO-K1 SEAP cells. To 
investigate whether the effect of miR-7 was reproducible in other cell lines, functional 
validation was performed in CHO-K1 SEAP, CHO1.14 and CHO2B6 cells. The 
presence of serum is not desirable in protein production therefore all assays were 
conducted in serum-free culture.  
 
6.6.1 Screening of miR-7 in CHO1.14 cells 
 
Transient transfection of pm-7, pm-neg, am-7 and am-neg molecules at a concentration 
of 100 nM was performed in CHO1.14 cells. As previously discussed for miR-24, this 
concentration may be considered high, possibly leading to off-target effects. However, 
this experiment was only designed to get some indication of miR-7 potential before 
being repeated at a lower concentration.  
Following transfection, cell growth, cell viability and cell productivity were monitored 
at day 2, day 4 and day 7. Cells treated with the transfection reagent (neofx) on its own, 
pre-miR or anti-miR controls showed high viability at early time points so no 
detrimental side effects were observed due to the transfection process (Figure 6.6.1.A). 
As previously shown, cell density was negatively impacted particularly four days after 
transfection. A siRNA against Valosin-containing protein was used as a positive control 
of transfection efficiency. Inhibition of VCP protein has been previously shown to have 
detrimental impact on CHO cell growth and viability (Doolan, et al. 2010). As expected, 
VCP knockdown led to a dramatic cell growth and cell viability reduction over the 
period of the assay (Figure 6.6.1.B). 
At day 4, transient up-regulation of miR-7 led to a 4-fold decrease in cell density. This 
phenotype was maintained at day 7 where cell density was further reduced by 20-fold 
compared to pm-neg treated cells (Figures 6.6.1.A &B). Low number of healthy cells 
(with high levels of viability) suggested that cells were arrested rather than growing and 
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being killed. On the other hand, transient inhibition of miR-7 increased cell growth 
more than two-fold (Figure 6.6.1.B).  
Thus the suppressive impact of miR-7 on cell proliferation seems to be conserved in 
CHO1.14 cells cultured in serum-free medium. In addition, miR-7 is likely to impact 
directly on cell viability. 
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Figure 6.6.1.A: Impact of pm-7 and am-7 transfection on CHO1.14 growth.  
miR-7 was transiently up-regulated or inhibited using mimics (pm) or inhibitors (am) at 
a concentration of 100nM. Cells were harvested at day2, day 4 and day 7, and stained 
with GuavaViacount reagent to monitor cell growth by Guava flow cytometry. cells: 
non-transfected cells; neofx: transfection reagent; vcp: siRNA against Valosin-
Containing Protein (positive control of transfection efficiency); pm-neg: negative 
control for mimics; pm-7; mimic of miR-7; am-neg: negative control for inhibitors; am-
7
 
: inhibitor for mir-7. At day 2, bars represent standard deviations of three biological 
samples. At day 4 and day 7, bars represent the high and low reading of two biological 
duplicates. In the absence of triplicates the significance of the impact of treatment could 
not be assessed. 
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Figure 6.6.1.B: Impact of pm-7 and am-7 transfection on CHO1.14 viability.  
miR-7 was transiently up-regulated or inhibited using mimics (pm) or inhibitors (am) at 
a concentration of 100nM. Cells were harvested at day2, day 4 and day 7, and stained 
with GuavaViacount reagent to monitor cell viability by Guava flow cytometry. cells: 
non-transfected cells; neofx: transfection reagent; vcp: siRNA against Valosin-
Containing Protein (positive control of transfection efficiency); pm-neg: negative 
control for mimics; pm-7; mimic of miR-7; am-neg: negative control for inhibitors; am-
7
 
: inhibitor for mir-7. At day 2, bars represent standard deviations of three biological 
samples. At day 4 and day 7, bars represent the high and low reading of two biological 
duplicates. In the absence of triplicates the significance of the impact of treatment could 
not be assessed. 
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6.6.2 Screening of miR-7 in CHO2B6 cells 
 
Functional validation was repeated in CHO2B6 cells using the conditions that were 
previously described in section 6.6.1. VCP knockdown induced cell growth arrest and 
reduced cell viability at day 4 and day 7 following transfection (Figure 6.6.2.A). 
Transient overexpression of miR-7 reduced cell density by 3-fold and by 2.5-fold at day 
4 and day 7. In contrast to pm-7 transfection in CHO1.14 cells, cell viability was 
reduced from day 2 by 4.35% (p-value= 0.0010) to day 4 in CHO2B6 cells (Figure 
6.6.2.B). Surprisingly, knockdown of miR-7 did not impact on cell proliferation.  
Thus the potential of miR-7 in impacting cell proliferation when transiently 
overexpressed was also conserved in CHO2B6 cells. 
This transient transfection assay was repeated several times at the same concentration in 
CHO1.14 and CHO2B6 cells. The same profiles were observed for miR-7 up-
regulation. However, the impact of miR-7 knockdown was variable across repeats.  
Taken together these results suggested that miR-7 may influence cell proliferation and 
possibly cell viability at later stages of culture. 
217 
 
 
 
Figure 6.6.2.A: Impact of pm-7 and am-7 transfection on CHO2B6 growth. 
miR-7 was transiently up-regulated or inhibited using mimics (pm) or inhibitors (am) at 
a concentration of 100nM in serum-free medium. Cells were harvested at day 2, day 4 
and day 7, and stained with GuavaViacount reagent to monitor cell density by Guava 
flow cytometry. cells: non-transfected cells; neofx: transfection reagent; vcp: siRNA 
against Valosin-Containing Protein (positive control of transfection efficiency); pm-
neg: negative control for mimics; pm-7; mimic of miR-7; am-neg: negative control for 
inhibitors; am-7: inhibitor for mir-7. At day 2, bars represent standard deviations of 
three biological samples. At day 4 and day 7, bars represent the high and low reading of 
two biological duplicates. In the absence of triplicates the significance of the impact of 
treatment could not be assessed. . 
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Figure 6.6.2.B: Impact of pm-7 and am-7 transfection on cell viability in CHO2B6 
cells. miR-7 was transiently up-regulated or inhibited using mimics (pm) or inhibitors 
(am) at a concentration of 100nM. Cells were harvested at day2, day 4 and day 7, and 
stained with GuavaViacount reagent to monitor cell viability by Guava flow cytometry. 
cells: non-transfected cells; neofx: transfection reagent; vcp: siRNA against Valosin-
Containing Protein (positive control of transfection efficiency); pm-neg: negative 
control for mimics; pm-7; mimic of miR-7; am-neg: negative control for inhibitors; am-
7
 
: inhibitor for mir-7. At day 2, bars represent standard deviations of three biological 
samples. At day 4 and day 7, bars represent the high and low reading of two biological 
duplicates. A Student t-test was performed to compare pm-7 and pm-neg treatment at 48 
hrs after transfection. **: p-value<0.01. 
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6.6.3 Validation of miR-7 overexpression and knockdown 
 
To verify that the impact on CHO cell growth and cell viability was triggered by miR-7 
up-regulation or inhibition, the levels of miR-7 expression were analysed by real-time 
PCR four days after transfection. At this time, miR-7 levels were increased by 6 x104 in 
CHO1.14 cells and by 1.52x104-fold in CHO2B6 cells (Figure 6.6.3.A). 
 
After transient transfection of miR-7 inhibitors, miR-7 was undetectable in CHO1.14 
cells thus suggesting that all molecules of endogenous miR-7 were targeted for 
degradation (Figure 6.6.3.B). Surprisingly, transfection of am-7 molecules provoked 
only a 6% decrease in CHO2B6 cells. As previously discussed for miR-24 inhibitor 
molecules, there are several possible explanations for this result. Knockdown of a 
particular miRNA could trigger the cells to produce more of this miRNA. However it is 
more likely that anti-miR molecules that are single-stranded molecules could be 
dissociated from their target miRNA during the RNA extraction process. The reverse 
transcription primer could compete with anti-miR molecules for binding to miRNA so 
the level of this miRNA would still be detectable. Another possibility is that anti-miR 
could be degraded in the cells before binding to their cognate miRNA because of their 
single-stranded structure.  
These data supported the results from the functional validation with mimics and 
suggested that the growth reduction observed in CHO1.14 and CHO2B6 cells was 
provoked by transient miR-7 overexpression. 
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Figure 6.6.3.A: Levels of miR-7 expression in CHO1.14 and in CHO2B6 cells at 
day 4 following pm-7 transfection. Changes in miR-7 expression were analysed at day 
4 after miR-7 mimic transfection with 100nM of pm-7 molecules using an AB7500 Real 
Time PCR instrument. The expression of miR-7 was normalised to snRNAU6 to correct 
for variation of RNA input. Bars represented the minimum and maximum value of two 
biological replicates. Each sample was run in three technical replicates. Relative 
quantification was evaluated using normalisation to pm-neg (pm-neg=1). 
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Figure 6.6.3.B: Levels of miR-7 expression in CHO1.14 and in CHO2B6 cells at 
day 4 after am-7 transfection. Changes in miR-7 expression were analysed at day 4 
after miR-7 inhibitor transfection with 100nM of am-7 molecules using an AB7500 
Real Time PCR instrument. The expression of miR-7 was normalised to snRNAu6 to 
correct for variation of RNA input. Bars represent the minimum and maximum value of 
two biological replicates. Each sample was run in three technical replicates. Relative 
quantification was evaluated using normalisation to pm-neg (pm-neg=1). 
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6.6.4 Screening of miR-7 in CHO-K1 SEAP cells 
 
6.6.4.1 Impact of miR-7 on cell growth and cell viability 
 
To validate the potential of miR-7 on cell proliferation and cell viability, functional 
analysis was repeated in CHO-K1 SEAP cells in CHO-S-SFMII media. The 
concentration of pre-miR and anti-miR molecules was reduced to 50nM to minimise the 
risk of off-target effects. CHO-K1 SEAP cell growth were analysed at day 3 and day 6 
after transfection. 
Non-transfected cells had the usual cell proliferation and viability profile (Figure 
6.6.4.1.A). VCP siRNA also performed as expected by impairing cell growth and 
inducing high levels of cell death. In contrast to the previous functional validation 
studies, the two controls, pm-neg and am-neg molecules, did not trigger non-specific 
effects on cell proliferation (Figure 6.6.4.1.A). The am-neg molecules appeared to 
protect cells against death (Figure 6.6.4.1.B). 
Transient overexpression of miR-7 induced a 1.85-fold to 1.87-fold reduction of cell 
growth at three (p-value= 0.0028) and six days (p-value= 0.017) after transfection 
(Figure 6.6.4.1.A). As observed previously in CHO1.14 and CHO2B6 cells, cell 
viability was 37% higher in pm-7 treated cells in comparison to the negative control 
treated cells at later stages of culture (p-value= 0.0002) (Figure 6.6.4.1.B). In addition 
there was no negative impact at earlier time points. 
Inhibition of miR-7 did not impact on cell density but it enhanced cell viability the third 
day after transfection (p-value= 0.0005). 
Thus we demonstrated that the cell growth reduction detected upon pm-transfection was 
reproducible in the different repeats. Therefore we speculated that the anti-proliferative 
role of miR-7 is conserved across CHO cell lines. There are also promising indications 
that miR-7 may exert a control on cell viability. 
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Figure 6.6.4.1.A: Impact of miR-7 on CHO-K1 SEAP growth in serum-free 
medium. 
miR-7 was transiently up-regulated using pm-7 molecules or inhibited using am-7 
molecules at a concentration of 50nM in serum-free culture. Cells were harvested at day 
3 and day 6 and stained with GuavaViacount reagent to monitor cell density by Guava 
flow cytometry. cells: non-transfected cells; vcp: siRNA against Valosin-containing 
protein (positive control of transfection efficiency); pm-neg: negative control for 
mimics; pm-7: mimic of miR-7; am-neg: negative control for inhibitors; am-7
 
: inhibitor 
for mir-7. For statistical significance, a Student t-test was carried out to comapre pm-7 
with pm-neg and am-7 was with am-neg. Bars represent standard deviations of three 
biological samples. One biological sample was tested for non-transfected cells and vcp 
treated cells. *: p-value< 0.05; **: p-value< 0.01. 
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Figure 6.6.4.1.B: Impact of miR-7 on CHO-K1 SEAP viability in serum-free 
medium.  
miR-7 was transiently up-regulated using pm-7 molecules or inhibited using am-7 
molecules at a concentration of 50nM in serum-free medium. Cells were harvested at 
day 3 and day 6 and stained with GuavaViacount reagent to monitor cell viability by 
Guava flow cytometry. cells: non-transfected cells; vcp: siRNA against Valosin-
containing protein (positive control of transfection efficiency); pm-neg: negative control 
for mimics; pm-7: mimic of miR-7; am-neg: negative control for inhibitors; am-7: 
inhibitor for mir-7. For statistical significance a Student t-test was carried out to 
compare pm-7 with pm-neg and am-7 was with am-neg. Bars represent standard 
deviations of three biological samples. One biological sample was tested for non-
transfected cells and vcp treated cells. ***: p-value< 0.001. 
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6.6.4.2 Impact of miR-7 on SEAP total yield and normalised productivity 
 
To assess the effect of miR-7 on SEAP total yield and normalised productivity, 
supernatants were harvested at day 3 after transfection. Total yield was negatively 
affected subsequent to transient overexpression of miR-7 (Figure 6.6.4.2). This is likely 
due to the small number of cells present in culture at this time point. Transient 
knockdown did not impact on total yield.  
Normalised productivity was slightly increased after miR-7 induction by 1.19-fold 
(Figure 6.6.4.2). However, it was not statistically significant.  
Thus the suppressive impact on cell proliferation and the maintenance of cell viability 
observed upon pm-7 transfection in CHO1.14 and CHO2B6 cells is also verified in 
CHO-K1 SEAP cells. Although the concentration of exogenous miR-7 was lower in this 
assay, the phenotype is still reproducible thus it is specific to miR-7 and not likely due 
to off-target effects.  
Together these results suggest that miR-7 may be a potential target for cell growth 
manipulation and cell viability improvement. The cell productivity might be improved 
following manipulation of miR-7 expression using other approaches than transient 
assays to extend the culture period. 
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Figure 6.6.4.2: Impact of miR-7 on SEAP total yield and normalised productivity 
in serum-free medium at day 3 following transfection.  
Supernatants of miR-7 treated cells were harvested at day 3 after transfection. The 
change in absorbance of SEAP substrate, p-nitrophenolphosphate, was assessed by a 
spectrophotometer at 405nm in a kinetic assay. pm-neg: negative control for mimics; 
pm-7: mimic of miR-7; am-neg: negative control for inhibitors; am-7
 
: inhibitor for mir-
7. Bars represent standard deviations of three biological samples. Each sample was run 
in technical duplicates. For statistical significance a Student t-test was carried out to 
compare pm-7 with pm-neg and am-7 was with am-neg. *:p-value<0.05 
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6.6.5 Screening of miR-7 in CHO cells cultured at high cell density  
 
To establish whether the high cell survival rate observed upon pm-7 treatment was 
specific to miR-7 up-regulation or whether it was due to a lower cell number in culture, 
transient transfection was repeated at high cell density. CHO-K1 SEAP and CHO1.14 
cells were seeded at 2x105cells/ml and cultured for three days. Transfection was 
performed the third day, which corresponds to the middle of the logarithmic growth 
phase. At this time point, cell density reached approximately 1x106cells/ml. The volume 
of transfection reagent used was the same as in the previous assays (2µl per tube) in a 
2ml final volume culture. A siRNA against VCP was used as a positive control to 
monitor cell growth reduction and cell death. In a previous study, we showed that CHO-
K1 SEAP cells shifted to lower temperature induced cell growth arrest and viability 
improvement (Barron, et al. 2011). Therefore cells cultured at 31°C were included as a 
positive control to assess cell viability maintenance. 
 
6.6.5.1 Screening of miR-7 in CHO-K1 SEAP cells cultured at high cell density 
 
Non-transfected cells grew well until day 3 after transfection. However, the next three 
days, cell density and viability decreased dramatically (Figure 6.6.5.1.A). In this assay, 
day 3 corresponds to six days of batch culture (three days before and three days after 
transfection). Thus it suggests that at day 3 after transfection cells are not healthy due to 
waste accumulation and nutrient deprivation in the culture. In addition, cells grown at 
31°C showed a similar growth profile with no indication of cell growth arrest as 
expected (Figure 6.6.5.1.A). Cells did not show an increase in viability for the three 
first days. There was a small improvement at later stages but it was not statistically 
significant.  
Following knockdown of VCP, cell growth was reduced by 4.44-fold to 9.18-fold in 
comparison to the non-transfected cells cultured at 37°C from day 3 to day 5 (5.61882E-
05 <p-values <8.69549E-06) (Figure 6.6.5.1.A). Levels of cell viability were decreased 
by 54.83% at day 3 in comparison to cells exposed at 37°C (9.34389E-07 <p-value< 
1.74995E-05) (Figure 6.6.5.1.B). Thus siRNA molecules were efficiently transfected in 
high cell density conditions.  
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Up-regulation of miR-7 reduced cell growth by 1.53-fold to 2.92-fold from day 3 to day 
5 after transfection (0.0010 <p-value<0.0021) (Figure 6.6.5.1.A). There was no 
indication of cell viability improvement in these conditions.  
Although the transfection of the siRNA against VCP was efficient in CHO-K1 SEAP 
cells seeded at high density, pm-7 treated cells did not improve cell viability. In 
addition, cells exposed to low temperature culture did not either show improvement in 
cell viability and their viability decreased dramatically at day 3.  
These data suggested that the transfection conditions were not optimal to assess cell 
viability enhancement upon miR-7 overexpression. Thus we could not exclude the 
possibility that the maintenance of high viability was due to the low number of healthy 
cells in culture. 
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Figure 6.6.5.1.A: Impact of pm-7 on CHO-K1 SEAP growth at high density 
culture. Cells were seeded at 2x105cells/ml and cultured for three days at 37˚C before 
transfection or transferred to 31˚C. miRNAs were transfected at a concentration of 
50nM. Cells were stained with GuavaViacount reagent to monitor cell growth by Guava 
flow Cytometry. cells 37˚C: non-transfected cells cultured at 37˚C for the whole assay; 
vcp: siRNA against Valosin-containing protein; pm-neg: negative control for mimics; 
pm-7: mimic of miR-7; cells 31˚C: cells cultured at 37˚C for three days and at 31˚C for 
the next five days. For analysis of statistical significance a Student t-test was performed. 
In this analysis, vcp and cells at 31˚ C were compared to cells grown at 37˚C; pm-7 was 
compared to pm-neg. Bars represent standard deviations of biological replicates. *: p-
value< 0.05; **: p-value< 0.01; ***: p-value< 0.001. 
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Figure 6.6.5.1.B: Impact of pm-7 on CHO-K1 SEAP viability at high density 
culture. Cells were seeded at 2x105cells/ml and cultured for three days at 37˚C before 
transfection or transferred to 31˚C. miRNAs were transfected at a concentration of 
50nM. .Cells were stained with GuavaViacount reagent to monitor cell viability by 
Guava flow Cytometry. cells 37˚C: non-transfected cells cultured at 37˚C for the whole 
assay; vcp: siRNA against Valosin-containing protein; pm-neg: negative control for 
mimics; pm-7: mimic of miR-7; cells 31˚C: cells cultured at 37˚C for three days and at 
31˚C for the next five days. For analysis of statistical significance a Student t-test was 
performed. In this test, vcp and cells at 31˚ C were compared to cells exposed at 37˚C; 
pm-7 was compared to pm-neg. Bars represent standard deviations of biological 
triplicates. *: p-value< 0.05; **: p-value< 0.01; ***: p-value< 0.001. 
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6.6.5.2 Screening of miR-7 in CHO1.14 cells cultured at high cell density  
 
To verify that the maintenance of cell viability was directly associated with high levels 
of miR-7 expression in the cells, transient transfection at high density was repeated in 
CHO1.14 cells. The conditions of transfection and controls used in this assays were the 
same as in CHO-K1 SEAP cell transfection (section 6.6.5.1).  
Non-transfected cells grew exponentially for two days but by day 3 their growth 
declined as well as their viability (Figure 6.6.5.2.A &B). Cells grown at 31°C showed a 
1.6-fold decrease of cell growth from day 1 to day 5 compared to cells cultured at 37°C 
, with an exception at day 3 (Figure 6.6.5.2.A). However, there was no major 
improvement of cell viability (Figure 6.6.5.2.B). 
Knockdown of VCP reduced cell density by 2.80-fold at day 3 (p-value= 0.0002) and 
3.86-fold at day 4 (p-value= 0.0058) (Figure 6.6.5.2.A). The cell viability levels were 
also significantly reduced (1.79096E-07 < p-value < 3.98937E-05) (Figure 6.6.5.2.B). 
On day 5, mostly healthy cells remained in culture. This could be due to the loss of VCP 
siRNA molecules or transfection efficiency thus leading to survival of a few cells in 
culture. This suggested that the transfection of siRNA molecules worked efficiently at 
high density in CHO1.14 cells.  
Transient overexpression of miR-7 provoked a 1.13-fold and a 1.45-fold cell density 
decrease at day 2 (p-value= 0.0130) and day 3 (p-value= 0.0017) respectively (Figure 
6.6.5.2.A).  
Cell viability was improved by 52% at later stages of culture in comparison to the 
control (p-value= 0.0003) and by 5.83% in comparison to the cells grown at 37˚C 
(Figure 6.6.5.2.B).  
The transient transfection at high density was repeated three times in CHO-K1 SEAP 
cells and CHO1.14 cells with different outcomes across the assays and the cell lines. 
The potential of miR-7 to reduce cell growth was not reproducible in all assays. Cells at 
31°C did not show cell survival improvement in all the repeats. Thus these results 
indicated that the maintenance of cell viability imparted by miR-7 overexpression could 
not overcome or counteract the lack of nutrients and waste accumulation in culture. This 
theory is supported by the significant drop in cell viability in most of the samples only 
three days after transfection. Usually at low density, transfection of miR-7 impacts on 
cell growth by day 2 or day 3 while cells still maintain high cell viability. However, we 
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cannot rule out that the higher rate of cell viability observed previously was due to a 
lower cell number leading to healthier culture environment or due to reduced 
intracellular delivery caused by the unchanged concentration of miR-7 as well as the 
transfection reagent (neofx) . 
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Figure 6.6.5.2.A: Impact of pm-7 on CHO1.14 growth at high density culture.  
Cells were seeded at 2x105cells/ml and cultured for three days at 37˚C before 
transfection or transferred to 31˚C. miRNAs were transfected at a concentration of 
50nM .Cells were stained with GuavaViacount reagent to monitor cell growth by Guava 
flow Cytometry. cells 37˚C: non-transfected cells cultured at 37˚C for the whole assay; 
vcp: siRNA against Valosin-containing protein; pm-neg: negative control for mimics; 
pm-7: mimic of miR-7; cells 31˚ C : cells cultured at 37˚ C for three days followed by 
31˚C for five days. A Student t-test was performed to analyse the statistical significance 
of the results. In this test, vcp and cells at 31˚ C were compared to cells grown at 37˚C; 
pm-7 was compared to pm-neg. Bars represent standard deviations of three biological 
replicates. *: p-value< 0.05; **: p-value< 0.01; ***: p-value< 0.001. 
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Figure 6.6.5.2.B: Impact of pm-7 on CHO1.14 viability at high density culture. 
Cells were seeded at 2x105cells/ml and cultured for three days at 37˚C before 
transfection or transferred to 31˚C. miRNAs were transfected at a concentration of 
50nM .Cells were stained with GuavaViacount reagent to monitor cell viability by 
Guava flow Cytometry. cells 37˚C: non-transfected cells cultured at 37˚C for the whole 
assay; vcp: siRNA against Valosin-containing protein; pm-neg: negative control for 
mimics; pm-7: mimic of miR-7; cells 31˚C : cells cultured at 37˚C for three days 
followed by 31˚C for five days. A Student t-test was performed to analyse the statistical 
significance of the results. In this test, vcp and cells at 31˚C were compared to cells 
grown at 37˚ C; pm-7 was compared to pm-neg. Bars represent standard deviations of 
three biological replicates. ***: p-value< 0.001. 
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6.7 CHO cell engineering using miR-7 
 
In the previous sections, we showed that the transient up-regulation of miR-7 using 
mimic molecules decreased cell growth, promoted high cell viability and had little 
impact on normalised productivity in three different CHO cell lines. Due to the nature 
of the batch culture, it was difficult to prove that high cell viability was directly 
associated with high levels of miR-7 in the cells. As seen earlier for miR-24 
knockdown, the inhibition of miR-7 using inhibitors was difficult to achieve and/or did 
not impact on CHO phenotypes. In addition, mimics and inhibitors are transient so are 
only applicable to short-term studies rather than long-term studies. Therefore to further 
validate the potential of miR-7 in cell proliferation control and to better evaluate its 
impact on cell viability and productivity, we decided to transiently overexpress miR-7 
using an inducible vector. If the outcomes were promising, CHO cells would be 
engineered to facilitate the constitutive and reproducible induction/knockdown of miR-
7. 
 
6.7.1 Overexpression of miR-7 using a tetracycline inducible system: 
pMF111/pSAM200 
 
 
The observed impact of miR-7 on cell growth led us to pursue the use of an inducible 
system. This system would allow cells to grow until the middle of the logarithmic 
growth phase and being turned on at this time point it would promote cell growth arrest 
and protein production. In this assay, we used the Tet-OFF system where a tetracycline 
activator (tTA) binds to a Tet response element (TRE) and activates transcription in the 
absence of doxycyline (a member of the tetracycline antibiotics group) (Figure 
6.7.1.A). In the presence of doxycyline, gene expression is turned off and after 
withdrawal of the drug, gene expression is on. For this pupose, pMF111 (containing 
precursor miR-7) and pSAM200 vectors were co-transfected into cells (refer to section 
6.3.2 for more details on the system and vector description). 
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Cloning of precursor miR-7 into pMF111 vector 
 
Precursor miR-7 (pre-miR-7) was previously amplified from CHO cells using the 
following primers.  
F: AATAGAATTCAGAGGCAGGAAACTCAGGTGTCA  
R: TATTGCGGCCGCATGTCCTTGTTTCTGGAGAAGTCC  
These primers were designed in conserved sequence loci of human and mouse pre-miR-
7. Prior to cloning, precursor miR-7 and pMF111 were digested with EcoRI and NotI. 
Following ligation (Figure 6.7.1.A) and amplification by transformation, another 
digestion was done to verify the size of the insert and the plasmid (Figure 6.7.1.B). The 
nucleotide sequence was checked by sequencing to ensure there were no mistakes in the 
cloning. 
 
 
 
 
Figure 6.7.1.A: Map of pMF111 vector and features of cloning 
Prior to cloning, pMF111 vector and precursor miR-7 were digested with EcoRI and 
NotI. A further 101bp of flanking sequences were also included either side (not shown). 
The sequence shown consists in mature miR-7 sequence (red letters) and flanking 
sequences (including the stem-loop, in black letters) from CHO genomic DNA (black 
letters). 
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Figure 6.7.1.B: Digestion of pMF111-miR-7 with EcoRI and NotI. 
The vector pMF111-miR-7 (3181bp) was digested with EcoRI and NotI. Following 
digestion, samples were run on a 1% agarose gel. Two bands were expected at 2833bp 
for pMF111 vector and at 348bp for precursor miR-7. M: 1kb Plus DNA ladder. Lane 
1&2: two positive clones showing the two bands expected. 
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6.7.1.1 Investigation of pMF111-miR-7 transfection on CHO1.14 growth and 
viability 
 
To study the impact of miR-7 up-regulation, cell growth and cell viability were 
monitored at day 1, day 4 and day 6 after transfection in CHO1.14 and CHO2B6 cell 
lines. The negative control used in this assay was pMF111 empty vector and pMF-GEO 
to assess inducible GFP expression by fluorescence microscopy.  
The growth profile of non-transfected cells was usual and viability was maintained at 
high levels until the end of culture (Figures 6.7.1.1.A&B). In presence of doxycline, the 
transfection negatively impacted on cell proliferation in all samples particularly at day 
4. Following removal of doxycyline, cell growth was further reduced above all four 
days after transfection (Figure 6.7.1.1.A). For some of the samples, this non-specific 
effect was abated by day 6 but for the others it was still detectable. In most cases, cell 
viability was decreased in presence and in absence of doxycyline (Figures 6.7.1.1. B). 
Thus the non-specific reduction of proliferation observed upon transfection of the 
controls did not facilitate the analysis of these results. In an attempted to detect any 
changes following pMF111-miR-7 transfection, we repeated this assay in another cell 
line. 
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Figure 6.7.1.1.A: Impact of pMF111-miR-7 transfection on CHO 1.14 growth.  
Transfection was performed in suspension with 2µl of lipofectamine 2000 reagent 
(Invitrogen), using 1µg of plasmids, in cells seeded at a concentration of 1x106cells/ml 
in 1ml final volume. Doxycyline was added six hours after transfection, at a final 
concentration of 1µg/ml. Bars represent standard deviations of three biological 
replicates. In this study, pMF111-miR-7/Dox+ was compared to pMF111/Dox+ and 
pMF111-miR-7/Dox - was compared to pMF111/Dox-. Dox+: Culture with doxycyline; 
Dox-
 
: Culture without doxycyline.  
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Figure 6.7.1.1.B: Impact of pMF111-miR-7 transfection on CHO 1.14 viability.  
Transfection was performed in suspension with 2µl of lipofectamine 2000 reagent 
(Invitrogen), using 1µg of plasmids, in cells seeded at a concentration of 1x106cells/ml 
in 1ml final volume. Doxycyline was added six hours after transfection, at a final 
concentration of 1µg/ml. Bars represent standard deviations of three biological 
replicates. In this study, pMF111-miR-7/Dox+ was compared to pMF111/Dox+ and 
pMF111-miR-7/Dox - was compared to pMF111/Dox-. Dox+: Culture with doxycyline; 
Dox-: Culture without doxycyline.  
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6.7.1.2 Investigation of pMF111-miR-7 transfection on CHO2B26 growth and 
viability 
 
In CHO1.14 cells, the transfection of pMF111-miR-7 induced cell proliferation 
reduction as well as the transfection of the controls. Therefore we performed a second 
assay to try to capture any specific changes correlated to pMF111-miR-7 transfection.  
The non-transfected cells showed an unusual cell proliferation pattern. At day 4 cell 
growth decreased and increased again by day 7 (Figure 6.7.1.2.A). However, cells 
showed high levels of viability so this is possibly a technical error (Figure 6.7.1.2.B). In 
the presence of doxycyline, all the controls as well as pMF111-miR-7 induced a non-
specific impact on cell growth (Figure 6.7.1.2.A). In the absence of doxycyline, the 
growth reduction was maintained in all controls but in contrast to the previous assay in 
CHO1.14 cells, it was not diminished four days after transfection. By day 7 cells had 
recovered from this effect. Surprisingly, the cell growth of pMF111-miR-7 transfected 
cells was enhanced by day 4 after withdrawal of doxycyline, when we would have 
expected a reduction of cell growth. Cell viability was maintained at high levels across 
all samples in presence and absence of doxycycline (Figure 6.7.1.2.B). Several repeats 
were performed to verify the influence of pMF111-miR-7 on cell proliferation (decrease 
or increase). The results obtained across the assays were inconsistent though the 
reduction of cell proliferation was observed in most cases, but no overall conclusions 
could be made. 
These results are similar to the observations made in the previous assay (section 6.3.2 
for miR-24). The transfection impacted negatively on cell proliferation and often on cell 
viability. Doxycyline removal prevented further cell growth and usually promoted cell 
death increase. In most cases, the non-specific impact diminished at day 6 likely due to 
the loss of the plasmid and recovery from the transfection process. To verify whether 
precursor miR-7 was processed into the mature form by the cellular machinery, we 
investigated the levels of expression of miR-7 in these cells. 
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Figure 6.7.1.2.A: Impact of pMF111-miR-7 transfection on CHO 2B6 growth.  
Transfection was performed in suspension with 2µl of lipofectamine 2000 reagent 
(Invitrogen), using 1µg of plasmids, in cells seeded at a concentration of 1x106cells/ml 
in 1ml final volume. Doxycyline was added six hours after transfection, at a final 
concentration of 1µg/ml. Bars represent standard deviations of three biological 
replicates. In this study, pMF111-miR-7/Dox+ was compared to pMF111/Dox+ and 
pMF111-miR-7/Dox - was compared to pMF111/Dox-. Dox+: Culture with doxycyline; 
Dox-: Culture without doxycyline.  
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Figure 6.7.1.2.B: Impact of pMF111-miR-7 transfection on CHO2B6 viability.  
Transfection was performed in suspension with 2µl of lipofectamine 2000 reagent 
(Invitrogen), using 1µg of plasmids, in cells seeded at a concentration of 1x106cells/ml 
in 1ml final volume. Doxycyline was added six hours after transfection, at a final 
concentration of 1µg/ml. Bars represent standard deviations of three biological 
replicates. In this study, pMF111-miR-7/Dox+ was compared to pMF111/Dox+ and 
pMF111-miR-7/Dox - was compared to pMF111/Dox-. Dox+: Culture with doxycyline; 
Dox-
 
: Culture without doxycyline.  
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6.7.1.3 Investigation of miR-7 levels in pMF111-miR-7 transfected cells 
 
To verify whether miR-7 precursor was processed correctly into the mature form and 
overexpressed following transfection of pMF111-miR-7 in absence of doxycylin, the 
levels of miR-7 expression were assessed using qPCR in CHO1.14 and CHO2B6 cells 
(Figure 6.7.1.3).  
The levels of miR-7 expression were increased by 1.83-fold and 7.81-fold in absence of 
doxycyline in CHO1.14 and CHO2B6 cells respectively. 
This indicated that precursor miR-7 was processed into mature miR-7 in both cell lines 
though the increase was to a lower extent in CHO1.14 cells. The processing of 
precursor miR-7 may be more efficient in CHO2B6 cells. It is also possible that 
pMF111-miR-7 was transfected at higher copies in this cell line. 
At the time of the study, we could not improve the outcomes of these assays so we 
considered another system of expression.  
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Figure 6.7.1.3: Levels of miR-7 expression in pMF111-miR-7 expressing CHO1.14 
and CHO2B6 cells. Changes in miR-7 expression were assessed after removal of 
doxycyline in pMF111-miR-7 expressing cells at day 4 after transfection compared to 
cultures containing doxycyline. The expression of miR-7 was normalised to U6 snRNA 
as an endogenous control to correct for variation of RNA input. Analysis was performed 
using AB7500 Real Time PCR instrument. Bars represent the minimum and maximum 
of two biological samples run in technical triplicates. 
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6.7.2 Overexpression of miR-7 using a tetracycline inducible system: 
pTet /Hyg vector 
 
6.7.2.1 Description of pTet /Hyg vector 
 
The first attempt to overexpress miR-7 using the inducible system pMF111/pSAM00 
presented some issues that could not be resolved at the time. Another inducible system 
named pTet /Hyg vector was used instead (Figure 6.7.2.1). Two constructs were 
designed pTet-miR-7 (for up-regulation of miR-7) and pTet-neg (negative control) 
(design and cloning were done by Dr Nga Lao). In this system, the tetracycline-
controlled transactivator (tTA) binds to the tetracycline-response element (TRE) and 
activates transcription in the absence of tetracycline or doxyxycline. An EGFP reporter 
was driven by the TRE-minimal CMV promoter. mir-7 was placed downstream of the 
EGFP (Figure 6.7.2.1). The mature miR-7 (the guide strand loaded in the RISC 
complex) and minor mir-7 (miR-7*, known as passenger strand or star strand) 
sequences were inserted between XhoI and EcoRI sites. Several RNA interference 
studies have demonstrated that the stem loop structure and the flanking sequences of 
human miR-30 precursor trigger optimal miRNA processing by the endogenous RNAi 
machinery (Zeng, Wagner and Cullen 2002, Boden, et al. 2004). Therefore the loop of 
the miR-30 precursor was cloned between the miR-7 and miR-7* sequences and the 
5’/3’arms of miR-30 precursor were inserted between the NotI and NheI sites. The 
negative control was designed in the same way except that miR-7 sequence was 
replaced with a random sequence. Prior to transfection, different concentrations of 
hygromycin were tested on non-transfected cells to find the minimum concentration 
required for selection. The concentration applied was 350µg/ml. 
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Figure 6.7.2.1: Map of pTet /Hyg vector. 
Tet07CMV: TRE-minimal promoter with seven direct repeats of the tetracycline 
operator sequences; EGFP: enhanced Green Fluorescent Proteint; 5’miR-30/3’miR-30: 
human flanking sequences of miR-30. pro: promoter; CMR: cmr gene that confers 
resistance to chloramphenicol. polyA: signal of polyadenylation for transcription 
termination; PGK: human phosphoglycerate promoter; tTA: tetracycline activator that 
consists of the fusion of the Tet repressor protein and Herpes simplex virus VP16 
activation domain; IRES: internal ribosome entry site for translation of tTA; HYG
 
: gene 
that confers resistance to hygromycin. 
6.7.2.2 Overexpression of miR-7  
 
Stable transfection was performed in a 6-well plate using 11µl lipofectamine and 5µg of 
pTet-miR-7 plasmid or 5µg of the control vector pTet-neg. A control vector, peGFP-C1 
was used to estimate transfection efficiency. GFP expression was observed by 
fluorescence miscroscopy. Doxycyline was added six hours after transfection at a final 
concentration of 1µg/ml. The next day, the medium was replaced by fresh medium. 
Transfection efficiency was estimated at 70% (Figure 6.7.2.2). 
As expected, the expression of GFP in pTet-NC and pTet-miR-7 transfected cells was 
blocked in presence of doxycyline. There was a small leak of GFP expression which did 
not interfere with the study (Figure 6.7.2.2). Although GFP expression levels increased 
following withdrawal of doxycyline, the levels were lower than the positive control 
(Figure 6.7.2.2). This observation suggested that the tet07-CMV promoter was not as 
strong as the wild-type CMV in the peGFP control.  
At day 2, cells were transferred to a T-25 flask in 5ml culture and selection was applied 
using 350µg/ml of hygromycin. However, the cells did not survive the selection 
process. The concentration of hygromycin was not seen as an issue as it was tested 
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previously in non-transfected cells. In addition, even at a low concentration, 
hygromycin triggered cell death indicating that cells were not resistant to hygromycin. 
Doxycylin was not an issue as cells died either in presence or in absence of doxycylin.  
Thus besides the tet07-CMV promoter being quite weak, we suspected the PGK 
promoter/ IRES may not have been correctly driving transcription/ translation of the 
hygromycin resistance marker. The integrity of the construct was checked by 
sequencing to ensure there was no issue with the design and cloning of the vector. No 
errors could be detected and we were unable to successfully resolve this issue. 
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Figure 6.7.2.2: Investigation of GFP positivity in peGFP-C1, pTet-NC and pTet-
miR-7 expressing cells. GFP positivity was appreciated by fluorescence microscopy in 
peGFP-C1 (A, positive control), pTet-NC (B&D, negative control) and pTet-miR-7 
(C&E) expressing cells, in absence (Dox-) or presence (Dox+) of doxycyline at day 1 
after transfection. Magnification x10. 
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6.7.3 Stable knockdown of miR-7 using miRNA “sponge” technology 
 
6.7.3.1 Description of miRNA “sponge” technology 
 
In a bioprocessing context, we were interested in improving the cell growth rate of CHO 
cells. We demonstrated that transient miR-7 overexpression led to cell growth 
reduction. Higher cell density was achieved successfully only with high levels of miR-7 
inhibitors and it was not consistent and reproducible. We thought that a stable system 
would be more appropriate to increase the cell proliferation rate and to monitor the 
specificity and efficiency of the inhibition. The “sponge”system was first described by 
Ebert and co-workers in 2007 (Ebert, Neilson and Sharp 2007). This system was 
developed to induce efficient endogenous miRNA inhibition by competing with the 
mRNA target for the miRNA binding site. Endogenously, a mature miRNA recognizes 
its mRNA target by sequence complementarity. The “seed region” of a miRNA, located 
at the position 2-8 nt of the 5’ end, binds to the 3’UTR of the mRNA target and induces 
post-transcriptional repression.  
Herein, four miR-7 binding sites were inserted in tandem in the 3’UTR of a destabilised 
enhanced GFP gene (dEGFP). This modified EGFP consists of the fusion of the 
ornithine decarboxylase degradation domain from mouse (MODC) and the C-terminal 
of an enhanced variant of GFP (EGFP). The resulting protein is very unstable with a 
short half-life of 2 hrs. The change of dEGFP fluorescence induced by the binding of 
the miRNA to the sponge can be correlated to the change in miRNA expression. By 
binding to the sponge, the miRNA prevents dEGFP from being translated so the dEGFP 
reporter acts as reporter of miRNA depletion. Once the miRNA is bound to the sponge, 
it is sequestered and less miRNA molecules are available to bind to their cognate 
mRNA targets. More than ten binding sites have been shown to promote sponge 
degradation (Ebert, Neilson and Sharp 2007, Ebert and Sharp 2010). To avoid RNAi-
type cleavage by Argonaute 2 and consequent degradation, the sponge system was 
designed to include a bulge at position 9-11. The characteristics of this system make it a 
very attractive tool, as miRNAs that belong to the same family share a common seed 
region thus the entire miRNA family can be inactivated. This tool provides the 
opportunity to synergistically target miRNAs potentially involved in common cellular 
251 
 
pathways. Thus this ‘sponge’ technology might be a valuable tool for cell growth 
manipulation. Cloning of miR-7 binding sites in pCMV-d2EGFP was performed by Dr 
Nga Lao (see section 6.5.1 for description of the vector). The four miR-7 binding sites 
arranged in tandem were cloned at XhoI and EcoRI sites. The resulting vector was 
called miR-7 sponge (Figure 6.7.3.1). A negative control was engineered in the same 
manner but non-specific sequences replaced the miR-7 binding sites; this construct was 
called control sponge. At the time of the study, the CHO genome was not available 
therefore the sequence of this construct was aligned against non-redundant database 
(NCBI) using BLAST to ensure there was no match between the negative control and 
other miRNAs existing in several species including mouse, rat and human. miR-7 
sponge and control sponge cassettes were sequence to verify the design and cloning of 
the vectors.  
 
 
 
 
Figure 6.7.3.1: miR-7 sponge cassette 
CMV: cytomegalovirus promoter; d2EGFP: destabilized enhanced Green Fluorescent 
Protein (2 hrs life time); polyA: signal of polyadenylation for transcription termination; 
PGK: human phosphoglycerate kinase promoter; Hyg: hygromycin (antibiotic for 
selection of positive clones). XhoI/EcoRI: restriction enzyme sites for cloning. 
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6.7.3.2 Transfection of control and miR-7 sponge 
 
Transfection was performed in a 6-well plate using 2µl lipofectamine reagent, with 
1µg/well of miR-7 or control sponge vector in CHO-K1 SEAP cells. The vector 
pEGFP-C1 was included as a control for transfection efficiency. The transfection was 
performed in biological triplicates. The day after transfection, two wells were used to 
collect cell pellets for miR-7 expression evaluation by qPCR. Surprisingly, the 
expression of miR-7 in miR-7 sponge expressing cells was only slightly reduced in 
comparison to its expression in the control sponge expressing cells (Figure 6.7.3.2). 
This suggested that miR-7 is not degraded immediately following its sequestration by 
miR-7 sponge and is released upon exposure to the denaturing conditions during lysis 
and total RNA extraction. 
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Figure 6.7.3.2: Expression of endogenous mature miR-7 levels in control and miR-
7 sponge transfected cells. The changes in the levels of miR-7 expression were 
investigated the day after transfection using the AB7500 Real Time PCR instrument. 
The expression of miR-7 was normalised to snRNAu6 to correct for RNA input. Bars 
represent the minimum and maximum expression levels of biological duplicates. Each 
biological sample was run in technical triplicates. 
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6.7.3.3 Impact of miR-7 sponge in a stable mixed population 
 
Two days after transfection, cells were transferred into a T-25 monolayer flask in 5ml 
adherent culture for three days and drugs were applied to the culture for selection (G418 
at 1000µg/ml to maintain SEAP protein production and hygromycin at 350µg/ml for the 
sponge cassette selection). After selection, cells were cultured in a T-75 monolayer flask 
in 10ml adherent culture for another three days. At this stage, samples from the mixed 
population were harvested for GFP expression evaluation using FACS (BD Bioscences) 
and for cell growth analysis using a Guava flow cytometry. In theory, cells that express 
the negative control (designed with a non-specific sequence) should have higher GFP 
positivity than cells transfected with miR-7 sponge because no sequence should bind to 
it.  
GFP positivity was 56.1% in the control sponge expressing cells in comparison to 
34.9% in sponge miR-7 expressing cells (Figure 6.7.3.3.A). This result was a positive 
indication that miR-7 was repressing reporter expression via binding to the miR-7 
sponge. 
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Figure 6.7.3.3.A: GFP positivity in miR-7 sponge (a) and control sponge (b) 
expressing cells from mixed populations. GFP expression was analysed using FITC 
channel (Emission: 525nm; Excitation: 488nm) by flow cytometry (FACS, BD 
Biosciences) using a strict cut-off gate for GFP negative cells versus GFP positive cells.  
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Cell growth and cell viability were monitored every day for six days. miR-7 sponge 
expressing cells showed an increase in cell density in comparison to the control sponge 
transfected cells by 1.45-fold at day 2 (1.6x106cells/ml versus 1.1x106cells/ml) and by 
1.14-fold at day 3 (3.4x106cells/ml versus 2.98x106cells/ml) (Figure 6.7.3.3.B). Cell 
growth rate was significantly higher at day 2 (0.0431 hr-1 versus 0.0352 hr-1) and 
slightly at day 3 in miR-7 sponge expressing cells (Figure 6.7.3.3.C). We also 
calculated the integrated viable cell density and the accumulated viable cell density. At 
day 2 and day 3, the IVCD of miR-7 sponge expressing cells was significantly higher 
by 1.28- and 1.11-fold in comparison to the control cells (Figure 6.7.3.3.D). Regarding 
the AIVCD, it was significantly higher in miR-7 sponge expressing cells from day 2 to 
day 4 (Figure 6.7.3.3.E). miR-7 sponge expressing cells seemed to have a small 
advantage on cell survival over the culture but it was not statistically significant (Figure 
6.7.3.3.F). Although this work was still at a preliminary stage and more validation was 
required, these results were positive indications that the sponge system worked inducing 
lower levels of active miR-7 by endogenous miR-7 sequestration and increasing cell 
density.  
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Figure 6.7.3.3.B: Cell density of control sponge and miR-7 sponge expressing cells 
in mixed populations. The cell growth rate is the increase in cell biomass per unit of 
time (hour). Cells were seeded at 2x105cells/ml in T-75 flaks in biological triplicates in 
serum-free medium. Samples were harvested every day for five days and resuspended 
into GuavaViacount reagent to monitor cell growth using Guava Flow cytometry 
technology. Bars represent standard deviations from three biological samples. Statistical 
significance of the data was analysed using a Student t-test. *: p-value<0.05; **: p-
value<0.01. 
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Figure 6.7.3.3.C: Cell growth rate of control sponge and miR-7 sponge expressing 
cells in mixed populations. The cell growth rate is the increase in cell biomass per unit 
of time (hour). Cells were seeded at 2x105cells/ml in T-75 flaks in biological triplicates. 
Samples were harvested everyday for five days and resuspended into GuavaViacount 
reagent to monitor cell growth using Guava Flow cytometry technology. Bars represent 
standard deviations from three biological samples.  
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Figure 6.7.3.3.D: Integral viable cell density (IVCD) of control sponge and miR-7 
sponge expressing cells in mixed populations. Cells were seeded at 2x105cells/ml in 
T-75 flaks in biological triplicates. Samples were harvested every day for five days and 
resuspended into GuavaViacount reagent to monitor cell growth. The IVCD is 
represented by the area under the curve when the concentration of viable cells is plotted 
against the culture time. Bars represent standard deviations from three biological 
samples. Statistical significance of the data was analysed using a Student t-test. *: p-
value<0.05 
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Figure 6.7.3.3.E: Accumulated integral cell density (AIVCD) of control sponge and 
miR-7 sponge expressing cells in mixed populations. Cells were seeded at 
2x105cells/ml in T-75 flaks in biological triplicates. Samples were harvested every day 
for five days and resuspended into GuavaViacount reagent to monitor cell growth using 
Guava Flow cytometry technology. Bars represent standard deviations from three 
biological samples. Statistical significance of the data was analysed using a Student t-
test. *: p-value<0.05; **: p-value<0.01. 
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Figure 6.7.3.3.F: Cell viability of control sponge and miR-7 sponge expressing cells 
in mixed populations. Cells were seeded at 2x105cells/ml in T-75 flaks in biological 
triplicates. Samples were harvested every day for five days and resuspended into 
GuavaViacount reagent to monitor cell viability using Guava Flow cytometry 
technology. 
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6.7.3.4 Impact of miR-7 sponge in single cell clones 
 
To validate knockdown of miR-7, the original transfection was repeated in CHO-K1 
SEAP and CHO1.14 cells using 5µg of plasmid DNA and 11µl of lipofectamine to 
increase the transfection efficiency and the copy number. The concentration of 
hygromycin for positive clone selection was kept at 350µg/ml in CHO-K1 SEAP cells 
and applied at 200µg/ml after optimisation in CHO1.14 cells. Single cell sorting using 
FACS flow cytometry was carried out. A range of clones with high and medium GFP 
expression were chosen for further investigation. When confluency reached 90%, 24 
single clones from the high GFP expression group and 24 single clones from the 
medium GFP expression group were transferred to 24-well plates in adherent culture. 
After drug selection, 23 clones per group from CHO-K1 SEAP population were seeded 
at 2x105cells/ml in a 24-well plate in suspension and serum-free medium. The selection 
applied in CHO1.14 cells resulted in 9 clones from the control sponge and 13 clones 
from miR-7 sponge group surviving and which were transferred to a 24-well plate in 
suspension, in serum-free medium. Cells were maintained in this format for several 
weeks. At day 3 after cell passaging, samples were harvested to monitor cell growth, 
cell viability and GFP fluorescence. 
 
6.7.3.4.1 Impact of miR-7 sponge in CHO-K1 SEAP single cell clones cultured in 
24-well plates 
 
In CHO-K1 SEAP cells, the data distribution of 23 clones for each group (control and 
miR-7 sponge) showed that the median cell density (represented by the 50th percentile-
band in the middle of the box) showed a 1.31-fold increase in miR-7 sponge expressing 
clones (Figure 6.7.3.4.A). The 25th and 75th percentiles of the data (bottom and top of 
the box) confirmed the cell growth advantage of miR-7 sponge expressing cells between 
the two groups. The analysis of the mean showed that this difference was statistically 
significant (p-value= 0.0024). Cell viability was slightly lower in miR-7 sponge 
expressing cells (Figure 6.7.3.4.A). However, there was no statistical significance. 
The median of GFP fluorescence representing the 50th percentile was 31.8% lower in 
miR-7 sponge expressing clones than in the control cells (Figure 6.7.3.4.A). The 25th 
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and 75th percentiles of the data confirmed the difference of GFP fluorescence between 
the two groups. In addition, the analysis of the mean showed that this difference was 
statistically significant (p-value= 0.0053). 
Thus the low levels of GFP fluorescence in miR-7 sponge expressing clones confirmed 
the results observed in the mixed population. All together these results suggested that 
active endogenous miR-7 was sequestered by the sponge leading to reduction of its 
levels of expression. Consequently, miR-7 inhibition triggered significant cell density 
increase. 
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Figure 6.7.3.4.A: Distribution of cell growth (a ), cell viability (b) and GFP 
fluorescence (c) in control sponge and miR-7 sponge expressing CHO-K1 SEAP 
cells. Cells were seeded at 2x105cells/ml in a 24-well plate in 1ml suspension. Cells 
were harvested at day 3 and stained with GuavaViacount reagent to monitor cell growth 
and viability using Guava Flow cytometry. GFP expression was also assessed using 
Guava Flow cytometry. Distribution of all data was analysed for each group using the 
minimum, the 25%, the 75% and the maximum of all the data. The bottom and top of 
the boxes represent the 25th and 75th percentiles (the lower and upper quartiles, 
respectively), the band near the middle of the boxes is the 50th percentile (the median) 
and the ends of the whiskers represent the minimum and the maximum of all 23 data. 
Student t-test was performed to check the statistical significance of the average values 
of 23 clones.  
**: p-value <0.01. 
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6.7.3.4.2 Impact of miR-7 sponge in CHO-K1 SEAP single cell clones cultured in 
5ml spin tubes  
 
CHO-K1 SEAP cell culture was scaled-up to 5ml suspension in CHO-S-SFMII serum-
free medium. 12 clones were transferred to this culture. Samples from each group were 
harvested for four days to monitor GFP expression, cell growth and viability. The cell 
growth phenotype observed in the miR-7 sponge expressing cells cultured in a 24-well 
plate was reproducible in the 5ml culture. The mean cell density was statistically 
increased by 1.5-fold (p= 0.048) at day 2 of the culture (Figure 6.7.3.4.B). The median 
of all clones was higher from day 1 to day 3 by 1.09-fold, 1.73-fold and 1.58-fold in 
miR-7 sponge expressing cells. The cell viability of miR-7 sponge expressing cells 
dropped suddenly the third day (Figure 6.7.3.4.C). The difference in GFP fluorescence 
between control sponge and miR-7 sponge expressing cells was not as clear as the assay 
in 24-well plate. There was a lot of variation between clones from the same group and 
between the different days over the period of the culture (Figure 6.7.3.4.D). The median 
GFP fluorescence of all data was higher in miR-7 sponge expressing cells. In addition, 
the whiskers showed high variation of GFP fluorescence in the different clones at 24 hrs 
and 48 hrs. The assay was repeated several times and the variability in GFP 
fluorescence was present in all the assays, between clones in the same group and for the 
same clone at different time points. This variability could be due to the inherent genetic 
heterogeneity of CHO cells or the site of integration in the genome. As we did not use a 
directed recombination method, the vector would have been integrated randomly at 
different sites in the genome in each of these clones. It may also be related to 
fluctuations in endogenous miR-7 expression over the duration of the culture, though it 
is not apparent why this would be the case in 5ml cultures and not in 24-well plates. 
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Figure 6.7.3.4.B: Distribution of cell growth in control sponge and miR-7 sponge 
expressing CHO-K1 SEAP cells. Cells were seeded at 2x105cells/ml in 5ml 
suspension. Cells were harvested at day 1 to day 4 and stained with GuavaViacount 
reagent to monitor cell growth using Guava Flow cytometry. Distribution of the 12 
clones was analysed for each group using the minimum, the 25%, the 75% and the 
maximum of all the data. The bottom and top of the boxes represent the 25th and 75th 
percentiles (the lower and upper quartiles, respectively), the band near the middle of the 
boxes is the 50th percentile (the median) and the ends of the whiskers represent the 
minimum and the maximum of all the 12 clones. Student t-test was performed for the 
analysis of the statistical significance of the average values of 12 clones.*: p-
value<0.05. 
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Figure 6.7.3.4.C: Distribution of cell viability in control sponge and miR-7 sponge 
expressing CHO-K1 SEAP cells. Cells were seeded at 2x105cells/ml in 5ml 
suspension. Cells were harvested at day 1 to day 4 and stained with GuavaViacount 
reagent to monitor cell viability using Guava Flow cytometry. Distribution of the 12 
clones was analysed for each group using the minimum, the 25%, the 75% and the 
maximum of all the data. The bottom and top of the boxes represent the 25th and 75th 
percentiles (the lower and upper quartiles, respectively), the band near the middle of the 
boxes is the 50th percentile (the median) and the ends of the whiskers represent the 
minimum and the maximum of all the 12 clones.  
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Figure 6.7.3.4.D: Distribution of GFP fluorescence in control sponge and miR-7 
sponge expressing CHO-K1 SEAP cells. Cells were seeded at 2x105cells/ml in 5ml 
suspension. Cells were harvested at day 3 to monitor GFP fluorescence by Guava Flow 
cytometry. Distribution of 12 clones was analysed for each group using the minimum, 
the 25%, the 75% and the maximum of all the data. The bottom and top of the boxes 
represent the 25th and 75th percentiles (the lower and upper quartiles, respectively), the 
band near the middle of the boxes is the 50th percentile (the median) and the ends of the 
whiskers represent the minimum and the maximum of all the 12 clones.  
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6.7.3.4.3 Impact of miR-7 sponge in CHO1.14 single cell clones cultured in 24-
well plates  
 
In CHO1.14 cells, the data distribution for each group demonstrated that the median of 
cell density showed a 2.26-fold increase in miR-7 sponge expressing clones (Figure 
6.7.3.4.E). The 25th and 75th percentiles of the data confirmed the cell growth advantage 
of miR-7 sponge expressing cells between the two groups. The analysis of the mean 
showed that this difference was statistically significant (p-value=0.01814). The levels of 
cell viability were similar in both groups (Figure 6.7.3.4.E).  
The median of GFP expression was higher in miR-7 sponge expressing clones (Figure 
6.7.3.4.E). However, the distribution of GFP fluorescence was in the same range in both 
groups indicating a high variability of GFP expression independent of control or miR-7 
sponge. Despite the observed GFP signal, these data suggested that the sponge system 
was efficient in depleting endogenous miR-7 and inducing significant cell growth 
increase in miR-7 sponge expressing CHO1.14 cells. 
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Figure 6.7.3.4.E: Distribution of cell growth (a), cell viability (b) and GFP 
fluorescence (c), in control sponge and miR-7 sponge expressing CHO1.14 cells. 
Cells were seeded at 2x105cells/ml in a 24-well plate in 1ml suspension. Cells were 
harvested at day 3 and stained with GuavaViacount reagent to monitor cell growth and 
cell viability using Guava Flow cytometry. GFP expression was also assessed using 
Guava Flow cytometry. Distribution of all data was analysed for each group using the 
minimum, the 25%, the 75% and the maximum of all the data. The bottom and top of 
the boxes represent the 25th and 75th percentiles (the lower and upper quartiles, 
respectively), the band near the middle of the boxes is the 50th percentile (the median) 
and the ends of the whiskers represent the minimum and the maximum of all the 9 and 
13 clones from the control and miR-7 sponge group respectively. A Student t-test was 
performed to investigate the statistical significance of the mean value of the clones from 
each group. *: p-value <0.05. 
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6.7.3.4.4 Impact of miR-7 sponge in CHO1.14 single cell clones cultured in 
5ml spin tubes  
 
The same assay was performed in CHO1.14 cells where 7 clones from each group were 
transferred to a 5ml suspension culture in serum-free medium. The median cell density 
was higher in miR-7 sponge expressing clones at day 1 by 1.17-fold, at day 2 by 1.35-
fold (p-value= 0.005742) and by 1.19-fold both at day 3 and day 4 (Figure 6.7.3.4.F). 
The cell viability was slightly improved at day 1 and day 2 in miR-7 sponge expressing 
cells (Figure 6.7.3.4.G). Although the whiskers indicated high variability of GFP 
expression, the median of all data was lower in miR-7 sponge expressing cells from day 
1 to day 5 (Figure 6.7.3.4.H). 
Thus stable knockdown of miR-7 enhanced cell growth significantly in CHO-K1 SEAP 
and CHO1.14 cultured in 5ml. However, the observed impact was significant at one or 
two time points only. This was likely due to the waste accumulation that triggered early 
cell death and reduction of cell density.  
272 
 
 
 
 
 
Figure 6.7.3.4.F: Distribution of cell growth in control sponge and miR-7 sponge 
expressing CHO1.14 cells. Cells were seeded at 2x105cells/ml in 24-well plate in 1ml 
suspension. Cells were harvested at day 3 and stained with GuavaViacount reagent to 
monitor cell growth using Guava Flow cytometry. Distribution of all data was analysed 
for each group using the minimum, the 25%, the 75% and the maximum of all the data. 
The bottom and top of the boxes represent the 25th and 75th percentiles (the lower and 
upper quartiles, respectively), the band near the middle of the boxes is the 50th 
percentile (the median) and the ends of the whiskers represent the minimum and the 
maximum of 7 clones in each group. A Student t-test was performed to investigate the 
statistical significance of the mean value of 7 clones from each group. **: p-value 
<0.01. 
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Figure 6.7.3.4.G: Distribution of cell viability in control sponge and miR-7 sponge 
expressing CHO1.14 cells. Cells were seeded at 2x105cells/ml in 24-well plate in 1ml 
suspension. Cells were harvested at day 3 and stained with GuavaViacount reagent to 
monitor cell viability using Guava Flow cytometry. Distribution of all data was 
analysed for each group using the minimum, the 25%, the 75% and the maximum of all 
the data. The bottom and top of the boxes represent the 25th and 75th percentiles (the 
lower and upper quartiles, respectively), the band near the middle of the boxes is the 
50th percentile (the median) and the ends of the whiskers represent the minimum and 
the maximum of 7 clones in each group. 
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Figure 6.7.3.4.H: Distribution of GFP fluorescence in control sponge and miR-7 
sponge expressing CHO1.14 cells. Cells were seeded at 2x105cells/ml in 5ml 
suspension. Cells were harvested at day 3 to monitor GFP fluorescence by Guava Flow 
cytometry. Distribution of 7 clones was analysed for each group using the minimum, the 
25%, the 75% and the maximum of all the data. The bottom and top of the boxes 
represents the 25th and 75th percentiles (the lower and upper quartiles, respectively), 
the band near the middle of the boxes is the 50th percentile (the median) and the ends of 
the whiskers represent the minimum and the maximum of all the 7 clones.  
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6.7.3.5 Cell cycle analysis  
 
To investigate whether the increase of cell growth observed in miR-7 sponge expressing 
cells was due to a rapid progression through the cell cycle control analysis was done 72 
hrs after passaging. At this time point, miR-7 sponge expressing cells showed a 
significant increase in proliferation compared to the control expressing cells. 
Cell cycle analysis revealed that control sponge expressing cells displayed a normal 
distribution with high percentage of cells in G1 and S phase (Figure 6.7.3.5) whereas 
miR-7 sponge cells showed a similar distribution in the different phases (Figure 
6.7.3.5). The ratio of cells detected in G1 phase was not very different in miR-7 sponge 
expressing cells and the control cells (34.34% vs 39.32%) (Figure 6.7.3.5). 
However, there was more miR-7 sponge expressing cells accumulated in the G2 phase 
(35.04% vs 16.64%), indicating that miR-7 sponge expressing cells progressed faster in 
the cell cycle. To verify that these results were not specific to one clone, we performed a 
cell cycle analysis in 12 clones from the control groups and 10 clones from miR-7 
sponge group. We found that the average ratio of cells accumulated in the different 
phases was very similar to what we observed in the first two clones. Control expressing 
cells were more frequently in the S phase compared to miR-7 sponge expressing cells 
(41.67% vs 33.39%; p-value= 0.00040) which in turn showed higher proportion in G2 
phase (32.04% vs 18.62%; p-value= 8.70623E-06) (Figure 6.7.3.5). Thus the advantage 
of miR-7 sponge expressing cells in proliferation can be explained by the rapid 
progression of these cells through the cell cycle. 
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Figure 6.7.3.5: Cell cycle analysis of control sponge and miR-7 sponge expressing 
CHO-K1 SEAP cells. Control sponge (a) and miR-7 sponge expressing clones (b) were 
harvested 72 hrs after passaging and stained with Guava Cell Cycle reagent (FL2-P, 
Propidium Iodide). Cell cycle analysis was carried out using a Guava Flow cytometry. 
The data enclosed in FCS files were extracted and analysed using FCS Express Plus 
software. The average of cell ratio for 12 control and 10 miR-7 sponge expressing 
clones was calculated and represented in c. Bars represent standard deviations between 
the clones (n=12 and n=10). For statistical significance of the mean value, a Student t-
test was performed. **: p-value<0.01; ***: p-value<0.001. 
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6.7.3.6 Validation of miR-7 sponge technology 
 
Before pursuing our investigation of the impact of miR-7 sponge in larger-scale and 
fed-batch culture, it was important to ensure that the cell growth phenotype observed in 
miR-7 sponge expressing cells was specific to endogenous miR-7. In this regard, levels 
of miR-7 expression were investigated in CHO-K1 SEAP cells. Surprisingly, the levels 
of mature miR-7 were significantly higher (by 5.11-fold) in miR-7 sponge expressing 
clones (p-value=0.000864) (Figure 6.7.3.6.A), suggesting that cells were possibly 
compensating for the lack of miR-7 by increasing pre-miR-7 transcription.  
To verify this hypothesis, cellular levels of precursor miR-7 were analysed. Although 
not significant, there appeared to be a slight decrease in pre-miR-7 expression in the 
miR-7 sponge clones (Figure 6.7.3.6.A). Thus the hypothesis that cells may be 
compensating for the perceived lack of miR-7 by activating transcription was 
unfounded. Another possibility could be the recently described phenomenon of target 
mediated miRNA protection (TMMP) whereby the miRNAs shielded from degradation 
by being bound to its target (Chatterjee, et al. 2011). This prevents exonucleases such as 
XRN-2 from accessing miRNA. By providing a large number of targets (the miR-7 
sponge transcript), mature miR-7 may be protected by TMMP and upon lysis the 
interaction is disrupted, releasing the miR-7 molecules and resulting in an apparent up-
regulation when analysed by qPCR.  
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Figure 6.7.3.6.A: Expression of mature miR-7 (a) and precursor miR-7 (b) in 
control and miR-7 sponge expressing clones. Changes in the levels of expression of 
miR-7 were analysed using AB7500 Real Time PCR instrument. Bars represent 
standard deviations of four biological replicates in figure a and triplicates in figure b. 
Each sample was run with three technical replicates. A Student t-test was carried out to 
investigate the statistical significance of the changes in miR-7 expression. ***: p-
value<0.001. The levels of expression of miR-7 were normalised to snRNAu6 and the 
levels of expression of precursor miR-7 were normalised to 18S rRNA. 
279 
 
To better understand the mode of action of the miRNA sponge and to verify whether the 
sponge protected miR-7 against degradation, a siRNA against dEGFP was transfected 
into miR-7 sponge expressing cells. Inhibition of dEGFP protein was confirmed by the 
low fluorescence of GFP (Figure 6.7.3.6.B).  
 
 
 
 
Figure 6.7.3.6.B: Knockdown of dEGFP by RNAi in miR-7 sponge expressing 
clones. GFP mean fluorescence was analysed using GFP Express Plus software by 
Guava flow cytometry. Bars represent standard deviations of three technical replicates 
for clones 1&2 treated with dEGFP siRNA (in blue). The control clones 1&2 (in red) 
represent one biological sample. The levels of GFP expression were normalised to the 
levels of 18S rRNA. 
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Following inhibition of dEGFP, the levels of miR-7 expression in miR-7 sponge 
expressing cells were similar to the levels of expression in the control cells. The range 
of Ct values were from 31.8 to 32.4 (Figure 6.7.3.6.C). The levels of precursor miR-7 
were also investigated after knockdown of dEGFP. There was no difference of 
expression between the control and miR-7 sponge expressing clones (Figure 6.7.3.6.C). 
Thus knockdown of dEGFP by RNAi may have promoted the degradation of the sponge 
cassette thus leading to reduction of miR-7 levels in the cells. These results suggested 
that the the sponge may have protected miR-7 against degradation resulting in 
apparently high levels of miR-7 in miR-7 sponge expressing clones (Figure 6.7.3.6.C).  
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Figure 6.7.3.6.C: Expression of mature miR-7 (a) and precursor miR-7 (b) in 
control and miR-7 sponge expressing clones after dEGFP knockdown. Change in 
expression of miR-7 was analysed using the AB7500 Real Time PCR instrument. The 
levels of expression of miR-7 and precursor miR-7 were normalised to U6 snRNA and 
to 18S rRNA respectively. Bars represent the ∆Ct standard errors of three clones. 
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To verify that the sponge was soaking up endogenous miR-7 in an efficient manner, a 
transient transfection was performed with pm-neg, am-neg and pm-7 molecules at a 
concentration of 30nM in control and miR-7 sponge expressing CHO-K1 SEAP 
cultures. Ten different clones expressing either control sponge or miR-7 sponge were 
subjected to this treatment. One day after transfection, transient up-regulation of miR-7 
induced further reduction in GFP signal fluorescence only in the miR-7 sponge 
expressing cells, indicating that the sponge worked appropriately to target not only 
endogenous miR-7 but also exogenous miR-7 (Figure 6.7.3.6.D). As expected, 
following transient miR-7 up-regulation, cell density dropped in the control treated cells 
(Figure 6.7.3.6.E). In theory, up-regulation of miR-7 should antagonize the positive 
impact of the miR-7 sponge on cell proliferation so no difference should be seen 
between pm-neg and pm-7 treated cells. This was verified for two clones that showed 
similar cell number after pm-neg and pm-7 treatment (Figure 6.7.3.6.E). However, the 
three other clones had a lower cell density after transient miR-7 overexpression. These 
clones may have a lower copy numbers of the sponge cassette resulting in less 
efficiency to counteract the excess of pm-7 molecules.  
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Figure 6.7.3.6.D: Analysis of GFP fluorescence after transfection of pm-neg or pm-
7 in control and miR-7 sponge expressing cells. Cells were seeded at 1*105cells/ml 
prior to transfection with pm-neg and pm-7 molecules at a concentration of 30nM in 
serum-free medium. GFP mean fluorescence was analysed using GFP Express Plus 
software by Guava flow cytometry 24 hrs after transfection. pm-neg: control for 
mimics; pm-7
 
: mimic of miR-7. 
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Figure 6.7.3.6.E: Analysis of cell density after transfection of pm-neg or pm-7 in 
control and miR-7 sponge expressing cells. Cells were seeded at 1*105cells/ml prior 
to transfection with pm-neg and pm-7 molecules at a concentration of 30nM in serum-
free medium. Cells were stained with GuavaViacount reagent and cell density was 
analysed by Guava Flow Cytometry three days after transfection. cells: non-transfected 
cells; neofx: transfection reagent in its own; vcp: siRNA against Valosin-containing 
protein; pm-neg: control for mimics; pm-7
 
: mimic of miR-7. 
285 
 
Another transfection was performed at higher concentration to investigate the efficiency 
of miR-7 sponge and its levels of saturation. Although the miR-7 sponge was efficient 
at sequestering the exogenous miRNAs at 30nM, the same profile was observed at 
50nM (Figure 6.7.3.6.F). As expected GFP fluorescence was reduced after pm-7 
treatment in miR-7 sponge expressing cells. Inhibitor molecules were also transfected at 
50 nM to investigate whether their presence in the cells would trigger competitive 
binding between these molecules and the sponge for miR-7. Transient inhibition of 
miR-7 slightly increased GFP fluorescence in four of the miR-7 sponge expressing 
clones (Figure 6.7.3.6.F).  
Together these results confirmed that the miR-7 sponge was highly expressed in the 
cells to efficiently sequester not only endogenous miR-7 but also exogenous miR-7 
molecules. This confirmed that the improvement in cell proliferation was a direct 
consequence of miR-7 sequestration. 
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Figure 6.7.3.6.F: Analysis of GFP fluorescence after transfection of pm-neg, pm-7 
or am-7 in control and miR-7 sponge expressing cells. Cells were seeded at 
1*105cells/ml prior to transfection with pm-neg, pm-7 and am-7 molecules at a 
concentration of 50 nM in serum-free medium. GFP mean fluorescence was analysed 
using GFP Express Plus software by Guava flow cytometry one day after transfection. 
pm-neg: control for mimics; pm-7: mimic of miR-7; am-7
 
: inhibitor for miR-7; 
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To verify whether the sponge cassette was degraded or not, mRNA levels of GFP were 
monitored after transient up-regulation of miR-7 in control and miR-7 sponge 
expressing cells. In theory, the GFP-sponge transcript should not be targeted for 
degradation as it was designed with a bulge.  
Surprisingly, there was a 27.67-fold reduction of GFP expression in miR-7 sponge 
expressing clones (p-value=0.009881) (Figure 6.7.3.6.G) thus suggesting that the 
sponge cassette underwent degradation. However, we postulated previously that the 
sponge may protect miR-7 from exonuclease-dependent degradation. Thus the bulge 
may be not effective in preventing destabilization of the transcript when miR-7 
molecules are in excess in the cells.  
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Figure 6.7.3.6.G: Levels of dEGFP expression following pm-7 transfection in 
control and miR-7 sponge expressing cells. GFP expression was evaluated 24 hrs after 
transfection by qPCR using the AB7500 Real Time PCR instrument. The levels of miR-
7 expression were normalised to U6 snRNA for correction of RNA input. Bars represent 
standard deviations of three clones. Statistical significance of dEGFP knockdown was 
investigated using a Student t-test. **: p-value< 0.01 
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6.7.3.7 Impact of stable miR-7 knockdown in CHO-K1 SEAP cell cultured in fed-
batch culture 
 
6.7.3.7.1 Investigation of miR-7 sponge impact on CHO-K1 SEAP growth and 
viability 
 
To further verify the advantage of miR-7 sponge expressing cells on cell growth, a fed-
batch assay was performed for 13 days at 37°C, in 30 ml starting volume with the two 
best performing clones from the control and miR-7 sponge expressing CHO-K1 SEAP 
cells. 4.5ml of Fed CHO CD EfficientFeed A™ (Invitrogen) medium was added to the 
culture at day 0. Then 3ml were added every three days to extend the culture period. 
Samples were harvested every day to assess cell growth, cell viability and cell 
productivity.  
miR-7 sponge expressing clone 2 and clone 7 showed a higher cell density from day 5 
of the culture (control sponge 2: 54.4x105cells/ml; control sponge 13: 
47.04x105cells/ml; miR-7 sponge 2: 58.32x105cells/ml; miR-7 sponge 7: 
56.74x105cells/ml) (Figure 6.7.3.7.A). This difference was increased at day 6 (control 
sponge 2: 62.74x105cells/ml; control sponge 13: 53.45x105cells/ml; miR-7 sponge 2: 
81.81x105cells/ml; miR-7 sponge 7: 69.82x105cells/ml). Although cell density dropped 
in the four cultures the following day, cell density in miR-7 sponge expressing cells 
dropped more slowly resulting  in an extended period of culture while maintaining high 
cell viability at later stages of culture (control sponge 2: 56.36%; control sponge 13: 
52.54%; miR-7 sponge 2: 83.32%; miR-7 sponge 7
Thus miR-7 knockdown significantly improved cell growth rate and maintained high 
viability in fed-batch culture. These results confirmed the value of the miR-7 sponge as 
a tool to improve CHO proliferation in culture. 
: 81.89%) (Figures 6.7.3.7.A&D). 
Cell growth rate (change in cell concentration per minute) and accumulated integral 
viable cell density (AIVCD; cell per time per unit volume accumulated over the culture) 
confirmed the advantage of miR-7 sponge expressing clones (Figures 6.7.3.7.B&C).  
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Figure 6.7.3.7.A: Evaluation of cell density in control and miR-7 sponge expressing 
in fed-batch culture. Two clones from the control sponge population and two clones 
from the miR-7 sponge group were seeded at 2x105cells/ml and cultured in 30ml in 
serum-free medium. Clones were run in biological triplicates for 13 days. 4.5ml of Fed 
CHO CD EfficientFeed A™ (Invitrogen) medium was added to the culture at day 0. 
Then 3ml were added every three days to extend the culture period. Cells were 
harvested every day and stained with trypan blue solution to monitor cell density by 
Cedex Automated Cell Counter (Roche). Bars represent standard deviations of three 
biological replicates. Two clones from the control sponge population and two clones 
from the miR-7 sponge group were seeded at 2x105cells/ml and cultured in 30ml in 
serum-free medium. A Student t-test was performed to evaluate the statistical 
significance between the density average of the control sponge clones with the density 
average of the miR-7 sponge clones. *: p-value< 0.05; **: p-value< 0.01; ***: p-value< 
0.001. 
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Figure 6.7.3.7.B: Evaluation of cell growth rate in control and miR-7 sponge 
expressing in fed-batch culture. Two clones from the control sponge population and 
two clones from the miR-7 sponge group were seeded at 2x105cells/ml and cultured in 
30ml in serum-free medium. Clones were run in biological triplicates for 13 days. 4.5ml 
of Fed CHO CD EfficientFeed A™ (Invitrogen) medium was added to the culture at 
day 0. Then 3ml were added every three days to extend the culture period. Cells were 
harvested every day and stained with trypan blue solution to monitor cell density by 
Cedex Automated Cell Counter (Roche). Bars represent standard deviations of three 
biological replicates. A Student t-test was performed to evaluate the statistical 
significance between the cell growth rate average of the control sponge clones with the 
average cell growth rate average of the miR-7 sponge clones. There was no statistical 
significance. 
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Figure 6.7.3.7.C: Evaluation of accumulated integrated viable cell density in 
control and miR-7 sponge expressing in fed-batch culture. Two clones from the 
control sponge population and two clones from the miR-7 sponge group were seeded at 
2x105cells/ml and cultured in 30ml in serum-free medium. Clones were run in 
biological triplicates for 13 days. 4.5ml of Fed CHO CD EfficientFeed A™ (Invitrogen) 
medium was added to the culture at day 0. Then 3ml were added every three days to 
extend the culture period. Cells were harvested every day and stained with trypan blue 
solution to monitor cell density by Cedex Automated Cell Counter (Roche). Bars 
represent standard deviations of three biological replicates. A Student t-test was 
performed to evaluate the statistical significance between the AIVCD average of the 
control sponge clones with the AIVCD average of the miR-7 sponge clones. *: p-value< 
0.05; **: p-value< 0.01; ***: p-value< 0.001. 
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Figure 6.7.3.7.D: Evaluation of cell viability in control and miR-7 sponge 
expressing in fed-batch culture. Two clones from the control sponge population and 
two clones from the miR-7 sponge group were seeded at 2x105cells/ml and cultured in 
30ml in serum-free medium. Clones were run in biological triplicates for 13 days. 4.5ml 
of Fed CHO CD EfficientFeed A™ (Invitrogen) medium was added to the culture at 
day 0. Then 3ml were added every three days to extend the culture period. Cells were 
harvested every day and stained with trypan blue solution to monitor cell viability by 
Cedex Automated Cell Counter (Roche). Bars represent standard deviations of three 
biological replicates. A Student t-test was performed to evaluate the statistical 
significance between the cell viability average of the control sponge clones with the cell 
viability average of the miR-7 sponge clones. *: p-value< 0.05; **: p-value< 0.01; ***: 
p-value< 0.001. 
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6.7.3.7.2 Investigation of miR-7 sponge impact on SEAP total yield and 
normalised productivity 
 
To investigate the impact of miR-7 sponge on SEAP productivity, in the same fed-batch 
culture, supernatants of samples were harvested every day to evaluate normalised 
productivity and total yield.  
Control sponge expressing clone 2 had the highest total yield over the culture period, 
followed by miR-7 sponge expressing clone 2 and clone 7 (Figure 6.7.3.7.E). Control 
sponge expressing clone 2 also had the highest normalised productivity. This impact 
was further increased from day 6 and prolonged until later stages of culture (Figure 
6.7.3.7.F). miR-7 sponge did not improve normalised productivity. 
Taken all together, these results suggested that sponge miR-7 is an efficient tool to 
extend the longevity of the culture as well as to improve cell growth rate, AIVCD and 
cell viability. The monitoring of more clones in culture would validate these results and 
would provide more information on the impact of miR-7 on protein production.  
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Figure 6.7.3.7.E: Evaluation of SEAP total yield in control and miR-7 sponge 
expressing cells cultured in fed-batch. Supernatants of samples were harvested every 
day for 13 days. Change in absorbance of SEAP substrate, p-nitrophenolphosphate, was 
analysed using a kinetic assay. Bars represent standard deviations of three biological 
replicates. 
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Figure 6.7.3.7.F: Evaluation of normalised productivity in control and miR-7 
sponge expressing cells cultured in fed-batch. Supernatants of samples were 
harvested every day for 13 days. Change in absorbance of SEAP substrate, p-
nitrophenolphosphate, was analysed using a kinetic assay. Bars represent standard 
deviations of three biological replicates. 
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6.8 The role of miR-7 in CHO cells 
 
6.8.1 Investigation of the role of miR-7 in cell cycle and apoptosis 
 
Previously, we showed that subsequent to pm-7 transfection cell growth was 
significantly reduced and cell viability was maintained. Once the effect of the 
transfection diminishes the cells re-enter the cell cycle and proliferate normally.  
To establish the role of miR-7 in the regulation of cell cycle, we performed cell cycle 
analysis 72 hrs after transfection. High levels of miR-7 triggered cell accumulation in 
G1 phase (59.73%) compared to pm-neg (31.86%) thus reducing the proportion of cells 
in S and G2 phases (Figure 6.8.1.A). There was no indication of cells in sub-G1 
population suggesting that cells did not undergo apoptosis while arrested. Thus pm-7 
treated cells were arrested in G0/G1 phase compared to pm-neg treated cells which 
progressed normally through the cell cycle. 
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Figure 6.8.1.A: Cell cycle analysis after pm-7 transfection. 
Cells were stained with Guava Cell Cycle reagent at day 3 following treatment with pm-
neg (a) or pm-7 (b). The data were captured using a Guava Flow cytometry. FCS files 
from cell cycle assay were extracted and analysed using FCS Express Plus, a curve 
fitting software. FL2-P: fluorescent light of the DNA dye, Propidium iodide.  
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We measured the apoptosis levels specifically using Nexin assay in the cells and found 
that there was no significant change 72hrs after transfection (Figure 6.8.1.B). However, 
at 120hrs after transfection the apoptotic percentage was very slightly but significantly 
increased in miR-7 treated cells (Figure 6.8.1.B). 
Thus the high cell viability and the lack of sub-G1 population observed in pm-7 treated 
cells suggested that the low cell densities observed were not due to increased levels of 
apoptosis. 
 
 
 
 
Figure 6.8.1.B: Analysis of the levels of apoptosis after pm-7 transfection. 
Apoptosis rate was evaluated with the Nexin assay reagent at day 3 (a) and day 5 (b) 
after pm-neg or pm-7 transfection. The data were captured using a Guava Flow 
cytometry. Bars represent standard deviations of five biological replicates in pm-neg 
and pm-7 treated cells. The statistical significance of these data was analysed using a 
Student t-test. ***: p-value< 0.001. 
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6.8.2 Investigation of the molecular mechanisms beyond the growth 
arrest in G1 phase 
 
We then investigated the possibility of senescence occurring subsequent to G1 arrest of 
cells by analysis of senescence-associated β-galactosidase activity. As a positive 
control, different concentrations of BrDU were used in an attempt to induce senescence 
in CHO cells (Figure 6.8.2.A). However, CHO cells did not become senescent even at 
high concentration of BrdU. CHO cells are known to replicate indefinitely and are likely 
to carry mutations in senescence-specific genes so it is possible that senescence cannot 
be induced in these cells. Another explanation is that senescence in CHO cells is not 
associated with β-galactosidase. 
 
 
 
 
Figure 6.8.2.A: Treatment of BrDU in CHO cells. A: non-treated cells; B: cells 
treated with 250 µM; C: cells treated with 500 µM; D: cells treated with 1mM. 
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As a positive control of senescence, a breast cancer cell line, HCC1419 cells, was 
treated with 50µM of BrDU. A blue color indicated the presence of β-galactosidase thus 
confirming that senescence was efficiently induced in this cell line (Figure 6.8.2.B). 
Treatment with a non-specific control or exogenous miR-7 molecules did not activate β-
galactosidase in CHO cells (Figure 6.8.2.B). We also previously showed that the 
impact of transient miR-7 transfection on cell growth was diminished at day 5 and lost 
at day 7 after transfection presumably allowing cells to re-enter the cell cycle. This 
would not be the case in senescent cells as their arrest is irreversible. Thus the cell 
growth arrest observed in G1 phase is not likely to be a result of senescence indicating 
that other mechanisms are responsible for the arrest of CHO cells in G1.  
 
 
 
 
Figure 6.8.2.B: miR-7 does not trigger senescence.  
β-galactosidase was assayed after 96 hrs using a senescence β-galactosidase staining kit 
in cells treated with BrdU, pm-neg or pm-7 treatment. Cells were observed using 
microscopy at 20X. A: HCC1419 cells treated with 50 µM BrdU as positive control; B: 
pm-neg-treated CHO cells; C: pm-7-treated cells. 
302 
 
6.8.3 Investigation of miR-7 targets 
 
6.8.3.1.1 Identification of miR-7 targets 
 
To further investigate the molecular mechanisms by which miR-7 influences cell 
growth, we performed gene expression profiling using CHO specific oligonucleotide 
arrays. The identification of direct miRNA targets presents some challenges in 
mammals. Unlike miRNAs in plants which have near-perfect complementarity with 
their targets, the specific binding between the seed region of a miRNA and the 3’UTR 
of its cognate mRNA target has different degrees of complementarity in mammals. In 
addition, the miRNA-mRNA binding can also occur elsewhere including in the 5’UTR, 
in the ORF or in multiple binding sites. At the time of the assay, the other challenge was 
the lack of genomic sequences publicly available for Cricetulus griseus or CHO. 
Therefore a custom CHO oligonucleotide WyeHamster3a microarray (Affymetrix) was 
used in this study. It contained a total of 19,809 CHO-specific transcripts, combining 
library-derived CHO and publicly-available hamster sequences, as well as 92 (non-
CHO) array quality control sequences (Housekeeping and Spike Controls) and 22 
product/process specific sequences, covering an estimated 85% of the CHO genome 
(unpublished at the time of the assay). The CHO-specific microarrays were provided by 
Pfizer (Pfizer Grange Castle, Dublin and Pfizer Andover, Massachussets). Cells were 
treated with non-specific control (pm-neg) or with mimic molecules of endogenous 
miR-7 (pm-7). Non-transfected cells were also included as a control. The changes in 
gene expression upon pm-neg treatment were compared to the changes in the non-
transfected cells to assess the impact of the transfection itself. Non-transfected cells 
were al so compared to pm-7 transfected cells and this latter was compared to pm-neg 
treated cells. All samples were run in biological triplicates. 
A heat map was generated using unsupervised hierarchical clustering and showed that 
the replicates clustered together but also that the pm-neg and non-transfected cells were 
more similar than the miR-7 transfected cells (Figure 6.8.3.A). Genes were considered 
to be differentially expressed and statistically significant if a 1.2 fold change in either 
direction was observed with a p-value<0.05. 
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Overall, the heat map showed that the gene expression data from the non-transfected 
cells and pm-neg treated cells were more similar than pm-7 (Figure 6.8.3.A). This 
observation was confirmed by the number of differentially expressed genes in each 
comparison. In fact, only a very small number of genes were detected as differentially 
regulated after transfection with pm-neg compared to non-transfected cells (13 up-
regulated and 39 down-regulated genes (Figure 6.8.3.A). On an array with >19,000 
probesets, we would expect more than this by chance. In addition, the comparison 
between pm7/pm-neg and pm-neg/cells showed no overlap between the two groups. 
Taken together these results indicated that the changes observed upon pm-7 transfection 
were specific to the increase in miR-7 levels and not due to the transfection itself. Also 
the changes in gene expression of the biological replicates of pm-7 transfected cells 
were in the same direction (up-regulation or knockdown) and to a very similar extent 
(Figure 6.8.3.A). This was also observed in the non-tranfected cells. Although, the 
three replicates in pm-neg treated cells showed some variation in the extent of the 
expression variation, the direction of the changes was the same. This consistency 
between biological replicates added more strength and confidence to our results and 
demonstrated that the array experiment performed well. 
Among the differentially regulated genes upon pm-7 transfection, 341 probesets were 
found to be significantly down-regulated and 219 were found to be up-regulated (1.2-
fold cut-off filter, p< 0.05) (Figure 6.8.3.A) (refer to appendices 2&3 for the full list of 
up- and down-regulated genes). This generated a list of 355 annotated, non-redundant, 
differentially expressed gene transcripts. This number is in line with the fact that 
miRNAs are known to typically target hundreds of genes (Bartel 2004). The magnitude 
of down- and up-regulation did not exceed fourfold (Appendices 2&3 respectively) 
which is also consistent with what has been reported previously (Baek, et al. 2008, 
Selbach, et al. 2008).  
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Figure 6.8.3.A: Heat map (a) and venn diagram representing the changes in CHO-
specific gene expression upon miR-7 up-regulation.  
Following pm-7 or pm-neg transfection, gene expression profiling was performed on 
biological triplicates using CHO specific oligonucleotide arrays. Genes were considered 
to be differentially expressed and statistically significant if a 1.2 fold change in either 
direction was observed along with a Bonferroni adjusted p-value <0.05. Using the 
LIMA method and Bonferroni algorithm, gene expression between the three groups was 
evaluated and compared. A heat map was generated using unsupervised hierarchical 
clustering (a). The relative expression of each gene is represented by the red colour for 
down-regulation and by the green colour for up-regulation. pm-7: mimic of miR-7; pm-
neg: negative control for pm-7; cells
A venn diagram was created (b) to identify the number of genes differentially regulated 
in three conditions pm-neg/cells, pm-7/cells and pm-7/pm-neg and the overlap between 
these groups. 
: non-transfected cells.  
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To identify the cellular pathways affected by the transient overexpression of miR-7, we 
conducted a Gene ontology analysis using PANTHER on the diffentially regulated 
genes found on the array. This revealed that apoptosis, cell cycle, cell proliferation, and 
DNA repair were in the first 30 overrepresented cellular processes (Figure 6.8.3.B; 
Table 4.8.3, Appendices 2-4).  
 
 
 
 
Figure 6.8.3.B: Gene ontology analysis using PANTHER software. 
The 10 most represented cellular pathways are displayed in this figure. 
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6.8.3.1.2 Validation of the array data 
 
To validate the quality of the array data, we checked for proven miR-7 targets. Spata2 
was found to be down-regulated by 3.16-fold in the array. This gene has been 
experimentally validated to be a miR-7 target using next-generation sequencing (Hafner 
M, 2010). Psme3, Ckap4, Cnot8, Cnn3, Pfn2 were also found to be down-regulated 
upon miR-7 transfection in A549 cells using also microarray analysis (Webster, et al. 
2009). However, the authors did not validate these genes by reporter assay. Although 
these genes were not validated as direct targets by a reporter assay, there was some 
overlap with our findings. 
To further confirm the array results, we selected 39 genes that were found to be down-
regulated in the array and verified their levels of expression by qPCR. Only down-
regulated genes were chosen due to the usual mode of action of miRNAs which is the 
repression of their targets by binding to the 3’UTR. These genes were all significantly 
down-regulated, with the exception of HDAC1 which was found significantly up-
regulated. This inconsistency between the array and the qRT-PCR methods could be the 
result of a poor quality probeset thus giving a wrong indication of the direction changes. 
Out of the 39 targets, 16 were predicted as miR-7 targets by different databases (Table 
6.8.3). Among these genes, 22 genes have been shown to be involved in the G1/S phase 
of the cell cycle including Cdk1/2 (down by 4.07-fold and 2.24-fold respectively) and 
Cyclin D1/3 (down by 4.67-fold and 2.11-fold respectively) (Figure 6.8.3.C). Others 
were associated with replication like the Mcm family (Mcm 2,3,5,7 down between 2.78-
fold and 5.33-fold), or with the DNA damage/repair pathway such as Rad52/Rad54l 
(down by 10.71-fold and 21.64-fold respectively), Psme3 (down by 19.20-fold) or Bcl-2 
associated factor (down by 7.27-fold) (Figure 6.8.3.C, Table 6.8.3). Thus these results 
confirmed the quality of the array data as well as the cellular pathways identified in 
silico. 
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Table 6.8.3: Validation of genes down-regulated in the microarray data 
 
    
Gene ID Fold change Prediction 
 Microarray qPCR  
Psme3 -3.924 -19.197 
Diana, miranda, mirwalk, 
targetscan 
Apex1 -3.493 -2.510 No 
Skp2 -3.267 -2.739 Diana 
Cno -3.236 -3.943 
Diana, miranda, 
mirwalk,targetscan 
Spata2 -3.167 -4.747 
Diana, miranda, miRwalk, 
pictar, targetscan 
Rad54l -3.148 -21.642 Mirwalk, pictar 
Ccnd3 -3.137 -2.109 No 
Peo1 -2.874 -8.863 Diana 
Ckap4 -2.871 -2.828 
Diana,miranda, mirwalk, 
pictar, targetscan 
Plp2 -2.815 -4.569 
Diana, miranda, mirwalk, 
pictar, targetscan 
DHFR -2.764 -5.126 No 
Setd8 -2.667 -2.648 
Diana, miranda, pictar, 
targetscan 
Ccnd1 -2.555 -4.669 No 
H2afx -2.552 -8.238 No 
Tmem55b -2.510 -3.493 No 
Slc7a5 -2.506 -4.710 No 
Mcm2 -2.493 -4.190 No 
Lig1 -2.485 -5.998 No 
Orc1l -2.424 -4.730 No 
Cdk2 -2.413 -2.245 MiRwalk 
Aup1 -2.399 -3.118 No 
Mcm5 -2.391 -5.332 No 
Mcm3 -2.251 -3.765 No 
Aplp2 -2.166 -5.207 No 
Bclaf1 -2.005 -7.266 No 
Slc39a9 -1.963 -3.434 No 
Cdc6 -1.861 -15.770 No 
Cnot8 -1.851 -2.622 Diana, miranda, pictar, 
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targetscan 
Mcm7 -1.847 -2.779 No 
Cenpo -1.783 -4.238 Diana, miranda 
Fen1 -1.767 -2.997 No 
Cdc25b -1.752 -3.706 No 
TFDP1 -1.544 -2.624 Miranda 
Pabpn1 -1.311 -2.005 Diana 
Cdc7 -1.244 -1.625 No 
Rad52 -0.851 -10.708 No 
Cdk1 -0.754 -4.071 Diana, targetscan 
BCL10 -0.737 -3.968 No 
Hdac1 2.529 2.920 Diana, targetscan 
 
 
Table 6.8.3: Validation of down-regulated genes  
Several genes found to be differentially regulated in the oligonucleotide array study 
were validated using the AB7500 Real Time PCR instrument. Gene expression was 
normalised to β-actin, the endogenous control. Different databases including DIANA 
LAB, Micro.org, miRWalk, PicTar and TargetScan (Grimson, et al. 2007, Krek, et al. 
2005, Maragkakis, et al. 2009, Dweep, et al. 2011, Friedman, et al. 2009, Betel, et al. 
2008) were used to identify predicted binding sites between miR-7 and its mRNA 
targets in mammals. 
309 
 
 
 
 
Figure 6.8.3.C: Validation of arrays results using qRT-PCR 
Genes involved in cell cycle regulation and DNA repair were validated using SYBR 
green qPCR in an AB7500 Real Time PCR instrument. Relative expression analysis 
was calculated using the 2-ΔΔCt method. Gene expression was normalised to β-actin as an 
endogenous control. 
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6.8.4 Investigation of other down-regulated genes upon pm-7 treatment 
 
The computational identification of the cellular pathways affected upon miR-7 
transfection indicated that cell proliferation, DNA repair and cell cycle were over 
represented. We checked in the list of down-regulated genes in the array whether we 
could find other genes involved in these pathways.  
The gene encoding for mitogen-activated protein kinase associated protein 1 (Mapkap1) 
was down-regulated by 2.18-fold (Appendix 2). Mapkap1 is a subunit of mTORC2, 
which regulates cell growth and survival in response to hormonal signals. The levels of 
expression of the gene encoding the cell division cycle-associated protein (Cdca4) were 
reduced by 3.52-fold. This gene may participate in the regulation of cell proliferation 
through the E2F/RB pathway. The cell division cycle associated 7 (Cdca7) protein-
encoding gene showed a 2.33-fold decrease. Cdca7 participates in MYC-mediated cell 
transformation. Eif4ebp2, a gene encoding the eukaryotic translation initiation factor 4E 
binding protein family was found to be down-regulated by 2.32-fold. Eif4ebp2 regulates 
the production of proteins implicated in cell proliferation. Together, these results gave 
some indication of how miR-7 may exert a control on cell proliferation. 
Other genes were involved in chromatin remodelling as well as cell proliferation 
including ATP-dependent DNA ligase I (Lig1), H4-K20-specific histone 
methyltransferase (Setd8), nucleus accumbens-associated protein 1 (NACC1). 
Following miR-7 transfection their levels of expression were reduced by 2.41-fold to 
2.66-fold. Thus miR-7 may be involved in chromatin remodelling. 
MYST2 and USP10, two genes which play a role in DNA damage/repair pathway, were 
found to be down-regulated by 2.02-fold to 2.31-fold. MYST2, a histone 
acetyltransferase may regulate DNA replication through chromatin acetylation and may 
act as a coactivator of TP53-dependent transcription. USP10, a ubiquitin specific 
peptidase acts as an essential regulator of p53/TP53 stability in unstressed cells, 
specifically deubiquitinating p53/TP53 in the cytoplasm to counteract MDM2 action 
and stabilize p53/TP53. These data suggested a role for miR-7 in p53 regulation. 
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6.8.5 Investigation of up-regulated genes upon pm-7 transfection 
 
Vasudevan and co-workers have demonstrated that miRNAs can induce translation up-
regulation of target mRNAs by AGO2-3’UTR interaction in non-proliferating cells that 
are in cell cycle arrest but on the other hand, miRNAs induce repression of translation 
in proliferating cells (Vasudevan, Tong and Steitz 2007a) . These authors proposed that 
translation regulation can switch between these two antagonistic mechanisms of 
repression and activation, depending on the cell cycle phase. 
In the list of up-regulated genes, we found that the levels of expression of TGFBR3 
(transforming growth factor, beta receptor III) were increased by 2.55-fold upon pm-7 
overexpression (Appendix 3). TGFBR3 is a member of the TGF-beta superfamily 
signaling pathways, which have essential roles in mediating cell proliferation, apoptosis, 
differentiation, and migration. This gene undergoes mutations in cancers and usually 
acts as a tumor suppressor. The role of TGFBR3 and its high levels of expression in 
miR-7 transfected cells corroborated our previous results which showed that cells were 
arrested in G0/G1 phase upon pm-7 treatment. 
Another gene Hbp1 was also found to be down-regulated by twofold. This gene is 
involed in cell growth regulation. It binds to the p16INK4A promoter to activate p16INK4A 
expression. This latter induces cell cycle arrest in G1 phase through inhibition of 
MDM2 and prevents MDM2-induced degradation of p53. 
Again these data fit nicely with the results from the array and qPCR assays and 
reinforces the idea that miR-7 triggers cell cycle arrest and is involved in apoptosis 
regulation. In addition, these results give more insight into the protein network involved 
in this regulation. 
312 
 
6.8.6 Validation of Psme3, Rad54l and Skp2 as direct targets of miR-7 
 
6.8.6.1 Computational prediction of Psme3, Rad54l and Skp2 in CHO cells 
 
Having established that several growth and DNA replication-related genes were 
deregulated upon miR-7 treatment, we wished to verify whether they were primary 
binding targets or secondary targets downstream of miR-7. We focused on three targets, 
Psme3 (REGγ or PA28γ), Rad54L and Skp2 which were representative of the cell 
proliferation and DNA repair pathways. None of them had previously been shown to be 
directly regulated by miRNAs, but were predicted to bind miR-7 through either their 
3’UTR (Psme3, Skp2) or coding sequence (Rad54L).  
The CHO mRNA sequences of these genes were aligned with the mature sequence of 
CHO miR-7 (cgr-miR-7) using RNA Hybrid (Rehmsmeier, et al. 2004). The predicted 
3’UTR binding sites of Psme3 and Skp2 were found to be conserved in Chinese 
Hamster (Figure 6.8.6.1). The non-canonical miR-7 binding site with the CDS of 
Rad54l was also conserved in Chinese Hamster and showed a high binding score 
(Figure 6.8.6.1).  
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Figure 6.8.6.1: Binding of miR-7 and its predicted targets Psme3, Rad54l and 
Skp2. The mature sequence of cgr-miR-7 was aligned with the sequences of its CHO 
mRNA targets, Psme3 (a), Skp2 (b) and Rad54l (c) using RNAhybrid (Rehmsmeier, et 
al. 2004), a tool to evaluate the score of the binding by calculating the minimum free 
energy of hybridisation (mfe).  
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6.8.6.2 Experimental validation of Psme3, Rad54l and Skp2  
 
6.8.6.2.1 Isolation and cloning of the 3’UTR of Psme3, Rad54l and Skp2 
 
Experimental validation of Psme3, Rad54l and Skp2 as direct targets of miR-7 was 
performed using a dEGFP reporter assay. The 3’UTR of Psme3 and Skp2 was PCR-
amplified using the primers described in section 6.3.4 of the materials and method. 
These 1760 bp and 417 bp amplicons were subcloned downstream of the dEGFP 
reporter gene in the pd2EGFP-Hyg2 vector (Figure 6.8.6.2.A) to create the pd2EGFP-
Psme3 and pd2EGFP-Skp2 plasmids (Figure 6.8.6.2.A). In the case of Rad54L we 
deliberately included 65 bp upstream of the translational stop codon in order to 
incorporate the RNA Hybrid-predicted miR-7 seed binding site. The size of Rad54L 
amplicon including the CDS sequence and the 3’UTR was 319 bp (Figure 6.8.6.2.A). 
The 319 bp fragment of Rad54L was cloned into the reporter vector to create the 
pd2EGFP-Rad54L plasmid (Figure 6.8.6.2.A). 
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Figure 6.8.6.2.A: Cloning steps of Psme3, Skp2 and Rad54L into pd2EGFP-Hyg2 
vector. 
a: Double digestion of pd2EGFP-Hyg2 vector with XhoI and EcoRI; b: Amplification of 
the 3’UTR of Psme3 in CHO cells; c: Double digestion of pd2EGFP-Psme3 vector with 
XhoI and EcoRI (Lane 1: positive clone; Lane 2 negative clone); d: Amplification of the 
3’UTR of Rad54L (Lane 1) and Skp2 (Lane 2) in CHO cells; e: Double digestion of 
pd2EGFP-Skp2 (Lane 1) and pd2EGFP-Rad54L (Lane 2) vectors with XhoI and EcoRI. 
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6.8.6.2.2 Validation of Psme3, Rad54l and Skp2 at the transcriptional level 
 
Following cloning, these plasmids were transfected into CHO cells in combination with 
either a pm-neg or pm-7. A GFP reporter without any UTR sequence was included as a 
negative control. The GFP signal in cells receiving this control was unchanged in the 
presence of either pm-neg or pm-7 (Figure 6.8.6.2.B). Addition of a GFP specific 
siRNA efficiently blocked fluorescence and provided a strong positive control for the 
assay. GFP fluorescence was significantly reduced for all three targets (Figure 
6.8.6.2.B). 
The reporter containing the Psme3 UTR showed a 21.97% reduction in mean 
fluorescence when co-transfected with pm-7 compared to pm-neg (p-value= 0.0029). 
The mean fluorescence of p2dEGFP-Rad54L and p2dEGFP-Skp2 was reduced by 23% 
(p-value= 0.0002) and 18.81% (p-value= 0.0123) respectively in comparison to the 
control. This reporter assay provided positive indications that Psme3, Skp2 and Rad54L 
may be direct targets of miR-7. 
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Figure 6.8.6.2.B: Validation of Psme3, Rad54l and Skp2 as direct targets of miR-7 
in a GFP reporter assay. The 3’UTR sequences of Psme3, Skp2 and Rad54l (including 
65bp of CDS sequence) were inserted between XhoI and EcoRI restriction sites of the 
CMV-d2 sponge vector. Following co-transfection of 1µg of reporter with 50nM of 
miR-7 and 2µl of lipofectamine, GFP signal fluorescence was analysed using Guava 
Flow cytometry. control: pd2EGFP-Hyg2 vector backbone with no UTR sequence. 
dEGFP: siRNA against dEGFP (dEGFP) as a positive control of GFP fluorescence 
reduction. pm-neg: negative control for miR-7 mimic; pm-7: mimic of miR-7; Psme3: 
pd2EGFP-Hyg2 containing Psme3 3’UTR; Skp2: pd2EGFP-Hyg2 containing Skp2 
3’UTR; Rad54L
 
: pd2EGFP-Hyg2 containing Rad54L 3’ CDS/UTR. Bars represent 
standard deviations of four biological replicates. Statistical significance of the d2EGFP 
expression reduction was assessed by a Student t-test.*: p-value<0.05; **: p-value< 
0.01; ***: p-value<0.001. 
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6.8.6.2.3 Validation of Psme3, Skp2 and Rad54L at the protein level 
 
To continue the validation of Psme3, Skp2 and Rad54L as true targets of miR-7, we 
investigated their protein expression using western blotting.  
Upon miR-7 treatment, the endogenous protein levels of SKP2 were strongly down-
regulated (Figure 6.8.6.2.C). PSME3 protein levels were also confirmed to be down-
regulated but to a lesser extent. A recent study done in our laboratory showed that 
PSME3 protein levels were reduced by 11-fold and by 30-fold at 48hours and 96 hours 
after treatment with miR-7, though it did not pass some of the selection filters 
(Meleady, et al. 2012). The validation of Rad54L could not be verified at the protein 
levels due to the unspecificity of the antibody tested in CHO cells. 
 
 
 
  
Figure 6.8.6.2.C: Validation of Psme3 and Skp2 protein levels upon pm-7 
transfection  
Levels of endogenous PSME3 and SKP2 proteins were investigated by western blotting 
following transfection with pm-neg or pm-7. GAPDH was used as a loading control. 
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6.8.7 Investigation of the impact of Psme3 and Skp2 on cell proliferation 
 
To establish to what extent the phenotypic impact of miR-7 transfection was due to 
targeting these genes, we depleted PSME3 and SKP2 individually using two siRNAs for 
each target.  
To confirm the knockdown of PSME3 and SKP2 following siRNA transfection, their 
protein levels were monitored by western blotting. Depletion of PSME3 was achieved 
with both siRNA a&b, though it was more efficient with siRNA a (Figure 6.8.7.A). The 
protein levels of SKP2 were dramatically down-regulated, particularly with siRNA b.  
 
 
 
   
Figure 6.8.7.A: Depletion of PSME3 and SKP2 by RNAi 
Following siRNA transfection, the protein levels of PSME3 and SKP2 were 
investigated by western blotting. Two siRNAs (a&b) were tested for each target. A 
negative control (scr) was included for comparison of the protein expression levels 
before and after treatment with siRNA. GAPDH was used as a loading control. 
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Psme3 knockdown led to a 22% reduction in cell density using siRNA b (p-value= 
0.0016) (Figure 6.8.7.B). Skp2 knockdown reduced cell density by 44% using siRNA a 
(p-value= 0.0001) and 36% using siRNA b (p-value= 0.0003). Although the cell 
viability was significantly reduced, knockdown of Psme3 and Skp2 had little impact on 
this phenotype (<3%) (Figure 6.8.7.B).  
To investigate the simultaneous effect of Psme3 and Skp2 depletion, the best siRNA 
was chosen for each target. The two siRNAs were co-transfected at a combined 
concentration of 50nM to avoid saturation of the RNAi machinery. The combined 
effects of Psme3 and Skp2 siRNAs had a small but significant impact on cell density 
(Figure 6.8.7.C). This observation may be the result of the lower concentration used for 
each co-transfected siRNA.  
Together, these results suggested that Skp2 plays a unique and important role in G1 
arrest. Although Psme3 showed lower impact on cell density than Skp2, Psme3 may 
also be involved in G1 arrest. This might be explained by compensation via redundant 
proteins in the same family or it may also be the result of a less effective siRNA leading 
to moderate depletion of Psme3 and consequently moderate impact of Psme3 on cell 
proliferation.  
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Figure 6.8.7.B: Impact of individual Psme3 and Skp2 depletion on cell 
proliferation.  
Two siRNAs (a&b) for Psme3 and Skp2 were transfected separately at a final 
concentration of 50nM. Non-transfected cells were included as a negative control and 
siRNA against Valosin-containing protein (VCP) was included as a positive control. 
Cell growth and viability were assessed at day 3 after transfection using GuavaViacount 
staining with a Guava Flow Cytometry. Standard deviations represent biological 
triplicates. A Student t-test was performed to analyse the statistical significance of the 
data. *: p-value<0.05; **: p-value< 0.01; ***: p-value<0.001 
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Figure 6.8.7.C: Impact of the simultaneous depletion of Psme3 and Skp2 on cell 
proliferation.  
The best performing siRNA was chosen for Psme3 as well as for Skp2 and were co-
transfected at a final concentration of 50nM. Cell growth and viability were assessed at 
day 3 after transfection using GuavaViacount staining with a Guava Flow Cytometry. 
Standard deviations represent biological triplicates. A Student t-test was performed to 
analyse the statistical significance of the data. ***: p-value<0.001 
323 
 
6.8.8 Investigation of other proteins involved in cell growth arrest 
response and impairment of apoptosis initiation 
 
 
To better understand the mechanisms related to miR-7-dependent cell growth arrest, we 
investigated the change in expression of well studied proteins involved in cell 
proliferation, cell cycle and apoptosis including Igf1-R, c-Myc, p53, p27KIP1 and p-Akt. 
The levels of Igf1-R protein were not affected despite Igf1-R having previously been 
shown to be a target of miR-7 in other cell type (Jiang, et al. 2010),(Zhao, et al. 2012) 
(Figure 6.8.8). The levels of p27KIP1 were increased after miR-7 transfection. This is 
consistent with reduction of Skp2 which is known to stabilise p27 thus impairing G1 to 
S transition. The proto-oncogene c-Myc was reduced significantly. Skp2 has been 
reported to interact directly with c-Myc promoting its degradation by ubiquitination thus 
regulating its turnover at the G1/S transition phase (von der Lehr, et al. 2003). 
Interestingly, p53, a key molecule in cell cycle and apoptosis regulation as well as other 
processes, was significantly down-regulated. Psme3 is known to promote Mdm2-p53 
interaction which triggers ubiquitination and degradation of p53 consequently leading to 
apoptosis inhibition (Zhang and Zhang 2008). One might expect that the down-
regulation of Psme3 would result in an increase in p53 levels. The levels of p-Akt, also 
known to rescue cells from apoptosis, were slightly increased after miR-7 transfection 
possibly explaining why miR-7 transfected cells do not become apoptotic despite 
growth arrest. Taken together, these results indicate that as well as Psme3 and Skp2, 
miR-7 also targets, either directly or indirectly, critical proteins including p27KIP1, c-
Myc, p53 and p-Akt in order to control cell fate. 
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Figure 6.8.8: Investigation of the expression levels of other potential miR-7 targets.  
Levels of IGF1-R, p27, c-Myc, p53 and p-AKT were analysed using western blotting. 
GAPDH was used as a loading control. 
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6.8.9 Identification of miR-7 responsive miRNAs  
 
miRNAs have an established role in modifying the levels of proteins as well as mRNAs 
in cells. Having identified a number of important genes deregulated in response to miR-
7 as well as proteins, we were interested to discover whether increasing miR-7 levels 
impacted on the cellular levels of other miRNAs. To this end, we identified 
differentially expressed miRNAs as a consequence of miR-7 transfection using TaqMan 
Low Density Array (TLDA). Unfortunately two of the six TLDA cards displayed poor 
QC upon analysis (<50miRNAs detected) making the data somewhat inconclusive. 
However, there was some indication that several well-studied miRNAs previously 
implicated in cell proliferation and apoptosis were differentially regulated, including 
miR-15b~16 cluster, miR-17~92 cluster, miR-21, miR-24 and let-7 family (Figure 
6.8.9.A). Thus these miRNAs may be involved in miR-7 network to regulate cell 
growth arrest and apoptosis avoidance in CHO cells.These results highlight the fact that 
miRNAs not only impact on mRNA targets but can instigate a coordinated response via 
the recruitment of other miRNAs in order to regulate cellular pathways via very 
complex interactions. A hypothetical and simplified miR-7 network was designed using 
the data we obtained from this study and the literature (Figure 6.8.9.B). 
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Figure 6.8.9.A: Identification of differentially regulated miRNAs following miR-7 
transfection.  
TaqMan Low Density Assay was performed in three biological triplicates following 
treatment with pm-neg or pm-7. A list of down- and up-regulated miRNAs was 
generated. Blue: let-family; red: miR-17~92 cluster; purple: miR-15a~16 cluster; green: 
other miRNAs reported to be associated with cell proliferation in the literature and 
found to be differentially regulated in different studies conducted in our laboratory. 
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Figure 6.8.9.B: Hypothetical model of miR-7 network in CHO cells.  
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DISCUSSION 
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7 Discussion 
 
In the past three decades, a great deal of effort has been put into answering the 
increasing demand for biopharmaceutical products. Improvements in medium 
formulation, vector design and process control have been responsible for major 
increases in product titer (Butler 2005, Wurm 2004, Kim, Kim and Lee 2012). 
However, to meet the needs of an increasing number of patients with chronic diseases 
(Kim, Kim and Lee 2012), other strategies will be necessary to further enhance the 
production of drugs for these indications. New approaches have focused particularly on 
the improvement of Chinese Hamster Ovary (CHO) cell growth and productivity 
capacities. For their ease of genetic manipulation, safety reasons and, most importantly, 
for their ability to synthesize and secrete glycoproteins with similar carbohydrate 
structures to those found in human, CHO cells are the most commonly used host in the 
production of complex recombinant proteins. Recently, single gene engineering 
approaches have proven to be an efficient method of enhancing individual cellular 
functions including cell proliferation, secretion capacities, specific productivity and to 
inhibit apoptosis (Hacker, De Jesus and Wurm 2009, Wu 2009). However, several 
studies have reported that targeting one single gene in one specific pathway does not 
necessarily benefit other pathways (Kim, et al. 2009, Lee and Lee 2003) or can result in 
negative side-effects (Davis, et al. 2000, Mohan, et al. 2008, Borth, et al. 2005).  
Therefore omics-based approaches (transcriptomics, proteomics and metabolomics) 
have been developed. The aim of these approaches compared to single-gene engineering 
is to understand how genetic manipulation can globally affect an entire pathway at the 
levels of DNA, RNA and protein. Currently, there is a particular interest in miRNAs 
and manipulation of their expression to achieve this objective. These small non-coding 
RNAs are attractive as tools as they display some unique characteristics: 1) they are 
capable of targeting hundreds of genes; 2) they are involved in the regulation of many 
cellular pathways including cell proliferation, apoptosis, cell metabolism, development 
and differentiation; 3) they are highly conserved between species and 4) they are not 
processed by the translational machinery (Bartel 2004). These characteristics have 
persuaded several research groups in the CHO area, including ours that miRNAs might 
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prove to be beneficial tools in the search for more efficient engineering targets. With 
this ambition in mind this project focused on characterising the function of several of 
these molecules in relation to their impact on CHO cell growth and recombinant protein 
production. 
 
7.1 Functional validation of miRNAs as potential candidates to improve 
bioprocess-relevant CHO characteristics 
 
7.1.1 Screening of miRNAs in fast growing cells 
 
A miRNA profiling study had been performed in our laboratory to identify differentially 
expressed miRNAs in temperature-shifted culture (from 37°C to 31°C) (Gammell, et al. 
2007). The aim of this study was to investigate the changes in miRNA expression 
associated with temperature reduction and the concurrent cell growth decrease. Several 
miRNAs with significant fold-changes in expression were selected including miR-490, 
miR-34a/c, miR-30e-5p, miR-10a, miR-29a and let-7e. The potential of these miRNAs 
in improving the phenotypes mentioned above was studied in functional assays using 
mimic and inhibitor molecules in several CHO cell lines cultured in serum-free 
medium. Despite the lack of publicly available Chinese Hamster genomic sequences at 
the time of the study, these molecules were deemed suitable for screening in CHO cells 
as they target the mature form of the miRNA which tends to be well conserved between 
species including human, rat and mouse (Bartel 2004). In the intervening period, the 
sequence homology of miRNAs has been confirmed to be well conserved in CHO cells 
(Hammond, et al. 2012, Johnson, et al. 2011). 
 
7.1.1.1 miR-490 
 
Based on Ct values after qRT-PCR, endogenous levels of miR-490 were low in CHO 
cells and increased at the middle of the logarithmic phase at 37˚C.  We anticipated that 
miR-490 overexpression using mimics might improve cell growth. However, transient 
up-regulation of miR-490 had the opposite effect, reducing proliferation by 1.28-fold. 
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One recent paper reported high levels of miR-490 in human uterine Leiomyoma, a 
female genital tract neoplasm, using high-throughput sequencing (Georgieva, et al. 
2012). This endorses the data from our profiling study which showed up-regulation of 
miR-490 levels at the exponential growth phase. Along with this report, there was no 
experimental validation using other approaches. In addition, the role of miR-490 has not 
been extensively described in the literature and the inconsistency of the phenotypes 
observed across repeats in our functional validation did not give additional information 
on the impact of miR-490 on cell proliferation. This suggests that in our profiling study, 
higher levels of miR-490 were probably a consequence of the enhanced cell growth 
rather than the cause. 
Transient transfection of miR-490 increased viability by 9.39% at early and later stages 
of culture as well as normalised productivity by 1.5-fold in CHO-K1 SEAP cells. As for 
the impact on cell proliferation, these effects were not observed consistently in the 
different transfection assays performed. Baek and co-workers demonstrated that the 
impact of miRNA on protein levels is usually less than twofold (Baek, et al. 2008). It 
has been suggested that this small change can also originate from random fluctuations in 
mRNA or protein level (Ebert and Sharp 2012). The subtle phenotypic impact can also 
be caused by off-target effects. Khan et al reported that the transfection of 
siRNA/miRNA perturbs the transcriptome by inducing the expression of genes that are 
normally repressed by endogenous miRNAs (Khan, et al. 2009). This may be caused by 
the excess of exogenous miRNA which competes with the endogenous miRNA to be 
loaded into the RISC complex or downstream of it for binding to the same target and 
leads to unexpected phenotype consequent to loss-of-function of the endogenous 
miRNA.  
In the aim to find promising targets, we sought for more convincing and reproducible 
impact. 
  
7.1.1.2 miR-34a and miR-34c 
 
miR-34a and miR-34c were found to be down-regulated upon temperature-shift from 
37°C to 31°C and to be associated with reduction in proliferation. However, the miR-34 
family has been reported as a tumor suppressor family which blocks proliferation and 
induces apoptosis following oxidative stress and DNA damage (He, et al. 2007b, He, et 
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al. 2007c, Yamakuchi and Lowenstein 2009, Yamakuchi, Ferlito and Lowenstein 2008). 
Therefore, despite the profiling results, we followed the reported findings and 
considered the depletion of these miR-34 family members to increase cell growth and 
prevent apoptosis. Despite the established role of miR-34 family in cell proliferation 
and DNA damage, knockdown of miR-34a/c did not affect significantly cell 
proliferation or cell viability in CHO cells. The Ct values from the array data indicated 
that miR-34a and miR-34c were expressed at low and moderate levels respectively in 
CHO cells. Due to the low levels of miR-34a, further inhibition of its expression might 
not result in further impact. The moderate levels of miR-34c expression made it a more 
suitable target for inhibition but, following am-34c transfection, there was no effect on 
proliferation or viability. However, total yield was slightly increased upon am-34a and 
am-34c transfection and normalised productivity was significantly improved upon am-
34a treatment. Thus miR-34a/c knockdown may be more impactful on total yield and 
productivity than cell proliferation or viability in CHO cells. Cheng and co-workers 
reported that the functional role of miRNAs is dependent of cell line, tissue and 
environmental conditions thus it is not surprising that miR-34a/c display distinct 
functions in CHO cells and in mouse embryonic fibroblasts or human cancer cells 
(Cheng, et al. 2005). To add more confidence to our data, this assay was repeated twice 
but showed variability and led to inconclusive results. As discussed for mimic 
molecules, the difference in the phenotype observed following transfection repeats may 
be due to off-target effects or compensation of the subtle change in mRNA target 
expression. The inhibitor molecules showed a transient impact therefore in contrast to 
dominant negative tools, their impact can be more easily compensate by other miRNAs 
sharing the same target so little impact might be seen (Ebert and Sharp 2012). On the 
other hand, inhibitors can also compete with endogenous miRNAs reducing the 
repression of their mRNA targets but instead repressing non-specific targets (Khan, et 
al. 2009). Vankoningsloo and co-workers showed that the non-psecific silencing of gene 
trancripts can be dependent of the cell line, the siRNA sequence, the duration of the 
transfection, transfection reagent and the time of the analysis following transfection. It 
has also been shown that the issue may not come from the synthetic molecules but from 
the mRNA target site accessibility (Cullen 2006). In vivo, the RISC complex can not 
access mRNA target sites if the RNA displays secondary structure or if there is protein 
binding thus the antisense miRNA may not be effective for this reason (Overhoff, et al. 
2005, Brown, Chu and Rana 2005). 
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Although the functional validation of miR-34a/c was not pursued, we believe that the 
impact of these two miRNAs would be interesting to follow up. 
 
7.1.1.3 miR-30e-5p 
 
In a recent report, we showed that miR-30e expression was activated upon temperature-
shift from 37˚C to 31˚C (Barron, et al. 2011). Under these conditions, it has been 
demonstrated that cell growth is arrested and the cellular machinery is directed towards 
protein production (Kaufmann, et al. 1999). Therefore we investigated whether miR-
30e-5p was an effector of arrest in response to temperature-shift. It has been shown that 
miR-30e-5p suppresses cell growth in cancer (Wu 2009). In agreement with this paper, 
transient overexpression of miR-30e-5p induced cell growth decrease in CHO-K1 
SEAP cells. However, it increased the growth in CHO1.14 cells. It has been 
demonstrated that one miRNA can have antagonising effects of the same biological 
function in two different cell lines (Cheng, et al. 2005). Thus it is possible that the 
impact of miR-30e-5p is CHO cell line dependent. To verify this statement, transient 
transfection of pm-30e-5p was carried out several times but resulted in contradictory 
results. Thus we could not affirm that the changes in expression of miR-30e observed at 
low temperature were merely a consequence of the shift in temperature and were not a 
mediator of the associated cell growth reduction.  
Li and colleagues reported that miR-30 family members can inhibit apoptosis by 
suppressing p53 expression (Li, et al. 2010). However, we found that the viability of 
CHO1.14 was reduced by 20.4% at later stages of culture and to a lesser extent in CHO-
K1 SEAP. Nonetheless, this phenotype was not reproducible. Thus a role for miR-30e-
5p in apoptosis regulation was not apparent.   
Besides its role in cell proliferation and apoptosis, miR-30-family might be involved in 
secretion regulation in CHO cells. Joglekar and co-workers showed that low levels of 
miR-30 were associated with the loss of insulin during epithelial-mesenchymal 
transition (Joglekar, et al. 2009). Tang et al., reported that miR-30d was up-regulated by 
glucose and increased insulin gene expression in pancreatic β-cell line MIN6 (Tang, et 
al. 2009). In CHO cells, we found that transient overexpression of miR-30e-5p 
enhanced total yield by 1.37-fold in CHO-K1 SEAP but no detectable improvement was 
observed in CHO1.14 cells or in normalised productivity in any of the two cell lines. 
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Also, this advantage in total yield was not clear in other repeats. Thus they were not 
enough valid indication to conclude on a role of miR-30e-5p in protein secretion. 
Double-stranded mimic molecules have to be processed into a mature single-strand 
through the RNAi machinery. It is possible that, during a transient transfection, the 
excess of mimic molecules may block endogenous miRNAs from being processed and 
lead to deregulation of their targets, which in turn may impact other phenotypes 
unintentionally (Khan, et al. 2009, Jackson, et al. 2006). Besides saturation of the RISC 
complex or downstream processing, the excess of exogenous miRNAs could trigger 
saturation of the P-bodies and/or stress granules by endogenous miRNA. Endogenous 
miRNAs, mRNAs and other molecules of the RNAi machinery are found in the P-
bodies or they may be also retained in the stress granules like AGO proteins in stress 
situations. Therefore this could accelerate endogenous miRNA degradation leading to 
attenuation of their function. 
Due to the erratic results from these assays, we discontinued the investigation of miR-
30e-5p. Approaches other than use of synthetic mimics/inhibitors might give additional 
information on the precise function of miR-30e-5p.  
 
7.1.1.4 miR-29a 
 
One of the members of miR-29 family, miR-29a was found to be down-regulated upon 
temperature shift in our previous miRNA profiling. In the literature, miR-29 family is 
often described as a tumor suppressor family (Muniyappa MK, et al. , Zhao, et al. 
2010). Due to its anti-proliferative role, we thought to deplete miR-29a to consequently 
improve cell proliferation. Surprisingly, knockdown of miR-29a did not impact on 
either CHO-K1 SEAP or CHO1.14 cell growth thus suggesting that low levels of miR-
29a were not directly associated with cell growth reduction but were probably just a 
consequence of the shift of temperature.  
Cell viability was enhanced by 9.91% in CHO-K1 SEAP but not in CHO1.14. Desjobert 
and co-workers reported that inhibition of miR-29a impaired apoptosis induction 
through ovexpression of the anti-apoptotic protein myeloid cell leukemia 1 (MCL-1) 
(Desjobert, et al. 2011). This may imply that the inhibition of miR-29a in CHO-K1 
SEAP may promote viability maintenance and also that the possible anti-apoptotic role 
of miR-29a may be cell line dependent.  
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In addition to its impact on cell viability, miR-29a knockdown enhanced SEAP total 
yield by 1.2- to 1.4-fold and normalised productivity by 4.93-fold. However, it did not 
increase the production of IgG1 in CHO1.14. High levels of miR-29a have been found 
to be associated with insulin resistance in diabetic rats (He, et al. 2007a) and its 
depletion promoted higher glucose-stimulated insulin-secretion in pancreatic β-cells 
(Bagge, et al. 2012). To confirm the increase of SEAP secretion observed upon am-29a 
transfection, this assay was performed again but resulted in variable impact. 
The data from these assays were again confusing and did not lead to a convincing 
impact thus the impact of miR-29a on CHO cell characteristics was not further 
investigated. The contrasting results may have been caused by the efficiency of the 
antisense oligonucleotides. These molecules work differently from the mimics. They are 
single-stranded molecules that are thought to bind competitively to the mature miRNA 
after it was selected as the guide strand to assemble into the RISC complex (Davis, et al. 
2006). To ensure an efficient knockdown, the dose of antisense oligonucleotides should 
be dependent on the levels of the targeted miRNA. If a miRNA is highly expressed in 
the cells then a higher dose of antimiRs may be necessary. If the miRNA is expressed at 
moderate levels its knockdown would require less antisense molecules. In the case of a 
low expressed miRNA it could be challenging to down-regulate its expression further. 
The data collected from the profiling study revealed that the endogenous levels of miR-
29a were in the average range so in theory the concentration of inhibitors used (50nM) 
should have been sufficient to ensure significant knockdown. It has also been reported 
that many cells both in vitro and in vivo are resistant to the uptake of oligonucleotides 
(Ebert and Sharp 2010). However, the CHO cell lines used in this assay as well as the 
transfection protocol proved to be efficient for miR-7 mimics in a recent study 
conducted in our laboratory (Barron, et al. 2011). It is possible that despite their 
chemical modifications, these single-stranded inhibitors are susceptible to degradation, 
though this has not been reported previously. It is more likely than these molecules can 
be diluted and lost after few cell divisions leading to poor efficiency of inhibition and 
small phenotype. As discussed previously, the accumulation of the molecules in the 
cytoplasm of the cells could lead to competition with the endogenous miRNA for 
mRNA binding leading to unexpected phenotypes. 
Despite inconclusive results, miR-29a seems an interesting candidate to improve 
viability and productivity but further investigation would require other tools than 
synthetic antisense molecules. 
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7.1.1.5 miR-10a  
 
Upon low-temperature culture, levels of expression of miR-10a were reduced compared 
to culture at 37°C. miR-10a is involved in cell proliferation, apoptosis and in various 
tumor pathologies (Ma, et al. 2010, Ovcharenko, et al. 2007, Sirotkin, et al. 2010). It is 
has been reported that miR-10a can have antagonising roles for a same biological 
function (i.e. pro- or anti-proliferative) depending on the cell types (Cheng, et al. 2005). 
To see whether we could reproduce the impact observed in temperature-shifted culture, 
we considered the inhibition of miR-10a. We found that transient knockdown of miR-
10a led to higher cell density (1.8-fold) as well as enhanced viability four days after 
transfection in CHO-K1 SEAP cells but little impact was detected on CHO1.14 growth. 
The reproducibility of these results was not convincing despite every effort to perform 
the assays in a routine, standard manner. However, a recent global expression profiling 
study using different technologies including qPCR, microarray and quantitative LC-
MS/MS was carried out in our laboratory on a set of Mab producing clones with varying 
growth rates (Clarke, et al. 2012). In this study, miR-10a was both up-regulated by 2.12-
fold and positively correlated with cellular growth rate. This finding is consistent with 
the reduced expression of miR-10a detected following shift of temperature culture. As 
previously discussed, we were unsure about the efficiency of the inhibitor molecules 
and their reproducible impact. Thus other approaches using shRNA or a sponge in a 
transient assay might be more suitable to reveal the impact of miR-10a. The use of 
shRNA may not guarantee the loss of off-target effects including saturation of the RNAi 
machinery (unprocessed shRNA or accumulation of shRNA) and the effective 
inhibition of the miRNA (Grimm, et al. 2006, McBride, et al. 2008). To be effective, the 
shRNA design must be optimised depending of the cell lines, the endogenous levels of 
miRNA and the application of transfection for in vivo or in vitro studies (Cullen 2006). 
Interestingly miR-10a has been reported to enhance ribosomal protein translation via 
binding to the 5’ UTR of their mRNAs and so via this regulation, miR-10a may impact 
on global protein synthesis (Orom, Nielsen and Lund 2008). Depletion of miR-10a 
increased total yield by 1.2- to 2-fold in both CHO1.14 and CHO-K1 SEAP cells as 
well as normalised productivity though it was not statistically significant.  
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Again repeats were not convincing enough to pursue the further validation of this 
miRNA. However, there was an impact on proliferation and productivity that was not 
negligible even if the directions were contrasting between the repeats and the 
approaches. Instead of synthetic molecules, other strategies may verify if miR10a is 
worth further investigation. 
 
7.1.1.6 let-7e  
 
let-7 (lethal-7) was one of the first miRNAs discovered in the nematode C.elegans. Let-
7 is conserved across species (Lee and Ambros 2001, Lagos-Quintana, et al. 2001, 
Pasquinelli, et al. 2000) and has an essential role in the development of C.elegans and 
other organisms (Thomson, et al. 2006, Sempere, et al. 2002, Reinhart, et al. 2000, Liu, 
et al. 2007). Let-7 family acts as a tumor suppressor family in many cancers (Roush and 
Slack 2008). We found that let-7e was expressed at low levels in CHO cells and its 
expression increased upon temperature-shift. Therefore to verify whether the tumor 
suppressor role of let-7e was conserved in CHO cells, we forced its expression using 
mimic molecules. Following transient up-regulation of let-7e cell density was 
dramatically reduced by 3- to 4-fold in CHO-K1 SEAP and CHO1.14 cells and 
CHO2B6 cells were growth arrested for five days. Thus the anti-proliferative role of let-
7e was conserved in CHO cells and across cell lines though the impact was to different 
extents. 
The cell viability in the three CHO cell lines was significantly decreased. In opposition 
to this finding, transfection of pm-let-7e has been shown to reduce the levels of 
expression of Caspase-3 protein as well as cellular apoptosis in PC12 cells upon 
anoxia/reoxygenation injury (Peng, et al. 2011). These contrasting results can be 
explained by the different conditions of transfection used which in this report was 
carried out in cells exposed to anoxia (depletion of oxygen) whereas in our study the 
viability of cells was assessed under normal conditions of culture. Thus let-7e may be a 
critical regulator of cell growth and viability in CHO cells and it may be a promising 
tool to improve these two phenotypes following its stable knockdown. 
To explore the potential of let-7e in impacting on total yield and productivity, we 
investigated the levels of SEAP and IgG1 expression in pm-let-7e transfected-CHO 
cells. Overexpression of let-7e resulted in reduced total yield in the three cell lines. This 
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is due to the anti-proliferative effect of let-7e which resulted in very few cells remaining 
in culture thus less protein produced than the controls. Normalised productivity was 
improved by 4- to 14.47-fold in CHO1.14 and CHO2B6 cells but it was negatively 
impacted in CHO-K1-SEAP at later stages of culture. This result is surprising as we 
expected the same behaviour from the three cell lines. They all exhibited lower cell 
density, viability as well as total yield thus we expected an increased normalised 
productivity in the three cell lines. 
It is worth noting that Dicer, the endonuclease requires for processing of precursor 
miRNA into mature miRNA form, is a direct target of miR-let-7a, c&d. The up-
regulation of miR-let-7 has been shown to reduce the levels of Dicer leading to 
knockdown of many miRNAs (Tokumaru, et al. 2008). Thus targeting any member of 
the miR-let-7 family in CHO cells may be an advantage to control several cellular 
pathways simultaneously. However, it could also be a problem if it impacts negatively 
on other pathways. Its overexpression might be used to enhance total yield when using 
an inducible system in a biphasic culture. However, the negative impact of up-regulated 
let-7e would have to be prevented by the use of an anti-apoptotic miRNA. 
 
7.1.2 Screening in fast versus slow cell lines 
 
The miRNAs derived from the temperature-shift profiling study yielded very mixed 
results in terms of impacting CHO behaviour in our functional assays. In a separate but 
related study which focused on cell proliferation, we had identified another group of 
miRNAs whose expression was correlated or anti-correlated with specific growth rate. 
This particular experiment was designed to minimize confounding parameters in order 
to maximize the possibility of filtering out non-growth related miRNAs. The clones in 
the study were all derived from the same transfection (in this case a cell line 
development project in our collaborators laboratories from Pfizer) of an antibody-
encoding plasmid. Subsequently the clones chosen had distinct growth rates (Slow< 
0.02hr-1 or Fast>0.025hr-1) but identical specific productivity (Qp). A group of 
differentially expressed miRNAs were chosen from the list generated after experimental 
profiling (Clarke, et al. 2012).  
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7.1.2.1 miR-23b*  
 
Recent studies have revealed that in contradiction with what was initially thought, 
miRNA* (also known as passenger strand) do not always undergo degradation but can 
be functional and expressed in an abundant manner in cells (Okamura, et al. 2008, Guo 
and Lu 2010). The selection between miRNA and miRNA* strand to incorporate into 
the RISC complex, may be tissue and developmental stage dependent (Ro, et al. 2007, 
Chiang, et al. 2010, Ruby, Jan and Bartel 2007). From the data generated in the miRNA 
profiling study described above, we found that miR-23b* was relatively abundant in fast 
growing cells and not present in slow growing cells. To our knowledge, there have been 
no reports to date focusing on the functions of miR-23b*. In contrast cancer research 
has been focused on the other strand of the hairpin miR-23b, which is more commonly 
selected by the RNAi machinery to be loaded into the RISC complex. Inhibition of 
miR-23a/b by c-Myc has been proven to enhance mitochondria glutaminase expression 
and glutamine metabolism (Gao, et al. 2009). miR-23b has also been associated with 
cell growth, apoptosis, cell migration and invasion in human colon cancer ((Zhang, et 
al. 2011). The linked between Myc and miR-23b has been highlighted in the altered 
glucose metabolism of cancer cells, which is known as the Warburg effect (or aerobic 
glycolysis). In this condition, cancer cells can take up excessive amounts of glucose and 
convert it to lactate even in the presence of oxygen (Vander Heiden, Cantley and 
Thompson 2009). Interestingly, Dang and co-workers reported that Myc stimulates 
glycolysis, glutamine oxidation and mitochondria biogenesis (Dang 2012, Dang 2010). 
Using a human B-cell lymphoma model carrying an inducible c-Myc, cells consume 
glucose and glutamine in presence of oxygen. In deprivation of oxygen (known as 
hypoxia), c-Myc cooperates with HIF-1 (Hypoxia-Inducible Factor-1) to promote the 
conversion of glucose to lactate. Thus this gives great sources of energy to cancerous 
cells by providing ATP and NADPH to promote their proliferation in the hypoxic as 
well as the more oxygenated regions of the tumor environment. As c-Myc is involved in 
the Warburg effect and it increases the expression of mitochondria glutaminase by 
repression of miR23a/b in transformed cells, we thought that as well as miR-23b, miR-
23b* would be an interesting target to investigate in CHO cells with a view to altering 
their metabolism. In fact, the production of recombinant protein is an energy-intensive 
process so an increase of metabolism should help to produce more building blocks to 
increase proliferation and product secretion.  
340 
 
Although miR-23b* and miR-23b derived from the same hairpin sequence, miR-23b 
was not differentially regulated in our profiling despite the large range of growth rates 
across clones and its reported role in proliferation. In addition, in the temperature-shift 
profiling study the expression of miR-23b was detected at low levels based on Ct-values 
and did not vary after the shift of temperature to 31°C. First, this suggests that miR-23b 
may not be involved in the regulation of CHO cell growth as it is the case in cancer 
cells. Secondly, the levels of miR-23b* were high in the fast growing cells indicating 
that in CHO cells miR-23b* is more abundant than miR-23b and is more likely to be 
involved in cell proliferation. In support of this statement, Okumar and co-workers 
demonstrated that from cloning data in drosophila S2 cells some miRNA* species were 
more abundant than the miRNA species including miR-276a*, bantam*, miR-34*, miR-
2a-2* miR-282*, miR-996* and miR-306* (Okamura, et al. 2008). In addition, they 
validated this accumulation by northern blot to prove that the levels of expression of 
these miRNA* species were indicative of miRNAs with proper biological function.  
To validate the correlation between high levels of miR-23b* and fast proliferating cells, 
we forced the expression of miR-23b* using mimic molecules in CHO-K1 SEAP, a fast 
growing CHO cell line. Transient overexpression of miR-23b* resulted in a significant 
reduction in cell density over two days as well as viability. A 44% improvement of cell 
viability was detected at later stages of culture likely due to the reduction of cell number 
at earlier time points. We observed across the different transfection assays of this 
screening study that the impact of the transient molecules was often abated by day 7. 
Thus in this case, cells could recover by day 7 due to the loss of pm-23b* molecules 
explaining the higher cell density and viability compared to the non-specific treated 
cells. The expected phenotype consequent to transient overexpression was the 
improvement of cell growth. However, the opposite effect was observed suggesting that 
the fast proliferation rate increased the levels of miR-23b* and not the other way 
around. Although these results were statistically significant and a repeated experiment 
showed the same profiles, only one CHO cell lines was tested. Repeats in different cell 
lines would confirm if the overexpression of miR-23b* triggers cell growth reduction 
and if the validation of miR-23* deserves further investigation. 
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7.1.2.2 miR-216b  
 
miR-216b was found to be down-regulated in fast growing cells. In agreement with this 
finding, miR-216 has been shown to be inversely correlated with Insulin-Growth Factor 
(IGF) activation in hepatocellular carcinoma (Tovar, et al. 2010). IGF signalling is a key 
regulator of cell proliferation and survival and its deregulation is often described in 
malignancies (Harris and Westwood 2012, Pollak 2008). To improve CHO 
proliferation, we used inhibitors of miR-216b which slightly enhanced cell density three 
and five days after transfection and provoked a 1.45-fold increase at day 7. These results 
are consistent with the profiling data and the reported role of miR-216 in the literature. 
In addition, cell viability was improved at later stages of culture by 16.57%. Peruzzi and 
co-workers showed that the activation of IGF receptor by its ligands protects different 
cell types from apoptosis (Peruzzi, et al. 1999). As miR-216 has been shown to anti-
correlate with IGF activation and its expression levels are down in fast growing CHO 
cells, its knockdown may suppress apoptosis through IGF activation.  
 
7.1.2.3 miR-409-5p  
 
In the miRNA profiling, expression levels of miR-409-5p were generally high in the 
cell lines and were reduced in fast growing cells. Little is known about the role of miR-
409. Recently, miR-409-3p, but not miR-409-5p, has been reported to suppress gastric 
cancer invasion and metastasis (Zheng, et al. 2012). However, miR-409-3p was not 
detected as a differentially regulated miRNA in our profiling. As discussed earlier, 
mature miRNA (in this case miR-409-3p) and miRNA* (miR-409-5p) have been shown 
to have different fates. Generally mature miRNA are more abundant in the cells than 
miRNA* species due to their presumably rapid turnover. However, though it is more 
rare, miRNA* can be also functional and accumulate at the same levels or even be, in 
rare cases, more abundant than the major miRNA species particularly when their seed 
sequences are well-conserved across species (Okamura, et al. 2008, Guo and Lu 2010). 
It is possible that miR-409-3p is more abundant in human cells and miR-409-5p is the 
dominant selected strand in CHO cells. Thus miR-409-5-p may be functional in CHO 
cells and involved in the regulation of cell proliferation whereas miR-409-3p might be 
considered as the passenger strand and so be degraded rapidly. The transient 
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knockdown of this miRNA showed no impact on either CHO cell growth or 
productivity. Thus it is likely that the variation of miR-409-5p levels in fast and slow 
growing cells was a consequence of the cell growth rate changes and not the opposite.  
 
7.1.2.4 miR-874  
 
miR-874 has been described as a tumor suppressor in maxillary sinus squamous cell 
carcinoma (Nohata, et al. 2011). This is in the same direction as our data which 
indicated low levels of miR-874 in fast growing cells. However, in the functional assay 
knockdown of miR-874 reduced cell proliferation to a small extent at day 3 and 
significantly five days after transfection. Cells recovered by day 7 likely due to the loss 
of am-874 at this stage. These contrasting outcomes suggest that miR-874 would 
influence positively cell proliferation after its induction. This could be verified in other 
transfection assays with different cell lines. 
Following miR-874 knockdown, cell viability was improved by 12.32 % at later stages 
of culture. miR-874 has been found to be a temperature-sensitive miRNA in human 
hypothermia conditions (Truettner, et al. 2011). It was highly expressed at 37°C after 
traumatic brain injury in rats and its levels of expression decreased after hypothermia 
treatment at 33°C, leading to protection of these injured and vulnerable cells against 
negative signals. Thus by analogy, miR-874 may be involved in the homeostasis of 
CHO cells and may protect them against perturbation fluctuations thus leading to an 
increase of viability as observed in the functional validation. The transfection of am-874 
did not impact significantly on total yield and normalised productivity.  
 
Summary of miRNA screening data 
In summary, our results from screening individual miRNAs were mixed and somewhat 
disappointing. The most striking observation was that in many cases the impact was the 
opposite to what would be expected based on either our own expression profiling 
experiments or from studies performed by others in other systems. It is difficult to 
identify the reasons for this. It may be that CHO, as a cell line or group of cell lines, is 
already well adapted to growth in vitro after many years of culture under these 
conditions. Mayr and Bartel reported an existing alternative cleavage and 
polyadenylation (APA) mechanism in cancer cell lines, which results in the expression 
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of multiple proto-oncogene isoforms which exhibit shorter 3’UTRs (Mayr and Bartel 
2009). The shorter mRNAs were more stable than the homolog mRNAs in the non-
transformed cells leading to the production of ten-fold more proteins, though the two 
cell lines had similar proliferation rates. This difference proved to be in part due to the 
loss of miRNA-mediated repression which generally occurs at the 3’UTRs of the 
mRNA targets thus conferring an advantage to the transformed cells through repression 
attenuation of oncogenes. Another study identified shorter 3’UTRs in activated T cells 
compared to resting T cells, and found that in general shorter 3’UTRs were associated 
with cell proliferation (Sandberg, et al. 2008). Previous reports showed that shorter 
3’UTR can also be caused by genomic deletions or substitutions at the 3’UTR site 
(Wiestner, et al. 2007). Therefore it is possible that similar mechanisms occur in CHO 
cells which are also transformed cells and undergo mutations to prevent for instance 
apoptosis through the aberrant expression of p53 (Hu, et al. 1999, Lee, Larner and 
Hamlin 1997). 
Alternatively, it may be the nature of the role that miRNAs, or many of them at least, 
play in the cell, ie to counteract genetic fluctuations across entire pathways using 
feedback loops and posttranscriptional repression (Ebert and Sharp 2012). To buffer 
these variations, miRNAs may work in unison with other miRNAs in a complex 
network so perturbing one maybe futile if compensation by other family members can 
occur.  
The timing of expression could also be critical during the phase of culture or during the 
phase of the cell cycle. Vaseduvan and co-workers have shown that depending on the 
cell cycle phase, miRNAs can induce translational up-regulation of target mRNAs in 
non-proliferating cells and on the other hand miRNA promoted posttranscriptional 
repression in proliferating cells (Vasudevan, Tong and Steitz 2007a). 
Transient transfection may not be the most suitable approach in a rapidly proliferating 
cell line like CHO. For instance, it is uneasy to measure apoptosis which occurs later in 
culture if mina levels are being diluted out. The transient transfection of mimics causes 
huge increase beyond what would be normal physiologically with unpredictable 
consequences so we were unsure if the phenotypes observed were due in part to off-
target effects. 
With these observations in mind we decided to pursue some alternative approaches – 
multiple knockdown of miRNAs from a cluster, ‘miRNA sponge’ to attenuate the 
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expression of an entire miRNA family and inducible systems for miRNA 
overexpression.  
 
7.2 Investigation of the individual miR-23a~miR-27a~24-2 cluster 
member potential in improving CHO cell characteristics 
 
7.2.1 Screening of miR-24 
 
The microarray profiling study carried out following temperature-shifted culture 
indicated that high levels of miR-24 were associated with cell growth inhibition 
(Gammell, et al. 2007). The role of miR-24 in cell growth, cell cycle and DNA repair 
has been well described (Lal, et al. 2009a, Lal, et al. 2008, Lin, et al. 2010, Liu, et al. 
2010, Mishra, et al. 2007). However, miR-24 has also been reported to be differentially 
regulated in different cell lines and in different conditions (Cheng, et al. 2005). This 
peculiarity applies to many miRNAs which have a unique expression level depending 
on the cell or tissue type as well as environmental conditions (Bartel 2004). 
With the intention to validate the anti-proliferative impact of miR-24 in CHO cells, we 
transiently overexpressed miR-24 using mimic molecules at moderate (50nM) and high 
concentrations (100nM). As anticipated with the data from the profiling study, the anti-
proliferative role of miR-24 was reproducible and consistent in different CHO cells 
lines, though the extent was dependent of the cell-line and on the exogenous miRNA 
concentration. At high concentrations, mimics of miR-24 led to a 1.68-fold decrease of 
CHO1.14 cell growth four days after transfection and arrested cell growth for five days 
in CHO2B6 cells. At lower concentrations, transient overeexpression of miR-24 
induced a 1.27-fold growth reduction in CHO-K1 SEAP cells. We confirmed up-
regulation of miR-24 levels using qRT-PCR to verify that cell growth reduction was 
caused directly by high levels of miR-24. 
To support these results, we aimed to promote cell growth through miR-24 inhibition 
using transient molecules. When using synthetic inhibitors of miR-24 at a high 
concentration, cell growth was improved by more than twofold in CHO1.14 cells but no 
impact was observed in CHO2B6 cells. At lower concentration, CHO-K1 SEAP growth 
was also increased by 1.27-fold. Surprisingly, the investigation of the expression levels 
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of miR-24 revealed only a small reduction in CHO2B6 whereas there was no noticeable 
phenotypic impact in these cells. On the other hand, it showed a small increase of miR-
24 levels in CHO1.14, though there was distinct increase in cell density in CHO1.14 
cells upon am-24 transfection. It is possible that antimiR molecules which are single-
stranded molecules may be dissociated from their target miRNA during RNA extraction 
process so the levels of miRNA would still be detectable. In addition, across the 
different transient assays performed in the different screening, it seems more difficult to 
observe a reproducible impact with the inhibitor molecules suggesting again that 
inhibitors might be less efficient than the mimics due to the nature of their binding. In 
fact, they compete with mRNA targets to bind to endogenous miR-24 which is 
expressed at high levels in CHO cells. 
The repeated attempts of pm-24 and am-24 transfection at different concentrations 
showed contrasting results. Based on Ct-values, miR-24 is expressed at high levels in 
CHO cells (Gammell 2007) so further overexpression might not be impactful. It is also 
possible that further exogenous addition of this miRNA merely results in saturation of 
the RNAi machinery and leads to off-target effects. Khan and co-workers proposed that 
siRNA transfection perturbs global gene regulation by endogenous miRNAs (Khan, et 
al. 2009). They postulated that exogenous molecules compete with endogenous 
miRNAs for miRISC complex, thus perturbing the levels of endogenous miRNAs and 
their many transcripts. In another study they showed that cells would have limited 
capacities to assemble the RISC complex for exogenous molecules (Jackson, et al. 
2006, Jackson and Linsley 2010). This could explain that the impact of mimic miR-24 
on CHO-K1 SEAP cells was not as striking as in CHO1.14 and CHO2B6 cells due to 
lower concentration of these transient molecules.  
On the other hand, if miR-24 is expressed at high levels then its knockdown may be 
achievable. Transient knockdown of miR-24 using moderate concentration of inhibitors 
promoted only a slight increase in cell growth and high concentration proved to be more 
efficient. However, there was no impact on CHO2B6 cells. The excess of exogenous 
inhibitor miRNAs which are single-stranded molecules and not processed by the RNAi 
machinery, could lead to accumulation in the cells and trigger unspecific targeting on 
mRNA transcripts thus little impact might be observed due to possible antagonizing 
signals from different transcripts. Another possibility, though never reported, is their 
rapid degradation or storage in P-bodies or stress granules caused by the excess of 
exogenous molecules present in the cells. 
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Having observed an impact on cell growth, we were interested to investigate the 
influence of miR-24 on SEAP total yield and normalised productivity. SEAP total yield 
was improved by 1.6-fold as well as normalised productivity though it was not 
statistically significant following miR-24 knockdown. The up-regulation of miR-24 
impacted negatively on total yield likely due to the lower cell number in culture.  
Thus these findings revealed positive indications that miR-24 was involved in cell 
proliferation but the issues with the mimic and inhibitor molecules posed some 
questions about their utility. The well established role of miR-24 in cell proliferation, 
cell cycle and its deregulation in many cancers convinced us to pursue the validation of 
miR-24. 
 
7.2.2 Investigation of the functional role of miR-24 in CHO cells 
 
Many reports have established a role for miR-24 in cell proliferation, cell cycle, 
apoptosis and DNA repair genes (Lal, et al. 2009a, Qin, et al. 2010, Mishra, et al. 2009, 
Lal, et al. 2009b, Lin, et al. 2010, Liu, et al. 2010, Mishra, et al. 2007). We showed that 
manipulation of mir-24 impacted on cell proliferation and cell viability though there 
was some inconsistency in the data. To ensure that the impact on cell proliferation and 
viability was specific to the up- or down-regulation of miR-24, we checked the levels of 
expression of validated mRNA targets upon pm-24 and am-24 transfection.  
Overexpression of miR-24 has been reported to trigger cell cycle arrest in G1 phase via 
targeting key nodes of the cell cycle like MYC and E2F2, and their downstream targets 
including CCNB1, CDC2, CDK4, p27KIP1 (Lal, et al. 2009a). Genes involved in other 
phases of the cell cycle were also down-regulated including FEN1, MCM4, MCM10, 
PCNA (S-phase) and AURKB (M-phase). A particularly interesting finding in this 
report was that miR-24 interaction with its mRNA targets did not involve canonical 
seed pairing binding. In addition, these targets were not predicted by seed recognition 
computational methods. However, miR-24 is a well conserved miRNA across species 
(Lal, et al. 2009a) so we considered validating the same targets using real-time PCR in 
CHO cells. PABPNI, a gene involved in polyA synthesis (Kuhn and Wahle 2004), was 
chosen as endogenous control for this study. It was identified as a non-varying gene in a 
microarray gene expression profiling study and validated by qPCR in CHO cells (Bahr, 
et al. 2009). This gene had a lower expression variability (CV=23.8%) than the usual 
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endogenous control used in qPCR including ACTINB (CV=27.13%), GAPDH 
(CV=44.97%) and B2M (β-2-microglobulin) (CV=38.23%). However, we observed that 
transient up-regulation or knockdown of miR-24 impacted significantly on the levels of 
expression of PABPNI therefore we used ACTINB instead as it showed lower 
variability between our samples. It is worth noting that the median %CV of the 
candidate housekeeping genes identified in the profiling was 23.8% (Bahr, et al. 2009). 
This value is quite high considering the application of these genes as endogenous 
controls for qPCR studies especially in the case of miRNA manipulation and the 
investigation of changes in the expression of their targets. Since miRNAs are able to 
target hundreds of genes, it has been demonstrated that they often cause moderate 
changes of gene expression (Krutzfeldt, et al. 2005, Lim, et al. 2005). If the endogenous 
control is also targeted by a miRNA, the difference in expression of its true targets may 
be hard to detect. Thus it may be quiet challenging to find an appropriate endogenous 
control in these conditions. To improve the accuracy of normalisation, it has been 
suggested to use the mean of several endogenous genes that have been selected prior to 
the experiment (Persson, Hamby and Ugozzoli 2005, Vandesompele, et al. 2002). 
To validate a role of miR-24 in cell proliferation and cell cycle in CHO cells, we 
focused on five of its established targets, MCM4, MYC, PCNA, CYCLIN A and FEN1.  
Transient knockdown of miR-24 led to increase of PCNA expression levels and slight 
down-regulation of FEN1. On the other hand, transient up-regulation of miR-24 induced 
knockdown of FEN1 and slight increase of PCNA. This was not statistically proven as 
only two biological samples were run in technical triplicates. PCNA is known to 
interact with FEN1 and to stimulate its activity in many FEN1 dependent DNA 
metabolic pathways including DNA replication (Li Zheng 2011). Disruption of the 
FEN1/PCNA interaction leads to DNA replication defects and newborn lethality in mice 
(Zheng, et al. 2007). PCNA stimulates DNA synthesis and is involved in DNA damage 
(Kannouche, Wing and Lehmann 2004, Haracska, et al. 2002). FEN1 is a member of the 
Rad2 structure-specific nuclease family and it processes the 5' ends of Okazaki 
fragments in lagging strand DNA synthesis and has an essential role in base excision 
repair (BER) (Lieber 1997, Liu, Kao and Bambara 2004). These two miRNAs seem to 
cooperate in the regulation of cellular function like DNA damage and replication thus 
the levels of expression of both genes PCNA and FEN1 might be linked together and 
fluctuate upon changes in miR-24 expression.  
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The expression levels of MCM4, MYC, PABPNI were increased following transfection 
with am-24. On the other hand, up-regulation of miR-24 induced knockdown of MCM4, 
MYC, PABPNI. Again these results were not supported by statistical significance due 
to the restricted number of biological replicates. However, the direction of the changes 
in expression of these targets was consistent between the data from the up-and down-
regulation of miR-24. MCM4 belongs to the mini-chromosome maintenance proteins 
(MCM) family and is involved in the initiation of replication in eukaryotes (Bochman 
and Schwacha 2009, Forsburg 2004). MYC is involved in many cellular pathways 
including cell proliferation, apoptosis, cell metabolism and is a key regulator of the 
G1/S transition phase (Obaya, Mateyak and Sedivy 1999, Dang 1999) (Herold, Herkert 
and Eilers 2009). Thus this indicates that MCM4 and MYC may be conserved targets of 
miR-24 in CHO cells as well as PABPNI.   
Further validation using a reporter assay would demonstrate the direct relationship 
between miR-24 and these targets and validate its role in cell cycle. 
 
7.2.3 Inducible overexpression of miR-24 using a tetracycline-inducible 
cassette 
 
Although there were some indications that manipulating the levels of miR-24 could lead 
to positive impact on growth, the variability in the results observed in the transient 
assays was unsatisfactory. In an attempt to gain greater control over the levels of miR-
24 expression in the cells, we decided to implement an inducible, plasmid-based system. 
The miR-24 precursor was cloned into pmF111, a tetracycline-inducible vector. 
Although transfection of pmF111-miR-24 reduced cell proliferation in CHO1.14 and 
CHO2B6 cells, this decrease was also observed following transfection of pmF111 and 
other controls of transfection in presence of doxycyline. Addition of doxycyline should 
prevent the expression of the gene of interest and in absence of this drug it should 
release its control and allow the gene to switch its expression. Upon withdrawal of 
doxycyline, cell growth was further reduced particularly four days after transfection in 
all samples. Cell viability was also negatively impacted in both conditions. This non-
specific impact was abated at day 7 likely due to the loss of plasmid. Thus the process 
of transfection had detrimental impact on all samples and could not allow comparison 
between the samples. If any small changes occurred it might not be noticeable. 
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We verified that the inducible system allowed the overexpression of miR-24, by 
investigating the levels of miR-24. Higher miR-24 levels were detected in pmF111-
miR-24 transfected CHO1.14 cells, indicating that precursor miR-24 was processed into 
mature miR-24 and this latter was up-regulated. However, the fold-change was quite 
small (4-fold). Recently, Jadhav and co-workers reported that following transfection of 
precursor miR-17 and other miRNA precursors using a shRNA approach in CHO cells, 
miRNA expression did not exceed 2.3-fold and the increase of growth rate reached a 
maximum of 15.4% (Jadhav, et al. 2012). However, in this study they used a chimeric 
precursor that consisted in CHO miRNA mature sequences inserted into a design pre-
miRNA sequence of murine miR-155. It has been reported that the stem-loop of a 
precursor miRNA may be critical and sufficient for miRNA processing (McManus and 
Sharp 2002). Thus it might be possible that the murine flanking and stem-loop 
sequences/structure, which are critical for processing was not properly recognised by 
the RNAi machinery in CHO cells. Zeng and co-workers reported that the flanking and 
loop sequences of miR-30 have important features and are sufficient to enhance 
siRNA/miRNA precursor processing into the mature form (Zeng, Wagner and Cullen 
2002, Boden, et al. 2004). In this study, they tested their approach by replacing the stem 
sequence of the human miR-30 with a drosophila-specific gene sequence which was not 
conserved in human and the chimeric sequence was successful expressed. However, 
they also inserted the predicted C. elegans lin-4 precursor as well as the human mir-27 
and let-7a3 precursors into the same expression vector but they could not detect up-
regulation of these three miRNAs. This suggests that miRNA processing might be 
dependent not only of structural features, for instance secondary structures/RNA folding 
but other mechanisms that could be species-related. 
In addition, transfection of shRNA has been reported to trigger competition with 
endogenous miRNAs and inhibit their function as they undergo the same processing by 
saturating the RNAi machinery (Yi, et al. 2005). In addition, Grimm and co-workers 
showed that oversaturation of shRNA molecules induced lethality in mice (Grimm, et 
al. 2006). Thus it is also possible that unexpected impact was seen due to off-target 
effects. If precursor miR-24 was processed in excess, the other miRNAs could not be 
processed and therefore would not regulate their targets leading to perturbation of other 
cellular functions. In addition, miR-24 is already expressed at high levels in CHO cells 
so the excess of mature miR-24 could also trigger binding to undesirable targets. These 
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undesirable effects may have masked the phenotype expected, in this case reduction of 
cell growth, by compensation of other routes. 
In CHO2B6 cells there was no indication of miR-24 up-regulation suggesting that 
precursor miR-24 was not processed into a mature strand in this cell line. The flanking 
sequences inserted on either sides of mature miR-24 were amplified from CHO cells 
thus we anticipated the correct processing of precursor miR-24 in both CHO cell lines. 
It has been reported that mature miRNAs are well conserved between species but it is 
not the case for precursor miRNAs (Bartel 2004). Thus it is possible that between cell 
lines that derived from a same parental clone, they might be some mutations in the 
precursor sequence that prevent its processing. Another explanation is that precursor 
miR-24 was processed into an isomiR form of miR-24 thus in this case it may be 
difficult to evaluate its levels of expression using miR-24 primers that would be non-
specific. IsomiRs have been described by Morin and co-workers as variants of the 
mature form of miRNAs induced by the variability in either Dicer1 or Drosha cleavage 
positions within the pre-miRNA hairpin (Morin, et al. 2008) . Using Illumina 
sequencing technology, they showed that miR-24 had several isomiRs expressed at low 
abundance in differentiating human embryonic stem cells (90 counts for isomiRs vs 
787counts for the miR-24 used as reference). Finally, to eliminate the possibility of an 
issue in the vector design and cloning, we verified the sequences of these constructs by 
sequencing and did not find secondary structures or nucleotide changes or deletions.  
Thus the issues encountered at the transfection levels and miRNA processing levels 
discouraged us from continuing in this direction. The optimisation of the transfection 
protocol, the concentration of plasmids as well as transfection reagent and the time of 
transfection might improve the success of this assay.  
 
7.2.4 Investigation of the simultaneous impact of miR-23a~miR-27a~24-2 
cluster members on CHO cell characteristics 
 
Many miRNAs are transcribed as polycistronic transcripts due to their organization in 
clusters. In humans, out of 721 miRNAs known, 247 of them are arranged within 64 
clusters at an inter-miRNA distance of less than 5000bp and most of these clusters are 
highly conserved across species (Griffiths-Jones, et al. 2008, Altuvia, et al. 2005). 
miRNAs within a genomic cluster are often related to each others but it is not always 
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the case (Lau, et al. 2001, Lagos-Quintana, et al. 2001). Due to the nature of their 
binding, miRNA sequence homology gives the possibility of targeting the same 
transcripts and the same cellular pathways (Bartel 2004, Olena and Patton 2010). 
Examples in the literature show that even when clustered miRNAs have no apparent 
sequence homology they may share a functional role (Bashirullah, et al. 2003, Sempere, 
et al. 2003, Aravin, et al. 2003). On the other hand, they may share homology and have 
different targets (Lau, et al. 2001). miR-24-2 is co-transcribed with miR-23a and miR-
27a as part of miR-23a~27a~24-2 cluster. In humans, miR-23a~27a~24-2 cluster is 
intergenic and localized on chromosome 9q22 and its paralogous intronic cluster, miR-
23b~27b~24-1, is localized on chromosome 19p13 (Chhabra, et al. 2009). Yu and co-
workers have reported that it is not uncommon for miRNA clusters to have homologs 
and paralogs (Yu, et al. 2006). It has been suggested that targeting only one miRNA of a 
cluster could lead to compensation from its co-transcribed miRNAs particularly in the 
case of clustered miRNAs sharing sequence homology and/or functions (Lu, et al. 
2009). This counteraction may result in restoring the original function and so little or no 
effect might be seen. Druz and co-workers reported the up-regulation of miR-297~669 
cluster upon nutrient-depleted medium and investigated the anti-apoptotic role of miR-
466h in CHO cells, which showed the highest levels of expression among the cluster 
members (Druz, et al. 2011). The inhibition of miR-466h using synthetic antisense 
oligonucleotides induced the up-regulation of genes invovled in apoptosis in nutrient-
depleted medium. Two mediators of the apoptosis pathways, caspase-3/7 were found to 
be down-regulated and the viability increased. However, this was not enough to rescue 
cells from apoptosis thus suggesting that the other miR-297~669 cluster members that 
were also found to be differentially expressed upon nutrient-depletion, may act in 
unison with miR-466h to regulate apoptosis. 
Therefore the single and synergic impact of the three miRNAs from miR-23a~27a~24-2 
cluster was investigated in transient assays.  
 
7.2.4.1 Screening of miR-23a 
 
miR-23a was not previously detected as differentially regulated in our miRNA profiling 
studies so there was no indication of the functional role of this miRNA in CHO cells. 
miR-23a has been shown to promote cell growth in gastric adenocarcinoma cell lines 
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(Zhu, et al. 2010). c-Myc is also involved in cell cycle progression, apoptosis and its 
deregulation is associated with cancers (Cascon and Robledo 2012, Dang 2012) 
suggesting that miR-23a/b might also contribute to the regulation of the same cellular 
pathways. As discussed previously, the Warburg effect, an altered glucose metabolism, 
stimulates cancer cells to promote the conversion of glucose to lactate and to induce 
glutamine metabolism changes (Dang 2010). It has been reported that inhibition of miR-
23a/b by c-Myc enhances mitochondria glutaminase expression and glutamine 
metabolism (Gao, et al. 2009). This is a really interesting characteristic of the regulation 
between c-Myc and miR-23a/b which might be exploited to increase the levels of 
energy in cells and activate further the metabolism and the proliferation of cells.  
The forced expression of miR-23a provoked a 1.61-fold growth reduction in CHO-K1 
SEAP cells whereas its inhibition did not reverse this phenotype. Cell viability was 
negatively impacted four days after pm-23a transfection and no impact was observed in 
am-23a transfected cells. As observed previously, in contrast to pm molecules the 
inhibitor molecules did not resulted in noticeable phenotypic impact. Based on the data 
obtained from previous study in our laboratory, miR-23a was expressed at low levels in 
CHO cells. Therefore further knockdown might be challenging to achieve. Despite the 
absence of a phenotype upon am-23 transfection, there were positive indications that, 
like miR-24, miR-23a may influence CHO cell proliferation. This suggested that the up-
/down-regulation of the entire cluster might lead to a stronger impact. 
 
7.2.4.2 Screening of miR-27a 
 
Similarly to miR-23a, the data from our profiling studies did not indicate that miR-27a 
was differentially regulated in temperature-shifted culture or fast growing cells. miR-27 
participates in the regulation of cell metabolism. PPARγ, a key regulator of 
adipogenesis has been validated as miR-27 target (Lin, et al. 2009) and miR-27 has 
been shown to affect cholesterol homeostasis, fatty acid metabolism and lipogenesis 
(Lin, et al. 2009, Fernandez-Hernando, et al. 2011, Fernandez-Hernando, et al. 2011). 
miR-27 is also involved in the G2/M checkpoint of the cell cycle in breast cancer cells 
(Mertens-Talcott, et al. 2007) and acts as an oncogene in gastric adenocarcinoma (Liu, 
et al. 2009). Thus miR-27 may influence cell proliferation and cell metabolism in CHO 
cells. 
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Transient manipulation of miR-27a expression using mimics/inhibitors at high 
concentration (100nM) led to contrasting results in CHO1.14 and CHO2B6 cells. 
Overexpression of miR-27a in CHO1.14 cells induced significant growth reduction for 
two days and improved viability by 8.23% at later stages of culture. In CHO2B6 cells, 
high levels of miR-27a induced cell growth increase at two and four days after 
transfection and reduced cell viability by 4.67% to 7.52%. Surprisingly, knockdown of 
miR-27a led to decrease in CHO1.14 growth at day 2, increase at day 4 and improve 
viability at the same time but it did not impact on CHO2B6 cells. Although we observed 
opposing results in these assay, there was phenotypic changes in the pm-27/am-27 
transfected cells compared to the controls. Therefore we continued the validation of this 
miRNA by considering the manipulation of miR-23a~27a~24-2 cluster expression in a 
transient assay. 
 
7.2.5 Investigation of the simultaneous impact of miR-23a~miR-27a~24-2 
cluster members on CHO cell characteristics 
 
 
The individual manipulation of miR-24, miR-23a and miR-27a resulted in contrasting 
phenotypes in CHO cells. As mentioned previously, targeting only one miRNA of a 
cluster could lead to compensation from its co-transcribed miRNAs so little or no effect 
might be seen (Lu, et al. 2009). Interestingly, the miR-23a~27a~24-2 cluster seems to 
be present only in vertebrates (Chhabra, Dubey and Saini 2010). Despite this, the 
functional role of the cluster in cell proliferation and apoptosis has been reported to be 
cell-line dependent. Up-regulation of miR-23a~27a~24-2 cluster has been shown to 
stimulate apoptosis in human embryonic kidney cells upon endoplasmic reticulum (ER) 
stress (Chhabra, Dubey and Saini 2010, Chhabra, et al. 2009, Chhabra, Dubey and Saini 
2011, Huang, et al. 2008)  
In CHO cells, we showed that transient up-regulation of the entire cluster induced a 
2.11-fold reduction of cell growth, 30% improvement in cell viability and enhanced 
total yield and normalised productivity by 1.44-fold and 1.84-fold respectively. 
Knockdown of the cluster did not impact on CHO cell growth at early time points and 
had little impact on viability. However, it did improve total and normalised productivity 
at later stages of culture by 1.35-fold and 1.71-fold respectively. To avoid saturation of 
354 
 
the RNAi machinery, the final concentration of the co-transfected molecules used was 
50nM thus reducing the concentration of each individual mimic and inhibitor to 16.66 
nM. Using this concentration, clear phenotypes could be observed suggesting that the 
synergic manipulation of the three miRNAs is a better approach than the manipulation 
of single miRNA. It is also possible that a lower concentration of synthetic molecules 
reduced the risk of off-target effects by allowing endogenous miRNAs to be processed 
normally and exert their control on their cognate mRNAs. Together these results 
confirmed that miR-23a~27a~24-2 cluster influences proliferation and productivity in 
CHO cells. Previous studies in our laboratory indicated that miR-24 was highly 
expressed, miR-27 was moderately expressed and miR-23a had a lower level of 
expression in CHO cells. Thus it would be interesting to use different combinations of 
mimic/inhibitor concentrations to investigate the simultaneous impact of miR-23a, miR-
27a and miR-24-2 within the cluster on different CHO characteristics. 
7.3 Generation of CHO cell clones with improved characteristics by 
stable knockdown of miR-23a~miR-27a~24-2 cluster 
 
 
Single or multiple knockdown of miR-24-2, miR-23a or miR-27a using inhibitor 
molecules did not impact significantly on cell proliferation or cell viability in contrast to 
its up-regulation which reduced cell proliferation by 2-fold and enhanced cell viability 
by 30%. In an attempt to improve cell proliferation we decided to try depleting all three 
cluster members simultaneously using a stable antisense approach named ‘multi-
antisense cluster’. One potential advantage of reducing cellular miRNA levels rather 
than increasing them is that it does not require processing via the RNAi machinery. In 
this attempt, two stable cell lines were generated; one expressing a multi-antisense 
cluster to target miR-23a~27a~24-2 cluster (wt cluster) and the other one with a random 
sequence (mut cluster).  
In a mixed population, wt cluster transfected cells showed 20-30% lower GFP signal 
fluorescence than in the control cells indicating that miR-23a~27~24-2 cluster miRNAs 
were binding to the multi-antisense cluster and blocking translation/catalyzing 
degradation of the reporter transcript. Although the median GFP fluorescence was 
generally lower in wt cluster expressing clones, there was a lot of variability between 
clones in both wt and mut cluster expressing clones. This is to be expected and is caused 
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by genetic heterogeneity induced by random integration of the vector DNA. It has been 
documented that this clonal heterogeneity is due to gene dosage/number of integrated 
copies and random integration of exogenous DNA affecting other cell traits (Wurtele, 
Little and Chartrand 2003). Pilbroug and co-workers suggested that in addition to clonal 
genetic heterogeneity, cells undergo random expression fluctuations leading to 
phenotypic differences between clones (Pilbrough, Munro and Gray 2009). It is this 
heterogeneity that is routinely exploited to select clones showing an advantage for a 
particular phenotype (Pichler, et al. 2011). 
Further evidence that the multi-antisense cluster was successfully binding the miRNAs 
of interest was found when the clones were transfected with mimics of miR-23a, miR-
27a or miR-24-2, resulting in lower reporter expression in the targeted multi-antisense 
cluster but not the control. This decrease was stronger when using mimics of miR-24-2 
or miR-27a. It is possible that mimics of miR-23a were not processed efficiently when 
loading to the RISC complex thus leading to less mimic molecules to bind to the multi-
antisense cluster. This may also be due to the endogenous levels of expression of these 
miRNAs. miR-24 and miR-27a have high and moderate levels of expression in CHO 
cells whereas miR-23a is expressed at low levels. Therefore more molecules of 
endogenous miR-24-2 and miR-27 may be bound to the multi-antisense cluster leading 
to further GFP reduction compared to less endogenous miR-23a inducing smaller 
reduction of GFP. If the concentration of miR-23a is not increased by the transfection of 
exogenous miR-23a molecules then the reduction of GFP would appear smaller. This 
difference in levels of expression between clustered miRNAs is not uncommon. 
Although these miRNAs are transcribed from the same promoter and belong to the same 
cluster, their subsequent biogenesis into mature form are likely to be regulated by very 
complex mechanisms (Lee et al;. 2004). Following overexpression of miR-23a~27a~24-
2 cluster in HEK293T cells, levels of miR-24-2 and miR-27a were increased but not 
miR-23a levels (Chhabra, et al. 2009). In another study, knockdown of miR-27a was 
independent of miR-23a and miR-24-2 (Buck, et al. 2010). This suggests that due to low 
levels of miR-23a, less endogenous and exogenous miR-23a molecules were bound to 
the multi-antisense cluster compared to miR-24-2 and miR-27a which are more 
abundant in the cells. The processing of endogenous miR-23a into mature miR-23a 
could also be blocked as reported in HEK293T cells (Lee, et al. 2008). Surprisingly, one 
clone out of the three tested in this assay did not show a reduction in GFP fluorescence. 
Although the impact on cell growth in this clone was not as obvious as in the two other 
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clones, there was a significant improvement in cell density in comparison to the control 
cells.  
Following validation the multi-antisense cluster approach, we focused on the impact of 
the simultaneous knockdown miR-23a, miR-27a and miR-24. Depletion of the miR-
23a~27~24-2 cluster resulted in cell density increase by 2.5-fold to 2.87-fold in mixed 
population and by 1.4-fold in single cell clones in batch-culture. Cell viability was also 
improved by 12.5% at day 5. One of the features of batch culture is waste accumulation 
and nutrient depletion which may explain the reduction in cell viability and cell density 
by day 5. To overcome this and to investigate the potential of miR-23a~27~24-2 cluster 
knockdown at later time points, fresh medium was added to the culture at day 3. In this 
culture, an increase in cell density was observed at day 3/day 4 and this improvement 
was extended until day 6. At day 5, the average cell density between the three clones 
was enhanced by 1.71-fold. There were no changes in cell viability between the two 
groups. The increase of cell density seems to be limited by the nature of the batch 
culture and it may be possible to further extent this potential in fed-batch culture. Thus 
we demonstrated that the multi-antisense cluster is an efficient approach to 
simultaneously target clustered miRNAs and in contrast to transient molecules, 
reproducible phenotypic impacts could be achieved. In addition, we proved that 
knockdown of miR-23a~27~24-2 cluster members resulted in significant cell growth 
increase in a batch-culture.  
Thus this suggests that the three miRNAs cooperate to strengthen the control of cell 
proliferation. Chabra and co-workers investigate the predicted targets of all three 
miRNAs using TargetScan program and found that these miRNAs shared only few 
predicted targets (Chhabra, Dubey and Saini 2010). However they also showed that 
these miRNAs are often differentially expressed in the same direction in several 
diseases. 
Thus the manipulation of the expression of the 23a~27~24-2 cluster members is a 
promising tool to improve CHO cell proliferation and possibly cell viability. The 
improvement of culture conditions (i.e; fed-batch culture) might further enhance the 
potential of this approach. 
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7.4 Investigation of miR-7 potential in improving CHO cell phenotypes  
 
7.4.1 Screening of miR-7 
 
miR-7 is involved in cell proliferation and apoptosis regulation and its deregulation has 
been reported in many cancers including breast, pancreatic, glioblastoma, lung and 
tongue squamous cell carcinoma (Chou, et al. 2010, Kefas, et al. 2008, Ikeda, et al. 
2012, Jiang, et al. 2010, McInnes, et al. 2011). In most of these studies, miR-7 plays a 
role of tumor suppressor, with its induction causing inhibition of tumor progression. 
miR-7 was previously identified as differentially regulated upon low temperature 
exposure in a miRNA profiling conducted in our laboratory (Gammell, et al. 2007). 
These findings led us to investigate the role of miR-7 in cell proliferation. Recently, we 
reported that cells were growth arrested for 96hrs and maintained high cell viability 
following treatment with miR-7 mimics in low-serum culture (Barron, et al. 2011). In 
the same study, normalised productivity was significantly improved but the total yield 
remained low consequent to impairment of cell proliferation. The impact of miR-7 on 
protein production is consistent with high levels of miR-7 reported in endocrine tissues 
including in the developing and adult human pancreas (Correa-Medina, et al. 2009, 
Joglekar, Joglekar and Hardikar 2009, Kredo-Russo, et al. 2012), in human pancreatic 
islets (Landgraf, et al. 2007), in the islets of zebrafish (Wienholds, et al. 2005), the 
neurosecretory cells of the annelid Platynereis dumerillii and zebra-fish (Tessmar-
Raible, et al. 2007) and in the pituitary gland (Landgraf, et al. 2007). As high levels of 
miR-7 has been reported in these endocrine tissues, which are gland systems that 
produce and secrete hormones, in different species, it is likely that in CHO cells miR-7 
might also influence the regulation of secretory pathways to improve the production of 
proteins. 
To continue the detailed study of miR-7 in CHO cells, we investigated whether the anti-
proliferative role of miR-7 was reproducible in serum-free culture and in different CHO 
cell lines. To engineer CHO cells, the ideal tool would be one which displays a 
ubiquitous phenotypic impact across all CHO cell lines. The suppressive role of miR-7 
on cell growth proved to be reproducible in serum-free culture and in different CHO cell 
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lines though the extent of growth reduction was cell line-dependent. At high 
concentrations of miR-7 mimics, CHO2B6 growth was reduced by 2.5-to 3-fold and 
CHO1.14 were growth arrested for five days. At lower concentrations, transfection of 
exogenous miR-7 impacted to a lesser extent but still induced a 1.8-fold reduction in 
CHO-K1 SEAP cell density. This is possibly related to the concentration of mimics 
used in the two different assays. Using miR-7 inhibitor molecules, we expected to 
observe the opposite phenotype. However, improvement of cell proliferation was only 
present in CHO1.14 cells at high concentrations. There was no impact on CHO2B6 or 
on CHO-K1 SEAP cells. From previous miRNA profiling studies, we knew that the 
levels of expression of miR-7 in CHO cells were quite low. Therefore significant impact 
of miR-7 upon further knockdown may be difficult to detect. It is also possible that an 
excess of synthetic single-stranded miRNAs (inhibitors) might trigger a stress response 
leading to recognition by nucleases and rapid degradation of these molecules before 
they could impact on their mRNA targets.  
Although the impact on cell proliferation was reproducible in the three cell lines upon 
pm-7 treatment, maintenance of cell viability was not observed in all repeats and in all 
cell lines. In CHO1.14, viability was slightly improved and in CHO-K1 SEAP cells, it 
was 37% higher than in the control treated cells at later stages of culture. To verify that 
the enhancement of cell viability was directly caused by high levels of miR-7 or due to 
a lower number of cells present in culture, the transient transfection assay was repeated 
at high density in CHO-K1 SEAP and CHO1.14 cells. First, the anti-proliferative role of 
miR-7 was not reproducible in every assay and there was no indication of cell viability 
improvement. In addition, non-transfected cells cultured at 31°C, as positive control, did 
not show the phenotype expected as their cell growth was not reduced and the viability 
was not prolonged. Many reports have demonstrated the use of low-temperature in 
biphasic culture to trigger cell growth arrest and extend cell viability, while more 
proteins are being produced (Kaufmann, et al. 1999, Oguchi, et al. 2006, Al-Fageeh, et 
al. 2006, Yoon, Kim and Lee 2003). We recently reported that CHO-K1 SEAP cells 
exposed to low temperature also display this behaviour (Barron, et al. 2011). To ensure 
that the transfection protocol was optimised at high density, a siRNA against Valosin 
Containing Protein (VCP) was included as a positive control. VCP has been previously 
reported to be a housekeeping gene in CHO cells, its deregulation leading to harmful 
effects on CHO cell growth and survival (Doolan, et al. 2010). The impact of VCP 
knockdown was reproducible in CHO-K1 SEAP and CHO1.14 cells cultured at high 
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density indicating that the transfection process performed well. Together these results 
suggest that the higher rate of cell viability observed in the previous transient 
transfection experiments was likely due to a lower cell number leading to healthier 
culture environment and not directly specific to miR-7 induction.  
This assay was done at high density in a batch culture leading to rapid waste 
accumulation and nutrient depletion (Butler 1987, Newland, et al. 1994, Butler 1985). 
Thus we cannot rule out that the impact of miR-7 up-regulation on cell growth and 
viability might have been perturbed in those suboptimal conditions. This is supported by 
the significant drop in cell viability in most of the samples only three days after 
transfection. Usually in a healthy culture, miR-7 starts to reveal its impact on cell 
growth at day 2/3 while cells maintain high cell viability. 
Regarding protein production, upon pm-7 transfection normalised productivity was 
slightly but not significantly improved in comparison to the non-specific control. We 
previously demonstrated that transient overexpression of miR-7 did significantly impact 
on normalised productivity in low serum-supplemented CHO-K1 SEAP culture 
(Barron, et al. 2011). In the present study, the cells were maintained in serum-free 
culture so the difference in culture conditions may affect the productivity of the cells 
(Cheng, et al. 2005). 
Thus we confirmed the anti-proliferative role of miR-7 in CHO cells cultured in serum-
free medium and continued the validation of this miRNA as candidate to improve CHO 
cell growth. 
 
7.4.2 miR-7 as a tool for CHO cell engineering 
 
Transient pm-neg and am-neg molecules were used for screening to reveal the impact of 
miR-7 expression manipulation on CHO phenotypes. These molecules are useful in 
short-term studies however, their transient effect, the low reproducibility between 
assays and cell lines, and the time consuming nature of these assays are major 
drawbacks for long-term studies. 
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7.4.2.1 Inducible overexpression of miR-7 
 
Due to the significant negative impact of miR-7 overexpression on cell growth, an 
inducible system would be more suitable to allow cells to grow until the middle of the 
logarithmic phase. At this stage, the system would trigger cell growth arrest and turn the 
cellular machinery towards protein production. The first system tested was a Tet OFF 
system that allows tight regulation of gene expression by responding to the presence or 
absence of doxycycline, a tetracycline analogue. The removal of the drug allows the 
expression of a specific gene of interest and its presence prevents any expression. The 
precursor of miR-7 was inserted with its CHO flanking sequences into the vector 
pmF111 to allow processing into mature sequence by the endogenous machinery. In 
presence of doxycycline, reduction of cell density was observed not only following 
pmF111-miR-7 transfection but also in all transfection controls in CHO1.14 and 
CHO2B6 cells. Cell growth was further decreased after withdrawal of doxycyline in all 
samples. Thus the transfection itself had such a dramatic impact on cell proliferation 
that any gene or miR-7 specific effects would not be detected.  
Zeng and co-workers reported the successful overexpression of miR-30 using a short 
hairpin RNA (shRNA) (Zeng, Wagner and Cullen 2002). This consisted of the insertion 
of precursor miR-30 (71nt) in a plasmid with a CMV promoter. They also demonstrated 
that the backbone of miR-30 that consists of the stem-loop was sufficient to enter the 
processing machinery therefore they created artificial miRNAs that were processed by 
the endogenous machinery into mature miRNAs. Thus the stem-loop of the precursor 
miRNA may be critical and sufficient for miRNA processing (McManus, et al. 2002). 
Since this report, many papers have reported efficient expression of miRNA or siRNA 
using miR-30 backbone in gene function studies but also for gene therapy applications 
(Boden, et al. 2004, Bauer, et al. 2009). In our study, the flanking sequences of miR-7 
were amplified from CHO cells so due to this specificity, we expected processing of the 
miR-7 precursor into mature form. In addition, the length of the sequences inserted into 
the plasmid pmF111 was more than 100 nt. Chang et al 2006 reported that primary 
sequences provide the highest levels of mature miRNA after processing thus our design 
was suitable for the expression of mature miRNA. In absence of doxycycline, the levels 
of miR-7 expression were increased by 7.81-fold in CHO2B6 cells but only by 1-83-
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fold in CHO1.14. As the conditions of transfection and the concentrations of plasmids 
were similar, we anticipated the same levels of expression in both cell lines. Recently, 
Jadhav and co-workers reported that following transfection of precursor miR-17 and 
other miRNA precursors using a shRNA approach in CHO cells, the increase in miRNA 
total levels did not exceed 2.3-fold (Jadhav, et al. 2012). The authors postulated that the 
small increase in miRNA expression was due to regulatory feedback loops which 
prevent saturation of the RNAi machinery by down-regulating the expression of 
endogenous miRNAs in the presence of artificial overexpression. However, in this study 
they used a chimeric precursor that consisted in CHO miRNA mature sequences 
inserted into a design pre-miRNA sequence of murine miR-155. Thus it might be 
possible that the murine flanking and stem-loop sequences/structure, which are critical 
for processing was not properly recognised by the RNAi machinery in CHO cells and 
this subtle change in miRNA levels could be due to random fluctuations (Ebert and 
Sharp 2012). This could also be the case in our study or it may be the transfection 
process which was possibly less efficient in CHO1.14 cells compared to CHO2B6 cells 
and less copies of the vector were delivered into the cells. Similarly, the transient 
expression of the plasmid did not allow integration in the genome so it could have been 
lost more rapidly in these cells after several cell doublings. Optimisation of the 
concentration of plasmids, the concentration of doxycyline and the transfection process 
might help to improve the outcome of this assay. 
 
In an attempt to overexpress miR-7 in an inducible manner, another Tet OFF system 
named pTet-Hyg was developed in the laboratory. The human flanking and stem-loop 
sequences of miR-30 were inserted into the pTet-Hyg vector. The expression of GFP 
following removal of doxycyline in pTet-Hyg transfected cells was lower than in the 
peGFP-C1 that constitutively expressed GFP, but it was sufficient for what we tried to 
achieve and indicated there was induction upon doxycyline withdrawal. In presence of 
doxycyline, minimal GFP fluorescence was detected suggesting that the system was 
under control of this drug. The hygromycin selection of positive cells transfected with 
pTet /Hyg vector resulted in cell death thus indicating that cells were not resistant to 
hygromycin. The PGK promoter and/or the Internal Ribosome Entry Site (IRES) might 
not have been sufficient to allow transcription/ translation of hygromycin. It would be 
interesting to verify whether the human flanking sequences containing the stem-loop of 
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miR-30 would be recognised by the CHO cell machinery and to which extent the 
expression of miR-7 would increased. 
 
7.4.2.2 Generation of CHO cell clones with improved characteristics by stable 
knockdown of miR-7 
 
The up-regulation of miR-7 using mimics revealed its anti-proliferative role in CHO 
cell lines. In a bioprocess context, we were interested in improving cell proliferation. 
Therefore we considered the inhibition of miR-7 to increase the cell growth rate (change 
in cell concentration per unit time). The efficiency of inhibitor molecules were not 
convincing in achieving knockdown of miR-7. To get a better control of endogenous 
miRNA inhibition and to minimise off-target effects, we thought to generate CHO cell 
clones stably expressing artificial miR-7 targets. In contrast to overexpression, 
knockdown of a miRNA does not require miRNA processing thus there is no risk of 
saturating the RNAi machinery. The ‘miRNA sponge’ technology was previously 
described to induce efficient endogenous miRNA inhibition by competing with 
endogenous mRNA targets for miRNA binding (Ebert, Neilson and Sharp 2007). A 
miRNA sponge sequesters the miRNA of interest through complementarity to its seed 
region.  
The application of miRNA sponges in transient and stable transfections has been 
extensively used since the technology has been described in 2007 (Ebert, Neilson and 
Sharp 2007, Ebert and Sharp 2010). Among a long list of assays performed in different 
cell lines, with different vector types, transient knockdown of individual miRNAs such 
as miR-155 (Bolisetty, et al. 2009) or large seed families like let-7 (Kumar, et al. 2008), 
have been successfully achieved using the sponge approach (Ebert and Sharp 2010). 
Stable expression of the sponge has also been extensively reported in vitro (Ma, et al. 
2010, Ma, et al. 2010, Valastyan, et al. 2009, Scherr, et al. 2007, Bonci, et al. 2008) as 
well as in vivo in plants, drosophila and mice (Loya, et al. 2009, Franco-Zorrilla, et al. 
2007). 
Three years after the development of this approach, endogenous miRNA decoys were 
discovered in plants. A non-coding RNA IPS1 (Induced by Phosphate Starvation 1) 
which displays sequence complementarity for miR-399 (a phosphate (Pi) starvation-
induced miRNA) presents a mismatch at the site of canonical miRNA cleavage. Its 
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overexpression induces sequestration of miR-399 which leads to release of PHO2 
mRNA and consequently lowers the shoot phosphate content (M. Franco-Zorrilla;2007). 
Posileno and co-workers reported that PTEN1, the pseudogene of PTEN, was 
biologically active (Poliseno, et al. 2010). For a long time, pseudogenes have been 
described as DNA genomic sequences, which derived from genetic duplication or 
retrotransposition and have no function due to the presence of premature stop-codons 
and/or mutations in their sequences (D'Errico, Gadaleta and Saccone 2004, Harrison, et 
al. 2005). PTEN1 has conserved seed matches for several miRNAs including miR-17, 
miR-21, miR-214, miR-19 and miR-26 families. Among these miRNAs, miR-17-
5p/miR-20-p and miR-19 are able to repress both PTENP1 and PTEN RNA levels to a 
similar degree. Knockdown of PTEN1 reduced the mRNA and protein levels of 
expression of PTEN in prostate cancer and concomitantly increased cell proliferation 
through competitive binding to these miRNAs. 
Thus the information released in these reports, led us to take the same approach as 
miRNA sponge seemed an ideal tool to inhibit an entire miRNA family and to target a 
specific function regulated by these miRNAs as reported for let-7 family (Kumar, et al. 
2008). 
To inhibit mature miRNAs, the affinity of antisense sequence is critical. The decoy 
target should be able to compete with the endogenous miRNA targets. Therefore, four 
miR-7 binding sites were tandemly inserted in the 3’UTR of a destabilised enhanced 
GFP (dEGFP) gene to increase the efficacy of sequestration. Ebert et al., speculated that 
if seven binding sites were inserted in the sponge and all seven targeted endogenous 
miRNAs, the levels of expression of the sponge would allow inhibition of most 
miRNAs in most cell types (estimated number at approximately 104) (Ebert, Neilson 
and Sharp 2007). To avoid a risk of saturation and degradation no more than ten binding 
sites are generally inserted in the sponge vector. The dEGFP is a very unstable protein 
with a half life of ~2hrs so once translation of new proteins is repressed by the binding 
of a miRNA to the sponge, there is a rapid drop in cellular fluorescence. The change in 
dEGFP fluorescence therefore, provides a read-out of miRNA binding to the sponge. To 
increase the stability of the sponge and avoid RNAi-type cleavage, a bulge region was 
included at the position 9-11, which is often recognised for degradation by Argonaute 2 
(Ebert, Neilson and Sharp 2007). The characteristics of the sponge, which binds to the 
seed region of a miRNA (positions 2-8), made it a very attractive tool as miRNAs that 
belong to a same family share a common seed region thus the entire miRNA family 
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could be inactivated. For the same reasons, the sponge might be more efficient than 
synthetic antisense oligonucleotides which are known to target one single miRNA with 
full sequence complementarity. The decoy mRNA would target miRNAs that share 
common targets so the concomitant phenotypic impact may be accentuated and more 
effective.  
 
CHO-K1 SEAP and CHO1.14 cells were engineered with a miRNA sponge to target 
specifically endogenous mature miR-7 (miR-7 sponge) or with a control sponge which 
consisted instead, of a random sequence inserted in the same cassette. In mixed 
populations, GFP fluorescence was 20% lower in miR-7 sponge transfected cells 
suggesting that miRNA sponge was expressed by the cells and recognised endogenous 
mature miR-7 for sequestration. miR-7 sponge expressing cells showed increased cell 
density compared to the control sponge transfected cells by 1.45-fold at day 2 and by 
1.14-fold at day 3. Cell growth rate was higher at day 2 (0.0577 hr-1 versus 0.0492 hr-1) 
in miR-7 sponge expressing cells, though it was not statistically significant due to high 
standard deviations. The advantage of cell growth was also confirmed by the statistical 
significant improvement of both integral viable cell density (IVCD; cell per time per 
unit volume) and accumulated integral viable cell density (AIVCD). The IVCD is 
represented by the area under the curve when the concentration of viable cells is plotted 
against the culture time. The integral of viable cell density is the most frequently used 
method to compare the average viable cell density among different gene expression 
systems. The AIVCD is the IVCD accumulated over culture duration. Thus both 
measurements are good indicators of cell proliferation improvement and the amount of 
‘work’ a culture can perform. 
miR-7 sponge expressing cells seemed to have a small advantage on cell survival in the 
first three days of culture but it was not statistically significant. Cell viability decreased 
at 72hrs in both control and miR-7 sponge transfected cells, likely due to the nature of 
the batch-culture. Despite that drop, miR-7 sponge expressing cells maintained higher 
cell viability compared to the control sponge treated cells in the next two days. Thus the 
sponge miR-7 might confer an advantage to these cells from being more resistant to cell 
death. 
Using a flow cytometry to sort single cells with high and medium levels of GFP 
expression, many positive clones were selected for further investigation. By choosing 
these clones, we eliminated the possibility to select only clones with low GFP 
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expression in the miR-7 sponge group and clones with high GFP in the control sponge. 
However, by doing so we also eliminated the possibility of selecting clones with very 
high copies of the transgene in miR-7 sponge and less importantly, clones from the 
control sponge group with very low copies of the cassette. The selection of clones with 
high and medium GFP expression allowed the monitoring of a wide range of clones 
therefore the elimination of miR-7 sponge expressing clones with low GFP fluorescence 
was not an issue. In contrast to transient expression, the generation of a stable 
population could allow us to monitor the impact of miR-7 over a longer period of time, 
to assess the different parameters we were interested in improving and to change the 
conditions of culture in order to have more impactful effect. 
To validate the preliminary results observed in mixed population, the impact of miR-7 
sponge on cell growth was monitored in different culture formats. In CHO-K1 SEAP 
cells, the median of GFP signal fluorescence of 23 clones cultured in 1ml suspension 
was also significantly reduced. The median of cell density showed a 1.31-fold increase 
in miR-7 sponge expressing clones at day 3. This confirmed the preliminary results and 
suggested that stable miR-7 knockdown is accountable for cell growth increase.  
The improvement of cell growth was reproducible in CHO1.14 cells. The median of cell 
density of 12 clones showed a 2.26-fold increase in miR-7 sponge expressing clones. 
Thus the impact of miR-7 knockdown on cell proliferation was also conserved in 
another CHO cell lines. The median of cell viability in both cell lines was slightly lower 
than in the control expressing cells. As expected with a randomly integrated vector, 
there was a high variability in GFP expression between the clones. The variation of GFP 
was likely due to genetic heterogeneity induced by random integration of the vector 
DNA. As discussed previously, the vector could be integrated in epigenetically 
regulated regions for instance by methylation or acetylation, leading to chromatin 
condensation and transcription repression. Although this technique of DNA delivery is 
an illegitimate integration and we cannot control the site of integration, it has been 
reported that this homology-independent integration occurs 1000–10,000 times more 
frequently than targeted integration (Smith 2001). Thus this technique of integration and 
the selection of GFP positive clones by flow cytometry are favourable to increase the 
number of positive clones and the choice of clones for selection. It has also been 
reported that rodent cells can integrate exogenous DNA 30–100 times more than human 
cells (Colbere-Garapin, et al. 1986, Hoeijmakers, Odijk and Westerveld 1987). This 
peculiarity is an advantage for recombinant protein production in CHO cells, which 
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have been used for the past 50 years for their easiness in genetic manipulation (Jayapal, 
et al. 2007).  
However, a random integration can have negative impact on the miRNA sponge 
inserted downstream of the GFP gene. The transfected gene can undergo mutations, 
complex rearrangements or form concatamers which can be truncated, deleted or 
amplified (Wurtele, Little and Chartrand 2003). Despite these drawbacks it has been 
shown that after homology-independent integration in cell culture, mutations and 
rearrangements are less frequent after expansion of cells (Merrihew, et al. 2001, 
Hoglund, Siden and Rohme 1992) and that even if the expression of the sponge is 
affected and concomitant miRNA inhibition is partial, the impact is still detectable and 
can result in interesting phenotypes (Ebert and Sharp 2010). Optimising the dose of 
transfected miRNA sponge may increase the number of integrated and fully functional 
copies into the genome.  
In addition to clonal genetic heterogeneity, CHO cells have been reported to undergo 
random expression fluctuations leading to phenotypic differences between clones 
(Pilbrough, Munro and Gray 2009, Ramunas, et al. 2007, Neildez-Nguyen, et al. 2008, 
Kaern, et al. 2005). In this context, if mRNAs and proteins undergo expression 
fluctuation due to intrinsic variability then miRNAs may also have their expression 
changed. It might be that miRNAs are responsible in some part for these fluctuations 
changes. Most miRNAs regulate their mRNA targets by fine-tuning (rather than 
switching their expression on or off) through feed-forward and feedback loops thus it is 
thought that they are involved in promoting homeostasis (Milo, et al. 2002, Hornstein 
and Shomron 2006). One of the miRNAs particularly studied for its role in this process 
is miR-7. Lin X and co-workers (Li, et al. 2009) showed that under temperature 
fluctuation (between 31°C and 18°C), miR-7 is able to buffer specific gene expression 
and ultimately cell fate in the development of Drosophila larvae (Li, et al. 2009). Upon 
temperature fluctuation in presence of miR-7, there were no changes in expression of 
two miR-7 targets, Ato and Yan. This latter is a critical factor for the development of 
insect sensory organs and Ato (atonal) is expressed in precursor cells of proprioceptor 
and olfactory organs. Under the same conditions, miR-7 mutants showed strong 
repression of Ato and high expression of Yan leading to development defects. It would 
be interesting to follow the fluctuation of miR-7 concomitant to fluctuations of GFP and 
also during the time course of the cell culture in both miR-7 and control sponge 
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expressing clones to have more insight in its levels of expression in the cells and its role 
in directing stability during environmental changes.  
Scale-up in 5ml suspension and a longer culture period confirmed the improvement in 
cell growth by 1.35-fold to 1.58-fold in both cell lines. This was significantly different 
from the control at day 2 and/or day 3 of the culture. Cell growth was maintained until 
day 4/day 5 then cell viability dropped dramatically. This can be explained by the 
culture conditions in a batch culture that consists of cells growing in suspension with 
limited nutrient supply and no replacement of fresh medium (Butler 1987, Newland, et 
al. 1994). The lack of nutrient and the waste accumulation was caused by the rapid 
growth of mir-7 sponge expressing clones thus leading to rapid cell density and viability 
decline. In this culture the variability of GFP expression was also present in both cell 
lines. The GFP varied between the clones of a same group (control or miR-7 sponge) 
but also for an individual clone at different time points.   
Cell cycle analysis confirmed the fast progression of miR-7 sponge expressing clones 
through the cell cycle. While control cells were accumulated in S phase (44.05%), miR-
7 sponge expressing cells progressed through the cell cycle and showed similar ratio in 
the different phases of the cell cycle. miR-7 sponge expressing cells were present at 
35.04% in G2 phase, in contrast to 16.64% of the controls cells. G2 phase is described 
as a period of rapid cell growth and protein synthesis which prepares for the segregation 
of chromosomes in mitosis (Yang, Hitomi and Stacey 2006). In addition, the fact that 
cells are not accumulated in the G2/M phase which is often used as a DNA damage 
checkpoint added more confidence that cells proliferate more rapidly when expressing 
the miR-7 sponge. Using bioinformatics approaches, John A. Foekens and co-workers 
showed that mir-7 was associated with the G2/M checkpoint in human breast cancer 
(Foekens, et al. 2008). Transfection with miR-7 induced cell cycle arrest at G1 and 
caused a significant decrease in A549 cell numbers and cell viability (Webster, et al. 
2009). This was also reported by Jiand and colleagues (Jiang, et al. 2010). However, 
when using anti-miR-7, cell proliferation and viability were restored and surprisingly 
there were no changes in the cell cycle. In ovarian cancer cells, following miR-7 up-
regulation there was a significant increase in the proportion of cells in G0/G1 and a 
significant decrease in the proportion of cells in the S and G2/M stages (Shahab, et al. 
2012). This is consistent with our findings and indicated that miR-7 may regulate the 
cell progression through cell cycle to decrease cell growth rate. 
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Simple batch culture is typically only used as a screening tool in research and 
development therefore we wanted to measure the performance of these clones in a more 
realistic fed-batch experiment more in line with what is employed commercially. 
Although there was still no control over parameters such as pH or dissolved O2, we 
wanted to see if providing a nutrient feed would improve the conditions of culture and 
lead to an extended viable period of culture. 
Two clones from the control group and two clones from miR-7 sponge expressing 
CHO-K1 SEAP cells were transferred to shaker flasks in 30ml final volume using a fed-
batch mode for 13 days. Fed-batch culture is a simple and reliable method consisting of 
the addition of nutrients at appropriate concentration (Bibila and Robinson 1995, Xie 
and Wang 2006). Unlike the batch culture, miR-7 sponge expressing cells had a very 
similar cell growth profile to control sponge expressing cells in the first six days of 
culture. Thus the feed extended the period of culture in both groups, keeping the control 
sponge as healthy as miR-7 sponge clones for six days compared to four in the batch-
culture. The impact of stable miR-7 knockdown on cell proliferation was revealed by 
day 7. Cell density and viability dropped in the control clones whereas miR-7 sponge 
clones continued their proliferation. Cell density was improved from day 3 and this 
enhancement was extended until the next ten days. At day 11, cell density was 
significantly increased by 3.27-fold. The advantage of miR-7 sponge expressing cells 
was confirmed by the higher cell growth rate, IVCD and accumulated IVCD. 
Consequently, cell viability was significantly improved from day 8 and increased by 
28.9% at later stages of culture. The improvement in miR-7 sponge clone proliferation 
in association with non-optimal culture conditions for more than six days suggested that 
depletion of miR-7 may protect cells from environmental stresses or, perhaps, fail to 
react to them. Thus the role of miR-7 in controlling homeostasis regulation may be 
conserved in CHO cells.  
Besides cell proliferation, we were also interested in improving cell productivity. Using 
a fed-batch culture, we intended to achieve high volumetric productivity (Li, et al. 2005, 
Dorka, et al. 2009). Herein, stable miR-7 knockdown had a moderate impact on total 
productivity. It was enhanced in comparison to one of the control sponge clones but the 
other control showed higher protein titers. Normalised productivity was not improved in 
these conditions but it was not negatively impacted. This has also been reported 
previously by Jadhav and co-workers who transiently overexpressed miR-17 using a 
shRNA approach and showed that the speed of cell proliferation was increased but there 
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was no improvement and no negative impact on cell productivity in CHO cells (Jadhav, 
et al. 2012). On the other hand, they reported a 20% reduction of specific productivity 
(Qp) without affecting growth rate upon miR-21-5p overexpression. Recent work from 
colleagues in our laboratory showed that the final volumetric titre of a product is tightly 
associated with high cell density, this latter being in some cases more important than the 
intrinsic productivity rate (Clarke, et al. 2011). 
The optimisation of feeding conditions might further prolong the culture period and 
improve the fed-batch conditions leading to further increase of cell growth rate and cell 
viability. Although waste accumulation cannot be avoided with this method, it can be 
minimized by slow feeding and low concentrations of essential components including 
glucose and glutamine (Butler 2004). Low levels of glucose and glutamine or 
replacement by other carbon sources prevent lactate and ammonia accumulation by 
improving oxidation of glucose to CO2 (Duval, et al. 1992, Altamirano, et al. 2004, 
Zhou, et al. 2011, De Alwis, et al. 2007).  
An attempt to improve productivity using inducible overexpression of miR-7 or at least 
ceasing down-regulation might be suitable at day 7 when the culture reached high 
density and viability remained high. The viability may be sustained if the suspected role 
of miR-7 in imparting robustness appears to be real. 
Thus we demonstrated that miR-7 sponge is a powerful tool to extend the longevity of 
the culture leading to improvement of cell density as well as cell viability in fed-batch 
culture. Metabolite measurement would add information regarding the role of miR-7 in 
keeping the culture active and healthy and its impact on other pathways. 
 
7.4.2.3 Validation of the sponge effect 
 
Different methods of validation were conducted to ensure that the improvement in cell 
growth rate and viability was specific to miR-7 knockdown. The levels of expression of 
endogenous miR-7 were analysed in control sponge and miR-7 sponge expressing cells 
in mixed population and single clones. Following transfection of miR-7 sponge, miR-7 
levels were only slightly reduced in comparison to its levels in the control sponge in 
mixed population. Surprisingly, we found that the levels of miR-7 were 5.11-fold higher 
in the single clones. Endogenous mature miR-7 molecules are single-stranded molecules 
and could be dissociated from the sponge during the RNA extraction process or during 
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the reverse transcription (RT) step. The specific miR-7 primer used in the RT might 
compete with the sponge, which could lose its sequestration capability outside the 
cellular context, resulting in primer-miR-7 binding and so the level of this miRNA 
would be detectable. From these results, it is tempting to speculate that miR-7 is not 
degraded immediately following its sequestration by miR-7 sponge.  
Measurement of precursor miR-7 levels indicated that there was no increase of 
expression thus it was unlikely that the transcription rate of miR-7 caused higher levels 
of mature miR-7 upon its sequestration. Another possibility is that the sponge may 
protect miR-7 from degradation leading to accumulation of mature form of miR-7 
bound to the sponge transcript and consequently higher levels would be detected upon 
cell lysis. Recently, Chatterjee and co-workers showed that miRNA turnover is 
regulated by the exoribonuclease XRN-2, via a new mechanism, known as target-
mediated miRNA protection (TMMP) (Chatterjee and Grosshans 2009, Chatterjee, et al. 
2011). TMMP may enable miRNA targets to protect their cognate miRNAs against 
XRN-2 induced degradation therefore leading to mature miRNA accumulation. To test 
this hypothesis, we investigated the levels of miR-7 in dEGFP depleted cells. Following 
inhibition of dEGFP, the levels of mature miR-7 detected in miR-7 sponge expressing 
cells were similar to the levels of miR-7 in control cells. The levels of miR-7 precursor 
were unchanged between the control and miR-7 sponge expressing clones. Thus an 
EGFP-specific siRNA not only promoted the degradation of the GFP-sponge transcript 
but reduced the detectable levels of mature miR-7. This suggests that by binding to the 
sponge, miR-7 not only is prevented from binding its endogenous mRNA targets but is 
stabilised and protected from degradation.  
The addition of exogenous miR-7 at two different concentrationsm, 30nM and 50nM, 
induced further repression of GFP expression in miR-7 sponge-expressing clones. If the 
miR-7 sponge was expressed abundantly enough to sequester additional exogenous 
miR-7 it would suggest that it was efficiently sequestering all endogenous miR-7. 
Inhibitor molecules were also added to the culture at 50nM causing a slight derepression 
of GFP expression for some of the clones. This suggests that inhibitors were competing 
with miR-7 sponge for endogenous miR-7 binding. Only a slight release of GFP 
expression was observed likely due to the high level of expression of miR-7 sponge. 
Having observed the apparent protection of mature miR-7 while bound to the sponge 
and the further reduction in GFP fluorescence upon pm-7 transfection we assumed that 
this must be due to translational repression. This would be in keeping with the initial 
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sponge design strategy which included a 2 nucleotide mismatch at positions 10-11 to 
create a bulge in the bound duplex in order to minimise cleavage. In addition, 
deliberately degrading the sponge via GFP-siRNA treatment returned the detectable 
level of miR-7 to that of the control, ie reversing the protective phenomenon. Based on 
these findings one would expect that the sponge transcript levels should therefore 
remain relatively constant upon pm-7 transfection. However, qPCR revealed a 
considerable reduction in sponge mRNA after transfection indicating 
destabilisation/degradation rather than translational repression. 
This suggests that very high levels of exogenous pm-7 combined with the multiple (4) 
binding sites in each sponge transcript might result in destabilisation of the mRNA. It 
would seem that under normal conditions however, the amount of sponge expressed in 
the clones was sufficient to ‘soak up’ endogenous miR-7 without excessive degradation 
occurring.  
 
7.5 The role and network of miR-7 in CHO cells 
 
Recently there have been several reports on a role for miR-7 in cell proliferation and its 
deregulation leading to various cancers (Kefas, et al. 2008, Ikeda, et al. 2012, McInnes, 
et al. 2012, Fang, et al. 2012, McInnes, et al. 2011). Herein, we showed that transfection 
with miR-7 induced cell growth reduction while maintaining high cell viability. Cell 
cycle and apoptosis analysis revealed that cells were arrested in G1 phase without 
exhibiting sign of apoptosis. In cancer cells the epidermal growth factor receptor 
(EGFR) and the insulin-like growth factor receptor 1 (IGF1-R) signalling, have been 
reported to be the routes regulated upon miR-7 induction to trigger proliferation 
inhibition (Chou, et al. 2010, Jiang, et al. 2010, Nieto, et al. 2011, Duex, et al. 2011, 
Lee, Choi and Kim 2011). However, EGFR signalling is not likely to be the pathway by 
which miR-7 regulates cell proliferation in CHO cells as these cells do not express 
EGFR (Shi, et al. 2000). In addition, we found that there was no difference in IGF1-R 
expression at the mRNA and protein levels following miR-7 transfection in CHO cells. 
To investigate other possible mechanisms of action by which miR-7 might control cell 
growth, we used CHO-specific oligonucleotide arrays to profile miR-7 mimic-treated 
cells. Many of the identified targets, including CylinD1/D3, Cdk1/2, Psme3, Rad52/54l 
and Skp2 are reported to be involved in cell cycle, DNA repair and are often 
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deregulated in cancers (Kanaar, et al. 1996, Bretones, et al. 2011, Roessler, et al. 2006, 
Zhang, et al. 2012a, Malumbres and Barbacid 2009, Shi, et al. 2012). We focused on 
three targets, Psme3 (REGγ or PA28γ), Rad54L and Skp2, none of which had 
previously been shown to be directly regulated by miRNAs but were predicted to bind 
miR-7 through either their 3’UTR (Psme3, Skp2) or coding sequence (Rad54L) and 
were representative of the cell proliferation and DNA repair pathways (Zhang and 
Zhang 2008, Kanaar, et al. 1996, Roessler, et al. 2006, Sistrunk, et al. 2011, Fang and 
Rajewsky 2011, Rajewsky 2011). Although miRNA binding sites in open reading 
frames are less common than UTR-based sites (Fang and Rajewsky 2011, Rajewsky 
2011) the predicted miR-7 target in Rad54L was highly complementary and considered 
worthy of investigation. A reporter assay indicated a direct interaction between this 
sequence and miR-7 though the reduction in signal was not as striking as the reduction 
in endogenous Rad54L mRNA levels observed by qPCR. This may be in part due to the 
fact that the reporter assay was restricted to only contain this predicted site plus the 
3’UTR downstream. There is actually a second predicted miR-7 binding site (in human 
as well as CHO cells) near the 5’ end of the coding sequence which may also contribute 
to the regulation of the endogenous transcript. In addition, GFP-based reporter assays 
tend to be more qualitative than quantitative. Unfortunately, there was no suitable 
antibody available to establish the levels of Rad54L protein in CHO cells in response to 
miR-7. Both Psme3 and Skp2 were found to be direct targets of miR-7 via their 
respective 3’UTRs and subsequent individual depletion of these genes using siRNA 
inhibited cell proliferation, in particular when Skp2 was knocked down. The more 
modest impact of Psme3 on proliferation might be explained by compensation via 
redundant proteins in the same family (Masson, Lundgren and Young 2003, Murata, et 
al. 1999) or possibly the less effective depletion of the target by RNAi.  
The role of Skp2 in miR-7-mediated G1/S block was confirmed by the observation that 
several of its downstream targets were also deregulated including an increase in p27KIP1 
(a cyclin D inhibitor) and reduced Cks1, Cdk1/2 and CyclinD1/3, all indicative of G1 
arrested cell (Kossatz, et al. 2004, Zhang, et al. 1995, Yu, Gervais and Zhang 1998). In 
addition, the levels of phospho-Akt, another substrate of Skp2, were increased upon 
miR-7 transfection. Akt is known to play a central role in the regulation of cell 
proliferation, cell viability and cell cycle arrest in G1 phase by indirect regulation of 
CyclinD1 inhibition (Brazil, Park and Hemmings 2002, Diehl, et al. 1998). In contrast 
to our findings, Skp2 knockdown has been shown to impair activation of Akt in 
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response to ErbB signalling (Chan, et al. 2012, Lin, et al. 2009). However, EGFR is not 
expressed in CHO cells thus the activation of Akt in the presence of reduced Skp2 must 
be via another pathway or another member of the EGFR family. c-Myc levels have also 
been reported to be regulated by Skp2 to promote cell cycle progression at the G1/S 
transition (Lal, et al. 2009a, Bretones, et al. 2011, Kim, et al. 2003) and in its turn, Myc 
is able to induce Skp2 transcription (Bretones, et al. 2011). We show that the levels of 
Myc were dramatically reduced in response to miR-7 upregulation, as would be 
expected in quiescent cells, and further re-enforcing the down-regulation of Skp2. 
Interestingly, Myc has been reported to be directly regulated by miR-24 through a 
seedless recognition element (Lal, et al. 2009a). In the same study, high levels of miR-
24 induce cell accumulation in G1 compartment. c-Myc degradation can also be 
promoted through the recruitment of miR-24 by a ribosomal protein L11 (Challagundla, 
et al. 2011).  
We identified several miRNAs to be down-regulated in miR-7 treated cells, including 
miR-24, suggesting that miR-7 might co-ordinate several molecular networks in order 
to mediate a temporary arrest in G1. Furthermore the interaction of Skp2 with DNA 
replication proteins including ORC1, Cdt1(Mendez, et al. 2002, Li, et al. 2003) and the 
depletion of other regulators of the S phase including Fen1, cdc6 and the MCM family 
(MCM2, MCM3, MCM5 and MCM7) would strengthen the blockage of G1/S 
transition.  
In normal cells, arrest in the G1/S phase and the inhibition of the replication machinery 
can be initiated by Chk1 or Chk2 in response to DNA damage and frequently results in 
initiation of apoptosis (Sancar, et al. 2004). However, in our study cells treated with 
miR-7 remained as viable as the control treated cells. Low Psme3 expression would 
normally be associated with elevated levels of p53, reduced proliferation and induction 
of apoptosis (Vousden and Prives 2009, Vousden and Lu 2002). Herein, we found p53 
levels to be suppressed despite miR-7-dependent reduction in Psme3, cell growth arrest 
and no apoptosis. Although miR-7 is acting to arrest cell growth, its role may be to 
simultaneously ensure that the response is not catastrophic (apoptosis) by directly or 
indirectly targeting p53 for degradation. Phosphorylation of Akt can also impair 
apoptosis initiation via subsequent inhibition of pro-apoptotic proteins including Bad 
and Foxo3a. On the other hand, Akt can act in synergy with p53 and c-Myc promote 
cell survival (Cantley 2002, Datta, Brunet and Greenberg 1999, Alessi, et al. 1996, 
Alessi and Cohen 1998, Mayo and Donner 2001). Interestingly, Foxo3a promotes Myc 
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post-transcriptional regulation via miR-34b and miR-34c induction (Kress, et al. 2011). 
Recently, Foxp3, another member of the Fork-head family of transcription factors, has 
been reported to induce miR-7, causing suppression of STAB1 by a feed-forward loop 
(McInnes, et al. 2011). Foxp3 is also known to directly repress Skp2 and c-Myc (Zuo, et 
al. 2007, Dehan and Pagano 2005, Wang, et al. 2009a). It is induced by p53 following 
DNA damage contributing to the growth suppressive activity of p53 (Jung, et al. 2010). 
Thus miR-7 might regulate the knockdown of Skp2 and c-Myc via induction of Fox3p 
by positive feedback loop (Gottlob, et al. 2001, Kim, Sasaki and Chao 2003, 
Yamaguchi and Wang 2001). The down-regulation of BCLAF1,a pro-apoptotic factor 
that induces p53, BAX and triggers downregulation of MDM2 (Sarras, Alizadeh Azami 
and McPherson 2010), again points toward a co-ordinating role of miR-7 in preventing 
apoptosis induction. Likewise, the up-regulation of HDAC, a histone deacetylase 
involved in p53 degradation is in keeping with the observed response (Ito, et al. 2002, 
Brooks and Gu 2003, Tang, et al. 2008).  
In addition, several miRNAs found differentially regulated upon miR-7 transfection, 
including let-7 family, miR-31, miR-15b~16 cluster, miR-17 and miR-106a may 
contribute to the regulation of p53. All have predicted binding sites for p53 and are 
often deregulated in cancer. Most importantly, the let-7 family, miR-17~92 cluster and 
miR-16 have been previously reported to be repressed by p53 (Saleh, et al. 2011, 
Suzuki, et al. 2009, Yan, et al. 2009) . Three let-7 family members, let-7b/c/d were 
found to be down-regulated upon pm-7 transfection which is associated with cell 
growth arrest. In our screen, we showed that transient up-regulation of let-7e impacted 
negatively on cell proliferation and viability in three CHO cell lines. In keeping with the 
protective role of miR-7 against detrimental perturbation, it is probable that miR-7 
influences the expression of let-7 family members to overcome major changes in 
viability and avoid apoptosis induction by negative feedback loop. 
The low levels of DNA repair proteins including H2af, Rad52, Rad54L and Parp1/2 as 
well as the regulation of H2afx by miR-24 are likely to strengthen the anti-apoptotic 
response (Lal, et al. 2009a). Thus we suggest that miR-7 has a dual role which 
counteracts pro-apoptotic signals and activates anti-apoptotic factors to prevent cells 
undergoing apoptosis-dependent cell death while simultaneously arresting growth in 
G1. Therefore in this context, miR-7 seems to act as a rheostat to maintain cellular 
homeostasis. This is supported by previous reports that demonstrated a role of miR-7 in 
fine-tuning development-specific genes to avoid major cell perturbation and to maintain 
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robustness during environmental flux (Aboobaker, et al. 2005, Li, et al. 2009). This is 
also supported by the fact that the stable knockdown of miR-7 promoted high cell 
growth and extended viability despite harmful conditions. 
 
7.6 Regulation of cell cycle and proliferation by miRNA network in CHO 
cells 
 
miRNAs have been reported to target hundreds of genes therefore it follows that some 
must share common targets (Bartel 2009). In addition, this property would suggest that 
they should also impact on the expression of other miRNAs – not necessarily by direct 
interaction but via secondary effects. For example the expression of one miRNA might 
repress a transcription factor that is involved in activating transcription of another 
miRNA. To identify downstream members of the miR-7 network, we conducted a 
miRNA profiling study following pm-7 transfection.  
Let-7b, let-7c and let-7d were found to be down-regulated upon miR-7 treatment which 
is associated with cell growth reduction. However, in our functional validation studies 
of candidates miRNAs, we showed that the anti-proliferative potential of let-7 family 
reported in cancers (Roush and Slack 2008), was conserved in CHO cells. Thus 
impairment of cell proliferation was expected to be associated with up-regulation of 
these three miRNAs. 
Similarly, miR-10a was also found down-regulated in this profiling but in the transient 
assay, miR-10a knockdown led to increased cell density by 1.8-fold. Despite the 
established role of miR-29 family in cancers (Pekarsky, et al. 2006), knockdown of 
miR-29a using inhibitor molecules did not impact on CHO cell proliferation. Upon pm-
7 transfection, miR-29a was found up-regulated. It is possible that in the functional 
study, miR-29a inhibitors were not efficient enough to impact on cell growth or that in 
CHO cells, miR-29 alone is not sufficient to impact on this phenotype.  
miR-21 expression has been correlated with slow growth in CHO cells continuously 
cultured at 31˚C (Gammell, et al. 2007, Gammell 2007). Upon miR-7 treatment, miR-21 
was found to be down-regulated. Similarly, miR-17 was found up-regulated following 
miR-7 overexpression. miR-17 belongs to the oncogenic miR-17~92 cluster (He, et al. 
2005, Volinia, et al. 2010, Hayashita, et al. 2005) and it has been shown to increase cell 
proliferation following its overexpression in CHO cells (Jadhav, et al. 2012). Taken 
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together these results suggest that miR-7 exerts a tight regulation on cell proliferation by 
modulating the expression not only of several important protein-encoding genes but also 
the expression of let-7 family, miR-10a, miR-21, miR-17 and possibly miR-29a. miR-7 
may repress or activate targets which in turn control the regulation of these miRNAs. 
We could imagine that if these miRNAs were not regulated by feed-forward and/or 
feed-back loops, cells would stop their growth for a longer period of time eventually 
leading to cell death. Thus this miRNA profiling study reinforces the hypothesis on the 
role of miR-7 in robustness.   
Conversely, miR-16 and miR-24 were found up-regulated. These two miRNAs have 
been shown to play critical roles in cell cycle regulation (Lal, et al. 2009a, Liu, et al. 
2008). Consistent with our study, miR-16 and miR-24 induced down-regulation of key 
regulators of the G1/S transition including CCND1, Myc and E2F to arrest cell growth 
in G1 without inducing apoptosis. Thus miR-16 and miR-24 may cooperate with miR-7 
to strengthen the block at the G1/S transition as the well as the avoidance of apoptosis. 
From individual studies in miR-7 and miR-23a~27~24-2 cluster, we found common 
cellular pathways that may be regulated by these miRNAs. Herein, the expression levels 
of Myc, one of the key nodes involved in cell cycle regulation was strongly down-
regulated by miR-24 and by miR-7 induction. Myc has been show to regulate glucose 
metabolism by promoting glycolysis in transformed cells (Osthus, et al. 2000, Kim, et 
al. 2004b). We discussed earlier that through the Warbug effect, glucose and glutamine 
are great sources of energy and provide ATP and NAPDH to promote the formation of 
new cancer cells (Dang 2012). By targeting Myc via miR-7 and miR-23a in CHO cells, 
the metabolism of the cells would be further activated thus leading to less accumulated 
waste and providing new ways to take-up energy and cell proliferation may be 
increased. 
In addition, overexpression of miR-7 led to cell growth arrest in G1 in CHO cells and 
induction of miR-24 also perturbs the G1 phase in hepatocellular carcinoma cells (Lal, 
et al. 2009a). Both miRNAs are able to arrest the cell cycle via targeting genes involved 
in cell cycle and DNA repair, including the CyclinD inhibitor p27kip1, CDC2, CDCA7, 
members of the MCM family, FEN1 and H2AX. This suggests that cell proliferation 
and cell cycle are regulated through cooperative activities of both miR-7 and miR-24 in 
CHO cells. Further validation of miR-24 targets would verify this hypothesis. In 
addition, we showed that the up-regulation of miR-7 was associated with the up-
regulation of miR-24 levels leading to knockdown of their common target H2AX. 
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H2AX is involved in double strand-break response for DNA repair. The up-regulation 
of miR-24 triggers knockdown of H2AX and induces cell sensitivity to DNA damage in 
differentiated blood cells (Lal, et al. 2009a). On the other hand, miR-7 up-regulation led 
to H2AX decrease maybe protect the cells against damage to avoid apoptosis induction 
thus reinforcing the cellular environment against stress. Analysis of apoptosis would 
verify the role of miR-24 in apoptosis induction in normal conditions and in miR-7 
depleted CHO cells and would give more information on the axis of regulation of 
apoptosis with these two miRNAs. 
 
7.7 miRNAs as promising targets for CHO cell engineering 
 
The use of single-gene engineering as an approach to improve bioprocess-relevant CHO 
characteristics has been extensively described and focused in improving cell growth 
rate, increasing apoptosis resistance and enhancing specific productivity (Kim, Kim and 
Lee 2012). Some of these studies resulted in successful impact on cell proliferation 
and/or cell viability maintenance but did not improve cell productivity. E2F-1 
overexpression has been reported to increase viable cell density by 20% and prolonged 
the batch culture for an additional day (Majors, et al. 2008). There was no impact on 
protein production. In the same manner, c-Myc increased maximal cell density by more 
than 70% through reduction of cell size as well as a significant decrease in glucose and 
amino acid consumption rate. Again, there was no improvement of cell productivity 
(Kuystermans and Al-Rubeai 2009). Up-regulation of bcl-2 expression also increased 
maximum viable cell by 75% (Tey, et al. 2000). In the same study, cells were growth 
arrested following addition of thymidine leading to a 40% increase in cell viability 
compared to the control. Under these conditions, the antibody titers were not enhanced 
(Tey, et al. 2000). Using RNAi, knockdown of caspase-8 and caspase-9 also increased 
cell viability by 30% and prolonged the period of high cell viability for 1.5-2 days in 
batch and fed-batch culture in CHO cells (Yun, et al. 2007). 
This is similar to what we observed following stable knockdown of miR-7. Despite the 
significant increase of cell growth rate and IVCD, normalised productivity was not 
impacted and total yield was moderate. The overexpression of other regulators involved 
in apoptosis and cell cycle improved cell viability as well as cell productivity. The 
overexpression of Bcl-x(L) enhanced cell viability by 20%, antibody titers by 80% and 
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specific productivities by almost two-fold on scale-up to bioreactors. In addition, cell 
viability and product titer were further increased when cells were cultured in a 
chemically defined media without impacting on product quality (Chiang and Sisk 
2005). Cyclin-dependent kinase inhibitor p27 expressing CHO cells had their 
proliferation arrested over a 5-day period and consequently showed a 10-15-fold 
increase in SEAP specific productivity (Mazur, et al. 1998). The combination of single-
gene approach and site-specific integration using zinc-finger nucleases was applied to 
deletion of BAK and BAX. It proved to be efficient in impairing apoptosis and 
produced two- to fivefold more IgG than wild-type CHO cells under serum-starvation 
conditions (Cost, et al. 2010). The addition of sodium butyrate (NaBu) to the culture is 
an efficient approach to enhance protein expression. However, it causes toxicity leading 
to cell proliferation inhibition and promotion of apoptosis. Inhibition of caspase-3 using 
RNAi was reported to successfully enhance apoptosis resistance. Cell culture was 
extended by more than 2 days and cell viability was increased by 50%. However, the 
final antibody concentration was not improved (Kim and Lee 2002). 
In comparison to the other studies which addressed the improvement of one or two 
CHO characteristics, Dreesen and co-workers reported the promising potential of 
mammalian target of rapamycin (mTOR) to simultaneously improve key bioprocess-
relevant phenotypes of CHO cells (Dreesen and Fussenegger 2011). Overexpression of 
mTOR resulted in a twofold increase of viable cell density by increasing cell-cycle 
progression, improved apoptosis resistance and robustness, increased cell size and 
protein content, enhanced specific productivity of therapeutic IgG and antibody titers by 
four-fold (50pg/cell/day). 
In contrast to single-gene engineering, miRNA are involved in the regulation of entire 
networks thus providing the possibility to target entire pathways individually and 
simultaneously. Yet, there has been only one study on the manipulation of miRNA 
which reported a modest increase of 15.4% in cell proliferation (Jadhav, et al. 2012). 
The overexpression of miRNA from a vector does not require the translational 
machinery thus does not lead to stress responses (i.e; UPR response) or compete with 
translation of a trangene. Identification of miRNA targets may increase the discovery of 
important cellular targets for CHO cell engineering like mTOR which improved 
simultaneously multiple bioprocess-relevant phenotypes of CHO cells. The 
simultaneous overexpression or knockdown of multiple miRNAs involved in the same 
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function can reinforce the impact on this function for instance to improve cell 
proliferation or to stop cell growth and enhance product titers. 
However, the fact that miRNAs regulate hundred of targets can be a major advantage 
but also a drawback. Manipulating one miRNA to improve a specific function could 
impact negatively on other pathways. On the other hand, the manipulation of multiple 
miRNAs involved in different pathways may help to counteract negative impact. In the 
same manner, using inducible system, multiple miRNAs can be switched on and off at 
different stages of the cell culture. In the first days of culture, a miRNA capable of 
increasing cell growth rate would be turned on and at maximum cell density, it would 
be switched off. At that same time point, another miRNA proven to arrest cell growth 
would be turned on as well as another miRNA efficient in improving productivity. 
Although the manipulation of miRNAs as tool to engineer CHO cells in large-scale is 
still in its infancy, the possibility of simultaneously manipulating several miRNAs at 
different stages of culture makes miRNAs promising tools to improve all bioprocess-
relevant CHO characteristics in a same culture thus reducing the cost and the timeline of 
protein production.   
The accumulation of information from the miR-7 sponge study proved that miRNA as 
tools to improve CHO characteristics are as efficient as single-gene engineering 
approaches. The optimisation of culture conditions including medium formulation in a 
fed-batch, removal of waste accumulation and the control of DNA integration may 
further improve the potential of miRNAs in enhancing cell proliferation and apoptosis 
resistance. 
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8 Conclusions 
 
8.1 Screening of candidate miRNAs as potential candidates to improve 
bioprocess-relevant CHO characteristics 
 
• The use of synthetic mimics and inhibitors as tools for functional validation was 
not convincing due to the lack of reproducibility and inconsistency in the 
phenotypes observed following transfection.  
 
• We believe that miR-30e-5p, miR-29a, miR-10a and let-7e would be worth 
further investigation. 
  
• We showed that miR-23b* and miR-409-5p, two miRNA* species were 
functional and expressed at high levels in CHO cells.  
 
8.2 Investigation of the individual miR-23a~miR-27a~24-2 cluster 
member potential in improving CHO cell characteristics  
 
• Functional validation assays using mimic and inhibitor molecules indicated that 
miR-24, miR-23a and miR-27a impacted on growth, viability and/or 
productivity.  
 
• Simultaneous transient overexpression or knockdown of the miR-23~27a~24-2 
cluster members proved to be a relevant approach to investigate the influence 
of the miR-23~27a~24-2 cluster on CHO characteristics,  
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• We conclude that 1) the impact of the miR-23~27a~24-2 cluster members on 
CHO phenotypes appeared to be cooperative, 2) miR-23~27a~24-2 cluster did 
influence these CHO phenotypes in a substantial manner.  
 
8.3 Generation of CHO cell clones with improved characteristics by 
stable knockdown of miR-23a~miR-27a~24-2 cluster 
 
• We showed that 1) the ‘multi-antisense cluster’ was a reliable strategy to 
simultaneously knockdown clustered miRNAs, 2) the resulting phenotypic 
impact was significant and reproducible in contrast to synthetic antisense 
oligonucleotides and 3) the miR-23a~27~24-2 cluster members acted 
cooperatively to improve cell density by 71% compared to the control. Thus we 
demonstrated that miR-23a~27~24-2 cluster is a good candidate to improve 
CHO cell proliferation.  
 
8.4 Investigation of miR-7 potential in improving CHO cell phenotypes  
 
• We demonstrated that the anti-proliferative role of miR-7 was reproducible in 
serum-free medium in different CHO cell lines. 
 
•  Knockdown of miR-7 using synthetic antisense oligonucleotides resulted in 
little or no impact on proliferation.  
 
• At low density, overexpression of miR-7 levels led to extended viability at later 
stages of culture. The apparent benefits of increased miR-7 levels to viability 
were not reproducible at higher densities. 
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8.5 Generation of CHO cell clones with improved characteristics by 
stable knockdown of miR-7 
 
• We showed that 1) the ‘miRNAsponge’approach was an effective strategy to 
deplete the levels of miR-7 in the cells, 2) the resulting phenotypic impact was 
significant and reproducible in contrast to synthetic antisense oligonucleotides 
and 3) upon stable knockdown of miR-7, cell growth was successfully improved 
by 130% as well as cell viability by 45% compared to the control.  
 
• We suggested that knockdown of miR-7 may promote a ‘cancer type-phenotype’ 
to the cells allowing uncontrolled growth and extended survival.  
 
• We conclude that stable knockdown of miR-7 is a potent strategy to affect 
global changes in cells and improve bioprocess-relevant CHO characteristics.  
 
8.6 Investigation of the functional role of miR-7 in CHO cells 
 
• We showed that high levels of miR-7 induced cell growth arrest in G1 phase of 
the cell cycle and did not induce apoptosis. 
 
• Profiling of miR-7 targets using CHO-specific oligonucleotide arrays upon pm-7 
transfection and gene ontology analysis indicated a role for miR-7 in G1/S phase 
of the cell cycle, DNA replication and DNA damage/repair pathways. 
 
• Three representative targets of these pathways, Psme3, Rad54L and Skp2, were 
validated as direct targets of miR-7. The validation of other key regulators of the 
G1 to S phase transition, including p27KIP and Myc as well as critical apoptotic 
regulators such as p53 and p-Akt confirmed the role of miR-7 in the regulation 
of cell proliferation and apoptosis. 
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• A miRNA profiling using TaMan Low Density arrays upon overexpression of 
miR-7 indicated that miR-7 exerts a tight regulation on cell proliferation and 
apoptosis by modulating the expression of not only protein-encoding genes but 
also other miRNAs in a complex regulatory network.   
 
• Finally we speculated that the phenotypes observed upon overexpression of 
miR-7- cell growth arrest and apoptosis avoidance- might mimic the response 
caused by environment stress. On the other hand, depletion of miR-7 may 
prevent a stress response and induce uncontrolled proliferation of cells. Thus we 
conclude that miR-7 acts as a sensor to control homeostasis regulation in CHO 
cells. 
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9 Future work 
 
9.1 Screening of candidate miRNAs as potential candidates to improve 
bioprocess-relevant CHO characteristics 
 
• The use of synthetic molecules in the manipulation of miR-30e-5p miR-29a, 
miR-10a and let-7e expression suggested a possible impact on cell proliferation, 
cell survival and protein production/secretion. Future work would include the 
functional validation of transient overexpression and knockdown of miRNAs 
using a shRNA vector instead of synthetic molecules. The use of shRNA might 
help to control the amount of exogenous molecules to minimise off-target effects 
due to RNAi machinery saturation.  
 
• Few miRNA* species have been shown to be functional and little has been 
reported on their role and their regulation. It would be interesting to pursue the 
investigation of miR-23b* in a functional validation using a shRNA vector for 
overexpression as well as the combined impact of miR-23b* and miR-23b.  
 
9.2 Generation of CHO cell clones with improved characteristics by 
stable knockdown of miR-23a~miR-27a~24-2 cluster 
 
• We demonstrated that the ‘multi-antisense cluster’ was a reliable strategy to 
simultaneously knockdown miR-23a~27~24-2 cluster members and also that 
miR-23a~27~24-2 cluster was a good candidate to improve CHO cell 
proliferation at later stages of a batch culture. Further validation would include 
the stable expression of the multi-antisense cluster in a fed-batch culture to 
assess cell proliferation, viability, total yield as well as normalised productivity. 
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9.3 Investigation of the functional role of miR-23a~27~24-2 cluster in 
CHO cells 
 
• The identification of miR-24, miR-23a and miR-27a targets could be 
investigated using CHO-specific oligonucleotide arrays following stable 
knockdown of the miR-23a~27~24-2 cluster members and validation would 
involve qPCR, western blotting and siRNA transfection. 
 
9.4 Generation of CHO cell clones with improved characteristics by 
stable manipulation of miR-7 
 
• We showed that stable depletion of miR-7 is a potent tool to improve cell 
proliferation and extent viability in CHO-K1 SEAP cells. To validate these 
findings, future work would include the fed-batch culture of a human 
recombinant IgG1-secreting cell line using CHO1.14 cells that are stably 
engineered to knockdown miR-7.  
 
• It would be interesting to take measurement of metabolites including 
glucose/glutamine to assess nutrients consumption and lactate/ammonia to 
monitor waste accumulation in these cultures in both the control and miR-7 
sponge expressing clones.  
 
• Larger scale-culture in 2L bioreactors may help to confirm the promising 
possibility of using miR-7 in large-scale culture in biopharmaceutical 
production.  
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9.5 Investigation of the network of factors involved in miR-7-dependent 
regulation of cell proliferation, cell cycle and DNA repair 
 
• To further investigate miR-7 network and its interactions, future work would 
involve the validation of Rad54L at the protein levels. 
 
• To validate the role of miR-7 in apoptosis resistance, it would be interesting to 
induce apoptosis in normal condition culture, in miR-7-depleted cells and in 
miR-7-overexpressing cells. 
 
• To validate the impact of miR-7 overexpression on let-7 family, miR-31, miR-
21, miR-24, miR-15b~16 cluster, miR-17~92 cluster and its paralog mir-106a-
363, future work would involve to repeat the TLDA array study combined with 
functional validation assays.  
 
• miR-7 and miR-24 may cooperate tightly to regulate similar cellular pathways in 
CHO cells including cell cycle, cell proliferation and apoptosis. Cell 
proliferation, cell cycle and apoptosis assays following simultaneous transient 
knockdown of miR-7 and miR-24 expression would add information on this 
statement.   
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11 Appendices 
 
11.1 Appendix 1: List of primers used for real-time PCR 
 
MCM4 F: GCAGTGCTGAAGGACTACATAGCA  
MCM4 R: GGCTGGCCTCCTCACTCA  
 
MYC F: TCAAGAACATCATTCATCCAAGATT  
MYC R: AAGCCAGCTTCTCGGAGAC  
 
FEN1 F: TGGTGAAGGCTGGCAAAGTT  
FEN1 R: GTACAGGGCTGCCAAAAGTGA  
 
PCNA F: GCTGTGTGGTAAAGATGCCTTCT  
PCNA R: CAGGATATTACAACAGCATCTCCAA  
 
 
Psme3 F: TAT CCC ACC TTG AGC CTG AC 
Psme3 R: TGC AGG AAG GAA GGC TAT GT 
 
Apex1 F: ACAGCAAGATCCGCTCCAAA 
Apex1 R: GGGCCTAAAGGACACTGGAC 
 
Skp2 F: GGT CCT TTA TGG AGC AAC CA 
Skp2 R: CCA CTG CAG ATT CGG AAA AT 
 
Cno F: ACC CAG TTT GGC TGT CTT GA 
Cno R: TGC AAT ATG GCA GAG CTG TT 
 
Spata2 F: TCT GGC CCA CAT ACT TCT CC 
Spata2 R: GAG TCT GCC CTC TCC AAG TG 
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Rad54 F: CCA TTA AGA AGC GAG CCA AG 
Rad54 R: GGG TTC CAG TCA GGA TCA AA 
 
Ccnd3 F: CCC CAC TAT GGT CAG AGG AA 
Ccnd3 R: CCA AGC TCA GTC CCT CAC TC 
 
Peo1 F: ATGTGGAGCAAGCAGCTGGT 
Peo1 R: CTCTTCCAGCCGTGTCACAG 
 
Ckap4 F: TGA CTC CAC TTG GCT CAC TG 
Ckap4 R: ACA GTG AAG AGC CTG GAG GA 
 
Plp2 F: TCA GGT AGA GGA TGG CTG CT 
Plp2 R: TGC TTC AGT GCT TCG ACA TC 
 
Dhfr F: AAT GAC CAC CAC CTC CTC AG 
Dhfr R: AGG CAT CGT CCA GAC TTT TG 
 
Setd8 F: GAG GCC ACA TGG TTA ATG CT 
Setd8 R: TAA GTG GGG AAT TGG CAG AC 
 
Ccnd1 F: CAC AAC GCA CTT TCT TTC CA 
Ccnd1 R: CTC CCT CTG CTT CTC CCT CT 
 
H2afx F: CTG AGG AAA GGC CAC TAT GC 
H2afx R: CTT GTT GAG CTC CTC GTC GT 
 
 
Slc7a5 F: CCA AAG AGC AGG GAC TCT TG 
Slc7a5 R: CCA AAA TGC AAA GCA CTG AA 
 
Mcm2 F: ACT TCC TAC CTG AGG CAC CA 
Mcm2 R: ACC TCA GTG AAC GCA ACT CC 
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Lig1 F: CCC TTT CTC TTT GTC CAC CA 
Lig1 R: AGG AGC ATC ACC AGA GCC TA 
 
Orc1l F: TGC CTG ACT CTC TTC CCT GT 
Orc1l R: TGC AGA CAG CGT ATG ACC TC 
 
Cdk2 F: AGT GGA GGC ACA ACT TTG CT 
Cdk2 R: GTG GAC TGA CGT CAA TGT GG 
 
Aup1 F: TTG TCT GAC GGA GTG AGT CG 
Aup1 R: TCC TGG GTC TCA GAA CTG CT 
 
Mcm5 F: ACA CTG GCT CCA CTG CTC TT 
Mcm5 R: TGT GTT TGG ATG CCT GAG AG 
 
 
Mcm3 F: CAG CCT CCA TCA GTG AAA CA 
Mcm3 R: TGT GTT TGG ATG CCT GAG AG 
 
 
Bclaf1 F: CAC CGG AAT ACT GAG GAG GA 
Bclaf1 R: TTT TGC AGT GCT AGG CCT TT 
 
Slc39a9 F: GCA GAC AGG TCC CTT GAA AA 
Slc39a9 R: GGA CCT GTA CCC AAA CGA GA 
 
Cdc6 F: TCT GTG CCC GAA AAG TAT CC 
Cdc6 R: CCG CTG AGA AAC AAG TCC TC 
 
Cnot8 F: ATC AGA GCA AAC CCC CTT CT 
Cnot8 R: ATG TGA ATT TTG CCC AGG AG 
 
Mcm7 F: AAG TCA AAC CTC GGA TGG TG 
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Mcm7 R: ATT TGG AAC CAC GAG TCT GC 
 
Cenpo F: CTG GTG TCC CTG ATC CAC TT 
Cenpo R: CTG ATA TCC AGC GCT TCC TC 
 
Fen1 F: AACCCCGAACCAAGCTTTAG 
Fen1 R: GGGCCACATCAGCAATTAGT 
 
Cdc25b F: AGA CGG GTA GCC AAG GTT TT 
Cdc25b R: AGC CAC TCT TCA GGT GCA TT 
 
Tfdp1 F: CCA AAC TTC TGG CCA CCT TA 
Tfdp1 R: GAC TGC AGC ATC TCC AAT GA 
 
PabpnI F: GTGGCCATCCTAAAGGGTTT 
PabpnI R: CGGGAGCTGTTGTAATTGGT 
 
 
Cdc7 F: CAT CTG ACC TTC CCT CCA AA 
Cdc7 R: GAT ACG GCA TGG CAA TAA CC 
 
Rad52 F: GGA GGC CAG AAG GTG TGT TA 
Rad52 R: CCC ACG TAG AAT TTG CCA TT 
 
Cdk1 F: CTC CAC CCC TGT TGA CAT CT 
Cdk1 R: CGT TGT TAG GAG TCC CCA GA 
 
Bcl10 F: TCT CCT CAG GCA CAC TTC CT 
Bcl10 R: CGT GAT CGT AAG GGG AGA AA 
 
Hdac1 F: GGA TGG CCA GAG ACA CTC AT 
Hdac1 R: AGC ATC CGG TTT CTG TTA CG 
 
458 
 
11.2 Appendix 2: List of down-regulated genes upon pm-7 treatment  
 
mouse human rat pm-7/pm-
neg 
pm-neg 
/cells 
pm-
7/cells 
P.Value 
Crtap NA Crtap -3,94 0,24 -3,71 5,75E-08 
Psme3 PSME3 Psme3 -3,92 0,32 -3,61 1,57E-08 
Rnf26 RNF26 Rnf26 -3,70 0,78 -2,92 5,39E-08 
NA NA Cdca4 -3,58 0,65 -2,93 3,74E-08 
Pdk3 NA Pdk3 -3,57 0,34 -3,23 1,60E-09 
NA NA Rfng -3,56 0,42 -3,13 1,80E-07 
NA NA NA -3,43 0,01 -3,42 6,10E-08 
Nadk NA Nadk -3,42 0,54 -2,88 1,08E-07 
Mosc2 NA NA -3,40 0,21 -3,19 2,67E-10 
Tex261 NA NA -3,34 0,74 -2,60 2,17E-07 
Tk1 NA NA -3,33 0,35 -2,98 1,34E-07 
Ado NA NA -3,28 0,26 -3,02 6,24E-09 
Skp2 SKP2 Skp2 -3,27 0,06 -3,21 5,36E-12 
NA NA NA -3,26 0,81 -2,45 5,54E-09 
Ppif PPIF Ppif -3,26 0,55 -2,71 3,77E-09 
Rcc2 NA NA -3,24 0,25 -2,99 1,39E-08 
Cno CNO Cno -3,24 0,54 -2,69 8,50E-08 
5930416I
19Rik 
NA MGC9428
2 
-3,23 0,20 -3,02 6,09E-09 
Zdhhc3 NA Zdhhc3 -3,22 0,69 -2,53 1,05E-07 
Mosc2 MOSC2 Mosc2 -3,17 0,22 -2,96 1,02E-08 
Spata2 SPATA2 NA -3,17 0,69 -2,47 6,26E-08 
Rad54l RAD54L Rad54l -3,15 -0,02 -3,17 1,32E-10 
Ccnd3 CCND3 Ccnd3 -3,14 0,49 -2,65 2,40E-07 
Ado ADO NA -3,06 0,25 -2,81 2,44E-09 
Ubqln4 UBQLN4 NA -3,01 0,34 -2,68 9,33E-09 
Gins1 NA Gins1 -3,01 0,26 -2,75 1,38E-09 
Heg1 HEG1 NA -3,01 0,20 -2,80 2,34E-10 
Tpbg NA Tpbg -3,00 0,04 -2,96 4,77E-07 
NA NA NA -3,00 0,46 -2,54 3,41E-07 
Grk6 GRK6 Grk6 -2,98 0,43 -2,54 5,08E-07 
Slc39a11 NA NA -2,93 0,64 -2,29 3,37E-07 
NA NA NA -2,92 0,42 -2,49 2,22E-07 
Dhx16 DHX16 Dhx16 -2,89 0,38 -2,52 1,09E-07 
Timm50 TIMM50 NA -2,87 0,40 -2,47 1,87E-07 
Peo1 NA NA -2,87 0,23 -2,65 9,57E-08 
459 
 
Ckap4 CKAP4 Ckap4 -2,87 0,09 -2,78 9,36E-08 
Emp1 NA Emp1 -2,83 0,25 -2,58 9,41E-11 
NA NA NA -2,83 -0,14 -2,97 9,31E-13 
NA PHF5A Phf5a -2,82 0,61 -2,20 5,19E-08 
Plp2 NA Plp2 -2,81 0,17 -2,64 3,37E-09 
Mesdc2 NA Mesdc2 -2,81 0,34 -2,47 1,03E-08 
NA NA NA -2,80 -0,07 -2,86 3,26E-10 
Dhfr NA NA -2,76 -0,17 -2,94 2,59E-08 
NA NA NA -2,75 0,61 -2,14 1,23E-07 
Ak3 NA NA -2,74 0,41 -2,33 8,14E-09 
NA NA NA -2,73 -0,09 -2,82 5,97E-11 
Mfsd5 MFSD5 Mfsd5 -2,68 0,57 -2,11 6,19E-07 
NA NA NA -2,68 -0,19 -2,87 1,71E-07 
Setd8 SETD8 Setd8 -2,67 0,52 -2,15 4,71E-10 
1810055
G02Rik 
C11orf24 RGD1311
946 
-2,65 0,17 -2,48 3,11E-08 
Lancl1 NA NA -2,63 0,75 -1,88 8,19E-09 
1110034
A24Rik 
C14orf10
4 
RGD1310
311 
-2,63 0,10 -2,53 1,30E-08 
NA NA NA -2,61 -0,35 -2,96 1,49E-10 
NA NA NA -2,56 0,46 -2,10 1,09E-06 
NA NA Ccnd1 -2,56 0,47 -2,09 5,38E-08 
H2afx NA H2afx -2,55 0,47 -2,08 2,84E-08 
Wipf1 WIPF1 NA -2,55 0,43 -2,12 1,69E-10 
NA NA NA -2,55 -0,14 -2,69 1,24E-10 
NA NA NA -2,53 -0,08 -2,61 1,64E-09 
Hdac1 HDAC1 Hdac1l -2,53 -0,31 -2,84 1,56E-07 
Emp1 EMP1 Emp1 -2,53 0,34 -2,18 3,93E-10 
Tmem55
b 
APEX1 Apex1 -2,51 0,17 -2,34 5,32E-09 
Slc7a5 NA NA -2,51 0,58 -1,93 1,71E-07 
Slc7a5 NA Slc7a5 -2,50 0,48 -2,02 1,33E-07 
Mcm2 NA Mcm2 -2,49 0,37 -2,12 5,87E-08 
Lig1 LIG1 Lig1 -2,49 0,28 -2,20 1,43E-06 
NA NA Slc7a5 -2,48 0,57 -1,91 3,25E-07 
Rela RELA Rela -2,48 0,53 -1,96 3,21E-07 
Hdlbp NA Hdlbp -2,43 0,20 -2,22 6,86E-09 
Orc1l ORC1L Orc1l -2,42 -0,27 -2,69 1,52E-08 
Nacc1 NA NA -2,42 0,60 -1,81 6,62E-07 
NA NA Cdk2 -2,41 0,51 -1,90 4,33E-07 
460 
 
Aup1 AUP1 Aup1 -2,40 0,44 -1,96 1,03E-06 
LOC1001
35765 
DYX1C1 NA -2,39 -0,06 -2,46 2,07E-07 
NA NA Mcm5 -2,39 0,44 -1,95 2,51E-07 
NA NA NA -2,39 0,01 -2,37 1,73E-08 
NA NA NA -2,38 0,26 -2,12 1,99E-08 
NA NA NA -2,38 0,44 -1,94 2,23E-07 
Dhdds DHDDS NA -2,38 0,56 -1,81 6,24E-07 
Klhl5 KLHL5 Klhl5 -2,36 -0,14 -2,51 8,51E-10 
Nolc1 NOLC1 Nolc1 -2,35 -0,34 -2,69 4,07E-07 
NA NA Cdca7 -2,34 -0,22 -2,56 3,64E-10 
Tnfaip3 NA NA -2,33 0,25 -2,09 3,22E-09 
Cmtm6 NA Cmtm6 -2,33 -0,20 -2,53 3,59E-07 
Eif4ebp2 NA NA -2,33 0,31 -2,02 4,25E-07 
Usp10 USP10 Usp10 -2,32 0,01 -2,30 1,98E-08 
Sigmar1 SIGMAR1 Sigmar1 -2,31 0,00 -2,31 6,40E-07 
NA NA NA -2,29 0,19 -2,10 2,21E-08 
Mcm3 NA LOC3679
76 
-2,25 0,04 -2,21 1,30E-09 
NA NA NA -2,24 -0,61 -2,84 1,96E-07 
NA UBQLN4 Ubqln4 -2,23 0,19 -2,05 1,93E-07 
Dhfr DHFR Dhfr -2,23 -0,48 -2,71 3,07E-07 
Exosc2 NA Exosc2 -2,21 -0,08 -2,29 3,72E-08 
Tada2b TADA2B Tada2b -2,21 0,66 -1,55 4,93E-08 
Mllt6 LOC1001
29395 
NA -2,20 0,64 -1,56 2,30E-07 
Mapkap1 NA NA -2,19 0,65 -1,54 9,87E-09 
Derl1 DERL1 Derl1 -2,19 0,60 -1,59 4,69E-07 
Aplp2 NA Aplp2 -2,17 0,26 -1,91 7,41E-08 
Prps1 PRPS1 Prps1 -2,15 -0,14 -2,28 4,16E-08 
Usp10 USP10 Usp10 -2,14 0,07 -2,07 9,85E-10 
NA NA NA -2,11 0,13 -1,98 2,04E-08 
NA NA NA -2,10 0,02 -2,08 8,76E-09 
Ubr7 NA Ubr7 -2,09 0,00 -2,09 2,98E-07 
Lrrc8a LRRC8A NA -2,08 0,50 -1,58 6,40E-07 
A730085
K08Rik 
ABHD5 Abhd5 -2,07 0,32 -1,75 2,44E-09 
A730071
L15Rik 
NA NA -2,06 0,45 -1,61 3,00E-07 
Lrrc59 LRRC59 Lrrc59 -2,06 0,18 -1,88 1,72E-07 
461 
 
Urb2 NA Urb2 -2,06 0,09 -1,97 3,88E-09 
Myst2 MYST2 Myst2 -2,03 0,30 -1,73 4,32E-09 
Naa40 NA Nat11 -2,01 0,01 -2,01 2,48E-06 
H2afx NA H2afx -2,01 0,28 -1,73 1,94E-08 
NA NA NA -2,01 0,58 -1,43 3,98E-07 
NA NA Bclaf1 -2,01 0,01 -2,00 9,05E-08 
NA LOC1001
31735 
Rbmx -2,00 -0,20 -2,20 2,94E-11 
Ykt6 NA Ykt6 -1,99 0,29 -1,70 3,67E-08 
NA NA NA -1,99 -0,12 -2,11 1,85E-08 
NA PFN2 Pfn2 -1,98 0,11 -1,87 2,20E-07 
NA NA NA -1,97 0,65 -1,32 4,37E-08 
Tmed9 TMED9 Tmed9 -1,96 0,19 -1,77 4,88E-07 
Slc39a9 SLC39A9 NA -1,96 0,27 -1,70 4,07E-08 
Cat CAT Cat -1,96 0,01 -1,95 1,05E-06 
Derl1 NA NA -1,95 0,36 -1,59 2,70E-07 
NA NA NA -1,94 0,43 -1,51 2,62E-09 
Znrf3 ZNRF3 NA -1,94 0,19 -1,75 3,18E-07 
NA NA NA -1,94 0,07 -1,87 2,62E-08 
Bysl BYSL Bysl -1,94 0,27 -1,66 1,12E-06 
NA NA NA -1,93 -0,13 -2,06 8,20E-08 
Trub1 NA NA -1,93 0,10 -1,83 1,53E-10 
Ormdl2 ORMDL2 Ormdl2 -1,93 0,63 -1,30 3,87E-07 
Atpaf1 NA Atpaf1 -1,91 -0,53 -2,44 8,90E-07 
Rqcd1 RQCD1 NA -1,90 0,41 -1,49 2,41E-07 
Tmed9 NA Tmed9 -1,88 0,14 -1,74 1,03E-07 
Pole2 POLE2 Pole2 -1,88 -0,53 -2,42 4,54E-07 
Kpna6 KPNA6 NA -1,88 0,02 -1,86 7,59E-10 
Lig3 NA NA -1,86 -0,14 -2,00 1,15E-07 
Cdc6 CDC6 Cdc6 -1,86 -0,47 -2,33 3,82E-07 
Derl1 NA NA -1,86 0,48 -1,38 1,09E-07 
Nfkbia NFKBIA Nfkbia -1,86 0,17 -1,69 1,87E-08 
NA NA Pfn2 -1,86 0,12 -1,74 3,28E-07 
Ppib PPIB Ppib -1,85 0,01 -1,84 2,27E-08 
Cnot8 CNOT8 Cnot8 -1,85 0,18 -1,67 5,25E-09 
NA MCM7 Mcm7 -1,85 0,13 -1,71 5,87E-09 
NA NA Racgap1 -1,85 0,41 -1,44 9,05E-09 
Ubqln1 UBQLN1 Ubqln1 -1,84 0,47 -1,37 1,68E-09 
Rnf114 NA NA -1,83 -0,09 -1,92 7,83E-07 
Pqlc3 NA Pqlc3 -1,82 0,57 -1,25 7,26E-11 
462 
 
NA NA NA -1,82 0,21 -1,61 2,03E-07 
Nfkbia NFKBIA Nfkbia -1,82 0,20 -1,62 6,47E-08 
NA NUDT21 Nudt21 -1,81 -0,13 -1,95 4,07E-10 
Clp1 CLP1 Clp1 -1,81 0,20 -1,61 1,91E-10 
Rtel1 NA NA -1,81 0,01 -1,79 6,09E-08 
NA NA Cenpa -1,81 0,24 -1,57 2,02E-10 
Uhrf1bp1 NA NA -1,81 0,34 -1,47 8,67E-10 
NA NA NA -1,80 0,23 -1,57 1,16E-07 
Parp1 NA NA -1,80 -0,04 -1,84 2,50E-08 
NA NA Usp39 -1,79 -0,45 -2,23 1,26E-08 
Pole POLE Pole -1,78 -0,44 -2,23 9,47E-08 
 CENPO NA -1,78 -0,51 -2,29 4,48E-08 
NA NA NA -1,78 0,21 -1,57 1,82E-08 
NA NA NA -1,77 -0,18 -1,95 3,20E-11 
Fen1 NA Fen1 -1,77 0,21 -1,56 1,30E-06 
NA NA NA -1,76 0,34 -1,43 1,51E-07 
Exo1 EXO1 Exo1 -1,76 -0,28 -2,04 1,68E-07 
Hip1 HIP1 Hip1 -1,76 0,26 -1,50 4,23E-08 
Pes1 NA Pes1 -1,75 0,19 -1,56 2,71E-08 
Cdc25b CDC25B Cdc25b -1,75 0,24 -1,51 6,72E-07 
NA ABHD2 NA -1,74 0,25 -1,49 1,24E-06 
Snx9 SNX9 NA -1,74 -0,07 -1,81 4,30E-09 
NA ABHD2 NA -1,74 0,24 -1,50 1,63E-08 
Cirh1a NA Cirh1a -1,74 -0,36 -2,09 5,17E-08 
NA NA NA -1,73 0,38 -1,35 6,53E-11 
Ccl2 NA Ccl2 -1,72 -0,78 -2,50 4,80E-08 
NA NA NA -1,71 -0,19 -1,90 1,57E-09 
Cat NA Cat -1,71 0,03 -1,68 5,81E-07 
1110008
F13Rik 
C20orf24 RGD1307
752 
-1,71 -0,03 -1,74 8,00E-09 
Dnajc5 NA NA -1,71 0,40 -1,30 1,42E-07 
Cnn3 CNN3 Cnn3 -1,70 -0,11 -1,81 4,00E-10 
NA NA NA -1,69 0,34 -1,35 1,17E-07 
F3 F3 F3 -1,69 0,10 -1,58 7,66E-08 
Snap29 NA Snap29 -1,67 -0,04 -1,71 7,93E-07 
NA NA NA -1,67 0,13 -1,54 9,48E-07 
9530053
P14Rik 
NA Ndufaf4 -1,63 0,09 -1,54 1,49E-07 
5830485
P09Rik 
NA NA -1,63 -0,47 -2,10 6,32E-08 
463 
 
Cirh1a CIRH1A Cirh1a -1,63 -0,40 -2,03 5,27E-09 
Rnf111 RNF111 Rnf111 -1,62 0,15 -1,47 2,56E-09 
Bri3bp NA NA -1,62 0,39 -1,23 4,59E-08 
Fam82a2 NA Fam82a2 -1,62 0,38 -1,24 6,40E-07 
Ddx39 DDX39 Ddx39 -1,62 -0,09 -1,70 2,48E-09 
Ahcy AHCY Ahcy -1,61 0,01 -1,61 1,45E-06 
NA NA Strap -1,61 0,15 -1,46 1,64E-07 
NA NA Wipf1 -1,61 0,24 -1,37 3,04E-07 
Tbc1d1 NA NA -1,60 0,34 -1,26 1,90E-09 
NA NA NA -1,58 0,47 -1,11 5,46E-08 
NA FSTL1 NA -1,57 -0,19 -1,77 2,10E-09 
Rpp30 RPP30 NA -1,56 -0,15 -1,71 2,62E-07 
NA NA NA -1,56 0,08 -1,48 1,14E-07 
Tsn NA NA -1,55 -0,40 -1,94 1,96E-07 
LOC6746
91 
TFDP1 MGC1128
30 
-1,54 -0,12 -1,66 7,46E-08 
Ykt6 YKT6 Ykt6 -1,54 -0,08 -1,62 1,40E-09 
Nucks1 NA Nucks1 -1,53 -0,05 -1,58 1,45E-09 
NA NA MGC1128
30 
-1,53 0,18 -1,35 6,03E-10 
Mgat2 MGAT2 Mgat2 -1,51 0,14 -1,37 6,78E-08 
Clns1a NA Clns1a -1,50 0,04 -1,46 1,68E-08 
Ppp1r7 NA Ppp1r7 -1,50 0,03 -1,46 2,37E-08 
Mcm7 MCM7 Mcm7 -1,49 -0,04 -1,53 3,50E-08 
NA NA NA -1,49 0,52 -0,97 1,07E-09 
NA NA NA -1,49 -0,30 -1,79 1,82E-07 
Amotl1 NA Amotl1 -1,49 0,45 -1,04 2,73E-07 
Rbbp5 RBBP5 Rbbp5 -1,47 -0,37 -1,84 1,89E-07 
Uqcr10 NA LOC6853
22 
-1,46 0,33 -1,13 1,28E-07 
NA NA Slc35f2 -1,46 0,17 -1,29 1,61E-06 
NA NA Kif2c -1,46 -0,03 -1,48 4,51E-07 
NA NA Trip13 -1,45 -0,05 -1,50 6,05E-07 
Uqcr10 NA LOC6853
22 
-1,44 0,33 -1,11 7,09E-08 
NA NA NA -1,43 0,51 -0,92 1,99E-07 
Cxcl1 NA Cxcl1 -1,43 -0,39 -1,82 8,64E-08 
Serp1 NA Serp1 -1,42 0,40 -1,02 2,28E-08 
NA NA Slc25a30 -1,42 0,29 -1,13 2,70E-08 
Enc1 ENC1 Enc1 -1,40 0,17 -1,23 1,91E-07 
464 
 
Thada NA NA -1,40 -0,06 -1,46 4,38E-08 
2610036
L11Rik 
NA NA -1,40 0,33 -1,07 7,34E-07 
Ncapd2 NCAPD2 NA -1,39 0,03 -1,36 1,60E-07 
Parp2 PARP2 Parp2 -1,39 -0,34 -1,73 4,05E-07 
Tsn NA NA -1,38 -0,19 -1,57 3,82E-10 
NA NA NA -1,37 0,02 -1,35 1,17E-06 
Atic ATIC Atic -1,36 -0,32 -1,68 8,11E-09 
Tomm22 TOMM22 Tomm22 -1,36 0,22 -1,14 9,77E-07 
Bzw2 BZW2 Bzw2 -1,36 -0,07 -1,43 1,74E-09 
Cnot8 NA Cnot8 -1,33 0,15 -1,18 1,23E-06 
Zfp259 NA Zfp259 -1,32 0,09 -1,24 6,80E-08 
Crkl NA NA -1,32 0,05 -1,27 1,09E-06 
1500003
O03Rik 
CHP Chp -1,32 0,10 -1,22 1,24E-06 
Celf1 CELF1 NA -1,32 0,63 -0,69 1,97E-08 
Pabpn1 PABPN1 Pabpn1 -1,31 -0,05 -1,36 7,66E-08 
NA NA NA -1,31 0,12 -1,19 1,78E-08 
NA SMS Sms -1,30 -0,05 -1,35 1,26E-09 
Tfam NA NA -1,30 -0,13 -1,43 4,99E-07 
NA NA NA -1,29 0,16 -1,13 1,71E-06 
Nedd8 NEDD8 Nedd8 -1,28 0,27 -1,01 3,28E-08 
Atxn7l1 ATXN7L1 Atxn7l4 -1,27 -0,22 -1,49 1,32E-08 
Kdm2a LOC1001
31150 
Kdm2a -1,27 0,15 -1,11 3,88E-07 
NA NA NA -1,26 -0,07 -1,34 2,30E-08 
Mbnl3 NA Mbnl3 -1,26 -0,01 -1,27 5,04E-07 
Cdc7 NA NA -1,24 -0,07 -1,31 2,02E-06 
NA KIAA017
4 
RGD1307
799 
-1,23 0,41 -0,81 1,78E-09 
NA NA NA -1,23 0,12 -1,10 2,47E-07 
NA GLI3 NA -1,22 -0,21 -1,42 9,20E-09 
Atl1 SAV1 Sav1 -1,22 0,12 -1,10 3,41E-09 
NA NA NA -1,21 0,17 -1,05 1,15E-08 
Dbr1 DBR1 Dbr1 -1,20 -0,22 -1,43 4,84E-08 
NA NA NA -1,20 -0,38 -1,58 1,35E-08 
Paxip1 PAXIP1 Paxip1 -1,20 -0,02 -1,21 1,44E-06 
Bicd2 BICD2 Bicd2 -1,18 0,38 -0,80 9,88E-09 
NA NA NA -1,18 0,03 -1,15 1,01E-09 
Nr2c1 NA NA -1,17 -0,01 -1,18 2,54E-06 
465 
 
Nup93 NUP93 Nup93 -1,17 0,00 -1,17 9,70E-07 
Ift52 NA Ift52 -1,16 0,14 -1,02 1,13E-07 
Dscc1 DSCC1 NA -1,14 -0,20 -1,34 2,88E-07 
Rbm17 RBM17 Rbm17 -1,14 -0,15 -1,29 4,95E-09 
Thbd NA Thbd -1,13 -0,76 -1,90 2,23E-08 
Prmt5 NA Prmt5 -1,13 0,23 -0,89 3,45E-07 
Cd44 NA Cd44 -1,11 0,17 -0,94 1,30E-07 
NA NA Hdhd2 -1,11 -0,09 -1,19 2,15E-08 
6720463
M24Rik 
C13orf34 RGD1309
522 
-1,10 -0,14 -1,24 2,34E-07 
Gtl3 C16orf80 Gtl3 -1,10 0,23 -0,87 2,27E-08 
Ptch1 PTCH1 NA -1,09 0,18 -0,91 2,81E-08 
Polr1e POLR1E Polr1e -1,08 0,12 -0,96 5,79E-07 
Snx9 SNX9 Snx9 -1,07 -0,13 -1,20 1,20E-08 
Ncaph NA Ncaph -1,06 -0,12 -1,18 9,67E-08 
Mthfd1l MTHFD1
L 
Mthfd1l -1,05 -0,06 -1,11 3,71E-07 
NA NA NA -1,05 0,34 -0,71 2,71E-07 
Gins4 GINS4 Gins4 -1,04 -0,18 -1,23 1,33E-06 
NA NA NA -1,04 0,07 -0,96 5,27E-07 
Dclre1b DCLRE1
B 
Dclre1b -1,03 -0,40 -1,43 1,21E-07 
Crkl NA NA -1,03 -0,15 -1,18 8,41E-08 
Cep72 NA NA -1,01 0,13 -0,88 2,34E-07 
Eif4b EIF4B Eif4b -1,01 0,17 -0,84 1,08E-06 
Zfp276 FANCA Zfp276 -0,99 -0,08 -1,07 2,55E-07 
Sfrs2 SFRS2 Sfrs2 -0,99 0,00 -0,99 1,44E-06 
Impdh2 IMPDH2 Impdh2 -0,99 -0,16 -1,15 7,16E-09 
Dnmt1 DNMT1 Dnmt1 -0,97 -0,22 -1,19 1,11E-08 
Ppil2 NA NA -0,95 0,18 -0,77 3,42E-07 
NA NA NA -0,94 0,22 -0,73 4,74E-07 
NA NA Prdx3 -0,93 -0,04 -0,97 8,56E-07 
Cks1b CKS1B RGD1561
797 
-0,93 0,27 -0,66 8,24E-08 
Gtl3 NA Gtl3 -0,93 0,16 -0,76 3,68E-08 
NA NA NA -0,92 -0,04 -0,96 1,21E-08 
Soat1 NA Soat1 -0,92 0,01 -0,90 2,37E-06 
Zfp207 ZNF207 Zfp207 -0,92 0,16 -0,75 2,66E-08 
Rnf4 RNF4 NA -0,92 0,15 -0,77 7,06E-08 
D9Mgi32 NOP56 Nop56 -0,91 -0,37 -1,29 3,44E-08 
466 
 
Hbxip HBXIP Hbxip -0,90 0,41 -0,50 5,06E-08 
NA NA Atp10a -0,90 0,01 -0,89 1,98E-07 
NA NA Odc1 -0,89 0,13 -0,76 6,95E-07 
Pnp2 NA Np -0,89 0,10 -0,79 2,88E-07 
A130006I
12Rik 
PDSS1 NA -0,89 -0,22 -1,11 7,50E-07 
NA CYB5R4 Cyb5r4 -0,88 -0,16 -1,04 3,04E-08 
NA NA NA -0,88 0,13 -0,74 9,58E-07 
1110005
A03Rik 
SFRS2 Sfrs2 -0,87 0,01 -0,86 1,27E-07 
NA SCD Scd1 -0,85 -0,11 -0,97 3,85E-09 
Rad52 NA Rad52 -0,85 -0,02 -0,87 3,81E-07 
NA NA NA -0,85 -0,07 -0,92 7,04E-08 
Csnk2a2 CSNK2A
2 
Csnk2a2 -0,84 -0,08 -0,93 1,35E-06 
NA NA NA -0,84 0,21 -0,63 6,07E-08 
Ptma PTMA NA -0,83 -0,14 -0,98 7,28E-08 
Gins2 NA Gins2 -0,81 0,08 -0,72 1,39E-08 
Gm9079 TMEM5 Tmem5 -0,80 0,12 -0,68 9,34E-08 
Pa2g4 PA2G4 Pa2g4 -0,80 -0,26 -1,06 4,85E-08 
Cnn3 CNN3 Cnn3 -0,80 -0,27 -1,06 3,07E-08 
Lpl LPL Lpl -0,79 -0,37 -1,16 3,77E-07 
Scd1 NA Scd1 -0,79 -0,15 -0,94 1,44E-07 
Gar1 GAR1 Gar1 -0,78 -0,07 -0,85 2,32E-07 
Racgap1 RACGAP
1 
Racgap1 -0,76 0,14 -0,62 3,15E-07 
Cdk1 CDK1 Cdc2 -0,75 -0,03 -0,79 3,56E-07 
2610028
A01Rik 
PINX1 Pinx1 -0,75 -0,06 -0,81 2,42E-07 
NA NA NA -0,74 -0,16 -0,91 4,25E-08 
NA BCL10 NA -0,74 0,02 -0,72 6,84E-08 
NA FAM120A NA -0,71 0,13 -0,58 1,41E-07 
NA NA NA -0,71 0,21 -0,50 2,42E-07 
NA NA NA -0,70 -0,13 -0,83 1,41E-07 
NA NA LOC2903
41 
-0,69 0,15 -0,54 7,87E-07 
Spin1 SPIN1 NA -0,69 -0,14 -0,83 1,01E-06 
Gars GARS Gars -0,69 -0,15 -0,84 2,91E-07 
Eif3d EIF3D Eif3d -0,68 -0,20 -0,89 8,43E-07 
Rpl26 RPL26 Rpl26 -0,68 0,07 -0,61 3,76E-07 
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Mat2a MAT2A NA -0,65 -0,29 -0,94 3,79E-08 
Mat2a MAT2A Mat2a -0,64 -0,24 -0,88 3,39E-07 
Eif3d EIF3D Eif3d -0,64 0,01 -0,63 1,73E-06 
LOC6770
86 
NA Pa2g4 -0,63 -0,18 -0,81 1,82E-07 
Ssrp1 NA Ssrp1 -0,62 -0,01 -0,63 8,05E-08 
Traf3ip1 NA NA -0,62 -0,04 -0,67 9,48E-07 
NA RPS26 Rps26 -0,60 0,06 -0,54 7,09E-07 
NA SLBP Slbp -0,59 -0,33 -0,92 2,62E-07 
NA NA Psat1 -0,59 -0,12 -0,71 2,56E-07 
Rbmxrt LOC1001
31735 
Rbmxrtl -0,57 -0,13 -0,70 2,28E-07 
NA NA NA -0,57 0,08 -0,49 5,00E-07 
Tmem15
6 
TMEM15
6 
NA -0,57 -0,16 -0,73 5,81E-07 
NA NA Psat1 -0,55 -0,16 -0,72 5,84E-07 
Shq1 NA Shq1 -0,55 -0,04 -0,59 9,67E-07 
Zfp207 ZNF207 Zfp207 -0,51 0,03 -0,48 1,40E-06 
Acsl5 ACSL5 Acsl5 -0,50 0,01 -0,49 2,52E-06 
 
468 
 
11.3 Appendix 3: List of up-regulated genes upon pm-7 treatment 
 
mouse human rat pm-7/pm-
neg 
pm-neg/ 
cells 
pm-
7/cells 
P.Value 
NA NA NA 3,65 0,13 3,77 1,22E-11 
NA NA NA 3,49 0,15 3,64 3,07E-10 
Ntn4 NTN4 NA 3,43 -0,03 3,39 8,13E-10 
Slc40a1 NA Slc40a1 3,20 -0,16 3,04 1,54E-08 
NA NA NA 3,11 0,91 4,02 5,77E-09 
Mmp12 MMP12 Mmp12 2,96 0,17 3,13 2,25E-08 
Ccdc67 NA Ccdc67 2,94 0,10 3,05 8,43E-09 
NA NA NA 2,86 -0,01 2,85 1,47E-08 
Tmprss
6 
NA NA 2,71 0,65 3,36 5,59E-07 
Tgfbr3 TGFBR3 NA 2,55 -1,53 1,02 1,26E-09 
Slc40a1 SLC40A
1 
Slc40a1 2,52 0,59 3,12 7,01E-09 
Armcx3 ARMCX
3 
Armcx3 2,35 -0,75 1,60 1,50E-11 
Ypel5 YPEL5 Ypel5 2,33 0,62 2,95 4,26E-10 
Ypel3 YPEL3 RGD156
4579 
2,25 0,44 2,69 3,77E-08 
6430548
M08Rik 
NA NA 2,16 0,75 2,91 4,50E-08 
2810407
C02Rik 
LOC100
133398 
Selt 2,15 -1,60 0,55 8,84E-11 
Vldlr VLDLR Vldlr 2,13 0,34 2,46 1,15E-07 
Hbp1 HBP1 Hbp1 2,07 -0,02 2,06 1,01E-06 
Ptprg PTPRG Ptprg 2,03 -0,09 1,94 1,34E-07 
Mx2 MX1 Mx2 1,99 0,27 2,26 4,77E-08 
Pde4dip PDE4DI
P 
Pde4dip 1,99 -0,32 1,67 2,02E-07 
Arhgef1
6 
NA LOC687
105 
1,96 0,66 2,63 1,95E-07 
NA COG5 Hbp1 1,95 0,05 2,00 1,95E-06 
NA NA NA 1,94 0,67 2,61 1,22E-09 
NA NA NA 1,93 0,18 2,11 2,47E-08 
NA SLC1A4 Slc1a4 1,91 0,24 2,15 4,08E-08 
Osgin1 NA Osgin1 1,91 0,87 2,78 8,60E-08 
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Mut MUT NA 1,90 -0,66 1,24 5,90E-08 
Synm NA Synm 1,88 0,03 1,91 6,39E-08 
Myo10 NA NA 1,88 0,28 2,15 2,27E-09 
Zpbp2 ZPBP2 Zpbp2 1,85 -0,28 1,57 1,23E-08 
Ctla2b NA Ctla2a 1,81 -0,42 1,39 3,60E-08 
NA NA NA 1,80 -0,44 1,36 7,25E-07 
C03004
3A13Rik 
TXNDC1
2 
Txndc1
2 
1,77 -1,05 0,72 5,64E-10 
Riok3 RIOK3 Riok3 1,75 0,03 1,78 3,51E-07 
Col4a3b
p 
COL4A3
BP 
Col4a3b
p 
1,73 -0,25 1,48 6,27E-08 
Ndfip2 NDFIP2 Ndfip2 1,71 -0,88 0,83 1,73E-09 
Nqo1 NQO1 NA 1,69 -0,12 1,57 2,58E-10 
Taok3 TAOK3 Taok3 1,69 -0,18 1,51 1,21E-07 
NA NA NA 1,69 -0,01 1,67 5,28E-10 
Fth1 BEST1 NA 1,67 0,19 1,86 9,13E-08 
1110003
E01Rik 
C4orf34 RGD131
1122 
1,65 0,01 1,66 2,28E-08 
NA NA NA 1,65 -0,08 1,57 5,26E-09 
NA NA NA 1,64 0,04 1,68 5,73E-07 
Tmem1
35 
TMEM1
35 
Tmem1
35 
1,64 0,23 1,87 5,44E-09 
Anxa3 ANXA3 Anxa3 1,64 -0,04 1,59 8,23E-07 
NA NA NA 1,60 -0,02 1,59 1,54E-06 
Ccdc93 CCDC93 Ccdc93 1,60 -0,31 1,30 3,01E-09 
Nt5c2 NT5C2 NA 1,59 -0,27 1,32 5,94E-10 
Vwa5a VWA5A Vwa5a 1,58 0,40 1,98 5,94E-10 
NA TCEAL4 NA 1,58 0,56 2,13 5,87E-07 
NA NA NA 1,57 0,52 2,09 6,52E-10 
Abcc5 ABCC5 Abcc5 1,57 0,04 1,61 6,72E-10 
Rab8b NA NA 1,56 -0,17 1,38 9,06E-07 
Rcan1 NA Rcan1 1,56 0,25 1,81 2,85E-09 
NA NA NA 1,56 -0,09 1,47 6,57E-07 
Nt5c2 NT5C2 NA 1,56 -0,22 1,34 1,89E-07 
NA NA NA 1,54 -0,10 1,44 4,76E-07 
Rit1 RIT1 Rit1 1,54 0,25 1,79 7,22E-09 
Rufy3 NA NA 1,53 -0,31 1,22 8,51E-07 
Gmpr2 GMPR2 Gmpr2 1,53 -0,61 0,91 1,23E-09 
NA NA NA 1,52 -0,33 1,20 9,29E-07 
2210403 NA NA 1,52 0,11 1,63 7,02E-07 
470 
 
K04Rik 
Zfp455 ZNF99 Zfp455 1,52 0,00 1,52 2,77E-06 
Sqrdl NA Sqrdl 1,51 0,15 1,65 1,31E-08 
Dusp3 NA Dusp3 1,48 1,04 2,52 4,79E-08 
Adam23 ADAM2
3 
Adam23 1,46 0,18 1,65 2,86E-08 
Hsdl2 HSDL2 Hsdl2 1,45 -0,38 1,07 5,47E-07 
Dusp16 NA Dusp16 1,42 0,01 1,43 7,39E-07 
Sri SRI LOC683
667 
1,42 -0,28 1,14 9,95E-09 
Clu NA Clu 1,41 -0,02 1,40 6,73E-08 
Ndrg3 NDRG3 Ndrg3 1,41 -0,04 1,37 3,87E-07 
Clic4 CLIC4 Clic4 1,39 0,02 1,41 7,22E-07 
Nit1 NIT1 Nit1 1,39 -0,22 1,17 8,67E-07 
1110003
E01Rik 
NA NA 1,39 0,16 1,55 1,19E-08 
Nit1 NIT1 Nit1 1,39 -0,08 1,30 5,62E-07 
NA NA NA 1,38 0,66 2,03 9,85E-09 
Ccnd2 NA NA 1,37 0,16 1,53 2,83E-08 
Ptpdc1 NA NA 1,36 0,34 1,70 1,01E-09 
Irf9 IRF9 Irf9 1,36 0,35 1,71 1,61E-07 
Taok3 TAOK3 Taok3 1,35 -0,25 1,11 3,79E-08 
NA OSTM1 NA 1,35 -0,56 0,79 1,13E-07 
Appl2 APPL2 Appl2 1,34 0,03 1,38 6,72E-07 
Rab4a NA Rab4a 1,34 0,09 1,43 3,46E-07 
Car5b CA5B Car5b 1,32 0,37 1,69 9,68E-07 
Xdh NA Xdh 1,32 0,59 1,91 1,81E-07 
Fundc1 FUNDC
1 
Fundc1 1,31 0,04 1,35 5,74E-09 
Pdyn NA NA 1,30 0,40 1,70 1,22E-09 
Gpnmb NA Gpnmb 1,29 0,38 1,68 2,24E-07 
Glcci1 GLCCI1 RGD156
3612 
1,29 -0,29 1,00 4,93E-07 
Lpin1 LPIN1 NA 1,29 0,03 1,32 4,69E-07 
Gyg NA Gyg1 1,29 0,00 1,28 1,52E-08 
Fbxl4 FBXL4 Fbxl4 1,28 0,32 1,61 1,05E-06 
Ahnak2 NA NA 1,28 0,48 1,75 3,17E-08 
Acaa2 ACAA2 Acaa2 1,28 -0,68 0,60 1,17E-09 
NA NA Tes 1,28 0,12 1,40 1,04E-06 
Nova1 NOVA1 Nova1 1,28 -0,31 0,97 4,89E-08 
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Kpna1 KPNA1 Kpna1 1,27 -0,16 1,11 3,92E-07 
Rcan1 NA Rcan1 1,24 0,32 1,57 5,95E-08 
Zpbp2 ZPBP2 Zpbp2 1,23 -0,62 0,61 2,50E-08 
Plcd3 NA Plcd3 1,21 0,27 1,49 8,58E-07 
Il18bp IL18BP Il18bp 1,21 -0,13 1,08 1,03E-06 
Chmp2b CHMP2
B 
NA 1,20 0,24 1,44 1,68E-08 
NA NA NA 1,19 0,36 1,55 9,37E-07 
NA NA NA 1,19 0,42 1,62 1,87E-08 
Ap2b1 AP2B1 NA 1,19 0,04 1,23 5,50E-07 
NA NA NA 1,19 0,32 1,51 2,01E-08 
NA NA Abcc3 1,18 0,37 1,54 8,25E-08 
Sh3glb1 SH3GL
B1 
Sh3glb1 1,17 -0,29 0,88 5,59E-09 
Zfand2a NA NA 1,17 0,17 1,33 1,49E-06 
Aig1 NA NA 1,15 0,20 1,34 1,47E-07 
NA NA NA 1,14 0,51 1,65 5,07E-08 
2210013
O21Rik 
LOC550
643 
NA 1,14 0,45 1,58 1,59E-07 
Lgmn LGMN Lgmn 1,14 0,26 1,40 3,37E-09 
Ptgr1 PTGR1 Ptgr1 1,13 0,05 1,18 4,89E-07 
NA NA NA 1,13 0,14 1,27 8,04E-09 
Ppcs NA NA 1,12 0,23 1,35 4,61E-07 
Anxa7 ANXA7 Anxa7 1,12 0,12 1,24 3,06E-07 
Scarb2 SCARB
2 
Scarb2 1,11 0,04 1,16 6,74E-07 
Gbas GBAS NA 1,10 -0,18 0,93 3,75E-07 
Akt3 AKT3 NA 1,10 0,40 1,50 6,15E-10 
Smcr8 NA NA 1,10 -0,14 0,95 7,32E-09 
NA RECK Reck 1,09 -0,19 0,90 8,35E-08 
NA NA NA 1,08 0,67 1,75 7,09E-08 
Btbd1 BTBD1 Btbd1 1,07 -0,04 1,04 1,29E-06 
NA NA NA 1,07 0,13 1,20 7,04E-09 
Wdr26 WDR26 Wdr26 1,07 0,07 1,14 1,51E-08 
Usp13 USP13 Usp13 1,04 0,19 1,23 2,34E-08 
Lactb2 LACTB2 Lactb2 1,03 0,18 1,21 6,59E-09 
Rab7 NA Rab7a 1,03 0,09 1,12 8,09E-09 
Elmo1 ELMO1 Elmo1 1,03 -0,04 0,99 5,20E-07 
Hars HARS Hars 1,02 -0,13 0,88 4,42E-09 
Sdf2 SDF2 Sdf2 1,01 0,24 1,25 1,25E-07 
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Galk2 GALK2 Galk2 1,01 0,17 1,19 1,15E-07 
NA NA NA 1,01 0,33 1,34 5,35E-07 
Clu NA Clu 1,01 0,33 1,34 1,24E-09 
NA INPP4A Inpp4a 1,01 0,24 1,25 2,33E-08 
Pex12 NA Pex12 1,00 0,13 1,13 7,65E-07 
NA NA NA 0,99 0,19 1,18 1,07E-07 
Tmeff2 TMEFF2 Tmeff2 0,98 0,10 1,08 9,71E-07 
Ube2w LOC729
696 
NA 0,98 -0,02 0,96 8,22E-08 
Nhlrc3 NA NA 0,98 0,16 1,14 1,46E-07 
NA LOC732
229 
Zfand5 0,98 0,13 1,11 2,27E-08 
Cyp2j13 CYP2J2 Cyp2j13 0,97 0,22 1,19 6,44E-07 
Gypc NA Gypc 0,97 0,36 1,33 2,28E-08 
Rnase4 NA Rnase4 0,97 0,64 1,61 2,34E-08 
Prdm2 NA Prdm2 0,95 0,16 1,11 8,45E-07 
Yipf4 YIPF4 Yipf4 0,94 -0,12 0,82 1,26E-06 
Nit2 NA NA 0,93 -0,15 0,78 1,23E-06 
Ppip5k1 PPIP5K
1 
Hisppd2
a 
0,93 0,14 1,07 2,77E-07 
Rnf19a RNF19A Rnf19a 0,92 -0,17 0,75 5,77E-07 
Ptgr1 PTGR1 Ptgr1 0,91 0,08 0,99 1,94E-06 
Gm1065
2 
RWDD3 Rwdd3 0,90 0,15 1,05 8,14E-07 
Cd109 CD109 NA 0,90 0,11 1,01 8,39E-07 
Sccpdh SCCPD
H 
Sccpdh 0,89 0,11 0,99 4,56E-07 
Tmed10 TMED10 Tmed10 0,88 -0,10 0,78 4,42E-08 
Fgf18 NA Fgf18 0,87 0,41 1,28 1,70E-07 
Psmd11 PSMD11 Psmd11 0,87 -0,12 0,75 8,40E-07 
Rab7 NA Rab7a 0,86 0,20 1,06 3,15E-08 
Minpp1 NA NA 0,85 -0,02 0,83 1,89E-06 
Fundc1 NA Fundc1 0,85 0,21 1,05 1,45E-07 
Dusp16 DUSP16 NA 0,85 0,31 1,16 6,44E-08 
Pacsin2 PACSIN
2 
Pacsin2 0,84 0,01 0,85 5,69E-07 
Pcnx PCNX Pcnx 0,84 0,21 1,05 3,62E-08 
Bdnf BDNF Bdnf 0,82 -0,01 0,81 3,06E-07 
Scpep1 NA Scpep1 0,80 0,25 1,06 8,64E-07 
NA NA NA 0,80 0,29 1,09 9,15E-08 
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Ugt1a1 NA NA 0,80 -0,01 0,80 2,77E-07 
NA NA NA 0,80 0,01 0,81 2,50E-06 
Plekhb2 NA Plekhb2 0,80 0,36 1,16 7,60E-08 
Nras NRAS Nras 0,80 -0,11 0,68 1,25E-06 
NA NA NA 0,80 0,08 0,87 2,53E-07 
Prdxdd1 PRDXD
D1P 
Ncrna00
117 
0,79 0,09 0,89 4,15E-07 
NA TMEM6
6 
Tmem6
6 
0,79 0,16 0,95 3,39E-07 
Rab11a RAB11A Rab11a 0,78 0,08 0,86 7,48E-08 
Cox16 NA Cox16 0,78 -0,01 0,77 1,39E-06 
Map1lc3
b 
NA NA 0,78 0,36 1,14 9,22E-08 
Ddx59 DDX59 Ddx59 0,78 -0,07 0,71 1,27E-06 
Dhrs7 DHRS7 NA 0,77 0,16 0,93 1,22E-06 
Usp4 NA Usp4 0,76 0,22 0,99 2,48E-07 
Sod1 SOD1 Sod1 0,76 0,14 0,90 9,80E-09 
App APP App 0,76 0,08 0,84 1,67E-07 
Dennd5
a 
DENND
5A 
Dennd5
a 
0,75 0,44 1,19 2,24E-07 
Dctn5 DCTN5 Dctn5 0,75 0,10 0,85 1,31E-07 
Gne GNE Gne 0,75 0,14 0,89 1,18E-06 
4930535
I16Rik 
NA NA 0,74 0,23 0,98 6,78E-07 
Clu NA Clu 0,74 0,24 0,98 4,42E-07 
Mark1 MARK1 Mark1 0,74 0,15 0,89 1,27E-07 
NA VAPA Vapa 0,71 -0,10 0,61 1,53E-07 
NA NA NA 0,71 0,28 0,99 6,60E-08 
Arl6ip5 ARL6IP
5 
Arl6ip5 0,70 0,22 0,92 1,40E-08 
Psap NA Psap 0,69 0,44 1,14 4,39E-08 
LOC100
233175 
NA LOC100
233176 
0,68 0,12 0,80 1,34E-06 
Mgst1 NA NA 0,67 0,10 0,77 6,93E-08 
LOC100
043810 
NA Rin2 0,67 0,20 0,87 2,98E-07 
Pts PTS Pts 0,66 -0,07 0,59 1,99E-06 
NA NA NA 0,64 -0,04 0,60 1,20E-06 
8430410
K20Rik 
KIAA18
26 
MGC105
560 
0,64 0,23 0,87 7,04E-07 
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Itgb1bp
1 
ITGB1B
P1 
Itgb1bp
1 
0,62 0,08 0,71 1,36E-07 
Cetn3 CETN3 Cetn3 0,62 -0,01 0,61 2,72E-06 
NA NA NA 0,62 0,05 0,67 2,06E-07 
Tmed4 TMED4 Tmed4 0,60 0,04 0,64 1,48E-06 
Tmem5
0a 
TMEM5
0A 
Tmem5
0a 
0,59 0,15 0,75 1,43E-07 
Ghitm GHITM Ghitm 0,59 0,09 0,68 1,81E-07 
Parl PARL Parl 0,59 0,03 0,62 7,59E-07 
Mbtps1 MBTPS
1 
Mbtps1 0,59 -0,04 0,55 9,35E-07 
App APP App 0,59 0,27 0,86 1,89E-08 
Lactb2 LACTB2 Lactb2 0,58 0,37 0,95 1,05E-07 
Leprot LEPRO
T 
Leprot 0,57 0,46 1,04 3,87E-08 
Ctps2 CTPS2 Ctps2 0,57 0,14 0,71 5,07E-07 
Mgst1 MGST1 Mgst1 0,57 0,10 0,66 4,59E-07 
Gclm GCLM Gclm 0,56 0,03 0,59 4,76E-07 
Tsc22d1 TSC22D
1 
Tsc22d1 0,56 0,03 0,59 7,83E-07 
Gpbp1l1 GPBP1L
1 
NA 0,53 0,05 0,58 1,28E-06 
Gla GLA Gla 0,51 0,46 0,97 4,02E-08 
Degs1 DEGS1 Degs1 0,50 0,05 0,55 6,70E-07 
AF0857
38 
NA Gnas 0,47 0,14 0,61 2,21E-07 
Pdia6 PDIA6 Pdia6 0,46 0,06 0,52 7,92E-07 
Ostf1 OSTF1 NA 0,41 0,34 0,75 8,05E-08 
 
 
